Datasets:

as-cle-bert

/

genetics-arxiv-wiki

like 1

Amelogenins are a group of protein isoforms produced by alternative splicing or proteolysis from the AMELX gene, on the X chromosome, and also the AMELY gene in males, on the Y chromosome. They are involved in amelogenesis, the development of enamel. Amelogenins are type of extracellular matrix protein, which, together with ameloblastins, enamelins and tuftelins, direct the mineralization of enamel to form a highly organized matrix of rods, interrod crystal and proteins. Although the precise role of amelogenin(s) in regulating the mineralization process is unknown, it is known that amelogenins are abundant during amelogenesis. Developing human enamel contains about 70% protein, 90% of which are amelogenins. Function Amelogenins are believed to be involved in the organizing of enamel rods during tooth development. The latest research indicates that these proteins regulate the initiation and growth of hydroxyapatite crystals during the mineralization of enamel. In addition, amelogenins appear to aid in the development of cementum by directing cementoblasts to the tooth's root surface. Variants The amelogenin gene has been most widely studied in humans, where it is a single copy gene, located on the X and Y chromosomes at Xp22.1–Xp22.3 and Yp 11.2 [5]. The amelogenin gene's location on sex chromosomes has implications for variability both between the X chromosome form (AMELX) and the Y chromosome form (AMELY), and between alleles of AMELY among different populations. This is because AMELY exists in the non-recombining region of chromosome Y, effectively isolating it from normal selection pressures. Other sources of amelogenin variation arise from the various isoforms of AMELX obtained from alternative splicing of mRNA transcripts. Specific roles for isoforms have yet to be established. Among other organisms, amelogenin is well conserved among eutherians, and has homologs in monotremes, reptiles and amphibians. Application in sex determination Differences between the X chromosome and Y chromosome versions of the amelogenin gene (AMELX and AMELY respectively) enable it to be used in sex determination of unknown human samples. AMELX’s intron 1 contains a 6-base-pair deletion relative to intron 1 of AMELY. This can be detected at low cost using polymerase chain reaction (PCR) of intron 1, followed by gel electrophoresis. Two bands of DNA, at 555 bps and 371 bps, are resolved if both the AMELX and AMELY versions of the gene are present (i.e. the sample is from a male) or one band of DNA, at 555 bps, if the AMELX version only is present (i.e. the sample is from a female).However, because of AMELY variation among individuals and populations, this method of sex determination is not 100% accurate. Mutation in regions of AMELY intron 1 commonly used as primer annealing sites may disable PCR amplification. A 6bp insertion to AMELY intron 1 results in an amplicon identical in length to that of AMELX. In some males AMELY may be deleted entirely. In any of these cases only one band is visualized during gel electrophoresis of PCR products, causing misidentification of the sample as female. The misidentification rate may vary among populations, but in general appears to be low. In one study in Spain, the amelogenin sex determination test using AMELX (977bps) and AMELY (790bps) bands was performed for 1224 individuals of known gender with a 99.84% (1222/1224) accuracy rate. Another study in India, however, found 5 of its 270 men studied (1.85%) possessed an AMELY deletion, terming them "deleted-amelogenin males" (DAMs). In response the authors suggested that while the amelogenin sex test may be accurate in general, other Y chromosome markers such as SRY, STR, or 50f2 can be used for less ambiguous gender identification. Clinical significance Mutations in AMELX can cause amelogenesis imperfecta, a disorder of tooth enamel development. == References ==

Amely was an American rock band from Orlando, Florida, United States, formed in 2008. The band comprised four members; Petie Pizarro (Vocals/Guitar), Brandon Walden (Guitar), Patrick Ridgen (Bass) and Nate Parsell (Drums). The sound of the band was a mix of rock with power pop elements. Having been a band for a short period of time, Amely managed to be signed to an independent record label, for this genre of music, Fearless Records. History Amely did not start out as a fully formed band. It started in 2008 with a studio project for the singer and rhythm guitarist Petie Pizarro (24 years old), who was moving forward as a soloist after the breakup of his previous band. He began writing songs that he would afterwards choose from, for the recording of an EP. Later on, he dubbed "On My Own," at Vision Sound Studios Vision Sound Studios in Jacksonville, Florida with producer Daryl Phennager (Red Jumpsuit Apparatus). Even though Pizarro played most of the instruments on the recording, including guitar, bass, piano and synths, he brought Nate Parsell in to record some complicated drum parts, since they had previously been together in a band. Upon the completion of this EP, in June 2008, Pizarro and Parsell realized they had something worth further exploring musically and agreed to form a band. Bassist, Patrick Ridgen, was soon found and lead guitarist, Brandon Walden, joined them a little later and so Amely was formed. Parsell started as a drummer in the basement of his old house in rural Ohio. He studied percussion privately throughout his high school career, while also playing in marching band, concert band, jazz ensemble, pep band, and pit orchestra for four years, as well as a handful of fruitless "rock bands." He then studied in a music conservatory and earned a degree in recording arts and music business from Full Sail University. Some of his early influences were John Bonham and Charlie Watts along with some more modern influences such as Dave Grohl, Travis Barker, Carter Beauford, and Zac Farro from Paramore. Touring, unsigned A blend of rock combined with a dose of power pop influences, Amely started making their mark on the music scene, despite only having been formed after Petie Pizarro's project/EP, for a year. Since playing their first show in March 2009, Amely had completed three national tours, opened for All Time Low, played at the Unsilent Night Festival, with A Day to Remember, Red Jumpsuit Apparatus and Breathe Carolina, and performed on the Kevin Says Stage at the Florida dates of Vans Warped Tour 2009. The band had such a success, that they played in American Samoa in the South Pacific, in front of 5000 people, for Blue Sky's 10 Year Bash. Regarding the geared used in their live shows, the drummer, Parsell, used a four-piece Tama Starclassic Birch kit: 10×12 rack, 16×16 floor, and 18×22 kick—one of the best-sounding kick drums out there, according to him. Also, he's been using Zildjian cymbals, a 24″ K Light ride, a 21″ Brilliant Sweet ride (as a left-side crash), a 20″ A Custom Projection crash, and 14″ A Custom Mastersound hats. In addition to their touring, the band reached nearly a million plays on their MySpace page and was named one of PureVolume's Top 20 Unsigned bands of 2009. Recording After touring, and their success, they caught a major recording label's eye. Although they had only been formed as a band for less than a year, in January 2010, Amely was signed by Fearless Records. After being signed, the band headed immediately into the studio with Zack Odem, Kenneth Mount (All Time Low, Mayday Parade), and Mike Green (Paramore, Breathe Carolina) to record their debut EP Hello World, which was released on May 25, 2010. The EP consisted of eight catchy tracks that introduced the band's melodic, pop rock-influenced sound. At this point, lead singer Pizzaro, compared their music to pop-rock bands such as The All American Rejects and Jimmy Eat World and wanted his band to have mass appeal without any age range, gender, or mindset restrictions. "We want to be a mature pop/rock band with a sound that kids can get into, but adults will also enjoy," Pizarro notes. Apart from their EP, the first holiday-themed compilation album series created by Fearless Records called 'Tis the Season to Be Fearless featuring eight Christmas-themed songs was released on November 22, 2010, including Amely's cover of the song "It's Christmas Time Again" originally by Backstreet Boys. The band has also covered the famous song "The Climb" by Miley Cyrus. The song was originally in the soundtrack of the Walt Disney Pictures's movie Hannah Montana and the album was released by Walt Disney Records, but the purpose of the band recording it was to be in the Fearless Records compilation album Punk Goes Pop 3. However, their cover was not on the album and, instead, one their original songs ("Come Back to Me") was included on the bonus CD of Punk Goes Pop 3. Apart from recording, the band went on "Let's Be Animals Tour" with The Downtown Fiction, He Is We and Cady Groves in spring 2011. Break-up On November 1, 2011 Amely announced via webchat that they would be breaking up. In addition, before the official break up, the band announced the release of another EP titled Raleigh Sessions, which was self recorded, produced, and mixed. The entire process from start to finish was created by the band alone in Raleigh, North Carolina. The EP was released on November 21, 2011. However, it was released only in a digital form and can be found on iTunes and Spotify. Despite the sad news for the fans, Pizarro, Parsell and Ridgen also announced that they will be forming a new band called Sovereign Soldiers, and Walden would be moving forward as a solo artist. The band's announcement stated: This decision did not come lightly and was the effect of a great number of things that seemed beyond our control. It has been a more than amazing journey with our best friends and this destination we've now reached is not an end, it is a new beginning. Although we have been extremely discouraged by the discourse that fell upon us, we have not let it knock us down and we hope that you can stay strong with all of us. Since the start of this year and even before that we have been writing for what we intended to be our first full-length album. As the chance to professionally produce our music appeared to grow further in distance we took it upon ourselves to record the songs that we had poured our hearts into. After combining the diverse and plenty skills of all 4 of us, these home recordings are all that's left of Amely. We believe this is some of our greatest work and we want to be able to share it with you. Though it may come as a parting gift, we hope this collection of songs finds you well. It may be the remains of Amely, but we hope it reminds you, this is not the end. Band members Petie Pizarro - Lead Vocalist/Rhythm Guitarist Brandon Walden – Lead Guitarist Patrick Ridgen - Bassist Nate Parsell - Drummer Jason Seife Guitarist Discography The Raleigh Sessions (2011) Live Under Lights (Live) EP (2011) 'Tis The Season To Be Fearless (2010) Hello World (2010) Amely EP (2009) References External links "Amely | Listen and Stream Free Music, Albums, New Releases, Photos, Videos". Myspace. "Amely". Facebook.com. "Amely". YouTube. "Page Title". Nomadnarrative.com. "Petie Pizarro Music". YouTube. "TheRecoveryFL". YouTube. "Fearless Records | Join The Fearless Family". Fearless Records. "Fearless Records". YouTube. "SovereignSoldiers". YouTube.

Aniridia is the absence of the iris, a muscular structure that opens and closes the pupil to allow light into the eye. It is also responsible for eye color. Without it, the central eye appears all black. It can be congenital, in which both eyes are usually involved, or caused by a penetrant injury. Isolated aniridia is a congenital disorder that is not limited to a defect in iris development, but is a panocular condition with macular and optic nerve hypoplasia, cataract, and corneal changes. Vision may be severely compromised and the disorder is frequently associated with some ocular complications: nystagmus, amblyopia, buphthalmos, and cataract. Aniridia in some individuals occurs as part of a syndrome, such as WAGR syndrome (kidney nephroblastoma (Wilms tumour), genitourinary anomalies and intellectual disability), or Gillespie syndrome (cerebellar ataxia). PAX6 The AN2 region of the short arm of chromosome 11 (11p13) includes the PAX6 gene (named for its PAired boX status), whose gene product helps regulate a cascade of other genetic processes involved in the development of the eye (as well as other non-ocular structures). This PAX6 gene is around 95% similar to the pax gene found in zebrafish, a creature whose ancestors diverged from human evolutionary development around 400 million years ago. Thus the PAX6 gene is highly conserved across evolutionary lineages. Defects in the PAX6 gene cause aniridia-like ocular defects in mice (as well as Drosophila). Aniridia is a heterozygous disorder, meaning that only one of the two chromosome 11 copies is affected. When both copies are altered (homozygous condition), the result is a uniformly fatal condition with near complete failure of entire eye formation. In 2001, two cases of homozygous aniridia patients were reported; the fetuses died prior to birth and had severe brain damage. In mice, homozygous small eye defect (mouse Pax-6) leads to loss of the eyes and nose and the murine fetuses sustain severe brain damage. Types Aniridia may be broadly divided into hereditary and sporadic forms. Hereditary aniridia is usually transmitted in an autosomal dominant manner (each offspring has a 50% chance of being affected), although rare autosomal recessive forms (such as Gillespie syndrome) have also been reported. Sporadic aniridia mutations may affect the WT1 region adjacent to the AN2 aniridia region, causing a kidney cancer called nephroblastoma (Wilms tumor). These patients often also have genitourinary abnormalities and intellectual disability (WAGR syndrome). Several different mutations may affect the PAX6 gene. Some mutations appear to inhibit gene function more than others, with subsequent variability in the severity of the disease. Thus, some aniridic individuals are only missing a relatively small amount of iris, do not have foveal hypoplasia, and retain relatively normal vision. Presumably, the genetic defect in these individuals causes less "heterozygous insufficiency," meaning they retain enough gene function to yield a milder phenotype. Online Mendelian Inheritance in Man (OMIM): 106210 AN Online Mendelian Inheritance in Man (OMIM): 106220 Aniridia and absent patella Online Mendelian Inheritance in Man (OMIM): 106230 Aniridia, microcornea, and spontaneously reabsorbed cataract Online Mendelian Inheritance in Man (OMIM): 206700 Aniridia, cerebellar ataxia, and mental deficiency (Gillespie syndrome) Mutational analysis Molecular (DNA) testing for PAX6 gene mutations (by sequencing of the entire coding region and deletion/duplication analysis) is available for isolated aniridia and the Gillespie syndrome. For the WAGR syndrome, high-resolution cytogenetic analysis and fluorescence in situ hybridization (FISH) can be utilized to identify deletions within chromosome band 11p13, where both the PAX6 and WT1 genes are located. Symptoms Aniridia can cause many symptoms, such as: Poor vision (not always present) More sensitivity to light Fast, uncontrolled, shaking "to and from" eye movements (nystagmus) Eyes don't line up (strabismus) Treatment In May 2018, the U.S. Food and Drug Administration approved the CustomFlex Artificial Iris, the first synthetic iris for use in adults and children with congenital aniridia or iris defects related to other conditions, such as albinism, traumatic injury, or surgical removal due to ocular melanoma. The artificial iris is a surgically implanted device made of thin, foldable, medical-grade silicone and is custom-sized and colored for each individual patient. The prosthetic iris is held in place by the anatomical structures of the eye or, if needed, by sutures. See also WAGR syndrome Scleral lenses References External links GeneReviews/NCBI/NIH/UW entry on Aniridia NCBI/Molecular diagnosis of aniridia OMIM entries on Aniridia GeneReviews/NIH/NCBI/UW entry on Wilms Tumor Overview

The antagonistic pleiotropy hypothesis was first proposed by George C. Williams in 1957 as an evolutionary explanation for senescence. Pleiotropy is the phenomenon where one gene controls more than one phenotypic trait in an organism. A gene is considered to possess antagonistic pleiotropy if it controls more than one trait, where at least one of these traits is beneficial to the organism's fitness early on in life and at least one is detrimental to the organism's fitness later on due to a decline in the force of natural selection. The theme of G. C. William's idea about antagonistic pleiotropy was that if a gene caused both increased reproduction in early life and aging in later life, then senescence would be adaptive in evolution. For example, one study suggests that since follicular depletion in human females causes both more regular cycles in early life and loss of fertility later in life through menopause, it can be selected for by having its early benefits outweigh its late costs. As a constraint on perfection Antagonistic pleiotropy is one of the several reasons evolutionary biologists give for organisms never being able to reach perfection through natural selection. Antagonistically pleiotropic genes are the explanation for fitness trade-offs. This means that genes that are pleiotropic control for some beneficial traits and some detrimental traits; thus, if they happen to persist through natural selection, this will prevent organisms from reaching perfection because if they possess the benefits of the gene, they must also possess the imperfections or faults. An example of this would be female rodents that live in a nest with other females and may end up feeding young that are not theirs due to their intense parental drive. This strong parental drive will be selected for, but the organisms will still make the mistake of feeding young that are not theirs and misallocating their resources. Benefits and costs Antagonistic pleiotropy has several negative consequences. It results in delayed adaptation, an altered path of evolution, and reduced adaptation of other traits. In addition, the overall benefit of alleles is cut down significantly (by about half) by pleiotropy. Still, antagonistic pleiotropy has some evolutionary benefits. In fact, the conservation of genes is directly related to the pleiotropic character of an organism. This implies that genes that control for multiple traits, even if the traits have different implications for the organism's fitness, have more staying power in an evolutionary context. Role in sexual selection It is generally accepted that the evolution of secondary sexual characteristics persists until the relative costs of survival outweigh the benefits of reproductive success. At the level of genes, this means a trade-off between variation and expression of selected traits. Strong, persistent sexual selection should result in decreased genetic variation for these traits. However, higher levels of variation have been reported in sexually-selected traits compared to non-sexually selected traits. This phenomenon is especially clear in lek species, where males' courtship behavior confers no immediate advantage to the female. Female choice presumably depends on correlating male displays (secondary sexual characteristics) with overall genetic quality. If such directional sexual selection depletes variation in males, why would female choice continue to exist? Rowe and Houle answer this question (the lek paradox) using the notion of genetic capture, which couples the sexually-selected traits with the overall condition of the organism. They posit that the genes for secondary sexual characteristics must be pleiotropically linked to condition, a measure of the organism's fitness. In other words, the genetic variation in secondary sexual characteristics is maintained due to variation in the organism's condition. Role in disease The survival of many serious genetic disorders in our long evolutionary history has led researchers to reassess the role of antagonistic pleiotropy in disease. If genetic disorders are defined by the existence of deleterious alleles, then natural selection acting over evolutionary time would result in a lower frequency of mutations than are currently observed. In a recent article, Carter and Nguyen identify several genetic disorders, arguing that far from being a rare phenomenon, antagonistic pleiotropy might be a fundamental mechanism for the survival of these non-optimal alleles. In one of these studies, 99 individuals with Laron syndrome (a rare form of dwarfism) were monitored alongside their non-dwarf kin for a period of ten years. Patients with Laron syndrome possess one of three genotypes for the growth hormone receptor gene (GHR). Most patients have an A->G splice site mutation in position 180 in exon 6. Some others possess a nonsense mutation (R43X), while the rest are heterozygous for the two mutations. Laron syndrome patients experienced a lower incidence of cancer mortality and diabetes compared to their non-dwarf kin. This suggests a role for antagonistic pleiotropy, whereby a deleterious mutation is preserved in a population because it still confers some survival benefit. Another instance of antagonistic pleiotropy is manifested in Huntington's disease, a rare neurodegenerative disorder characterized by a high number of CAG repeats within the Huntingtin gene. The onset of Huntington's is usually observed post-reproductive age and generally involves involuntary muscle spasms, cognitive difficulties and psychiatric problems. Incidentally, the high number of CAG repeats is associated with increased activity of p53, a tumor suppressing protein that participates in apoptosis. It has been hypothesized that this explains the lower rates of cancer among Huntington's patients. Huntington's disease is also correlated with high fecundity.Additionally, it was found that individuals with a higher pro-inflammatory ratio TNFα/IL-10 had a significantly higher incidence of death due to cardiovascular disease in old age. Yet, it was hypothesized that this genotype was prevalent because higher ratios of TNFα/IL-10 allow individuals to more effectively combat infection during reproductive years.Sickle cell anemia, Beta-thalassemia, and cystic fibrosis are some other examples of the role antagonistic pleiotropy may play in genetic disorders. Ubiquity Although there are so many negative effects related to genes that are antagonistically pleiotropic, it is still present among most forms of life. Indeed, pleiotropy is one of the most common traits possessed by genes overall. In addition to that, pleiotropy is under strong stabilizing selection. In one experiment with mice and the morphology of the mandible, 1/5 of the loci had effects of pleiotropy for the entire mandible. One other example was in the Russian biologist Dmitry K. Belyaev's study on the domestication of the fox. In Dmitry K. Belyaev's farm-fox experiment, wild foxes were bred for docile behavior alone. After 40 generations, other physiological changes had surfaced including shortened tails, floppy ears, a white star in the forehead, rolled tails, shorter legs. Since the only thing being selected for was behavior, this leads scientists to believe that these secondary characteristics were controlled by the same gene or genes as docile behavior. Adaptivity and senescence An antagonistically pleiotropic gene can be selected for if it has beneficial effects in early life while having its negative effects in later life because genes tend to have larger impacts on fitness in an organism's prime than in their old age. An example of this is testosterone levels in male humans. Higher levels of this hormone lead to increased fitness in early life, while causing decreased fitness in later life due to a higher risk for prostate cancer. This is an example of antagonistic pleiotropy being an explanation for senescence. Senescence is the act of ageing in individuals; it's the failure over time of the individual's life processes by natural causes. Williams's theory has been the motivation for many of the experimental studies on the reasons for aging in the last 25 years. However, there is more than one theory out there for aging. The competing model to explain senescence is Medawar's "mutation accumulation" hypothesis, saying that "over evolutionary time, late-acting mutations will accumulate at a much faster rate than early-acting mutation. These late-acting mutations will thus lead to declining viability and/or fertility as an organism ages." Medawar's theory is based around the older concept of selection shadow that had been discussed throughout the early 1900s and led to Medawar's theory after discussions with J. B. S. Haldane in the 1940s. Potential Examples DNA repair DNA Damage Theory of Aging A prominent explanation for aging at the molecular level is the DNA damage theory of aging. It has been proposed that genetic elements that regulate DNA repair in somatic cells may constitute an important example of age-dependent pleiotropic "genes". As pointed out by Vijg, genome repair and maintenance is beneficial early in life by swiftly eliminating DNA damage or damaged cells. However, studies of DNA repair in the brain and in muscle indicate that the transition from mitotic cell division to the post-mitotic condition that occurs early in life is accompanied by a reduction in DNA repair. The reduced expression of DNA repair is presumably part of an evolutionary adaptation for diverting the resources of the cell that were previously used for DNA repair, as well as for replication and cell division, to more essential neuronal and muscular functions.The harmful effect of this genetically controlled reduction in expression is to allow increased accumulation of DNA damage. Reduced DNA repair causes increased impairment of transcription and progressive loss of cell and tissue function. However, these harmful effects of DNA damage are cumulative and most severe in chronologically older individuals whose numbers diminish with time (by causes of death that can be independent of senescence). As a consequence, the beneficial effects of the genetic elements that control the reduction of DNA repair early in life would predominate. Thus regulatory genetic elements that reduce expression of DNA repair genes in post-mitotic cells appear to be important examples of the postulated pleiotropic "genes" that are beneficial in youth but deleterious at an older age. Telomere Theory Another example related to aging is the Telomere theory. Telomere theory proposes that telomeres shorten with repeated cell division which attribute to cell senescence and tissue damage. The end replication problem explains the mechanism behind the inability of DNA polymerase to commence the RNA primer to perform its function in completing the lagging strand due to the shortening of DNA. Telomere shortening is common in somatic cells. However, germ line and stem cells prevent the end replication problem with the help of telomerase. Telomerase elongates the 3’ end that is then formed into a t-loop to prevent the cell from entering the G0 phase and cell senescence.Inflammation and damage to tissue are the underlying problems due to increased senescent cells. In several studies shortened telomeres have been associated with age related sarcopenia, atherosclerotic cardiovascular disease, and cancer. However, there is still the question whether telomere length causes these diseases or if the diseases cause shortened telomeres. Hence, the shortening of telomeres complies with antagonistic pleiotropy theory. The trade-off exists as the cell benefits from telomerase which prevents permanent growth arrest but telomere shortening is associated with functional loss. Free Radical Theory Another example related to aging is the Free Radical theory. Free Radical Theory suggests that the free radicals, which are being produced by aerobic respiration, are causing oxidative stress to be put on the body. This oxidative stress will result in aging and lead to death. Oxygen centered radicals are very reactive and can cause the accumulation of damage on lipids, nucleic acids as well as proteins within the body. This accumulation of damage on the biological molecules changes the framework and leads to a reduction in the molecules' activity levels. Lipid peroxides accumulate in the membrane phospholipids, which in turn diminishes the mitochondrial membrane's effectiveness as a barrier. The process of DNA transcription and translation also acquires oxidative damage. The result is alterations in the base pairings of the DNA sequence. Research has found that DNA mutations from free radical damage are highly uncommon but would still lead to the build up of damaged proteins as well as decreased biological activity.However, a large body of research has shown that antioxidants (compounds that defuse free radicals) do not slow aging or age-related diseases, putting the popular free radical theory into doubt. See also Evolution of ageing == References ==

In biology, an atavism is a modification of a biological structure whereby an ancestral genetic trait reappears after having been lost through evolutionary change in previous generations. Atavisms can occur in several ways, one of which is when genes for previously existing phenotypic features are preserved in DNA, and these become expressed through a mutation that either knocks out the dominant genes for the new traits or makes the old traits dominate the new one. A number of traits can vary as a result of shortening of the fetal development of a trait (neoteny) or by prolongation of the same. In such a case, a shift in the time a trait is allowed to develop before it is fixed can bring forth an ancestral phenotype. Atavisms are often seen as evidence of evolution.In social sciences, atavism is the tendency of reversion. For example, people in the modern era reverting to the ways of thinking and acting of a former time. The word atavism is derived from the Latin atavus—a great-great-great-grandfather or, more generally, an ancestor. Biology Evolutionarily traits that have disappeared phenotypically do not necessarily disappear from an organism's DNA. The gene sequence often remains, but is inactive. Such an unused gene may remain in the genome for many generations. As long as the gene remains intact, a fault in the genetic control suppressing the gene can lead to it being expressed again. Sometimes, the expression of dormant genes can be induced by artificial stimulation. Atavisms have been observed in humans, such as with infants born with vestigial tails (called a "coccygeal process", "coccygeal projection", or "caudal appendage"). Atavism can also be seen in humans who possess large teeth, like those of other primates. In addition, a case of "snake heart", the presence of "coronary circulation and myocardial architecture [that closely] resemble those of the reptilian heart", has also been reported in medical literature. Atavism has also recently been induced in avian dinosaur (bird) fetuses to express dormant ancestral non-avian dinosaur (non-bird) features, including teeth.Other examples of observed atavisms include: Hind limbs in cetaceans and sirenians. Extra toes of the modern horse. Reappearance of limbs in limbless vertebrates. Re-evolution of sexuality from parthenogenesis in oribatid mites. Teeth in avian dinosaurs (birds). Dewclaws in dogs. Reappearance of prothoracic wings in insects. Reappearance of wings on wingless stick insects and leaf insects and earwigs. Atavistic muscles in several birds and mammals such as the beagle and the jerboa. Extra toes in guinea pigs. Reemergence of sexual reproduction in the flowering plant Hieracium pilosella and the Crotoniidae family of mites. Webbed feet in adult axolotls. Human tails (not pseudo-tails) and supernumerary nipples in humans (and other primates). Color blindness in humans. Culture Atavism is a term in Joseph Schumpeter's explanation of World War I in twentieth-century liberal Europe. He defends the liberal international relations theory that an international society built on commerce will avoid war because of war's destructiveness and comparative cost. His reason for World War I is termed "atavism", in which he asserts that senescent governments in Europe (those of the German Empire, Russian Empire, Ottoman Empire, and Austro-Hungarian Empire) pulled the liberal Europe into war, and that the liberal regimes of the other continental powers did not cause it. He used this idea to say that liberalism and commerce would continue to have a soothing effect in international relations, and that war would not arise between nations which are connected by commercial ties. This latter idea is very similar to the later Golden Arches theory. University of London professor Guy Standing has identified three distinct sub-groups of the precariat, one of which he refers to as "atavists", who long for what they see as a lost past. Social Darwinism During the interval between the acceptance of evolution in the mid-1800s and the rise of the modern understanding of genetics in the early 1900s, atavism was used to account for the reappearance in an individual of a trait after several generations of absence—often called a "throw-back". The idea that atavisms could be made to accumulate by selective breeding, or breeding back, led to breeds such as Heck cattle. This had been bred from ancient landraces with selected primitive traits, in an attempt of "reviving" the aurochs, an extinct species of wild cattle. The same notions of atavisms were used by social Darwinists, who claimed that "inferior" races displayed atavistic traits, and represented more primitive traits than other races. Both atavism's and Ernst Haeckel's recapitulation theory are related to evolutionary progress, as development towards a greater complexity and a superior ability.In addition, the concept of atavism as part of an individualistic explanation of the causes of criminal deviance was popularised by the Italian criminologist Cesare Lombroso in the 1870s. He attempted to identify physical characteristics common to criminals and labeled those he found as atavistic, 'throw-back' traits that determined 'primitive' criminal behavior. His statistical evidence and the closely related idea of eugenics have long since been abandoned by the scientific community, but the concept that physical traits may affect the likelihood of criminal or unethical behavior in a person still has some scientific support. See also Atavistic regression Exaptation Spandrel (biology) Torna atrás References External links Bar-Maor, JA; Kesner, KM; Kaftori, JK (November 1980). "Human tails". The Journal of Bone and Joint Surgery. British Volume. 62-B (4): 508–510. doi:10.1302/0301-620x.62b4.7430236. PMID 7430236. Photograph of an additional (third) hoof of cows

Autogamy depression can be defined as the "lowered viability of autogamous progeny relative to geitonogamous progeny". Viability has also been evaluated in terms of percent fruit set or seed set rather than reproductive fitness of the progeny. The experimental design for observing the occurrence of autogamy depression is called an "autogamy depression test" which has been described by researchers as analogous to a test for inbreeding depression. The ability for fitness of autogamous progeny to differ from geitonogamous progeny comes from the understanding that plants can accumulate heritable mutational variation through both mitotic division and meiotic division. Because plants have indeterminate growth, the apical meristems that contribute to the development of the reproductive structures of a plant have the potential to undergo continual mitosis resulting in the accumulation of somatic mutations (acquired mutations). It has been demonstrated through research that long lived plants can have higher per generation mutation rate (based on occurrences of more mitotic cell divisions compared to short lived plants). Any deleterious mutations that appear during mitotic growth are filtered out through cell lineage selection, in which deleterious mutations that are subject to developmental selection during mitotic growth are replaced by vigorous cell lineages, however, somatic mutations that are not expressed will not be subject to selection during growth of the plant and will accumulate in the apical meristem. Phenotypic effects of somatic mutations There is evidence of the phenotypic effects of somatic mutations in increased chlorophyll mutants of some long-lived plants. Chlorophyll mutants are inherently easy to observe because of the phenotypic effects of the chlorophyll mutations. Because of the highly conserved nature of photosynthetic processes, these chlorophyll mutation rates can be generalized to most angiosperms. Somatic mutations accumulating during vegetative growth have also been found to affect the fitness of seedlings in the next generation. Expectations of autogamy depression test Individual crowns are treated as "independent mitotic mutation-accumulation lines" and so the appearance of deleterious somatic mutations in the autogamous crosses will be heterozygous or homozygous at the same locus (~25% homozygous) and the appearance of deleterious somatic mutations in the geitonogamous crosses will be heterozygous. The autogamy depression can be calculated through the simple equation AD = 1 − (wa/wg), where AD is the autogamy depression, wa is the fitness of the autogamous progeny and wg is the fitness of the geitonogamous progeny. When the fitnesses are equal the AD is 0. The difference can be calculated by the equation D = wg − wa. == References ==

Backcrossing is a crossing of a hybrid with one of its parents or an individual genetically similar to its parent, to achieve offspring with a genetic identity closer to that of the parent. It is used in horticulture, animal breeding, and production of gene knockout organisms. Backcrossed hybrids are sometimes described with acronym "BC"; for example, an F1 hybrid crossed with one of its parents (or a genetically similar individual) can be termed a BC1 hybrid, and a further cross of the BC1 hybrid to the same parent (or a genetically similar individual) produces a BC2 hybrid. Plants Advantages If the recurrent parent is an elite genotype, at the end of the backcrossing programme, an elite genotype is recovered. As no "new" recombination results, the elite combination is not lost. Disadvantages It works poorly for quantitative traits. It is more restricted for recessive traits. In practice, sections of genome from the nonrecurrent parents are often still present and can have unwanted traits associated with them. For very wide crosses, limited recombination may maintain thousands of "alien" genes within the elite cultivar. Many backcrosses are required to produce a new cultivar, which can take many years. Natural backcrossings York radiate groundsel (Senecio eboracensis) is a naturally occurring hybrid species of Oxford ragwort (Senecio squalidus) and common groundsel (Senecio vulgaris). It is thought to have arisen from a backcrossing of the F1 hybrid with S. vulgaris.Again, the pure tall (TT) and pure dwarf (tt) pea plants when crossed in the parental generation, produce all heterozygote (Tt) tall pea plants in the first filial generation. The cross between first filial heterozygote tall (Tt) pea plant and pure tall (TT) or pure dwarf (tt) pea plant of the parental generation is also an example for the back-crossing between two plants. In this case, the filial generation formed after the back cross may have a phenotype ratio of 1:1 if the cross is made with recessive parent or else all offspring may be having phenotype of dominant trait if the backcross is with a parent having the dominant trait. The former of these traits is also called a test cross. Artificially recombinant lines In plants, the term inbred backcross line (IBL) refers to a line (i.e. population) of plants derived from the repeated backcrossing of a line with artificially recombinant DNA with the wild type, operating some kind of selection that can be phenotypical or through a molecular marker (for the production of an introgression line). Animals Backcrossing may be deliberately employed in animals to transfer a desirable trait in an animal of inferior genetic background to an animal of preferable genetic background. In gene-knockout experiments in particular, where the knockout is performed on easily cultured stem cell lines, but is required in an animal with a different genetic background, the knockout animal is backcrossed against the animal of the required genetic background. As the figure shows, each time that the mouse with the desired trait (in this case the lack of a gene (i.e. a knockout), indicated by the presence of a positive selectable marker) is crossed with a mouse of a constant genetic background, the average percentage of the genetic material of the offspring that is derived from that constant background increases. The result, after sufficient reiterations, is an animal with the desired trait in the desired genetic background, with the percentage of genetic material from the original stem cells reduced to a minimum (on the order of 0.01%).Due to the nature of meiosis, in which chromosomes derived from each parent are randomly shuffled and assigned to each nascent gamete, the percentage of genetic material deriving from either cell line varies between offspring of a single crossing, but will have an expected value. The genotype of each member of offspring may be assessed to choose not only an individual that carries the desired genetic trait, but also the minimum percentage of genetic material from the original stem cell line. A consomic strain is an inbred strain with one of its chromosomes replaced by the homologous chromosome of another inbred strain via a series of marker-assisted backcrosses. See also Introgression Incest References External links The Plant Breeding and Genomics Community of Practice on eXtension - education and training materials for plant breeders and allied professionals

A Barr body (named after discoverer Murray Barr) or X-chromatin is an inactive X chromosome. In species with XY sex-determination (including humans), females typically have two X chromosomes, and one is rendered inactive in a process called lyonization. Errors in chromosome separation can also result in male and female individuals with extra X chromosomes. The Lyon hypothesis states that in cells with multiple X chromosomes, all but one are inactivated early in embryonic development in mammals. The X chromosomes that become inactivated are chosen randomly, except in marsupials and in some extra-embryonic tissues of some placental mammals, in which the X chromosome from the sperm is always deactivated.In humans with euploidy, a genotypical female (46, XX karyotype) has one Barr body per somatic cell nucleus, while a genotypical male (46, XY) has none. The Barr body can be seen in the interphase nucleus as a darkly staining small mass in contact with the nucleus membrane. Barr bodies can be seen in neutrophils at the rim of the nucleus. In humans with more than one X chromosome, the number of Barr bodies visible at interphase is always one fewer than the total number of X chromosomes. For example, people with Klinefelter syndrome (47, XXY) have a single Barr body, and people with a 47, XXX karyotype have two Barr bodies. Mechanism Someone with two X chromosomes (such as most human females) has only one Barr body per somatic cell, while someone with one X chromosome (such as most human males) has none. Mammalian X-chromosome inactivation is initiated from the X inactivation centre or Xic, usually found near the centromere. The center contains twelve genes, seven of which code for proteins, five for untranslated RNAs, of which only two are known to play an active role in the X inactivation process, Xist and Tsix. The centre also appears to be important in chromosome counting: ensuring that random inactivation only takes place when two or more X-chromosomes are present. The provision of an extra artificial Xic in early embryogenesis can induce inactivation of the single X found in male cells.The roles of Xist and Tsix appear to be antagonistic. The loss of Tsix expression on the future inactive X chromosome results in an increase in levels of Xist around the Xic. Meanwhile, on the future active X Tsix levels are maintained; thus the levels of Xist remain low. This shift allows Xist to begin coating the future inactive chromosome, spreading out from the Xic. In non-random inactivation this choice appears to be fixed and current evidence suggests that the maternally inherited gene may be imprinted. Variations in Xi frequency have been reported with age, pregnancy, the use of oral contraceptives, fluctuations in menstrual cycle and neoplasia.It is thought that this constitutes the mechanism of choice, and allows downstream processes to establish the compact state of the Barr body. These changes include histone modifications, such as histone H3 methylation (i.e. H3K27me3 by PRC2 which is recruited by Xist) and histone H2A ubiquitination, as well as direct modification of the DNA itself, via the methylation of CpG sites. These changes help inactivate gene expression on the inactive X-chromosome and to bring about its compaction to form the Barr body. Reactivation of a Barr body is also possible, and has been seen in breast cancer patients. One study showed that the frequency of Barr bodies in breast carcinoma were significantly lower than in healthy controls, indicating reactivation of these once inactivated X chromosomes. See also X-inactivation Sex-determination system Nuclear sexing, a genetic sex determination technique Demethylation Acetylation Xist Tsix (gene) References Links to full text articles are provided where access is free, in other cases only the abstract has been linked. Further reading Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. (2002). Molecular Biology of the Cell, Fourth Edition. Garland Science. pp. 428–429. ISBN 978-0-8153-4072-0. (Web Edition, Free access) Turnpenny & Ellard: Emery's Elements of Medical Genetics 13E (http://www.studentconsult.com/content/default.cfm?ISBN=9780702029172&ID=HC006029 Archived 2020-04-13 at the Wayback Machine)

A blood type (also known as a blood group) is a classification of blood, based on the presence and absence of antibodies and inherited antigenic substances on the surface of red blood cells (RBCs). These antigens may be proteins, carbohydrates, glycoproteins, or glycolipids, depending on the blood group system. Some of these antigens are also present on the surface of other types of cells of various tissues. Several of these red blood cell surface antigens can stem from one allele (or an alternative version of a gene) and collectively form a blood group system.Blood types are inherited and represent contributions from both parents of an individual. As of December 2023, a total of 45 human blood group systems are recognized by the International Society of Blood Transfusion (ISBT). The two most important blood group systems are ABO and Rh; they determine someone's blood type (A, B, AB, and O, with + or − denoting RhD status) for suitability in blood transfusion. Blood group systems A complete blood type would describe each of the 45 blood groups, and an individual's blood type is one of many possible combinations of blood-group antigens. Almost always, an individual has the same blood group for life, but very rarely an individual's blood type changes through addition or suppression of an antigen in infection, malignancy, or autoimmune disease. Another more common cause of blood type change is a bone marrow transplant. Bone-marrow transplants are performed for many leukemias and lymphomas, among other diseases. If a person receives bone marrow from someone of a different ABO type (e.g., a type O patient receives a type A bone marrow), the patient's blood type should eventually become the donor's type, as the patient's hematopoietic stem cells (HSCs) are destroyed, either by ablation of the bone marrow or by the donor's T-cells. Once all the patient's original red blood cells have died, they will have been fully replaced by new cells derived from the donor HSCs. Provided the donor had a different ABO type, the new cells' surface antigens will be different from those on the surface of the patient's original red blood cells.Some blood types are associated with inheritance of other diseases; for example, the Kell antigen is sometimes associated with McLeod syndrome. Certain blood types may affect susceptibility to infections, an example being the resistance to specific malaria species seen in individuals lacking the Duffy antigen. The Duffy antigen, presumably as a result of natural selection, is less common in population groups from areas having a high incidence of malaria. ABO blood group system The ABO blood group system involves two antigens and two antibodies found in human blood. The two antigens are antigen A and antigen B. The two antibodies are antibody A and antibody B. The antigens are present on the red blood cells and the antibodies in the serum. Regarding the antigen property of the blood all human beings can be classified into four groups, those with antigen A (group A), those with antigen B (group B), those with both antigen A and B (group AB) and those with neither antigen (group O). The antibodies present together with the antigens are found as follows: Antigen A with antibody B Antigen B with antibody A Antigen AB with neither antibody A nor B Antigen null (group O) with both antibody A and BThere is an agglutination reaction between similar antigen and antibody (for example, antigen A agglutinates the antibody A and antigen B agglutinates the antibody B). Thus, transfusion can be considered safe as long as the serum of the recipient does not contain antibodies for the blood cell antigens of the donor.The ABO system is the most important blood-group system in human-blood transfusion. The associated anti-A and anti-B antibodies are usually immunoglobulin M, abbreviated IgM, antibodies. It has been hypothesized that ABO IgM antibodies are produced in the first years of life by sensitization to environmental substances such as food, bacteria, and viruses, although blood group compatibility rules are applied to newborn and infants as a matter of practice. The original terminology used by Karl Landsteiner in 1901 for the classification was A/B/C; in later publications "C" became "O". Type O is often called 0 (zero, or null) in other languages. Rh blood group system The Rh system (Rh meaning Rhesus) is the second most significant blood-group system in human-blood transfusion with currently 50 antigens. The most significant Rh antigen is the D antigen, because it is the most likely to provoke an immune system response of the five main Rh antigens. It is common for D-negative individuals not to have any anti-D IgG or IgM antibodies, because anti-D antibodies are not usually produced by sensitization against environmental substances. However, D-negative individuals can produce IgG anti-D antibodies following a sensitizing event: possibly a fetomaternal transfusion of blood from a fetus in pregnancy or occasionally a blood transfusion with D positive RBCs. Rh disease can develop in these cases. Rh negative blood types are much less common in Asian populations (0.3%) than they are in European populations (15%).The presence or absence of the Rh(D) antigen is signified by the + or − sign, so that, for example, the A− group is ABO type A and does not have the Rh (D) antigen. ABO and Rh distribution by country As with many other genetic traits, the distribution of ABO and Rh blood groups varies significantly between populations. While theories are still debated in the scientific community as to why blood types vary geographically and why they emerged in the first place, evidence suggests that the evolution of blood types may be driven by genetic selection for those types whose antigens confer resistance to particular diseases in certain regions – such as the prevalence of blood type O in malaria-endemic countries where individuals of blood type O exhibit the highest rates of survival. Other blood group systems As of December 2022, 42 blood-group systems have been identified by the International Society for Blood Transfusion in addition to the ABO and Rh systems. Thus, in addition to the ABO antigens and Rh antigens, many other antigens are expressed on the RBC surface membrane. For example, an individual can be AB, D positive, and at the same time M and N positive (MNS system), K positive (Kell system), Lea or Leb negative (Lewis system), and so on, being positive or negative for each blood group system antigen. Many of the blood group systems were named after the patients in whom the corresponding antibodies were initially encountered. Blood group systems other than ABO and Rh pose a potential, yet relatively low, risk of complications upon mixing of blood from different people.Following is a comparison of clinically relevant characteristics of antibodies against the main human blood group systems: Clinical significance Blood transfusion Transfusion medicine is a specialized branch of hematology that is concerned with the study of blood groups, along with the work of a blood bank to provide a transfusion service for blood and other blood products. Across the world, blood products must be prescribed by a medical doctor (licensed physician or surgeon) in a similar way as medicines. Much of the routine work of a blood bank involves testing blood from both donors and recipients to ensure that every individual recipient is given blood that is compatible and as safe as possible. If a unit of incompatible blood is transfused between a donor and recipient, a severe acute hemolytic reaction with hemolysis (RBC destruction), kidney failure and shock is likely to occur, and death is a possibility. Antibodies can be highly active and can attack RBCs and bind components of the complement system to cause massive hemolysis of the transfused blood.Patients should ideally receive their own blood or type-specific blood products to minimize the chance of a transfusion reaction. It is also possible to use the patient's own blood for transfusion. This is called autologous blood transfusion, which is always compatible with the patient. The procedure of washing a patient's own red blood cells goes as follows: The patient's lost blood is collected and washed with a saline solution. The washing procedure yields concentrated washed red blood cells. The last step is reinfusing the packed red blood cells into the patient. There are multiple ways to wash red blood cells. The two main ways are centrifugation and filtration methods. This procedure can be performed with microfiltration devices like the Hemoclear filter. Risks can be further reduced by cross-matching blood, but this may be skipped when blood is required for an emergency. Cross-matching involves mixing a sample of the recipient's serum with a sample of the donor's red blood cells and checking if the mixture agglutinates, or forms clumps. If agglutination is not obvious by direct vision, blood bank technologist usually check for agglutination with a microscope. If agglutination occurs, that particular donor's blood cannot be transfused to that particular recipient. In a blood bank it is vital that all blood specimens are correctly identified, so labelling has been standardized using a barcode system known as ISBT 128. The blood group may be included on identification tags or on tattoos worn by military personnel, in case they should need an emergency blood transfusion. Frontline German Waffen-SS had blood group tattoos during World War II. Rare blood types can cause supply problems for blood banks and hospitals. For example, Duffy-negative blood occurs much more frequently in people of African origin, and the rarity of this blood type in the rest of the population can result in a shortage of Duffy-negative blood for these patients. Similarly, for RhD negative people there is a risk associated with travelling to parts of the world where supplies of RhD negative blood are rare, particularly East Asia, where blood services may endeavor to encourage Westerners to donate blood. Hemolytic disease of the newborn (HDN) A pregnant woman may carry a fetus with a blood type which is different from her own. Typically, this is an issue if a Rh- mother has a child with a Rh+ father, and the fetus ends up being Rh+ like the father. In those cases, the mother can make IgG blood group antibodies. This can happen if some of the fetus' blood cells pass into the mother's blood circulation (e.g. a small fetomaternal hemorrhage at the time of childbirth or obstetric intervention), or sometimes after a therapeutic blood transfusion. This can cause Rh disease or other forms of hemolytic disease of the newborn (HDN) in the current pregnancy and/or subsequent pregnancies. Sometimes this is lethal for the fetus; in these cases it is called hydrops fetalis. If a pregnant woman is known to have anti-D antibodies, the Rh blood type of a fetus can be tested by analysis of fetal DNA in maternal plasma to assess the risk to the fetus of Rh disease. One of the major advances of twentieth century medicine was to prevent this disease by stopping the formation of Anti-D antibodies by D negative mothers with an injectable medication called Rho(D) immune globulin. Antibodies associated with some blood groups can cause severe HDN, others can only cause mild HDN and others are not known to cause HDN. Blood products To provide maximum benefit from each blood donation and to extend shelf-life, blood banks fractionate some whole blood into several products. The most common of these products are packed RBCs, plasma, platelets, cryoprecipitate, and fresh frozen plasma (FFP). FFP is quick-frozen to retain the labile clotting factors V and VIII, which are usually administered to patients who have a potentially fatal clotting problem caused by a condition such as advanced liver disease, overdose of anticoagulant, or disseminated intravascular coagulation (DIC).Units of packed red cells are made by removing as much of the plasma as possible from whole blood units. Clotting factors synthesized by modern recombinant methods are now in routine clinical use for hemophilia, as the risks of infection transmission that occur with pooled blood products are avoided. Red blood cell compatibility Blood group AB individuals have both A and B antigens on the surface of their RBCs, and their blood plasma does not contain any antibodies against either A or B antigen. Therefore, an individual with type AB blood can receive blood from any group (with AB being preferable), but cannot donate blood to any group other than AB. They are known as universal recipients. Blood group A individuals have the A antigen on the surface of their RBCs, and blood serum containing IgM antibodies against the B antigen. Therefore, a group A individual can receive blood only from individuals of groups A or O (with A being preferable), and can donate blood to individuals with type A or AB. Blood group B individuals have the B antigen on the surface of their RBCs, and blood serum containing IgM antibodies against the A antigen. Therefore, a group B individual can receive blood only from individuals of groups B or O (with B being preferable), and can donate blood to individuals with type B or AB. Blood group O (or blood group zero in some countries) individuals do not have either A or B antigens on the surface of their RBCs, and their blood serum contains IgM anti-A and anti-B antibodies. Therefore, a group O individual can receive blood only from a group O individual, but can donate blood to individuals of any ABO blood group (i.e., A, B, O or AB). If a patient needs an urgent blood transfusion, and if the time taken to process the recipient's blood would cause a detrimental delay, O negative blood can be issued. Because it is compatible with anyone, O negative blood is often overused and consequently is always in short supply. According to the American Association of Blood Banks and the British Chief Medical Officer's National Blood Transfusion Committee, the use of group O RhD negative red cells should be restricted to persons with O negative blood, women who might be pregnant, and emergency cases in which blood-group testing is genuinely impracticable. Table note 1. Assumes absence of atypical antibodies that would cause an incompatibility between donor and recipient blood, as is usual for blood selected by cross matching. An Rh D-negative patient who does not have any anti-D antibodies (never being previously sensitized to D-positive RBCs) can receive a transfusion of D-positive blood once, but this would cause sensitization to the D antigen, and a female patient would become at risk for hemolytic disease of the newborn. If a D-negative patient has developed anti-D antibodies, a subsequent exposure to D-positive blood would lead to a potentially dangerous transfusion reaction. Rh D-positive blood should never be given to D-negative women of child-bearing age or to patients with D antibodies, so blood banks must conserve Rh-negative blood for these patients. In extreme circumstances, such as for a major bleed when stocks of D-negative blood units are very low at the blood bank, D-positive blood might be given to D-negative females above child-bearing age or to Rh-negative males, providing that they did not have anti-D antibodies, to conserve D-negative blood stock in the blood bank. The converse is not true; Rh D-positive patients do not react to D negative blood. This same matching is done for other antigens of the Rh system as C, c, E and e and for other blood group systems with a known risk for immunization such as the Kell system in particular for females of child-bearing age or patients with known need for many transfusions. Plasma compatibility Blood plasma compatibility is the inverse of red blood cell compatibility. Type AB plasma carries neither anti-A nor anti-B antibodies and can be transfused to individuals of any blood group; but type AB patients can only receive type AB plasma. Type O carries both antibodies, so individuals of blood group O can receive plasma from any blood group, but type O plasma can be used only by type O recipients. Table note 1. Assuming absence of strong atypical antibodies in donor plasma Rh D antibodies are uncommon, so generally neither D negative nor D positive blood contain anti-D antibodies. If a potential donor is found to have anti-D antibodies or any strong atypical blood group antibody by antibody screening in the blood bank, they would not be accepted as a donor (or in some blood banks the blood would be drawn but the product would need to be appropriately labeled); therefore, donor blood plasma issued by a blood bank can be selected to be free of D antibodies and free of other atypical antibodies, and such donor plasma issued from a blood bank would be suitable for a recipient who may be D positive or D negative, as long as blood plasma and the recipient are ABO compatible. Universal donors and universal recipients In transfusions of packed red blood cells, individuals with type O Rh D negative blood are often called universal donors. Those with type AB Rh D positive blood are called universal recipients. However, these terms are only generally true with respect to possible reactions of the recipient's anti-A and anti-B antibodies to transfused red blood cells, and also possible sensitization to Rh D antigens. One exception is individuals with hh antigen system (also known as the Bombay phenotype) who can only receive blood safely from other hh donors, because they form antibodies against the H antigen present on all red blood cells.Blood donors with exceptionally strong anti-A, anti-B or any atypical blood group antibody may be excluded from blood donation. In general, while the plasma fraction of a blood transfusion may carry donor antibodies not found in the recipient, a significant reaction is unlikely because of dilution. Additionally, red blood cell surface antigens other than A, B and Rh D, might cause adverse reactions and sensitization, if they can bind to the corresponding antibodies to generate an immune response. Transfusions are further complicated because platelets and white blood cells (WBCs) have their own systems of surface antigens, and sensitization to platelet or WBC antigens can occur as a result of transfusion. For transfusions of plasma, this situation is reversed. Type O plasma, containing both anti-A and anti-B antibodies, can only be given to O recipients. The antibodies will attack the antigens on any other blood type. Conversely, AB plasma can be given to patients of any ABO blood group, because it does not contain any anti-A or anti-B antibodies. Blood typing Typically, blood type tests are performed through addition of a blood sample to a solution containing antibodies corresponding to each antigen. The presence of an antigen on the surface of the blood cells is indicated by agglutination. Blood group genotyping In addition to the current practice of serologic testing of blood types, the progress in molecular diagnostics allows the increasing use of blood group genotyping. In contrast to serologic tests reporting a direct blood type phenotype, genotyping allows the prediction of a phenotype based on the knowledge of the molecular basis of the currently known antigens. This allows a more detailed determination of the blood type and therefore a better match for transfusion, which can be crucial in particular for patients with needs for many transfusions to prevent allo-immunization. History Blood types were first discovered by an Austrian physician, Karl Landsteiner, working at the Pathological-Anatomical Institute of the University of Vienna (now Medical University of Vienna). In 1900, he found that blood sera from different persons would clump together (agglutinate) when mixed in test tubes, and not only that, some human blood also agglutinated with animal blood. He wrote a two-sentence footnote: The serum of healthy human beings not only agglutinates animal red cells, but also often those of human origin, from other individuals. It remains to be seen whether this appearance is related to inborn differences between individuals or it is the result of some damage of bacterial kind. This was the first evidence that blood variation exists in humans. The next year, in 1901, he made a definitive observation that blood serum of an individual would agglutinate with only those of certain individuals. Based on this he classified human bloods into three groups, namely group A, group B, and group C. He defined that group A blood agglutinates with group B, but never with its own type. Similarly, group B blood agglutinates with group A. Group C blood is different in that it agglutinates with both A and B. This was the discovery of blood groups for which Landsteiner was awarded the Nobel Prize in Physiology or Medicine in 1930. (C was later renamed to O after the German Ohne, meaning without, or zero, or null.) Another group (later named AB) was discovered a year later by Landsteiner's students Adriano Sturli and Alfred von Decastello without designating the name (simply referring it to as "no particular type"). Thus, after Landsteiner, three blood types were initially recognised, namely A, B, and C.Czech serologist Jan Janský was the first to recognise and designate four blood types in 1907 that he published in a local journal, using the Roman numerical I, II, III, and IV (corresponding to modern O, A, B, and AB respectively). Unknown to Janský, an American physician William L. Moss introduced almost identical classification in 1910; but his I and IV corresponding Janský's IV and I. Moss came across Janský's paper as his was being printed, mentioned it in a footnote. Thus the existence of two systems immediately created confusion and potential danger in medical practice. Moss's system was adopted in Britain, France, and the US, while Janský's was preferred in most other European countries and some parts of the US. It was reported that "The practically universal use of the Moss classification at that time was completely and purposely cast aside. Therefore in place of bringing order out of chaos, chaos was increased in the larger cities." To resolve the confusion, the American Association of Immunologists, the Society of American Bacteriologists, and the Association of Pathologists and Bacteriologists made a joint recommendation in 1921 that the Jansky classification be adopted based on priority. But it was not followed particularly where Moss's system had been used.In 1927, Landsteiner, who had moved to the Rockefeller Institute for Medical Research in New York, and as a member of a committee of the National Research Council concerned with blood grouping suggested to substitute Janský's and Moss's systems with the letters O, A, B, and AB. There was another confusion on the use of O which was introduced by Polish physicians Ludwik Hirszfeld and German physician Emil von Dungern in 1910. It was never clear whether it was meant for the figure 0, German null for zero or the upper case letter O for ohne, meaning without; Landsteiner chose the latter. In 1928 the Permanent Commission on Biological Standardization adopted Landsteiner's proposal and stated:The Commission learns with satisfaction that, on the initiative of the Health Organization of the League of Nations, the nomenclature proposed by von Dungern and Hirszfeld for the classification of blood groups has been generally accepted, and recommends that this nomenclature shall be adopted for international use as follows: 0 A B AB. To facilitate the change from the nomenclature hitherto employed the following is suggested: Jansky ....0(I) A(II) B(III) AB(IV) Moss ... O(IV) A(II) B(III) AB(I)This classification became widely accepted and after the early 1950s it was universally followed.Hirszfeld and Dungern discovered the inheritance of blood types as Mendelian genetics in 1910 and the existence of sub-types of A in 1911. In 1927, Landsteiner, with Philip Levine, discovered the MN blood group system, and the P system. Development of the Coombs test in 1945, the advent of transfusion medicine, and the understanding of ABO hemolytic disease of the newborn led to discovery of more blood groups. As of December 2023, the International Society of Blood Transfusion (ISBT) recognizes 45 blood groups. Society and culture A popular pseudoscientific belief in Eastern Asian countries (especially in Japan and South Korea) known as 血液型 ketsuekigata / hyeoraekhyeong is that a person's ABO blood type is predictive of their personality, character, and compatibility with others. Researchers have established no scientific basis exists for blood type personality categorization, and studies have found no "significant relationship between personality and blood type, rendering the theory 'obsolete' and concluding that no basis exists to assume that personality is anything more than randomly associated with blood type." See also Blood type (non-human) Human leukocyte antigen hh blood group References Further reading Dean, Laura (2005). Blood Groups and Red Cell Antigens, a guide to the differences in our blood types that complicate blood transfusions and pregnancy. Bethesda MD: National Center for Biotechnology Information. ISBN 1-932811-05-2. NBK2261. Mollison PL, Engelfriet CP, Contreras M (1997). Blood Transfusion in Clinical Medicine (10th ed.). Oxford UK: Blackwell Science. ISBN 0-86542-881-6. External links BGMUT Blood Group Antigen Gene Mutation Database at NCBI, NIH has details of genes and proteins, and variations thereof, that are responsible for blood types Online Mendelian Inheritance in Man (OMIM): ABO Glycosyltransferase; ABO - 110300 Online Mendelian Inheritance in Man (OMIM): Rhesus Blood Group, D Antigen; RHD - 111680 "Blood group test". Gentest.ch GmbH. Archived from the original on 2017-03-24. Retrieved 2017-03-23. "Blood Facts – Rare Traits". LifeShare Blood Centers. Archived from the original on September 26, 2006. Retrieved September 15, 2006. "Modern Human Variation: Distribution of Blood Types". Dr. Dennis O'Neil, Behavioral Sciences Department, Palomar College, San Marcos, California. 2001-06-06. Archived from the original on 2001-06-06. Retrieved November 23, 2006. "Racial and Ethnic Distribution of ABO Blood Types – BloodBook.com, Blood Information for Life". bloodbook.com. Archived from the original on 2010-03-04. Retrieved September 15, 2006. "Molecular Genetic Basis of ABO". Retrieved July 31, 2008.

In genetics, a centimorgan (abbreviated cM) or map unit (m.u.) is a unit for measuring genetic linkage. It is defined as the distance between chromosome positions (also termed loci or markers) for which the expected average number of intervening chromosomal crossovers in a single generation is 0.01. It is often used to infer distance along a chromosome. However, it is not a true physical distance. Relation to physical distance The number of base pairs to which it corresponds varies widely across the genome (different regions of a chromosome have different propensities towards crossover) and it also depends on whether the meiosis in which the crossing-over takes place is a part of oogenesis (formation of female gametes) or spermatogenesis (formation of male gametes). One centimorgan corresponds to about 1 million base pairs in humans on average. The relationship is only rough, as the physical chromosomal distance corresponding to one centimorgan varies from place to place in the genome, and also varies between males and females since recombination during gamete formation in females is significantly more frequent than in males. Kong et al. calculated that the female genome is 4460 cM long, while the male genome is only 2590 cM long. Plasmodium falciparum has an average recombination distance of ~15 kb per centimorgan: markers separated by 15 kb of DNA (15,000 nucleotides) have an expected rate of chromosomal crossovers of 0.01 per generation. Note that non-syntenic genes (genes residing on different chromosomes) are inherently unlinked, and cM distances are not applicable to them. Relation to the probability of recombination Because genetic recombination between two markers is detected only if there are an odd number of chromosomal crossovers between the two markers, the distance in centimorgans does not correspond exactly to the probability of genetic recombination. Assuming J. B. S. Haldane's map function, in which the number of chromosomal crossovers is distributed according to a Poisson distribution, a genetic distance of d centimorgans will lead to an odd number of chromosomal crossovers, and hence a detectable genetic recombination, with probability P ( recombination | linkage of d cM ) = ∑ k = 0 ∞ P ( 2 k + 1 crossovers | linkage of d cM ) {\displaystyle \ P({\text{recombination}}|{\text{linkage of }}d{\text{ cM}})=\sum _{k=0}^{\infty }\ P(2k+1{\text{ crossovers}}|{\text{linkage of }}d{\text{ cM}})} = ∑ k = 0 ∞ e − d / 100 ( d / 100 ) 2 k + 1 ( 2 k + 1 ) ! = e − d / 100 sinh ⁡ ( d / 100 ) = 1 − e − 2 d / 100 2 , {\displaystyle {}=\sum _{k=0}^{\infty }e^{-d/100}{\frac {(d/100)^{2\,k+1}}{(2\,k+1)!}}=e^{-d/100}\sinh(d/100)={\frac {1-e^{-2d/100}}{2}}\,,} where sinh is the hyperbolic sine function. The probability of recombination is approximately d/100 for small values of d and approaches 50% as d goes to infinity. The formula can be inverted, giving the distance in centimorgans as a function of the recombination probability: d = 50 ln ⁡ ( 1 1 − 2 P ( recombination ) ) . {\displaystyle d=50\ln \left({\frac {1}{1-2\ P({\text{recombination}})}}\right)\,.} Etymology The centimorgan was named in honor of geneticist Thomas Hunt Morgan by J. B. S. Haldane. However, its parent unit, the morgan, is rarely used today. See also Mutation rate References == Further reading ==

Chemogenetics is the process by which macromolecules can be engineered to interact with previously unrecognized small molecules. Chemogenetics as a term was originally coined to describe the observed effects of mutations on chalcone isomerase activity on substrate specificities in the flowers of Dianthus caryophyllus. This method is very similar to optogenetics; however, it uses chemically engineered molecules and ligands instead of light and light-sensitive channels known as opsins. In recent research projects, chemogenetics has been widely used to understand the relationship between brain activity and behavior. Prior to chemogenetics, researchers used methods such as transcranial magnetic stimulation and deep brain stimulation to study the relationship between neuronal activity and behavior. Comparison to optogenetics Optogenetics and chemogenetics are the more recent and popular methods used to study this relationship. Both of these methods target specific brain circuits and cell population to influence cell activity. However, they use different procedures to accomplish this task. Optogenetics uses light-sensitive channels and pumps that are virally introduced into neurons. Cells' activity, having these channels, can then be manipulated by light. Chemogenetics, on the other hand, uses chemically engineered receptors and exogenous molecules specific for those receptors, to affect the activity of those cells. The engineered macromolecules used to design these receptors include nucleic acid hybrids, kinases, variety of metabolic enzymes, and G-protein coupled receptors such as DREADDs.DREADDs are the most common G protein–coupled receptors used in chemogenetics. These receptors solely get activated by the drug of interest (inert molecule) and influence physiological and neural processes that take place within and outside of the central nervous system.Chemogenetics has recently been favored over optogenetics, and it avoids some of the challenges of optogenetics. Chemogenetics does not require the expensive light equipment, and therefore, is more accessible. The resolution in Optogenetic declines due to light scattering and illuminance declined levels as the distance between the subject and the light source increases. These factors, therefore, don’t allow for all cells to be affected by light and lead to a lower spatial resolution. Chemogenetics, however, does not require light usage and therefore can achieve a higher spatial resolution. Applications G-protein coupled receptors' usage and chemogenetics are nowadays the targets for many of the pharmaceutical companies to cure and alleviate symptoms of diseases that involve all tissues of the body. More specifically, DREADDs have been used to explore treatment options for various neurodegenerative and psychological conditions such as Parkinson’s disease, depression, anxiety, and addiction. These aforementioned conditions involve processes that occur within and outside of the nervous system involving neurotransmitters such as gamma-aminobutyric acid and glutamate. Chemogenetics has therefore been used in pharmacology to adjust the levels of such neurotransmitters in specific neuron while minimizing the side effects of treatment. To treat and relieve the symptoms of any disease using the DREADDs, these receptors are delivered to the area of interest via viral transduction.Recently some studies have considered using a new method called retro DREADDs. This method allows specific neuronal pathways to be studied under cellular resolution. Unlike classic DREADDs, this method is usually used in wild type animals, and these receptors are given to the targeted cells via injection of two viral vectors. Animal Models DREADDS have been used in many animal models (e.g., mice and other non-primate animals) to target and influence the activity of various cells. Chemogenetics used in animals assists with demonstrating human disease models such as Parkinson's disease. Having this information allows scientists understand whether viral expression of DREADD proteins, both in-vivo enhancers and inhibitors of neuronal function can be used to bidirectionally affect the behaviors and the activity of the involved neurons. Recent studies have shown that DREADDs were successfully used to treat the motor deficits of rats modeling Parkinson's disease. Other studies have had successes linking the usage of DREADDs and influencing drug seeking and drug sensitization behavior.The progression of chemogenetics from rodents to non-human primates has been slow due to increased demand in time and expense surrounding these projects. However, some recent studies in 2016 have been able to demonstrate successes showing that silencing the activity of neurons in the orbitofrontal cortex along with the removal of rhinal cortex, restricted the reward task performance in macaques. Limitation and future directions Chemogenetics and usage of DREADDs have allowed researchers to advance in biomedical research areas including many neurodegenerative and psychiatric conditions. Chemogenetics have been used in these fields to induce specific and reversible brain lesions and therefore, study specific activities of neuron population. Although chemogenetics offers specificity and high spatial resolution, it still faces some challenges when used in investigating neuropsychiatric disorders. Neuropsychiatric disorders usually have a complex nature where lesions in the brain have not been identified as the main cause. Chemogenetics has been used to reverse some of the deficits revolving such conditions; however, it has not been able to identify the main cause of neuropsychiatric diseases and cure these conditions completely due to complex nature of these conditions. Nevertheless, chemogenetics has been used successfully in a preclinical model of drug-resistant epilepsy, where seizures arise from a discrete part of the brain. See also Receptor activated solely by a synthetic ligand == References ==

Color Health, Inc. is a population health technology company which provides genetic tests and analysis directly to patients as well as through employers. The product focuses on genes that indicate risk for heart disease, cancer, and that affect medication response. History The company was co-founded in 2015 by Elad Gil, Nish Bhat, Taylor Sittler, and Othman Laraki, who now serves as company CEO, in Burlingame, California. In November 2021, the company had a valuation of $4.6B and collected $100 million in a series E financing round. Expansion to population health Color provides technology, software, and clinical services for population health programs. Color has partnered with health systems including NorthShore University Health System, Ochsner Health System, and Jefferson Health. COVID-19 testing programs In early 2020, recognizing the growing threat that the COVID-19 pandemic presented, Color mobilized its existing software, logistics expertise and lab operations to focus on mass COVID-19 testing.Color operates a high-throughput CLIA-certified COVID-19 testing laboratory and processes thousands of samples a day. The integrated process includes sign up, the self-collection kit, and results returned via text and email to patients, clinicians, and public health authorities. Color returns results, on average, within 24–48 hours.In August 2020, Color was running some of the highest-capacity test sites in the country. Color was also responsible for the majority of San Francisco’s COVID-19 testing with an average turnaround time within 24 hours, and most results returned in under 48 hours. Color worked with San Francisco’s CityTestSF program, Alameda County Health Services and federally qualified health centers in Alameda County, Marin County and others. The company has also partnered with a wide variety of universities, employers and public health entities, including USC and United Airlines.In January 2022, Color had computer difficulties that resulted in delayed test results and closed testing stations. Testing system Genetics Color’s physician-ordered test can be initiated by individuals online, and a sample collection kit is sent in the mail. Individuals provide a saliva sample and return the kit in a pre-paid package. Color's CLIA-certified and CAP-approved lab analyzes for variants in the breast cancer genes BRCA1 and BRCA2, as well as 28 other genes associated with breast, prostate, colon, uterine, stomach, melanoma, pancreatic, and ovarian cancers. The test also identifies variants in 30 genes related to hereditary heart conditions as well as genes that may impact medication response. Genetic counseling with board-certified genetic counselors is available for free to all individuals who use Color. COVID-19 Color’s FDA Emergency Use Authorization (EUA) COVID-19 test can be accessed as a part of testing programs initiated by a public health entity, university, employer or other organization. The test is a dry anterior nasal swab, approved for use either in an on-site or at-home setting without the need for a healthcare provider to monitor sample collection, which eases the burden on the healthcare system and reduces testing costs.The company has received an FDA EUA for the testing assay, which is a nucleic acid amplification method called LAMP, or loop-mediated isothermal amplification. This enables processing test results 50% faster than RT-PCR, the amplification method used at most other labs. LAMP relies on a different set of chemical reagents than standard PCR tests, which helps the process avoids supply chain scarcity. Research In 2018, Color was selected, alongside the Broad Institute of MIT and Harvard, and the Laboratory for Molecular Medicine (LMM) at Partners HealthCare, to establish one of three genome centers around the country for the National Institutes of Health’s historic All of Us Research Program. All of Us will sequence one million or more people across the US, with the goal of accelerating health research and enabling individualized prevention, treatment, and care. The program has a focus on recruitment from populations that have been historically underrepresented in clinical science and genomic medicine, in order to build a diverse biomedical data resource that provides a foundation for better insights into the biological, environmental, and behavioral factors that influence health.In 2019, Color was named the sole awardee to deliver all of the genetic counseling for All of Us. As the awardee, Color will customize software and tools to integrate data from all the genome centers, standardize reporting across the program, and ensure all results are returned in a unified way. This is a first year $4.6 million grant as part of a multi-year $25 million project. In collaboration with the Women’s Health Initiative and Dr. Mary-Claire King at the University of Washington, Color provided genetic sequencing for the cohort of 10,000 Fabulous Ladies Over Seventy (FLOSSIES). This is the largest publicly available dataset of genetic variants associated with hereditary cancer in healthy, older individuals.Color Data, a database containing aggregated genetic and clinical information from 50,000 individuals who took a Color test, helps researchers and scientists identify genotype-phenotype correlations and novel variants for functional analysis, as well as enables data-driven drug discovery and development. It is the largest public database of its kind.As a part of the MAGENTA Study, which aims to improve availability of genetic testing for hereditary cancer syndromes to at-risk individuals through the use of an online genetic testing service, Color is working with a Stand Up to Cancer Dream Team that includes physicians, scientists and researchers from the MD Anderson Cancer Center and the University of Washington to provide genetic counseling to high-risk individuals through delivery models such as tele-counseling.In collaboration with Dr. Laura Esserman at University of California and Sanford Health, Color is providing genetic testing for WISDOM, a 100,000-woman study that is comparing annual screenings with personalized, risk-based breast cancer screenings.As part of the GENtleMEN Study, Color is working with Dr. Heather Cheng at the Fred Hutchinson Cancer Research Center and the University of Washington to provide genetic testing and counseling to men with advanced prostate cancer.Color contributes anonymized variants to ClinVar, a free database managed by the National Center for Biotechnology Information (NCBI) at the National Institutes of Health (NIH) that helps researchers identify links between genes and disease.Color's research collaborators include: Mary-Claire King: advisor, scientific collaborator Sekar Kathiresan: advisor, scientific collaborator Heidi Rehm: scientific collaborator == References ==

In genetics, two organisms that differ in only one locus and a linked segment of chromosome are defined as congenic. Similarly, organisms that are coisogenic differ in one locus only and not in the surrounding chromosome. Unlike congenic organisms, coisogenic organisms cannot be bred and only occur through spontaneous or targeted mutation at the locus. Generating congenic strains Congenic strains are generated in the laboratory by mating two inbred strains (usually rats or mice), and back-crossing the descendants 5–10 generations with one of the original strains, known as the recipient strain. Typically selection for either phenotype or genotype is performed prior to each back-cross generation. In this manner either an interesting phenotype, or a defined chromosomal region assayed by genotype, is passed from the donor strain onto an otherwise uniform recipient background. Congenic mice or rats can then be compared to the pure recipient strain to determine whether they are phenotypically different if selection was for a genotypic region, or to identify the critical genetic locus, if selection was for a phenotype. Speed congenics can be produced in as little as five back-cross generations, through the selection at each generation of offspring that not only retain the desired chromosomal fragment, but also 'lose' the maximum amount of background genetic information from the donor strain. This is also known as marker-assisted congenics, due to the use of genetic markers, typically microsatellite markers, but now, more commonly, single nucleotide polymorphism markers (SNPs). The process can be further aided by the superovulation of females, to produce many more eggs. See also Gene knockout Notes and references Further reading Congenic strains are discussed in detail in Lee Silver's online book Mouse Genetics: Concepts and Applications: "Mouse Genetics: Concepts and Applications". Lee Silver. Retrieved 2007-10-18.[1]

Cotransformation is the simultaneous transformation of two or more genes. Only genes in the same chromosomal vicinity can be transformed; the closer together the genes lie, the more frequently they will be cotransformed. By contrast, genes sufficiently far apart that they cannot appear together on a fragment of foreign DNA will almost never be cotransformed, because transformation is so inefficient that recipient cells usually take up only a single DNA. Example In one study of natural transformation, investigators isolated B. subtilis bacteria with two mutations—trpC2 and hisB2—that made them Trp- , His- auxotrophs. These double auxotrophs served as the recipient in the study, wild-type cells (Trp+ , His+ ) were the donors. In this study, the numbers of Trp+ and His+ transformants were equal. Further tests showed that 40 of every 100 Trp+ transferred colonies were also His+. Similarly, tests of the His+ transformants showed that roughly 40% are also Trp+ . Thus, in 40% of the analyzed colonies, the trpC+ and hisB+ genes had been cotransformed. Explanation Since during transformation, donor DNA replaces only a small percentage of the recipient's chromosome, why are the two B.subtilis genes cotransformed with such high frequency? Because the trpC and hisB genes lie very close together on the chromosome and are thus genetically linked. Although the donor chromosome is fragmented into small pieces of about 20 kb during its extraction for the transformation process, the wild-type trpC+ and hisB+ alleles are so close that they often appear in the same donor DNA molecule. Sequence analysis shows that trpC and hisB genes are only about 7 kb apart. == References ==

Countergradient variation is a type of phenotypic plasticity that occurs when the phenotypic variation determined by a biological population's genetic components opposes the phenotypic variation caused by an environmental gradient. This can cause different populations of the same organism to display similar phenotypes regardless of their underlying genetics and differences in their environments.To illustrate a common example known as countergradient growth rate, consider two populations. The two populations live in different environments that affect growth differently due to many ecological factors, such as the temperature and available food. One population is genetically predisposed to have an increased growth rate but inhabits an environment that reduces growth rate, such as a cool environment, and thereby limits the opportunities to take full advantage of any genetic predisposition. The second population is genetically predisposed to have a decreased growth rate but inhabits an environment that supports an increased growth rate, such as a warm environment, and allows members of the population to grow faster despite their genetic disadvantage. Since the genetic influence directly counteracts the environmental influence in each population, both populations will have a similar intermediate growth rate. Countergradient variation can reduce apparent variability by creating similar phenotypes, but it is still possible for the two populations to show phenotypic diversity if either the genetic gradient or the environmental gradient has a stronger influence. Many examples of countergradient variation have been discovered through the use of transplant experiments. Countergradient variation of growth rate is one of the most common examples. Growth rate and body size have important ecological implications, such as how they impact an organism's survival, life history, and fecundity. Countergradient variation has been described in many ectothermic animals, since ectotherms rely on environmental temperature to regulate their metabolic rates, and thus, their growth rates. Ectotherms grow at a slower rate as latitude increases due to this impact of temperature. However, under countergradient variation, when these same animals are placed in a common environment with their low-latitude relatives, they grow faster relative to the low-latitude population. These studies are useful in predicting how animals can adapt to and will survive in different environmental conditions. History Countergradient variation, originally termed "contra-gradient variation", was coined by Richard Levins in his 1968 book Evolution in Changing Environments. Levins first used the term when describing patterns of body size across an altitudinal gradient in populations of Drosophila, and since then many other instances of countergradient variation have been discovered. A study by Keith Berven and others was the first to find countergradient variation in a vertebrate. Specifically, they found that in comparing montane, high altitude, populations to lowland, low altitude populations of the green frog (Lithobates clamitans, formerly Rana clamitans), rates of growth and development were higher in the montane populations. This is counter to what is expected since high altitude populations grow slower than low altitude ones in their respective environments. Similar to the results of this study, most of the known instances of countergradient variation are associated with a latitudinal or altitudinal gradient having an effect on growth rate (see Examples section). Examples The following are among the discovered cases of countergradient variation. The species name is followed by the trait affected and the environmental gradient studied. Animals Drosophila melanogaster – body size; altitude Menidia menidia – growth; latitude Lithobates clamitans – developmental rate; altitude Lithobates sylvatica – growth; latitude and altitude Sceloporus undulatus – growth; latitude Plants Laminaria saccharina – growth; latitude Carex aquatilis – shoot height; temperature and latitude Spartina angilca – growth and survival; tide elevation and succession stage Mechanisms Countergradient variation is the opposite of cogradient variation, in which the environmental effect on the phenotype enhances the genetic effect on the phenotype. One common way to test for both of these patterns is with transplant experiments. By bringing the two populations to the same environment, the environmental effect on phenotype is eliminated and only the genetic effect will cause variation. If cogradient variation is occurring, the same relationship will be seen in the common environment as the two natural environments. However, if countergradient variation is occurring the opposite relationship of what is seen in the natural environments will be seen in the common environment. For example, if Population 1 has higher growth than Population 2 in their respective natural environments, countergradient variation can be detected if, when brought to the same environment, Population 1 now has lower growth than Population 2. Many of the examples listed above were discovered through these types of experiments. However, the mechanisms of how these differential growth rates arise is not fully understood. Take the example of Sceloporus undulatus, the eastern fence lizard. These lizards demonstrate countergradient variation in growth rate across a latitudinal gradient. That is, in a common environment eggs from populations from the northern part of their range hatch out sooner than the eggs from populations at a more southern range. This is opposite the pattern seen in their native habitats. One explanation for this could be that the northern eggs are also naturally larger, so they have more yolk energy available. Originally this maternal investment in larger eggs was thought to support increased developmental rate. However when yolk is removed from the eggs so that the populations have equal energy sources, there is still a substantial difference in growth. Therefore, the mechanism behind this differential growth rate may lie in the efficiency of energy use. Ecological relevance Populations that inhabit high latitudes experience shorter growing seasons than those that inhabit low latitudes due to the differences in seasonality. Because of this, it is thought that countergradient variation of growth is a means to compensate for the short amount of time juveniles have to prepare for winter. With a genetic disposition to grow faster, these individuals can reach a large enough body size to survive through the winter. Increased body size is also associated with higher reproductive output. Additionally, when countergradient variation acts on developmental rates, embryos that develop sooner or hatch out larger will have more time to grow or require less resources, respectively. Since these inherently fast growth rates are not observed in all populations, it seems there are potential trade-offs that would prevent this from being beneficial in low latitude populations. One proposed detriment of enhanced embryonic growth is that animals use too much of their supplied nutrients or yolk during development. In some species of lizards the yolk remaining after hatching is absorbed into the body and used as energy for growth as a hatchling. The use of more yolk energy during development diminishes the reserves available for hatchling growth and can impact hatchling survival. Another hypothesis is that animals that grow quickly do not expend as much energy on differentiation or cellular maintenance because they have shorter incubation times. This allows more energy to be used for growth, but less energy for differentiation. Increased growth has been shown to lead to higher occurrences of defects or complications that cause higher rates of mortality. Some examples include rapid growth leading to bone deformities in sandhill cranes and increased risk of cardiovascular problems in Atlantic salmon.Animals are able to employ different strategies for growth and development to counteract environmental challenges. However, the fact that all individuals do not grow faster and the presence of the mentioned potential fitness trade-offs show that there must be some limit to how much animals can use countergradient growth to compensate for environmental conditions that cause slow growth. Studies of countergradient variation are being explored as a useful way to predict the evolutionary constraints animals face in differing environmental conditions. == Notes ==

The Cytodeme is the total assembly of organisms that use an identical suite of chromosomes to carry their genes. The term was first printed in the 1950s in a book by Heslop-Harrison. Discussing the Deme Terminology - he continued "cytodeme, a population differing in some distinctive cytological feature from others." In most cases the suite is composed of several pairs of homologous chromosomes with or without a pair of sex chromosomes. Since the only acceptable proof of the identity (homology) of chromosomes lies in their ability to pair fully from end to end during meiosis it follows that: In asexual taxa membership of a cytodeme can only be presumed on such evidence as visual similarity of chromosomal ideotype, but never proved. In sexual taxa all of the members of one cytodeme are fully intercompatible (within the limits of sex and other genetical constraints like self-incompatibility mechanisms) yielding the fertile progeny which proves their membership.As a general rule for most species all of its members are of the same cytodeme excepting only the infrequent aneuploid aberrants. However some species are known to include several chromosome races which must necessarily belong to different cytodemes. Although it is not intrinsic in the formal definition it is a matter of common observation that members of different cytodemes are essentially cross-incompatible and any hybrids that do arise are usually highly infertile. Significance The current surge of interest in cytodemes stems from the realisation that membership of the cytodeme is not necessarily restricted to the members of one species: frequently two or more species are in fact of the same cytodeme. Although fully intercompatible and yielding fertile hybrids when they do cross these species never or rarely cross-breed in the natural environment because they are spatially isolated, geographically and/or ecologically. Typically the species involved are members of the same genus. There are now a substantial number of cases in which two or more species of the same cytodeme are clearly different and even in different genera. Thus all five diploid species recognised in the genus Brassicella and both species recognised in the genus Hutera (7spp. in total) are in the same cytodeme. Perhaps the most extreme case on record concerns the wild grass, teosinte, Euchlaena mexicana and the strikingly different Maize, or Indian Corn, Zea mays, both 2n=20, fully interfertile and yielding fertile hybrids. There is perhaps a remote possibility that two such very different species could have evolved independently from distinct sources and converged in their chromosomal ideotype until they became members of the same cytodeme (including the capacity to cross-breed). It is more likely, though, that the cytodeme arose first complete with its suite of chromosomes and breeding patterns all intact and then, remaining constant in its fundamentals, it diversified into species sometimes so different as to merit generic distinction. Thus, in what may be termed the cytodeme adjunct to Darwinian theory, evolution becomes a two-stage process - first, the establishment of distinct cytodemes reproductively isolated both from one another and from all previously existing cytodemes; second, diversification within cytodeme to yield taxonomically recognisable (but not reproductively isolated) species. Whereas the second stage is Natural Selection as expounded by Darwin, the first stage is not necessarily Darwinian. In the special case of polyploidy it is known that the first stage is not Darwinian. Doubling the chromosome number of the sterile hybrid between two diploid cytodemes yields an allotetraploid which is both fertile within its bounds and essentially incompatible with all previous life forms. As yet no mechanism is known which could account for the origin of new diploid cytodemes - nor is there any proof that there are any diploid cytodemes of recent origin. Indeed, the evidence is that cytodemes are remarkably long lived. Presumably the Platanus cytodeme existed on Pangaea before that land fragmented. The present day forms of Platanus - P. orientalis in Europe and P. occidentalis in America - are fully intercompatible when brought together artificially in Botanic Gardens yielding fertile hybrids like the London plane, establishing not only that they are in the same cytodeme as one another but also that they are both in the same cytodeme as their common ancestor of approximately 200 million years ago. References Further reading Lannér, Carita. "Genetic relationships within the Brassica oleracea cytodeme: comparison of molecular marker systems." Acta Universitatis Agriculturae Sueciae. Agraria (Sweden) (1997). LIU, Yao, and Wei QIAN. "Crossability among Variant Types of Brassica oleracea Cytodeme." Journal of Plant Genetic Resources 14.2 (2013): 342-346. Warwick, S.I.; Black, L.D. (1991). "Molecular systematics of Brassica and allied genera (Subtribe Brassicinae, Brassiceae) ?chloroplast genome and cytodeme congruence". Theoretical and Applied Genetics. 82 (1): 81–92. doi:10.1007/BF00231281. ISSN 0040-5752. PMID 24212864. S2CID 10758800. Gómez-Campo, César, ed. Biology of Brassica coenospecies. Vol. 4. Elsevier, 1999. Kowalski, Stanley P., et al. "Comparative mapping of Arabidopsis thaliana and Brassica oleracea chromosomes reveals islands of conserved organization."Genetics 138.2 (1994): 499-510. Mei, J., et al. "Genetic investigation of the origination of allopolyploid with virtually synthesized lines: application to the C subgenome of Brassica napus."Heredity 106.6 (2011): 955-961.

Cytotaxonomy is the classification of organisms using comparative studies of chromosomes during mitosis. Description Cytotaxonomy is a branch of taxonomy that uses the characteristics of cellular structures to classify organisms. In cytotaxonomy, the chromosomal configuration of an organism is the most widely used parameter to infer the relationship between two organisms. The inference of species relationships is based on the assumption that closely related species share similar characteristics in their chromosomal setup (referred to as karyotype). By analysing the similarities and differences in the chromosomes, karyotype evolution and species evolution can be reconstructed. The number, structure, and behaviour of chromosomes is of great value in taxonomy, with chromosome number being the most widely used and quoted character. Chromosome numbers are usually determined at the metaphase stage during mitosis. Usually, the diploid chromosome number (2n) is referenced, unless dealing with a polyploid series in which case the base number or number of chromosomes in the genome of the original haploid is quoted. Another useful taxonomic character is the position of the centromere. Meiotic behaviour may show the heterozygosity of inversions. This may be constant for a taxon, offering further taxonomic evidence. Often, cytological evidence is accompanied and strengthened by other analyses, including genomics and DNA-based phylogenies. Cytology has contributed to tracking the evolutionary history of many organisms, especially primates and flowering plants. As example, karyotype comparisons have largely clarified the evolution of Arabidopsis thaliana and of saffron crocus, though there are many more studies that deserve highlighting. == References ==

In biology, a deme, in the strict sense, is a group of individuals that belong to the same taxonomic group. However, when biologists, and especially ecologists, use the term ‘deme’ they usually refer to it as the definition of a gamodeme: a local group of individuals (from the same taxon) that interbreed with each other and share a gene pool. The latter definition of a deme is only applicable to sexual reproducing species, while the former is more neutral and also takes asexual reproducing species into account, such as certain plant species. In the following sections the latter (and most frequently used) definition of a deme will be used. In evolutionary computation, a "deme" often refers to any isolated subpopulation subjected to selection as a unit rather than as individuals. Local adaptation A population of a species usually has multiple demes. Environments between these demes can differ. Demes could, therefore, become locally adapted to their environment. A good example of this is the Adaptive Deme Formation (ADF) hypothesis in insects. The ADF hypothesis states that herbivorous insects can become adapted to specific host plants in their local environment because local plants can have unique nutrient patches to which insects may become adapted. This hypothesis predicts that less mobile insect demes are more likely to become locally adapted than more dispersive insect. However, a meta-analysis, based on 17 studies on this subject, showed that dispersive insect demes were as likely to become locally adapted as less mobile insects. Moreover, this study found a small indication that feeding behaviour might stimulate the local adaptation of demes. Endophagous insects were more likely to become locally adapted than exophagous insects. The explanation for this could be that endophagous insects come in more close and continuous contact to the plant's mechanical, chemical and phenological defensive mechanisms. Speciation and demes Speciation could occur at the level of demes. When a deme gets geographically isolated from other demes of the same species, gene-flow between these demes will stop which could lead to speciation after a long time. This is called allopatric speciation and is generally a slow process.On the contrary, sympatric speciation can be more rapid when a species has multiple small demes. This rapid speciation is both observed in plants and vertebrates. Rapid speciation is explained by the ecology and social structure of demes. Species that behave more territorial, live in patchy environments and/or have a polygynous breeding system with only one reproductive male tend to have smaller deme sizes. Interbreeding between small demes is rare due to these factors. Furthermore, alleles fixate more rapidly in smaller demes. Small demes could, therefore, become genetically distinct from each other.Primates, for example, have the second highest speciation rate among mammals, with one speciation event per lineage every 3 million years. However, not all primate species have a high speciation rate; this is reflected in their deme size and social structure. Guenons (Cercopithecus), for example, live together in small polygynous troops and are a quite diverse genus. On the other hand, baboons (Papio) have a much lower speciation rate. Baboons have larger deme sizes because they live in polygynous multi-male troops. These baboon demes are usually allopatric but gene-flow still exists between demes with hybridization being common. Examples Various populations of gorillas can be understood by their geographical separation and have been assessed to determine distinct and disjointed gene pools. The polar bear, Ursus maritimus, is understood to have 19 identifiable demes, even though their circumpolar distribution allows some interchange among the demes. See also Fragmented habitat Population genetics Memetics == References ==

Dermatoglyphics (from Ancient Greek derma, "skin", and glyph, "carving") is the scientific study of fingerprints, lines, mounts and shapes of hands, as distinct from the superficially similar pseudoscience of palmistry. Dermatoglyphics also refers to the making of naturally occurring ridges on certain body parts, namely palms, fingers, soles, and toes. These are areas where hair usually does not grow, and these ridges allow for increased leverage when picking up objects or walking barefoot. In a 2009 report, the scientific basis underlying dermatoglyphics was questioned by the National Academy of Sciences, for the discipline's reliance on subjective comparisons instead of conclusions drawn from the scientific method. History 1823 marks the beginning of the scientific study of papillary ridges of the hands and feet, with the work of Jan Evangelista Purkyně.By 1858, Sir William Herschel, 2nd Baronet, while in India, became the first European to realize the value of fingerprints for identification. Sir Francis Galton conducted extensive research on the importance of skin-ridge patterns, demonstrating their permanence and advancing the science of fingerprint identification with his 1892 book Fingerprints. In 1893, Sir Edward Henry published the book The classification and uses of fingerprints, which marked the beginning of the modern era of fingerprint identification and is the basis for other classification systems. In 1929, Harold Cummins and Charles Midlo M.D., together with others, published the influential book Fingerprints, Palms and Soles, a bible in the field of dermatoglyphics. In 1945, Lionel Penrose, inspired by the works of Cummins and Midlo, conducted his own dermatoglyphic investigations as a part of his research into Down syndrome and other congenital medical disorders. In 1976, Schaumann and Alter published the book Dermatoglyphics in Medical Disorders, which summarizes the findings of dermatoglyphic patterns under disease conditions. In 1982, Seltzer, et al., conducted a study on patients with breast cancer, and concluded that the presence of six or more whorls on a woman's fingertips indicated her being at high risk for breast cancer. Although the study of dermatoglyphics has some adjunctive value in the diagnosis of genetic syndromes (see examples below), there is insufficient evidence to indicate that there is any value in the examination of dermal ridge patterns for the diagnosis of disease or for identifying disease susceptibility. Dermatoglyphics and genetic conditions Dermatoglyphics, when correlated with genetic abnormalities, aids in the diagnosis of congenital malformations at birth or soon after. Klinefelter syndrome: excess of arches on digit 1, more frequent ulnar loops on digit 2, overall fewer whorls, lower ridge counts for loops and whorls as compared with controls, and significant reduction of the total finger ridge count. Cri du chat (5p-): abnormal dermatoglyphics, including single transverse palmar creases and triradii in the t' position on both hands, are associated with 92% of patients, according to a critical review of multiple studies. Congenital blindness: Initial data points to abnormal triradius. Naegeli–Franceschetti–Jadassohn syndrome: patients lack dermatoglyphics of any kind. Noonan syndrome: increased frequency of whorls on fingertips; and the axial triradius t, as in Turner syndrome, is more often in position t' or t" than in controls. Increased incidence of the single transverse palmar crease. Trisomy 13 (Patau syndrome): excess of arches on fingertips and single transverse palmar creases in 60% of patients. Additionally, the hallucal fibular arches tend to form "S" patterns. Trisomy 18 (Edward's syndrome): 6–10 arches on fingertips and single transverse palmar creases in 30% of patients. Trisomy 21 (Down syndrome): people with Down syndrome have a fingerprint pattern with mainly ulnar loops, and a distinct angle between the triradia a, t, and d (the 'adt angle'). Other differences include a single transverse palmar crease ("Simian line") (in 50% of patients), patterns in the hypothenar and interdigital areas, and lower ridge counts along digital midlines, especially in little fingers, which corresponds to finger shortening in those with Down syndrome. There is less variation in dermatoglyphic patterns between people with Down syndrome than between controls, and dermatoglyphic patterns can be used to determine correlations with congenital heart defects in individuals with Down syndrome by examining the left hand digit ridge count minus the right hand digit ridge count, and the number of ridges on the fifth digit of the left hand. Turner syndrome: predominance of whorls, though the pattern frequency depends on the particular chromosomal abnormality. Rubinstein-Taybi Syndrome: preponderance of broad thumbs, low mean ridge count, and fingerprint patterns occurring on interdigital areas. Schizophrenia: A-B ridge counts are generally lower than in controls. Tel Hashomer camptodactyly syndrome : Dermatoglyphic characters that need to be present to diagnose THC are: (a) presence of seven or more whorls on digits (these whorls extend beyond the borders of the terminal phalanges), (b) low main line index, caused by the highly vertical orientation of the A to D radiants, and (c) numerous palmar creases that obliterate the normal structure of the ridges and openings of the sweat pores. Dermatoglyphics and Medical conditions The relationship between different dermatoglyphic traits and various medical diseases have been widely evaluated. Hypertension: A systematic review shows some evidence suggesting that hypertensive patients tend to have an elevated frequency of digital whorl patterns that goes along with having higher average ridge counts than controls. References == Further reading ==

Distyly is a type of heterostyly in which a plant demonstrates reciprocal herkogamy. This breeding system is characterized by two separate flower morphs, where individual plants produce flowers that either have long styles and short stamens (L-morph flowers), or that have short styles and long stamens (S-morph flowers). However, distyly can refer to any plant that shows some degree of self-incompatibility and has two morphs if at least one of the following characteristics is true; there is a difference in style length, filament length, pollen size or shape, or the surface of the stigma. Specifically these plants exhibit intra-morph self-incompatibility, flowers of the same style morph are incompatible. Distylous species that do not exhibit true self-incompatibility generally show a bias towards inter-morph crosses - meaning they exhibit higher success rates when reproducing with an individual of the opposite morph. Background The first scientific account of distyly can be found in Stephan Bejthe's Caroli book Clusii Atrebatis Rariorum aliquot stirpium . Bejthe describes the two floral morphs of Primula veris. Charles Darwin popularized distyly with his account of it in his book The Different Forms of Flowers on Plants of the Same Species. Darwin's book represents the first account of intramorphic self-incompatibility in distylous plants and focuses on garden experiments in which he looks at seed set of different distylous Primula. Darwin names the two floral morphs S- and L-morph, moving away from the vernacular names, Pin (for L-morph) and Thrum (for S-morph), which he states were initially assigned by florist. Distylous species have been identified in 28 families of Angiosperm, likely evolving independently in each family. This means, the system has evolved at least 28 times, though it has been suggested the system has evolved multiple times within some families. Since distyly has evolved more than once, it is considered a case of convergent evolution. Reciprocal herkogamy Reciprocal herkogamy likely evolved to prevent the pollen of the same flower from landing on its own stigma. This in turn promotes outcrossing. In a study of Primula veris it was found that pin flowers exhibit higher rates of self-pollination and capture more pollen than the thrum morph. Different pollinators show varying levels of success while pollinating the different Primula morphs, the head or proboscis length of a pollinator is positively correlated to the uptake of pollen from long styled flowers and negatively correlated for pollen uptake on short styled flowers. The opposite is true for pollinators with smaller heads, such as bees, they uptake more pollen from short styled morphs than long styled ones. The differentiation in pollinators allows the plants to reduce levels of intra-morph pollination. Models of evolution There are two main hypothetical models for the order in which the traits of distyly evolved, the 'selfing avoidance model' and the 'pollen transfer model'. The selfing avoidance model suggests self-incompatibility (SI) evolved first, followed by the morphological difference. It was suggested that the male component of SI would evolve first via a recessive mutation, followed by female characteristics via a dominant mutation, and finally male morphological differences would evolve via a third mutation. The pollen transfer model argues that morphological differences evolved first, and if a species is facing inbreeding depression, it may evolve SI. This model can be used to explain the presence of reciprocal herkogamy in self-compatible species. Genetic control of distyly A supergene, called the self-incompatibility (or S-) locus, is responsible for the occurrence of distyly. The S-locus is composed of three tightly linked genes (S-genes) which segregate as a single unit.Traditionally it was hypothesized that one S-gene controls all female aspects of distyly, one gene that controls the male morphological aspects, and one gene that determines the male mating type. While this hypothesis appears to be true in Turnera, it is not true in Primula nor Linum. The S-morph is hemizygous for the S-locus and the L-morph does not have an allelic counterpart . The hemizygotic nature of the S-locus has been shown in Primula , Gelsemium, Linum , Fagopyrum , Turnera, and Nymphoides.The presence of the S-locus results in changes to gene expression between the two floral morphs, as has been demonstrated using transcriptomic analyses of Lithospermum multiflorum , Primula veris, Primula oreodoxa , Primula vulgaris and Turnera subulata. The S-locus of Fagopyrum The S-morph of Fagopyrum contains ~2.8 Mb hemizygous region which likely represents the S-locus as it contains S-ELF4 which establishes female morphology and mating type. The S-locus of Gelsemium In Gelsemium, the S-locus is composed of four genes, GeCYP, GeFRS6, and GeGA3OX are hemizygous and TAF2 appears to be allelic with a truncated copy in the L-morph. GeCYP appears to share a last common ancestor (or ortholog) with the Primula S-gene CYPT. It is currently hypothesized that the for S-genes in Gelsemium were inherited as a group rather than separately. This is the only known case of the S-genes being inherited as a group rather than individually. The S-locus of Linum In Linum the S-locus is composed of nine genes, two are LtTSS1 and LtWDR-44 the other seven are unnamed and are of unknown function. LtTSS1 is hypothesized to regulate style length in the S-morph. Synonymous substitution analysis of three of the S-genes suggest the S-locus in Linum evolved in a step by step manner, though only three of the nine genes were analyzed. The S-locus of Nymphoides The S-locus of Nymphoides contains three genes NinS1, NinKHZ2, and NinBAS1. NinBAS1 is only expressed in the style and is hypothetical involved in regulation of brassinosteroids, NinS1 is only expressed in the stamen, NinKHZ2 is expressed in both stamen and style. Similar to other S-loci, the Nymphoides S-locus appears to have evolved via stepwise duplication events. The S-locus of Primula In Primula the S-locus is composed of five genes, CYPT(or CYP734A50), GLOT (or GLOBOSA2), KFBT, PUMT, and CCMT. The supergene evolved in a step-by-step manner, meaning each S-gene duplicated and move to the pre-S-locus independently of the others. Synonymous substitution analysis of the S-genes suggest the oldest S-gene in Primula is likely KFBT which likely duplicated about 104 million years ago, followed by CYPT(42.7 MYA),GLOT (37.4 MYA), CCMT(10.3 MYA). It is unknown when PUMT evolved as it does not have a paralog within the Primula genome. Of the five S-genes, two have been characterized. CYPT, a cytochrome P450 family member, is the female morphology and it is the female self-incompatibility gene, meaning it promotes rejection of self pollen. CYPT is likely producing these phenotypes via inactivation of brassinosteroids. Inactivation of brassinosteroids in the S-morph by CYPT results in repression of cell elongation in the style by repressing expression of PIN5, ultimately producing the short pistil phenotype. GLOT , a MADS-BOX family member, is the male morphology gene as it promotes corolla tube growth under the stamen. It is unknown how the other three S-genes are contributing to distyly in Primula. The S-locus of Turnera In Turnera the S-locus is composed of three genes, BAHD, SPH1, and YUC6. BAHD is likely an acyltransferase involved in inactivation of brassinosteroids; it is both the female morphology and female self-incompatibility gene. YUC6 is likely involved in auxin biosynthesis based on homology; it is the male self-incompatibility gene and establishes pollen size dimorphisms. SPH1 is likely involved in filament elongation based on short filament mutant analysis. List of families with distylous species Source: == References ==

A diversity panel is a collection of genetic material or individual samples taken from a diverse population of a certain species. The idea is to illustrate the genetic and phenotypic diversity of the species. Diversity panels exist for human populations, mouse and other organisms. Researchers in the area of genetics often use diversity panels in order to reveal genotypes that are linked to certain traits, such as in QTL mapping with Genome-wide association study. Those study analyze the Gene–environment interaction underneath simple and complex traits. Examples Human Genome Diversity Project The Hybrid Mouse Diversity Panel Maize NAM population (Nested association mapping) Arabidopsis thaliana 1001 Genome project See also Genetics Biodiversity Evolution == References ==

In psychology, a trait (or phenotype) is called emergenic if it is the result of a specific combination of several interacting genes (rather than of a simple sum of several independent genes). Emergenic traits will not run in families, but identical twins will share them. Traits such as "leadership", "genius" or certain mental illnesses may be emergenic. Although one may expect epigenetics to play a significant role in the phenotypic manifestation of twins reared apart, the concordance displayed between them can be attributed to emergenesis. == References ==

Endemixit is a project that studies the effects of reduced population size in five Italian endemic species at risk of extinction. The final objective is to estimate the risk of extinction from genomic data and contribute to the preservation of these species. The project was funded by the MUR (Italian Ministry for Research) and coordinated by the Department of Life Sciences and Biotechnology of the University of Ferrara with the involvement of five other Italian universities: Ancona, Florence, Padua, Rome Tor Vergata and Trieste. Species under study The species considered are all classified in danger or in critical danger of extinction in the IUCN Red List: Podarcis raffonei (Aeolian wall lizard), a lizard with a current range restricted to three Aeolian Islands and subdivided into isolated and relatively distant populations. Hipparchia sbordonii (Ponza grayling), currently only found on some Pontine Islands. Acipenser naccarii (Adriatic sturgeon), once widespread in the Northern Adriatic Sea and in many rivers of Northern Italy, but today almost extinct in nature. Bombina pachypus (Apennine yellow-bellied toad), an endemic and endangered species of the Italian Peninsula closely related to the most common European yellow-bellied toad (B. variegata). Ursus arctos marsicanus (Marsican, or Apennine, brown bear), a subspecies of brown bear (U. arctos), present exclusively in a small region of the central Apennines Mountains. Applications and innovative aspects Endemixit is a genomic project applied to the conservation of biodiversity. Five reference genomes will be produced (one for each endemic species/subspecies), and 20 to 30 individuals per species will be re-sequenced (whole genomes at intermediate coverage). Population genomics analyses will be used to reconstruct past demographic processes and to estimate the genetic load possibly accumulated due to genetic drift. The results will be theoretically important to understand the genetic load dynamic. Practically, they will provide guidelines and priorities for the conservation of these endemics.Endemixit is a partner of the European Reference Genome Atlas (ERGA), a pan-European consortium that aims to produce reference genomes of high quality for all European biodiversity to contribute to the protection of the same. Endemixit is also affiliated to the Earth Biogenome Project (EBP), an international project that aims to sequence the complete genome of all eukaryotic living beings in 10 years. == References ==

Endoreduplication (also referred to as endoreplication or endocycling) is replication of the nuclear genome in the absence of mitosis, which leads to elevated nuclear gene content and polyploidy. Endoreduplication can be understood simply as a variant form of the mitotic cell cycle (G1-S-G2-M) in which mitosis is circumvented entirely, due to modulation of cyclin-dependent kinase (CDK) activity. Examples of endoreduplication characterised in arthropod, mammalian, and plant species suggest that it is a universal developmental mechanism responsible for the differentiation and morphogenesis of cell types that fulfill an array of biological functions. While endoreduplication is often limited to specific cell types in animals, it is considerably more widespread in plants, such that polyploidy can be detected in the majority of plant tissues. Polyploidy and aneuploidy are common phenomena in cancer cells. Given that oncogenesis and endoreduplication likely involve subversion of common cell cycle regulatory mechanisms, a thorough understanding of endoreduplication may provide important insights for cancer biology. Examples in nature Endoreduplicating cell types that have been studied extensively in model organisms Endoreduplication, endomitosis and polytenization Endoreduplication, endomitosis and polytenization are three different processes resulting in polyploidization of a cell in a regulated manner. In endoreduplication cells skip M phase completely by exiting the mitotic cell cycle in the G2 phase after completing the S phase several times, resulting in a mononucleated polyploid cell. The cell ends up with twice as many copies of each chromosome per repeat of the S phase. Endomitosis is a type of cell cycle variation where mitosis is initiated, but stopped during anaphase and thus cytokinesis is not completed. The cell ends up with multiple nuclei in contrast to a cell undergoing endoreduplication. Therefore depending on how far the cell progresses through mitosis, this will give rise to a mononucleated or binucleated polyploid cell. Polytenization arises with under- or overamplification of some genomic regions, creating polytene chromosomes. Biological significance Based on the wide array of cell types in which endoreduplication occurs, a variety of hypotheses have been generated to explain the functional importance of this phenomenon. Unfortunately, experimental evidence to support these conclusions is somewhat limited. Cell differentiation In developing plant tissues the transition from mitosis to endoreduplication often coincides with cell differentiation and morphogenesis. However it remains to be determined whether endoreduplication and polyploidy contribute to cell differentiation or vice versa. Targeted inhibition of endoreduplication in trichome progenitors results in the production of multicellular trichomes that exhibit relatively normal morphology, but ultimately dedifferentiate and undergo absorption into the leaf epidermis. This result suggests that endoreduplication and polyploidy may be required for the maintenance of cell identity. Cell/organism size Cell ploidy often correlates with cell size, and in some instances, disruption of endoreduplication results in diminished cell and tissue size suggesting that endoreduplication may serve as a mechanism for tissue growth. Relative to mitosis, endoreduplication does not require cytoskeletal rearrangement or the production of new cell membrane and it often occurs in cells that have already differentiated. As such it may represent an energetically efficient alternative to cell proliferation among differentiated cell types that can no longer afford to undergo mitosis. While evidence establishing a connection between ploidy and tissue size is prevalent in the literature, contrary examples also exist. Oogenesis and embryonic development Endoreduplication is commonly observed in cells responsible for the nourishment and protection of oocytes and embryos. It has been suggested that increased gene copy number might allow for the mass production of proteins required to meet the metabolic demands of embryogenesis and early development. Consistent with this notion, mutation of the Myc oncogene in Drosophila follicle cells results in reduced endoreduplication and abortive oogenesis. However, reduction of endoreduplication in maize endosperm has limited effect on the accumulation of starch and storage proteins, suggesting that the nutritional requirements of the developing embryo may involve the nucleotides that comprise the polyploid genome rather than the proteins it encodes. Buffering the genome Another hypothesis is that endoreduplication buffers against DNA damage and mutation because it provides extra copies of important genes. However, this notion is purely speculative and there is limited evidence to the contrary. For example, analysis of polyploid yeast strains suggests that they are more sensitive to radiation than diploid strains. Stress response Research in plants suggests that endoreduplication may also play a role in modulating stress responses. By manipulating expression of E2fe (a repressor of endocycling in plants), researchers were able to demonstrate that increased cell ploidy lessens the negative impact of drought stress on leaf size. Given that the sessile lifestyle of plants necessitates a capacity to adapt to environmental conditions, it is appealing to speculate that widespread polyploidization contributes to their developmental plasticity Genetic control of endoreplication The best-studied example of a mitosis-to-endoreduplication transition occurs in Drosophila follicle cells and is activated by Notch signaling. Entry into endoreduplication involves modulation of mitotic and S-phase cyclin-dependent kinase (CDK) activity. Inhibition of M-phase CDK activity is accomplished via transcriptional activation of Cdh/fzr and repression of the G2-M regulator string/cdc25. Cdh/fzr is responsible for activation of the anaphase-promoting complex (APC) and subsequent proteolysis of the mitotic cyclins. String/cdc25 is a phosphatase that stimulates mitotic cyclin-CDK complex activity. Upregulation of S-phase CDK activity is accomplished via transcriptional repression of the inhibitory kinase dacapo. Together, these changes allow for the circumvention of mitotic entry, progression through G1, and entry into S-phase. The induction of endomitosis in mammalian megakaryocytes involves activation of the c-mpl receptor by the thrombopoietin (TPO) cytokine and is mediated by ERK1/2 signaling. As with Drosophila follicle cells, endoreduplication in megakaryocytes results from activation of S-phase cyclin-CDK complexes and inhibition of mitotic cyclin-CDK activity. Entry into S-phase during endoreduplication (and mitosis) is regulated through the formation of a prereplicative complex (pre-RC) at replication origins, followed by recruitment and activation of the DNA replication machinery. In the context of endoreduplication these events are facilitated by an oscillation in cyclin E-Cdk2 activity. Cyclin E-Cdk2 activity drives the recruitment and activation of the replication machinery, but it also inhibits pre-RC formation, presumably to ensure that only one round of replication occurs per cycle. Failure to maintain control over pre-RC formation at replication origins results in a phenomenon known as “rereplication” which is common in cancer cells. The mechanism by which cyclin E-Cdk2 inhibits pre-RC formation involves downregulation of APC-Cdh1-mediated proteolysis and accumulation of the protein Geminin, which is responsible for sequestration of the pre-RC component Cdt1.Oscillations in Cyclin E-Cdk2 activity are modulated via transcriptional and post-transcriptional mechanisms. Expression of cyclin E is activated by E2F transcription factors that were shown to be required for endoreduplication. Recent work suggests that observed oscillations in E2F and cyclin E protein levels result from a negative-feedback loop involving Cul4-dependent ubiquitination and degradation of E2F. Post-transcriptional regulation of cyclin E-Cdk2 activity involves Ago/Fbw7-mediated proteolytic degradation of cyclin E and direct inhibition by factors such as Dacapo and p57. Premeiotic endomitosis in unisexual vertebrates The unisexual salamanders (genus Ambystoma) are the oldest known unisexual vertebrate lineage, having arisen about 5 million years ago. In these polyploid unisexual females, an extra premeiotic endomitotic replication of the genome, doubles the number of chromosomes. As a result, the mature eggs that are produced subsequent to the two meiotic divisions have the same ploidy as the somatic cells of the adult female salamander. Synapsis and recombination during meiotic prophase I in these unisexual females is thought to ordinarily occur between identical sister chromosomes and occasionally between homologous chromosomes. Thus little, if any, genetic variation is produced. Recombination between homeologous chromosomes occurs rarely, if at all. == References ==

An enhanceosome is a protein complex that assembles at an enhancer region on DNA and helps to regulate the expression of a target gene. Formation Enhancers are bound by transcription activator proteins and transcriptional regulation is typically controlled by more than one activator. Enhanceosomes are formed in special cases when these activators cooperatively bind together along the enhancer sequence to create a distinct three-dimensional structure. Each enhanceosome is unique towards its specific enhancer. This assembly is facilitated by energetically favorable protein: protein and protein: DNA interactions. Therefore, all the necessary activators need to be present for the enhanceosome to be formed and able to function. Function Once the enhanceosome has been formed, it recruits coactivators and general transcription factors to the promoter region of the target gene to begin transcription. The effectiveness of this is dependent on DNA conformation. As a result, the enhanceosome also recruits non histone architectural transcription factors, called high-mobility group (HMG) proteins, which are responsible for regulating chromatin structure. These factors do not bind to the enhancer, but instead are used to restructure the DNA to ensure that the genes can be accessed by the transcription factors. Role Most enhanceosomes have been discovered pertaining to genes requiring tight regulation, like those associated with the cells defense system. Using more than one kind of transcriptional activator protein could help to ensure that a gene is not transcribed prematurely. Furthermore, the use of multiple factors enables gene regulation through a combination of cellular stimuli that function through multiple signaling cascades. Examples INF-β The best known example of the enhanceosome acts on the human interferon-beta gene, which is upregulated in cells that are infected by viruses. Three activator proteins—NF-κB, an interferon activator protein such as IRF-3, and the ATF-2/c-Jun complex—cooperatively bind to the upstream enhancer region upon viral infection. The interaction is mediated by a fourth protein HMG-I, which assists in stabilizing the complex by promoting inter-protein interactions. The assembled enhanceosome recruits transcriptional machinery such as RNA polymerase to the promoter region to initiate gene expression. References External links Enhanceosome Molecule of the Month (February 2010) by David Goodsell

The exome is composed of all of the exons within the genome, the sequences which, when transcribed, remain within the mature RNA after introns are removed by RNA splicing. This includes untranslated regions of messenger RNA (mRNA), and coding regions. Exome sequencing has proven to be an efficient method of determining the genetic basis of more than two dozen Mendelian or single gene disorders. Statistics The human exome consists of roughly 233,785 exons, about 80% of which are less than 200 base pairs in length, constituting a total of about 1.1% of the total genome, or about 30 megabases of DNA. Though composing a very small fraction of the genome, mutations in the exome are thought to harbor 85% of mutations that have a large effect on disease. Definition It is important to note that the exome is distinct from the transcriptome, which is all of the transcribed RNA within a cell type. While the exome is constant from cell-type to cell-type, the transcriptome changes based on the structure and function of the cells. As a result, the entirety of the exome is not translated into protein in every cell. Different cell types only transcribe portions of the exome, and only the coding regions of the exons are eventually translated into proteins. Next-generation sequencing Next-generation sequencing (NGS) allows for the rapid sequencing of large amounts of DNA, significantly advancing the study of genetics, and replacing older methods such as Sanger sequencing. This technology is starting to become more common in healthcare and research not only because it is a reliable method of determining genetic variations, but also because it is cost effective and allows researchers to sequence entire genomes in anywhere between days to weeks. This compares to former methods which may have taken months. Next-gen sequencing includes both whole-exome sequencing and whole-genome sequencing. Whole-exome sequencing Sequencing an individual's exome instead of their entire genome has been proposed to be a more cost-effective and efficient way to diagnose rare genetic disorders. It has also been found to be more effective than other methods such as karyotyping and microarrays. This distinction is largely due to the fact that phenotypes of genetic disorders are a result of mutated exons. In addition, since the exome only comprises 1.5% of the total genome, this process is more cost efficient and fast as it involves sequencing around 40 million bases rather than the 3 billion base pairs that make up the genome. Whole-genome sequencing On the other hand, whole genome sequencing has been found to capture a more comprehensive view of variants in the DNA compared to whole-exome sequencing. Especially for single nucleotide variants, whole genome sequencing is more powerful and more sensitive than whole-exome sequencing in detecting potentially disease-causing mutations within the exome. One must also keep in mind that non-coding regions can be involved in the regulation of the exons that make up the exome, and so whole-exome sequencing may not be complete in showing all the sequences at play in forming the exome. Ethical considerations With either form of sequencing, whole-exome sequencing or whole genome sequencing, some have argued that such practices should be done under the consideration of medical ethics. While physicians strive to preserve patient autonomy, sequencing deliberately asks laboratories to look at genetic variants that may be completely unrelated to the patient's condition at hand and have the potential of revealing findings that were not intentionally sought. In addition, such testing have been suggested to have imply forms of discrimination against particular groups for having certain genes, creating the potential for stigmas or negative attitudes towards that group as a result. Diseases and diagnoses Rare mutations that affect the function of essential proteins constitute the majority of Mendelian diseases. In addition, the overwhelming majority of disease-causing mutations in Mendelian loci can be found within the coding region. With the goal of finding methods to best detect harmful mutations and successfully diagnose patients, researchers are looking to the exome for clues to aid in this process. Whole-exome sequencing is a recent technology that has led to the discovery of various genetic disorders and increased the rate of diagnoses of patients with rare genetic disorders. Overall, whole-exome sequencing has allowed healthcare providers to diagnose 30–50% of patients who were thought to have rare Mendelian disorders. It has been suggested that whole-exome sequencing in clinical settings has many unexplored advantages. Not only can the exome increase our understanding of genetic patterns, but under clinical settings, it has the potential to the change in management of patients with rare and previously unknown disorders, allowing physicians to develop more targeted and personalized interventions.For example, Bartter Syndrome, also known as salt-wasting nephropathy, is a hereditary disease of the kidney characterized by hypotension (low blood pressure), hypokalemia (low potassium), and alkalosis (high blood pH) leading to muscle fatigue and varying levels of fatality. It is an example of a rare disease, affecting fewer than one per million people, whose patients have been positively impacted by whole-exome sequencing. Thanks to this method, patients who formerly did not exhibit the classical mutations associated with Bartter Syndrome were formally diagnosed with it after the discovery that the disease has mutations outside of the loci of interest. They were thus able to gain more targeted and productive treatment for the disease. Much of the focus of exome sequencing in the context of disease diagnosis has been on protein coding "loss of function" alleles. Research has shown, however, that future advances that allow the study of non-coding regions, within and without the exome, may lead to additional abilities in the diagnoses of rare Mendelian disorders. The exome is the part of the genome composed of exons, the sequences which, when transcribed, remain within the mature RNA after introns are removed by RNA splicing and contribute to the final protein product encoded by that gene. It consists of all DNA that is transcribed into mature RNA in cells of any type, as distinct from the transcriptome, which is the RNA that has been transcribed only in a specific cell population. The exome of the human genome consists of roughly 180,000 exons constituting about 1% of the total genome, or about 30 megabases of DNA. Though composing a very small fraction of the genome, mutations in the exome are thought to harbor 85% of mutations that have a large effect on disease. Exome sequencing has proved to be an efficient strategy to determine the genetic basis of more than two dozen Mendelian or single gene disorders. See also Coding strand Exome sequencing Gene structure Non-coding DNA Non-coding RNA Transcriptome Transcriptomics == References ==

Extranuclear inheritance or cytoplasmic inheritance is the transmission of genes that occur outside the nucleus. It is found in most eukaryotes and is commonly known to occur in cytoplasmic organelles such as mitochondria and chloroplasts or from cellular parasites like viruses or bacteria. Organelles Mitochondria are organelles which function to transform energy as a result of cellular respiration. Chloroplasts are organelles which function to produce sugars via photosynthesis in plants and algae. The genes located in mitochondria and chloroplasts are very important for proper cellular function. The mitochondrial DNA and other extranuclear types of DNA replicate independently of the DNA located in the nucleus, which is typically arranged in chromosomes that only replicate one time preceding cellular division. The extranuclear genomes of mitochondria and chloroplasts however replicate independently of cell division. They replicate in response to a cell's increasing energy needs which adjust during that cell's lifespan. Since they replicate independently, genomic recombination of these genomes is rarely found in offspring, contrary to nuclear genomes in which recombination is common. Mitochondrial diseases are inherited from the mother, not from the father. Mitochondria with their mitochondrial DNA are already present in the egg cell before it gets fertilized by a sperm. In many cases of fertilization, the head of the sperm enters the egg cell; leaving its middle part, with its mitochondria, behind. The mitochondrial DNA of the sperm often remains outside the zygote and gets excluded from inheritance. Parasites Extranuclear transmission of viral genomes and symbiotic bacteria is also possible. An example of viral genome transmission is perinatal transmission. This occurs from mother to fetus during the perinatal period, which begins before birth and ends about 1 month after birth. During this time viral material may be passed from mother to child in the bloodstream or breastmilk. This is of particular concern with mothers carrying HIV or Hepatitis C viruses. Symbiotic cytoplasmic bacteria are also inherited in organisms such as insects and protists. Types Three general types of extranuclear inheritance exist. Vegetative segregation results from random replication and partitioning of cytoplasmic organelles. It occurs with chloroplasts and mitochondria during mitotic cell divisions and results in daughter cells that contain a random sample of the parent cell's organelles. An example of vegetative segregation is with mitochondria of asexually replicating yeast cells. Uniparental inheritance occurs in extranuclear genes when only one parent contributes organellar DNA to the offspring. A classic example of uniparental gene transmission is the maternal inheritance of human mitochondria. The mother's mitochondria are transmitted to the offspring at fertilization via the egg. The father's mitochondrial genes are not transmitted to the offspring via the sperm. Very rare cases which require further investigation have been reported of paternal mitochondrial inheritance in humans, in which the father's mitochondrial genome is found in offspring. Chloroplast genes can also inherit uniparentally during sexual reproduction. They are historically thought to inherit maternally, but paternal inheritance in many species is increasingly being identified. The mechanisms of uniparental inheritance from species to species differ greatly and are quite complicated. For instance, chloroplasts have been found to exhibit maternal, paternal and biparental modes even within the same species. In tobacco (Nicotiana tabacum), the mode of chloroplast inheritance is affected by the temperature and the enzymatic activity of an exonuclease during male gametogenesis. Biparental inheritance occurs in extranuclear genes when both parents contribute organellar DNA to the offspring. It may be less common than uniparental extranuclear inheritance, and usually occurs in a permissible species only a fraction of the time. An example of biparental mitochondrial inheritance is in the yeast Saccharomyces cerevisiae. When two haploid cells of opposite mating type fuse they can both contribute mitochondria to the resulting diploid offspring. Mutant mitochondria Poky is a mutant of the fungus Neurospora crassa that has extranuclear inheritance. Poky is characterized by slow growth, a defect in mitochondrial ribosome assembly and deficiencies in several cytochromes. The studies of poky mutants were among the first to establish an extranuclear mitochondrial basis for inheritance of a particular genotype. It was initially found, using genetic crosses, that poky is maternally inherited. Subsequently, the primary defect in the poky mutants was determined to be a deletion in the mitochondrial DNA sequence encoding the small subunit of mitochondrial ribosomal RNA. See also Maternal effect Plasmid Xenia (plants) References External links https://web.archive.org/web/20080521093531/http://www.tamu.edu/classes/magill/gene603/Lecture%20outlines/cytoplasmic%20inh/CYTOPLASMIC_INHERITANCE.html

Gene mapping or genome mapping describes the methods used to identify the location of a gene on a chromosome and the distances between genes. Gene mapping can also describe the distances between different sites within a gene. The essence of all genome mapping is to place a collection of molecular markers onto their respective positions on the genome. Molecular markers come in all forms. Genes can be viewed as one special type of genetic markers in the construction of genome maps, and mapped the same way as any other markers. In some areas of study, gene mapping contributes to the creation of new recombinants within an organism.Gene maps help describe the spatial arrangement of genes on a chromosome. Genes are designated to a specific location on a chromosome known as the locus and can be used as molecular markers to find the distance between other genes on a chromosome. Maps provide researchers with the opportunity to predict the inheritance patterns of specific traits, which can eventually lead to a better understanding of disease-linked traits.The genetic basis to gene maps is to provide an outline that can potentially help researchers carry out DNA sequencing. A gene map helps point out the relative positions of genes and allows researchers to locate regions of interest in the genome. Genes can then be identified quickly and sequenced quickly.Two approaches to generating gene maps (gene mapping) include physical mapping and genetic mapping. Physical mapping utilizes molecular biology techniques to inspect chromosomes. These techniques consequently allow researchers to observe chromosomes directly so that a map may be constructed with relative gene positions. Genetic mapping on the other hand uses genetic techniques to indirectly find association between genes. Techniques can include cross-breeding (hybrid) experiments and examining pedigrees. These technique allow for maps to be constructed so that relative positions of genes and other important sequences can be analyzed. Mapping approaches There are two distinctive mapping approaches used in the field of genome mapping: genetic maps (also known as linkage maps) and physical maps. While both maps are a collection of genetic markers and gene loci, genetic maps' distances are based on the genetic linkage information, while physical maps use actual physical distances usually measured in number of base pairs. While the physical map could be a more accurate representation of the genome, genetic maps often offer insights into the nature of different regions of the chromosome, for example the genetic distance to physical distance ratio varies greatly at different genomic regions which reflects different recombination rates, and such rate is often indicative of euchromatic (usually gene-rich) vs heterochromatic (usually gene-poor) regions of the genome. Genetic mapping Researchers begin a genetic map by collecting samples of blood, saliva, or tissue from family members that carry a prominent disease or trait and family members that do not. The most common sample used in gene mapping, especially in personal genomic tests is saliva. Scientists then isolate DNA from the samples and closely examine it, looking for unique patterns in the DNA of the family members who do carry the disease and the DNA of those who do not carry the disease do not have. These unique molecular patterns in the DNA are referred to as polymorphisms, or markers.The first steps of building a genetic map are the development of genetic markers and a mapping population. The closer two markers are on the chromosome, the more likely they are to be passed on to the next generation together. Therefore, the "co-segregation" patterns of all markers can be used to reconstruct their order. With this in mind, the genotypes of each genetic marker are recorded for both parents and each individual in the following generations. The quality of the genetic maps is largely dependent upon these factors: the number of genetic markers on the map and the size of the mapping population. The two factors are interlinked, as a larger mapping population could increase the "resolution" of the map and prevent the map from being "saturated". In gene mapping, any sequence feature that can be faithfully distinguished from the two parents can be used as a genetic marker. Genes, in this regard, are represented by "traits" that can be faithfully distinguished between two parents. Their linkage with other genetic markers is calculated in the same way as if they are common markers and the actual gene loci are then bracketed in a region between the two nearest neighboring markers. The entire process is then repeated by looking at more markers that target that region to map the gene neighborhood to a higher resolution until a specific causative locus can be identified. This process is often referred to as "positional cloning", and it is used extensively in the study of plant species. One plant species, in particular in which positional cloning is utilized is in maize. The great advantage of genetic mapping is that it can identify the relative position of genes based solely on their phenotypic effect. Genetic mapping is a way to identify exactly which chromosome has which gene and exactly pinpointing where that gene lies on that particular chromosome. Mapping also acts as a method in determining which gene is most likely to recombine based on the distance between two genes. The distance between two genes is measured in units known as centimorgan or map units, these terms are interchangeable. A centimorgan is a distance between genes for which one product of meiosis in one hundred is recombinant. The farther two genes are from each other, the more likely they are going to recombine. If it were closer, the opposite would occur. Linkage analysis The basis to linkage analysis is understanding chromosomal location and identifying disease genes. Certain genes that are genetically linked or associated with each other reside close to each other on the same chromosome. During meiosis, these genes are capable of being inherited together and can be used as a genetic marker to help identify the phenotype of diseases. Because linkage analysis can identify inheritance patterns, these studies are usually family based. Gene association analysis Gene association analysis is population based; it is not focused on inheritance patterns, but rather is based on the entire history of a population. Gene association analysis looks at a particular population and tries to identify whether the frequency of an allele in affected individuals is different from that of a control set of unaffected individuals of the same population. This method is particularly useful to identify complex diseases that do not have a Mendelian inheritance pattern. Physical mapping Since actual base-pair distances are generally hard or not possible to directly measure, physical maps are actually constructed by first shattering the genome into hierarchically smaller pieces. By characterizing each single piece and assembling back together, the overlapping path or "tiling path" of these small fragments would allow researchers to infer physical distances between genomic features. Restriction mapping is a method in which structural information regarding a segment of DNA is obtained using restriction enzymes. Restriction enzymes are enzymes that help cut segments of DNA at specific recognition sequences. The basis to restriction mapping involves digesting (or cutting) DNA with restriction enzymes. The digested DNA fragments are then run on an agarose gel using electrophoresis, which provides one with information regarding the size of these digested fragments. The sizes of these fragments help indicate the distance between restriction enzyme sites on the DNA analyzed, and provides researchers with information regarding the structure of DNA analyzed. The resulting pattern of DNA migration – its genetic fingerprint is used to identify what stretch of DNA is in the clone. By analyzing the fingerprints, contigs are assembled by automated (FPC) or manual means (pathfinders) into overlapping DNA stretches. Now a good choice of clones can be made to efficiently sequence the clones to determine the DNA sequence of the organism under study. In physical mapping, there are no direct ways of marking up a specific gene since the mapping does not include any information that concerns traits and functions. Genetic markers can be linked to a physical map by processes like in situ hybridization. By this approach, physical map contigs can be "anchored" onto a genetic map. The clones used in the physical map contigs can then be sequenced on a local scale to help new genetic marker design and identification of the causative loci. Macrorestriction is a type of physical mapping wherein the high molecular weight DNA is digested with a restriction enzyme having a low number of restriction sites. There are alternative ways to determine how DNA in a group of clones overlaps without completely sequencing the clones. Once the map is determined, the clones can be used as a resource to efficiently contain large stretches of the genome. This type of mapping is more accurate than genetic maps. Restriction mapping Restriction mapping is a method in which structural information regarding a segment of DNA is obtained using restriction enzymes. Restriction enzymes are enzymes that help cut segments of DNA at specific recognition sequences. The basis to restriction mapping involves digesting (or cutting) DNA with restriction enzymes. The digested DNA fragments are then run on an agarose gel using electrophoresis, which provides one with information regarding the size of these digested fragments. The sizes of these fragments help indicate the distance between restriction enzyme sites on the DNA analyzed, and provides researchers with information regarding the structure of DNA analyzed. Fluorescent in situ hybridization Fluorescence in situ hybridization (FISH) is a method used to detect the presence (or absence) of a DNA sequence within a cell. DNA probes that are specific for chromosomal regions or genes of interest are labeled with fluorochromes. By attaching fluorochromes to probes, researchers are able to visualize multiple DNA sequences simultaneously. When a probe comes into contact with DNA on a specific chromosome, hybridization will occur. Consequently, information regarding the location of that sequence of DNA will be attained. FISH analyzes single stranded DNA (ssDNA). Once the DNA is in its single stranded state, the DNA can bind to its specific probe. Sequence-tagged site (STS) mapping A sequence-tagged site (STS) is a short sequence of DNA (about 100 - 500 base pairs in length) that is seen to appear multiple times within an individual's genome. These sites are easily recognizable, usually appearing at least once in the DNA being analyzed. These sites usually contain genetic polymorphisms making them sources of viable genetic markers (as they differ from other sequences). Sequenced tagged sites can be mapped within our genome and require a group of overlapping DNA fragments. PCR is generally used to produce the collection of DNA fragments. After overlapping fragments are created, the map distance between STSs can be analyzed. In order to calculate the map distance between STSs, researchers determine the frequency at which breaks between the two markers occur (see shotgun sequencing) Mapping mutational sites In the early 1950s the prevailing view was that the genes in a chromosome are discrete entities, indivisible by genetic recombination and arranged like beads on a string. During 1955 to 1959, Benzer performed genetic recombination experiments using rII mutants of bacteriophage T4. He found that, on the basis of recombination tests, the sites of mutation could be mapped in a linear order. This result provided evidence for the key idea that the gene has a linear structure equivalent to a length of DNA with many sites that can independently mutate. In 1961, Francis Crick, Leslie Barnett, Sydney Brenner and Richard Watts-Tobin performed genetic experiments that demonstrated the basic nature of the genetic code for proteins. These experiments, involving mapping of mutational sites within the rIIB gene of bacteriophage T4, demonstrated that three sequential nucleobases of the gene's DNA specify each successive amino acid of its encoded protein. Thus the genetic code was shown to be a triplet code, where each triplet (called a codon) specifies a particular amino acid. They also obtained evidence that the codons do not overlap with each other in the DNA sequence encoding a protein, and that such a sequence is read from a fixed starting point. Edgar et al. performed mapping experiments with r mutants of bacteriophage T4 showing that recombination frequencies between rII mutants are not strictly additive. The recombination frequency from a cross of two rII mutants (a x d) is usually less than the sum of recombination frequencies for adjacent internal sub-intervals (a x b) + (b x c) + (c x d). Although not strictly additive, a systematic relationship was demonstrated that likely reflects the underlying molecular mechanism of genetic recombination. Genome sequencing Genome sequencing is sometimes mistakenly referred to as "genome mapping" by non-biologists. The process of shotgun sequencing resembles the process of physical mapping: it shatters the genome into small fragments, characterizes each fragment, then puts them back together (more recent sequencing technologies are drastically different). While the scope, purpose and process are totally different, a genome assembly can be viewed as the "ultimate" form of physical map, in that it provides in a much better way all the information that a traditional physical map can offer. Use Identification of genes is usually the first step in understanding a genome of a species; mapping of the gene is usually the first step of identification of the gene. Gene mapping is usually the starting point of many important downstream studies. Disease association The process to identify a genetic element that is responsible for a disease is also referred to as "mapping". If the locus in which the search is performed is already considerably constrained, the search is called the fine mapping of a gene. This information is derived from the investigation of disease manifestations in large families (genetic linkage) or from populations-based genetic association studies. Using the methods mentioned above, researchers are capable of mapping disease genes. Generating a gene map is the critical first step towards identifying disease genes. Gene maps allow for variant alleles to be identified and allow for researchers to make predictions about the genes they think are causing the mutant phenotype. An example of a disorder that was identified by Linkage analysis is Cystic Fibrosis. For example, with Cystic Fibrosis (CF), DNA samples from fifty families affected by CF were analyzed using linkage analysis. Hundreds of markers pertaining to CF were analyzed throughout the genome until CF was identified on the long arm of chromosome 7. Researchers then had completed linkage analysis on additional DNA markers within chromosome 7 to identify an even more precise location of the CF gene. They found that the CF gene resides around 7q31-q32 (see chromosomal nomenclature). See also Eukaryotic chromosome fine structure Fate mapping G banding Genetic fingerprinting Genome project Human Genome Project Optical mapping Quantitative trait locus Sulston score References Further reading External links "Genetic Mapping Fact Sheet". Bethesda, MD: National Human Genome Research Institute, National Institutes of Health. Retrieved 2013-09-06. "Canada's Michael Smith Genome Sciences Centre". Vancouver, British Columbia. Retrieved 2013-09-06.

The genetic code is the set of rules used by living cells to translate information encoded within genetic material (DNA or RNA sequences of nucleotide triplets, or codons) into proteins. Translation is accomplished by the ribosome, which links proteinogenic amino acids in an order specified by messenger RNA (mRNA), using transfer RNA (tRNA) molecules to carry amino acids and to read the mRNA three nucleotides at a time. The genetic code is highly similar among all organisms and can be expressed in a simple table with 64 entries. The codons specify which amino acid will be added next during protein biosynthesis. With some exceptions, a three-nucleotide codon in a nucleic acid sequence specifies a single amino acid. The vast majority of genes are encoded with a single scheme (see the RNA codon table). That scheme is often referred to as the canonical or standard genetic code, or simply the genetic code, though variant codes (such as in mitochondria) exist. History Efforts to understand how proteins are encoded began after DNA's structure was discovered in 1953. The key discoverers, English biophysicist Francis Crick and American biologist James Watson, working together at the Cavendish Laboratory of the University of Cambridge, hypothesied that information flows from DNA and that there is a link between DNA and proteins. Soviet-American physicist George Gamow was the first to give a workable scheme for protein synthesis from DNA. He postulated that sets of three bases (triplets) must be employed to encode the 20 standard amino acids used by living cells to build proteins, which would allow a maximum of 43 = 64 amino acids. He named this DNA–protein interaction (the original genetic code) as the "diamond code".In 1954, Gamow created an informal scientific organisation the RNA Tie Club, as suggested by Watson, for scientists of different persuasions who were interested in how proteins were synthesised from genes. However, the club could have only 20 permanent members to represent each of the 20 amino acids; and four additional honorary members to represent the four nucleotides of DNA.The first scientific contribution of the club, later recorded as "one of the most important unpublished articles in the history of science" and "the most famous unpublished paper in the annals of molecular biology", was made by Crick. Crick presented a type-written paper titled "On Degenerate Templates and the Adaptor Hypothesis: A Note for the RNA Tie Club" to the members of the club in January 1955, which "totally changed the way we thought about protein synthesis", as Watson recalled. The hypothesis states that the triplet code was not passed on to amino acids as Gamow thought, but carried by a different molecule, an adaptor, that interacts with amino acids. The adaptor was later identified as tRNA. Codons The Crick, Brenner, Barnett and Watts-Tobin experiment first demonstrated that codons consist of three DNA bases. Marshall Nirenberg and J. Heinrich Matthaei were the first to reveal the nature of a codon in 1961. They used a cell-free system to translate a poly-uracil RNA sequence (i.e., UUUUU...) and discovered that the polypeptide that they had synthesized consisted of only the amino acid phenylalanine. They thereby deduced that the codon UUU specified the amino acid phenylalanine. This was followed by experiments in Severo Ochoa's laboratory that demonstrated that the poly-adenine RNA sequence (AAAAA...) coded for the polypeptide poly-lysine and that the poly-cytosine RNA sequence (CCCCC...) coded for the polypeptide poly-proline. Therefore, the codon AAA specified the amino acid lysine, and the codon CCC specified the amino acid proline. Using various copolymers most of the remaining codons were then determined. Subsequent work by Har Gobind Khorana identified the rest of the genetic code. Shortly thereafter, Robert W. Holley determined the structure of transfer RNA (tRNA), the adapter molecule that facilitates the process of translating RNA into protein. This work was based upon Ochoa's earlier studies, yielding the latter the Nobel Prize in Physiology or Medicine in 1959 for work on the enzymology of RNA synthesis.Extending this work, Nirenberg and Philip Leder revealed the code's triplet nature and deciphered its codons. In these experiments, various combinations of mRNA were passed through a filter that contained ribosomes, the components of cells that translate RNA into protein. Unique triplets promoted the binding of specific tRNAs to the ribosome. Leder and Nirenberg were able to determine the sequences of 54 out of 64 codons in their experiments. Khorana, Holley and Nirenberg received the 1968 Nobel for their work.The three stop codons were named by discoverers Richard Epstein and Charles Steinberg. "Amber" was named after their friend Harris Bernstein, whose last name means "amber" in German. The other two stop codons were named "ochre" and "opal" in order to keep the "color names" theme. Expanded genetic codes (synthetic biology) In a broad academic audience, the concept of the evolution of the genetic code from the original and ambiguous genetic code to a well-defined ("frozen") code with the repertoire of 20 (+2) canonical amino acids is widely accepted. However, there are different opinions, concepts, approaches and ideas, which is the best way to change it experimentally. Even models are proposed that predict "entry points" for synthetic amino acid invasion of the genetic code.Since 2001, 40 non-natural amino acids have been added into proteins by creating a unique codon (recoding) and a corresponding transfer-RNA:aminoacyl – tRNA-synthetase pair to encode it with diverse physicochemical and biological properties in order to be used as a tool to exploring protein structure and function or to create novel or enhanced proteins.H. Murakami and M. Sisido extended some codons to have four and five bases. Steven A. Benner constructed a functional 65th (in vivo) codon.In 2015 N. Budisa, D. Söll and co-workers reported the full substitution of all 20,899 tryptophan residues (UGG codons) with unnatural thienopyrrole-alanine in the genetic code of the bacterium Escherichia coli.In 2016 the first stable semisynthetic organism was created. It was a (single cell) bacterium with two synthetic bases (called X and Y). The bases survived cell division.In 2017, researchers in South Korea reported that they had engineered a mouse with an extended genetic code that can produce proteins with unnatural amino acids.In May 2019, researchers reported the creation of a new "Syn61" strain of the bacterium Escherichia coli. This strain has a fully synthetic genome that is refactored (all overlaps expanded), recoded (removing the use of three out of 64 codons completely), and further modified to remove the now unnecessary tRNAs and release factors. It is fully viable and grows 1.6× slower than its wild-type counterpart "MDS42". Features Reading frame A reading frame is defined by the initial triplet of nucleotides from which translation starts. It sets the frame for a run of successive, non-overlapping codons, which is known as an "open reading frame" (ORF). For example, the string 5'-AAATGAACG-3' (see figure), if read from the first position, contains the codons AAA, TGA, and ACG ; if read from the second position, it contains the codons AAT and GAA ; and if read from the third position, it contains the codons ATG and AAC. Every sequence can, thus, be read in its 5' → 3' direction in three reading frames, each producing a possibly distinct amino acid sequence: in the given example, Lys (K)-Trp (W)-Thr (T), Asn (N)-Glu (E), or Met (M)-Asn (N), respectively (when translating with the vertebrate mitochondrial code). When DNA is double-stranded, six possible reading frames are defined, three in the forward orientation on one strand and three reverse on the opposite strand.: 330  Protein-coding frames are defined by a start codon, usually the first AUG (ATG) codon in the RNA (DNA) sequence. In eukaryotes, ORFs in exons are often interrupted by introns. Start and stop codons Translation starts with a chain-initiation codon or start codon. The start codon alone is not sufficient to begin the process. Nearby sequences such as the Shine-Dalgarno sequence in E. coli and initiation factors are also required to start translation. The most common start codon is AUG, which is read as methionine or as formylmethionine (in bacteria, mitochondria, and plastids). Alternative start codons depending on the organism include "GUG" or "UUG"; these codons normally represent valine and leucine, respectively, but as start codons they are translated as methionine or formylmethionine.The three stop codons have names: UAG is amber, UGA is opal (sometimes also called umber), and UAA is ochre. Stop codons are also called "termination" or "nonsense" codons. They signal release of the nascent polypeptide from the ribosome because no cognate tRNA has anticodons complementary to these stop signals, allowing a release factor to bind to the ribosome instead. Effect of mutations During the process of DNA replication, errors occasionally occur in the polymerization of the second strand. These errors, mutations, can affect an organism's phenotype, especially if they occur within the protein coding sequence of a gene. Error rates are typically 1 error in every 10–100 million bases—due to the "proofreading" ability of DNA polymerases.Missense mutations and nonsense mutations are examples of point mutations that can cause genetic diseases such as sickle-cell disease and thalassemia respectively. Clinically important missense mutations generally change the properties of the coded amino acid residue among basic, acidic, polar or non-polar states, whereas nonsense mutations result in a stop codon.Mutations that disrupt the reading frame sequence by indels (insertions or deletions) of a non-multiple of 3 nucleotide bases are known as frameshift mutations. These mutations usually result in a completely different translation from the original, and likely cause a stop codon to be read, which truncates the protein. These mutations may impair the protein's function and are thus rare in in vivo protein-coding sequences. One reason inheritance of frameshift mutations is rare is that, if the protein being translated is essential for growth under the selective pressures the organism faces, absence of a functional protein may cause death before the organism becomes viable. Frameshift mutations may result in severe genetic diseases such as Tay–Sachs disease.Although most mutations that change protein sequences are harmful or neutral, some mutations have benefits. These mutations may enable the mutant organism to withstand particular environmental stresses better than wild type organisms, or reproduce more quickly. In these cases a mutation will tend to become more common in a population through natural selection. Viruses that use RNA as their genetic material have rapid mutation rates, which can be an advantage, since these viruses thereby evolve rapidly, and thus evade the immune system defensive responses. In large populations of asexually reproducing organisms, for example, E. coli, multiple beneficial mutations may co-occur. This phenomenon is called clonal interference and causes competition among the mutations. Degeneracy Degeneracy is the redundancy of the genetic code. This term was given by Bernfield and Nirenberg. The genetic code has redundancy but no ambiguity (see the codon tables below for the full correlation). For example, although codons GAA and GAG both specify glutamic acid (redundancy), neither specifies another amino acid (no ambiguity). The codons encoding one amino acid may differ in any of their three positions. For example, the amino acid leucine is specified by YUR or CUN (UUA, UUG, CUU, CUC, CUA, or CUG) codons (difference in the first or third position indicated using IUPAC notation), while the amino acid serine is specified by UCN or AGY (UCA, UCG, UCC, UCU, AGU, or AGC) codons (difference in the first, second, or third position). A practical consequence of redundancy is that errors in the third position of the triplet codon cause only a silent mutation or an error that would not affect the protein because the hydrophilicity or hydrophobicity is maintained by equivalent substitution of amino acids; for example, a codon of NUN (where N = any nucleotide) tends to code for hydrophobic amino acids. NCN yields amino acid residues that are small in size and moderate in hydropathicity; NAN encodes average size hydrophilic residues. The genetic code is so well-structured for hydropathicity that a mathematical analysis (Singular Value Decomposition) of 12 variables (4 nucleotides x 3 positions) yields a remarkable correlation (C = 0.95) for predicting the hydropathicity of the encoded amino acid directly from the triplet nucleotide sequence, without translation. Note in the table, below, eight amino acids are not affected at all by mutations at the third position of the codon, whereas in the figure above, a mutation at the second position is likely to cause a radical change in the physicochemical properties of the encoded amino acid. Nevertheless, changes in the first position of the codons are more important than changes in the second position on a global scale. The reason may be that charge reversal (from a positive to a negative charge or vice versa) can only occur upon mutations in the first position of certain codons, but not upon changes in the second position of any codon. Such charge reversal may have dramatic consequences for the structure or function of a protein. This aspect may have been largely underestimated by previous studies. Codon usage bias The frequency of codons, also known as codon usage bias, can vary from species to species with functional implications for the control of translation. The codon varies by organism; for example, most common proline codon in E. coli is CCG, whereas in humans this is the least used proline codon. Alternative genetic codes Non-standard amino acids In some proteins, non-standard amino acids are substituted for standard stop codons, depending on associated signal sequences in the messenger RNA. For example, UGA can code for selenocysteine and UAG can code for pyrrolysine. Selenocysteine came to be seen as the 21st amino acid, and pyrrolysine as the 22nd. Unlike selenocysteine, pyrrolysine-encoded UAG is translated with the participation of a dedicated aminoacyl-tRNA synthetase. Both selenocysteine and pyrrolysine may be present in the same organism. Although the genetic code is normally fixed in an organism, the achaeal prokaryote Acetohalobium arabaticum can expand its genetic code from 20 to 21 amino acids (by including pyrrolysine) under different conditions of growth. Variations There was originally a simple and widely accepted argument that the genetic code should be universal: namely, that any variation in the genetic code would be lethal to the organism (although Crick had stated that viruses were an exception). This is known as the "frozen accident" argument for the universality of the genetic code. However, in his seminal paper on the origins of the genetic code in 1968, Francis Crick still stated that the universality of the genetic code in all organisms was an unproven assumption, and was probably not true in some instances. He predicted that "The code is universal (the same in all organisms) or nearly so". The first variation was discovered in 1979, by researchers studying human mitochondrial genes. Many slight variants were discovered thereafter, including various alternative mitochondrial codes. These minor variants for example involve translation of the codon UGA as tryptophan in Mycoplasma species, and translation of CUG as a serine rather than leucine in yeasts of the "CTG clade" (such as Candida albicans). Because viruses must use the same genetic code as their hosts, modifications to the standard genetic code could interfere with viral protein synthesis or functioning. However, viruses such as totiviruses have adapted to the host's genetic code modification. In bacteria and archaea, GUG and UUG are common start codons. In rare cases, certain proteins may use alternative start codons. Surprisingly, variations in the interpretation of the genetic code exist also in human nuclear-encoded genes: In 2016, researchers studying the translation of malate dehydrogenase found that in about 4% of the mRNAs encoding this enzyme the stop codon is naturally used to encode the amino acids tryptophan and arginine. This type of recoding is induced by a high-readthrough stop codon context and it is referred to as functional translational readthrough.Despite these differences, all known naturally occurring codes are very similar. The coding mechanism is the same for all organisms: three-base codons, tRNA, ribosomes, single direction reading and translating single codons into single amino acids. The most extreme variations occur in certain ciliates where the meaning of stop codons depends on their position within mRNA. When close to the 3' end they act as terminators while in internal positions they either code for amino acids as in Condylostoma magnum or trigger ribosomal frameshifting as in Euplotes.The origins and variation of the genetic code, including the mechanisms behind the evolvability of the genetic code, have been widely studied, and some studies have been done experimentally evolving the genetic code of some organisms. Inference Variant genetic codes used by an organism can be inferred by identifying highly conserved genes encoded in that genome, and comparing its codon usage to the amino acids in homologous proteins of other organisms. For example, the program FACIL infers a genetic code by searching which amino acids in homologous protein domains are most often aligned to every codon. The resulting amino acid (or stop codon) probabilities for each codon are displayed in a genetic code logo.As of January 2022, the most complete survey of genetic codes is done by Shulgina and Eddy, who screened 250,000 prokaryotic genomes using their Codetta tool. This tool uses a similar approach to FACIL with a larger Pfam database. Despite the NCBI already providing 27 translation tables, the authors were able to find new 5 genetic code variations (corroborated by tRNA mutations) and correct several misattributions. Codetta was later used to analyze genetic code change in ciliates. Origin The genetic code is a key part of the history of life, according to one version of which self-replicating RNA molecules preceded life as we know it. This is the RNA world hypothesis. Under this hypothesis, any model for the emergence of the genetic code is intimately related to a model of the transfer from ribozymes (RNA enzymes) to proteins as the principal enzymes in cells. In line with the RNA world hypothesis, transfer RNA molecules appear to have evolved before modern aminoacyl-tRNA synthetases, so the latter cannot be part of the explanation of its patterns.A hypothetical randomly evolved genetic code further motivates a biochemical or evolutionary model for its origin. If amino acids were randomly assigned to triplet codons, there would be 1.5 × 1084 possible genetic codes.: 163  This number is found by calculating the number of ways that 21 items (20 amino acids plus one stop) can be placed in 64 bins, wherein each item is used at least once. However, the distribution of codon assignments in the genetic code is nonrandom. In particular, the genetic code clusters certain amino acid assignments. Amino acids that share the same biosynthetic pathway tend to have the same first base in their codons. This could be an evolutionary relic of an early, simpler genetic code with fewer amino acids that later evolved to code a larger set of amino acids. It could also reflect steric and chemical properties that had another effect on the codon during its evolution. Amino acids with similar physical properties also tend to have similar codons, reducing the problems caused by point mutations and mistranslations.Given the non-random genetic triplet coding scheme, a tenable hypothesis for the origin of genetic code could address multiple aspects of the codon table, such as absence of codons for D-amino acids, secondary codon patterns for some amino acids, confinement of synonymous positions to third position, the small set of only 20 amino acids (instead of a number approaching 64), and the relation of stop codon patterns to amino acid coding patterns.Three main hypotheses address the origin of the genetic code. Many models belong to one of them or to a hybrid: Random freeze: the genetic code was randomly created. For example, early tRNA-like ribozymes may have had different affinities for amino acids, with codons emerging from another part of the ribozyme that exhibited random variability. Once enough peptides were coded for, any major random change in the genetic code would have been lethal; hence it became "frozen". Stereochemical affinity: the genetic code is a result of a high affinity between each amino acid and its codon or anti-codon; the latter option implies that pre-tRNA molecules matched their corresponding amino acids by this affinity. Later during evolution, this matching was gradually replaced with matching by aminoacyl-tRNA synthetases. Optimality: the genetic code continued to evolve after its initial creation, so that the current code maximizes some fitness function, usually some kind of error minimization.Hypotheses have addressed a variety of scenarios: Chemical principles govern specific RNA interaction with amino acids. Experiments with aptamers showed that some amino acids have a selective chemical affinity for their codons. Experiments showed that of 8 amino acids tested, 6 show some RNA triplet-amino acid association. Biosynthetic expansion. The genetic code grew from a simpler earlier code through a process of "biosynthetic expansion". Primordial life "discovered" new amino acids (for example, as by-products of metabolism) and later incorporated some of these into the machinery of genetic coding. Although much circumstantial evidence has been found to suggest that fewer amino acid types were used in the past, precise and detailed hypotheses about which amino acids entered the code in what order are controversial. However, several studies have suggested that Gly, Ala, Asp, Val, Ser, Pro, Glu, Leu, Thr may belong to a group of early-addition amino acids, whereas Cys, Met, Tyr, Trp, His, Phe may belong to a group of later-addition amino acids. Natural selection has led to codon assignments of the genetic code that minimize the effects of mutations. A recent hypothesis suggests that the triplet code was derived from codes that used longer than triplet codons (such as quadruplet codons). Longer than triplet decoding would increase codon redundancy and would be more error resistant. This feature could allow accurate decoding absent complex translational machinery such as the ribosome, such as before cells began making ribosomes. Information channels: Information-theoretic approaches model the process of translating the genetic code into corresponding amino acids as an error-prone information channel. The inherent noise (that is, the error) in the channel poses the organism with a fundamental question: how can a genetic code be constructed to withstand noise while accurately and efficiently translating information? These "rate-distortion" models suggest that the genetic code originated as a result of the interplay of the three conflicting evolutionary forces: the needs for diverse amino acids, for error-tolerance and for minimal resource cost. The code emerges at a transition when the mapping of codons to amino acids becomes nonrandom. The code's emergence is governed by the topology defined by the probable errors and is related to the map coloring problem. Game theory: Models based on signaling games combine elements of game theory, natural selection and information channels. Such models have been used to suggest that the first polypeptides were likely short and had non-enzymatic function. Game theoretic models suggested that the organization of RNA strings into cells may have been necessary to prevent "deceptive" use of the genetic code, i.e. preventing the ancient equivalent of viruses from overwhelming the RNA world. Stop codons: Codons for translational stops are also an interesting aspect to the problem of the origin of the genetic code. As an example for addressing stop codon evolution, it has been suggested that the stop codons are such that they are most likely to terminate translation early in the case of a frame shift error. In contrast, some stereochemical molecular models explain the origin of stop codons as "unassignable". See also List of genetic engineering software Codon tables References Further reading External links The Genetic Codes: Genetic Code Tables The Codon Usage Database — Codon frequency tables for many organisms History of deciphering the genetic code

Genetics is the study of genes, genetic variation, and heredity in organisms. It is an important branch in biology because heredity is vital to organisms' evolution. Gregor Mendel, a Moravian Augustinian friar working in the 19th century in Brno, was the first to study genetics scientifically. Mendel studied "trait inheritance", patterns in the way traits are handed down from parents to offspring over time. He observed that organisms (pea plants) inherit traits by way of discrete "units of inheritance". This term, still used today, is a somewhat ambiguous definition of what is referred to as a gene. Trait inheritance and molecular inheritance mechanisms of genes are still primary principles of genetics in the 21st century, but modern genetics has expanded to study the function and behavior of genes. Gene structure and function, variation, and distribution are studied within the context of the cell, the organism (e.g. dominance), and within the context of a population. Genetics has given rise to a number of subfields, including molecular genetics, epigenetics and population genetics. Organisms studied within the broad field span the domains of life (archaea, bacteria, and eukarya). Genetic processes work in combination with an organism's environment and experiences to influence development and behavior, often referred to as nature versus nurture. The intracellular or extracellular environment of a living cell or organism may increase or decrease gene transcription. A classic example is two seeds of genetically identical corn, one placed in a temperate climate and one in an arid climate (lacking sufficient waterfall or rain). While the average height of the two corn stalks may be genetically determined to be equal, the one in the arid climate only grows to half the height of the one in the temperate climate due to lack of water and nutrients in its environment. Etymology The word genetics stems from the ancient Greek γενετικός genetikos meaning "genitive"/"generative", which in turn derives from γένεσις genesis meaning "origin". History The observation that living things inherit traits from their parents has been used since prehistoric times to improve crop plants and animals through selective breeding. The modern science of genetics, seeking to understand this process, began with the work of the Augustinian friar Gregor Mendel in the mid-19th century.Prior to Mendel, Imre Festetics, a Hungarian noble, who lived in Kőszeg before Mendel, was the first who used the word "genetic" in hereditarian context. He described several rules of biological inheritance in his works The genetic laws of the Nature (Die genetischen Gesetze der Natur, 1819). His second law is the same as that which Mendel published. In his third law, he developed the basic principles of mutation (he can be considered a forerunner of Hugo de Vries). Festetics argued that changes observed in the generation of farm animals, plants, and humans are the result of scientific laws. Festetics empirically deduced that organisms inherit their characteristics, not acquire them. He recognized recessive traits and inherent variation by postulating that traits of past generations could reappear later, and organisms could produce progeny with different attributes. These observations represent an important prelude to Mendel's theory of particulate inheritance insofar as it features a transition of heredity from its status as myth to that of a scientific discipline, by providing a fundamental theoretical basis for genetics in the twentieth century. Other theories of inheritance preceded Mendel's work. A popular theory during the 19th century, and implied by Charles Darwin's 1859 On the Origin of Species, was blending inheritance: the idea that individuals inherit a smooth blend of traits from their parents. Mendel's work provided examples where traits were definitely not blended after hybridization, showing that traits are produced by combinations of distinct genes rather than a continuous blend. Blending of traits in the progeny is now explained by the action of multiple genes with quantitative effects. Another theory that had some support at that time was the inheritance of acquired characteristics: the belief that individuals inherit traits strengthened by their parents. This theory (commonly associated with Jean-Baptiste Lamarck) is now known to be wrong—the experiences of individuals do not affect the genes they pass to their children. Other theories included Darwin's pangenesis (which had both acquired and inherited aspects) and Francis Galton's reformulation of pangenesis as both particulate and inherited. Mendelian genetics Modern genetics started with Mendel's studies of the nature of inheritance in plants. In his paper "Versuche über Pflanzenhybriden" ("Experiments on Plant Hybridization"), presented in 1865 to the Naturforschender Verein (Society for Research in Nature) in Brno, Mendel traced the inheritance patterns of certain traits in pea plants and described them mathematically. Although this pattern of inheritance could only be observed for a few traits, Mendel's work suggested that heredity was particulate, not acquired, and that the inheritance patterns of many traits could be explained through simple rules and ratios.The importance of Mendel's work did not gain wide understanding until 1900, after his death, when Hugo de Vries and other scientists rediscovered his research. William Bateson, a proponent of Mendel's work, coined the word genetics in 1905. (The adjective genetic, derived from the Greek word genesis—γένεσις, "origin", predates the noun and was first used in a biological sense in 1860.) Bateson both acted as a mentor and was aided significantly by the work of other scientists from Newnham College at Cambridge, specifically the work of Becky Saunders, Nora Darwin Barlow, and Muriel Wheldale Onslow. Bateson popularized the usage of the word genetics to describe the study of inheritance in his inaugural address to the Third International Conference on Plant Hybridization in London in 1906.After the rediscovery of Mendel's work, scientists tried to determine which molecules in the cell were responsible for inheritance. In 1900, Nettie Stevens began studying the mealworm. Over the next 11 years, she discovered that females only had the X chromosome and males had both X and Y chromosomes. She was able to conclude that sex is a chromosomal factor and is determined by the male. In 1911, Thomas Hunt Morgan argued that genes are on chromosomes, based on observations of a sex-linked white eye mutation in fruit flies. In 1913, his student Alfred Sturtevant used the phenomenon of genetic linkage to show that genes are arranged linearly on the chromosome. Molecular genetics Although genes were known to exist on chromosomes, chromosomes are composed of both protein and DNA, and scientists did not know which of the two is responsible for inheritance. In 1928, Frederick Griffith discovered the phenomenon of transformation: dead bacteria could transfer genetic material to "transform" other still-living bacteria. Sixteen years later, in 1944, the Avery–MacLeod–McCarty experiment identified DNA as the molecule responsible for transformation. The role of the nucleus as the repository of genetic information in eukaryotes had been established by Hämmerling in 1943 in his work on the single celled alga Acetabularia. The Hershey–Chase experiment in 1952 confirmed that DNA (rather than protein) is the genetic material of the viruses that infect bacteria, providing further evidence that DNA is the molecule responsible for inheritance.James Watson and Francis Crick determined the structure of DNA in 1953, using the X-ray crystallography work of Rosalind Franklin and Maurice Wilkins that indicated DNA has a helical structure (i.e., shaped like a corkscrew). Their double-helix model had two strands of DNA with the nucleotides pointing inward, each matching a complementary nucleotide on the other strand to form what look like rungs on a twisted ladder. This structure showed that genetic information exists in the sequence of nucleotides on each strand of DNA. The structure also suggested a simple method for replication: if the strands are separated, new partner strands can be reconstructed for each based on the sequence of the old strand. This property is what gives DNA its semi-conservative nature where one strand of new DNA is from an original parent strand.Although the structure of DNA showed how inheritance works, it was still not known how DNA influences the behavior of cells. In the following years, scientists tried to understand how DNA controls the process of protein production. It was discovered that the cell uses DNA as a template to create matching messenger RNA, molecules with nucleotides very similar to DNA. The nucleotide sequence of a messenger RNA is used to create an amino acid sequence in protein; this translation between nucleotide sequences and amino acid sequences is known as the genetic code.With the newfound molecular understanding of inheritance came an explosion of research. A notable theory arose from Tomoko Ohta in 1973 with her amendment to the neutral theory of molecular evolution through publishing the nearly neutral theory of molecular evolution. In this theory, Ohta stressed the importance of natural selection and the environment to the rate at which genetic evolution occurs. One important development was chain-termination DNA sequencing in 1977 by Frederick Sanger. This technology allows scientists to read the nucleotide sequence of a DNA molecule. In 1983, Kary Banks Mullis developed the polymerase chain reaction, providing a quick way to isolate and amplify a specific section of DNA from a mixture. The efforts of the Human Genome Project, Department of Energy, NIH, and parallel private efforts by Celera Genomics led to the sequencing of the human genome in 2003. Features of inheritance Discrete inheritance and Mendel's laws At its most fundamental level, inheritance in organisms occurs by passing discrete heritable units, called genes, from parents to offspring. This property was first observed by Gregor Mendel, who studied the segregation of heritable traits in pea plants, showing for example that flowers on a single plant were either purple or white—but never an intermediate between the two colors. The discrete versions of the same gene controlling the inherited appearance (phenotypes) are called alleles.In the case of the pea, which is a diploid species, each individual plant has two copies of each gene, one copy inherited from each parent. Many species, including humans, have this pattern of inheritance. Diploid organisms with two copies of the same allele of a given gene are called homozygous at that gene locus, while organisms with two different alleles of a given gene are called heterozygous. The set of alleles for a given organism is called its genotype, while the observable traits of the organism are called its phenotype. When organisms are heterozygous at a gene, often one allele is called dominant as its qualities dominate the phenotype of the organism, while the other allele is called recessive as its qualities recede and are not observed. Some alleles do not have complete dominance and instead have incomplete dominance by expressing an intermediate phenotype, or codominance by expressing both alleles at once.When a pair of organisms reproduce sexually, their offspring randomly inherit one of the two alleles from each parent. These observations of discrete inheritance and the segregation of alleles are collectively known as Mendel's first law or the Law of Segregation. However, the probability of getting one gene over the other can change due to dominant, recessive, homozygous, or heterozygous genes. For example, Mendel found that if you cross homozygous dominate trait and homozygous recessive trait your odds of getting the dominant trait is 3:1. Real geneticist study and calculate probabilities by using theoretical probabilities, empirical probabilities, the product rule, the sum rule, and more. Notation and diagrams Geneticists use diagrams and symbols to describe inheritance. A gene is represented by one or a few letters. Often a "+" symbol is used to mark the usual, non-mutant allele for a gene.In fertilization and breeding experiments (and especially when discussing Mendel's laws) the parents are referred to as the "P" generation and the offspring as the "F1" (first filial) generation. When the F1 offspring mate with each other, the offspring are called the "F2" (second filial) generation. One of the common diagrams used to predict the result of cross-breeding is the Punnett square.When studying human genetic diseases, geneticists often use pedigree charts to represent the inheritance of traits. These charts map the inheritance of a trait in a family tree. Multiple gene interactions Organisms have thousands of genes, and in sexually reproducing organisms these genes generally assort independently of each other. This means that the inheritance of an allele for yellow or green pea color is unrelated to the inheritance of alleles for white or purple flowers. This phenomenon, known as "Mendel's second law" or the "law of independent assortment," means that the alleles of different genes get shuffled between parents to form offspring with many different combinations. Different genes often interact to influence the same trait. In the Blue-eyed Mary (Omphalodes verna), for example, there exists a gene with alleles that determine the color of flowers: blue or magenta. Another gene, however, controls whether the flowers have color at all or are white. When a plant has two copies of this white allele, its flowers are white—regardless of whether the first gene has blue or magenta alleles. This interaction between genes is called epistasis, with the second gene epistatic to the first.Many traits are not discrete features (e.g. purple or white flowers) but are instead continuous features (e.g. human height and skin color). These complex traits are products of many genes. The influence of these genes is mediated, to varying degrees, by the environment an organism has experienced. The degree to which an organism's genes contribute to a complex trait is called heritability. Measurement of the heritability of a trait is relative—in a more variable environment, the environment has a bigger influence on the total variation of the trait. For example, human height is a trait with complex causes. It has a heritability of 89% in the United States. In Nigeria, however, where people experience a more variable access to good nutrition and health care, height has a heritability of only 62%. Molecular basis for inheritance DNA and chromosomes The molecular basis for genes is deoxyribonucleic acid (DNA). DNA is composed of deoxyribose (sugar molecule), a phosphate group, and a base (amine group). There are four types of bases: adenine (A), cytosine (C), guanine (G), and thymine (T). The phosphates make hydrogen bonds with the sugars to make long phosphate-sugar backbones. Bases specifically pair together (T&A, C&G) between two backbones and make like rungs on a ladder. The bases, phosphates, and sugars together make a nucleotide that connects to make long chains of DNA. Genetic information exists in the sequence of these nucleotides, and genes exist as stretches of sequence along the DNA chain. These chains coil into a double a-helix structure and wrap around proteins called Histones which provide the structural support. DNA wrapped around these histones are called chromosomes. Viruses sometimes use the similar molecule RNA instead of DNA as their genetic material.DNA normally exists as a double-stranded molecule, coiled into the shape of a double helix. Each nucleotide in DNA preferentially pairs with its partner nucleotide on the opposite strand: A pairs with T, and C pairs with G. Thus, in its two-stranded form, each strand effectively contains all necessary information, redundant with its partner strand. This structure of DNA is the physical basis for inheritance: DNA replication duplicates the genetic information by splitting the strands and using each strand as a template for synthesis of a new partner strand. Genes are arranged linearly along long chains of DNA base-pair sequences. In bacteria, each cell usually contains a single circular genophore, while eukaryotic organisms (such as plants and animals) have their DNA arranged in multiple linear chromosomes. These DNA strands are often extremely long; the largest human chromosome, for example, is about 247 million base pairs in length. The DNA of a chromosome is associated with structural proteins that organize, compact, and control access to the DNA, forming a material called chromatin; in eukaryotes, chromatin is usually composed of nucleosomes, segments of DNA wound around cores of histone proteins. The full set of hereditary material in an organism (usually the combined DNA sequences of all chromosomes) is called the genome. DNA is most often found in the nucleus of cells, but Ruth Sager helped in the discovery of nonchromosomal genes found outside of the nucleus. In plants, these are often found in the chloroplasts and in other organisms, in the mitochondria. These nonchromosomal genes can still be passed on by either partner in sexual reproduction and they control a variety of hereditary characteristics that replicate and remain active throughout generations.While haploid organisms have only one copy of each chromosome, most animals and many plants are diploid, containing two of each chromosome and thus two copies of every gene. The two alleles for a gene are located on identical loci of the two homologous chromosomes, each allele inherited from a different parent.Many species have so-called sex chromosomes that determine the sex of each organism. In humans and many other animals, the Y chromosome contains the gene that triggers the development of the specifically male characteristics. In evolution, this chromosome has lost most of its content and also most of its genes, while the X chromosome is similar to the other chromosomes and contains many genes. This being said, Mary Frances Lyon discovered that there is X-chromosome inactivation during reproduction to avoid passing on twice as many genes to the offspring. Lyon's discovery led to the discovery of X-linked diseases. Reproduction When cells divide, their full genome is copied and each daughter cell inherits one copy. This process, called mitosis, is the simplest form of reproduction and is the basis for asexual reproduction. Asexual reproduction can also occur in multicellular organisms, producing offspring that inherit their genome from a single parent. Offspring that are genetically identical to their parents are called clones.Eukaryotic organisms often use sexual reproduction to generate offspring that contain a mixture of genetic material inherited from two different parents. The process of sexual reproduction alternates between forms that contain single copies of the genome (haploid) and double copies (diploid). Haploid cells fuse and combine genetic material to create a diploid cell with paired chromosomes. Diploid organisms form haploids by dividing, without replicating their DNA, to create daughter cells that randomly inherit one of each pair of chromosomes. Most animals and many plants are diploid for most of their lifespan, with the haploid form reduced to single cell gametes such as sperm or eggs.Although they do not use the haploid/diploid method of sexual reproduction, bacteria have many methods of acquiring new genetic information. Some bacteria can undergo conjugation, transferring a small circular piece of DNA to another bacterium. Bacteria can also take up raw DNA fragments found in the environment and integrate them into their genomes, a phenomenon known as transformation. These processes result in horizontal gene transfer, transmitting fragments of genetic information between organisms that would be otherwise unrelated. Natural bacterial transformation occurs in many bacterial species, and can be regarded as a sexual process for transferring DNA from one cell to another cell (usually of the same species). Transformation requires the action of numerous bacterial gene products, and its primary adaptive function appears to be repair of DNA damages in the recipient cell. Recombination and genetic linkage The diploid nature of chromosomes allows for genes on different chromosomes to assort independently or be separated from their homologous pair during sexual reproduction wherein haploid gametes are formed. In this way new combinations of genes can occur in the offspring of a mating pair. Genes on the same chromosome would theoretically never recombine. However, they do, via the cellular process of chromosomal crossover. During crossover, chromosomes exchange stretches of DNA, effectively shuffling the gene alleles between the chromosomes. This process of chromosomal crossover generally occurs during meiosis, a series of cell divisions that creates haploid cells. Meiotic recombination, particularly in microbial eukaryotes, appears to serve the adaptive function of repair of DNA damages.The first cytological demonstration of crossing over was performed by Harriet Creighton and Barbara McClintock in 1931. Their research and experiments on corn provided cytological evidence for the genetic theory that linked genes on paired chromosomes do in fact exchange places from one homolog to the other.The probability of chromosomal crossover occurring between two given points on the chromosome is related to the distance between the points. For an arbitrarily long distance, the probability of crossover is high enough that the inheritance of the genes is effectively uncorrelated. For genes that are closer together, however, the lower probability of crossover means that the genes demonstrate genetic linkage; alleles for the two genes tend to be inherited together. The amounts of linkage between a series of genes can be combined to form a linear linkage map that roughly describes the arrangement of the genes along the chromosome. Gene expression Genetic code Genes express their functional effect through the production of proteins, which are molecules responsible for most functions in the cell. Proteins are made up of one or more polypeptide chains, each composed of a sequence of amino acids. The DNA sequence of a gene is used to produce a specific amino acid sequence. This process begins with the production of an RNA molecule with a sequence matching the gene's DNA sequence, a process called transcription. This messenger RNA molecule then serves to produce a corresponding amino acid sequence through a process called translation. Each group of three nucleotides in the sequence, called a codon, corresponds either to one of the twenty possible amino acids in a protein or an instruction to end the amino acid sequence; this correspondence is called the genetic code. The flow of information is unidirectional: information is transferred from nucleotide sequences into the amino acid sequence of proteins, but it never transfers from protein back into the sequence of DNA—a phenomenon Francis Crick called the central dogma of molecular biology.The specific sequence of amino acids results in a unique three-dimensional structure for that protein, and the three-dimensional structures of proteins are related to their functions. Some are simple structural molecules, like the fibers formed by the protein collagen. Proteins can bind to other proteins and simple molecules, sometimes acting as enzymes by facilitating chemical reactions within the bound molecules (without changing the structure of the protein itself). Protein structure is dynamic; the protein hemoglobin bends into slightly different forms as it facilitates the capture, transport, and release of oxygen molecules within mammalian blood.A single nucleotide difference within DNA can cause a change in the amino acid sequence of a protein. Because protein structures are the result of their amino acid sequences, some changes can dramatically change the properties of a protein by destabilizing the structure or changing the surface of the protein in a way that changes its interaction with other proteins and molecules. For example, sickle-cell anemia is a human genetic disease that results from a single base difference within the coding region for the β-globin section of hemoglobin, causing a single amino acid change that changes hemoglobin's physical properties. Sickle-cell versions of hemoglobin stick to themselves, stacking to form fibers that distort the shape of red blood cells carrying the protein. These sickle-shaped cells no longer flow smoothly through blood vessels, having a tendency to clog or degrade, causing the medical problems associated with this disease.Some DNA sequences are transcribed into RNA but are not translated into protein products—such RNA molecules are called non-coding RNA. In some cases, these products fold into structures which are involved in critical cell functions (e.g. ribosomal RNA and transfer RNA). RNA can also have regulatory effects through hybridization interactions with other RNA molecules (such as microRNA). Nature and nurture Although genes contain all the information an organism uses to function, the environment plays an important role in determining the ultimate phenotypes an organism displays. The phrase "nature and nurture" refers to this complementary relationship. The phenotype of an organism depends on the interaction of genes and the environment. An interesting example is the coat coloration of the Siamese cat. In this case, the body temperature of the cat plays the role of the environment. The cat's genes code for dark hair, thus the hair-producing cells in the cat make cellular proteins resulting in dark hair. But these dark hair-producing proteins are sensitive to temperature (i.e. have a mutation causing temperature-sensitivity) and denature in higher-temperature environments, failing to produce dark-hair pigment in areas where the cat has a higher body temperature. In a low-temperature environment, however, the protein's structure is stable and produces dark-hair pigment normally. The protein remains functional in areas of skin that are colder—such as its legs, ears, tail, and face—so the cat has dark hair at its extremities.Environment plays a major role in effects of the human genetic disease phenylketonuria. The mutation that causes phenylketonuria disrupts the ability of the body to break down the amino acid phenylalanine, causing a toxic build-up of an intermediate molecule that, in turn, causes severe symptoms of progressive intellectual disability and seizures. However, if someone with the phenylketonuria mutation follows a strict diet that avoids this amino acid, they remain normal and healthy.A common method for determining how genes and environment ("nature and nurture") contribute to a phenotype involves studying identical and fraternal twins, or other siblings of multiple births. Identical siblings are genetically the same since they come from the same zygote. Meanwhile, fraternal twins are as genetically different from one another as normal siblings. By comparing how often a certain disorder occurs in a pair of identical twins to how often it occurs in a pair of fraternal twins, scientists can determine whether that disorder is caused by genetic or postnatal environmental factors. One famous example involved the study of the Genain quadruplets, who were identical quadruplets all diagnosed with schizophrenia. Gene regulation The genome of a given organism contains thousands of genes, but not all these genes need to be active at any given moment. A gene is expressed when it is being transcribed into mRNA and there exist many cellular methods of controlling the expression of genes such that proteins are produced only when needed by the cell. Transcription factors are regulatory proteins that bind to DNA, either promoting or inhibiting the transcription of a gene. Within the genome of Escherichia coli bacteria, for example, there exists a series of genes necessary for the synthesis of the amino acid tryptophan. However, when tryptophan is already available to the cell, these genes for tryptophan synthesis are no longer needed. The presence of tryptophan directly affects the activity of the genes—tryptophan molecules bind to the tryptophan repressor (a transcription factor), changing the repressor's structure such that the repressor binds to the genes. The tryptophan repressor blocks the transcription and expression of the genes, thereby creating negative feedback regulation of the tryptophan synthesis process. Differences in gene expression are especially clear within multicellular organisms, where cells all contain the same genome but have very different structures and behaviors due to the expression of different sets of genes. All the cells in a multicellular organism derive from a single cell, differentiating into variant cell types in response to external and intercellular signals and gradually establishing different patterns of gene expression to create different behaviors. As no single gene is responsible for the development of structures within multicellular organisms, these patterns arise from the complex interactions between many cells.Within eukaryotes, there exist structural features of chromatin that influence the transcription of genes, often in the form of modifications to DNA and chromatin that are stably inherited by daughter cells. These features are called "epigenetic" because they exist "on top" of the DNA sequence and retain inheritance from one cell generation to the next. Because of epigenetic features, different cell types grown within the same medium can retain very different properties. Although epigenetic features are generally dynamic over the course of development, some, like the phenomenon of paramutation, have multigenerational inheritance and exist as rare exceptions to the general rule of DNA as the basis for inheritance. Genetic change Mutations During the process of DNA replication, errors occasionally occur in the polymerization of the second strand. These errors, called mutations, can affect the phenotype of an organism, especially if they occur within the protein coding sequence of a gene. Error rates are usually very low—1 error in every 10–100 million bases—due to the "proofreading" ability of DNA polymerases. Processes that increase the rate of changes in DNA are called mutagenic: mutagenic chemicals promote errors in DNA replication, often by interfering with the structure of base-pairing, while UV radiation induces mutations by causing damage to the DNA structure. Chemical damage to DNA occurs naturally as well and cells use DNA repair mechanisms to repair mismatches and breaks. The repair does not, however, always restore the original sequence. A particularly important source of DNA damages appears to be reactive oxygen species produced by cellular aerobic respiration, and these can lead to mutations. In organisms that use chromosomal crossover to exchange DNA and recombine genes, errors in alignment during meiosis can also cause mutations. Errors in crossover are especially likely when similar sequences cause partner chromosomes to adopt a mistaken alignment; this makes some regions in genomes more prone to mutating in this way. These errors create large structural changes in DNA sequence—duplications, inversions, deletions of entire regions—or the accidental exchange of whole parts of sequences between different chromosomes, chromosomal translocation. Natural selection and evolution Mutations alter an organism's genotype and occasionally this causes different phenotypes to appear. Most mutations have little effect on an organism's phenotype, health, or reproductive fitness. Mutations that do have an effect are usually detrimental, but occasionally some can be beneficial. Studies in the fly Drosophila melanogaster suggest that if a mutation changes a protein produced by a gene, about 70 percent of these mutations are harmful with the remainder being either neutral or weakly beneficial. Population genetics studies the distribution of genetic differences within populations and how these distributions change over time. Changes in the frequency of an allele in a population are mainly influenced by natural selection, where a given allele provides a selective or reproductive advantage to the organism, as well as other factors such as mutation, genetic drift, genetic hitchhiking, artificial selection and migration.Over many generations, the genomes of organisms can change significantly, resulting in evolution. In the process called adaptation, selection for beneficial mutations can cause a species to evolve into forms better able to survive in their environment. New species are formed through the process of speciation, often caused by geographical separations that prevent populations from exchanging genes with each other.By comparing the homology between different species' genomes, it is possible to calculate the evolutionary distance between them and when they may have diverged. Genetic comparisons are generally considered a more accurate method of characterizing the relatedness between species than the comparison of phenotypic characteristics. The evolutionary distances between species can be used to form evolutionary trees; these trees represent the common descent and divergence of species over time, although they do not show the transfer of genetic material between unrelated species (known as horizontal gene transfer and most common in bacteria). Research and technology Model organisms Although geneticists originally studied inheritance in a wide variety of organisms, the range of species studied has narrowed. One reason is that when significant research already exists for a given organism, new researchers are more likely to choose it for further study, and so eventually a few model organisms became the basis for most genetics research. Common research topics in model organism genetics include the study of gene regulation and the involvement of genes in development and cancer. Organisms were chosen, in part, for convenience—short generation times and easy genetic manipulation made some organisms popular genetics research tools. Widely used model organisms include the gut bacterium Escherichia coli, the plant Arabidopsis thaliana, baker's yeast (Saccharomyces cerevisiae), the nematode Caenorhabditis elegans, the common fruit fly (Drosophila melanogaster), the zebrafish (Danio rerio), and the common house mouse (Mus musculus). Medicine Medical genetics seeks to understand how genetic variation relates to human health and disease. When searching for an unknown gene that may be involved in a disease, researchers commonly use genetic linkage and genetic pedigree charts to find the location on the genome associated with the disease. At the population level, researchers take advantage of Mendelian randomization to look for locations in the genome that are associated with diseases, a method especially useful for multigenic traits not clearly defined by a single gene. Once a candidate gene is found, further research is often done on the corresponding (or homologous) genes of model organisms. In addition to studying genetic diseases, the increased availability of genotyping methods has led to the field of pharmacogenetics: the study of how genotype can affect drug responses.Individuals differ in their inherited tendency to develop cancer, and cancer is a genetic disease. The process of cancer development in the body is a combination of events. Mutations occasionally occur within cells in the body as they divide. Although these mutations will not be inherited by any offspring, they can affect the behavior of cells, sometimes causing them to grow and divide more frequently. There are biological mechanisms that attempt to stop this process; signals are given to inappropriately dividing cells that should trigger cell death, but sometimes additional mutations occur that cause cells to ignore these messages. An internal process of natural selection occurs within the body and eventually mutations accumulate within cells to promote their own growth, creating a cancerous tumor that grows and invades various tissues of the body. Normally, a cell divides only in response to signals called growth factors and stops growing once in contact with surrounding cells and in response to growth-inhibitory signals. It usually then divides a limited number of times and dies, staying within the epithelium where it is unable to migrate to other organs. To become a cancer cell, a cell has to accumulate mutations in a number of genes (three to seven). A cancer cell can divide without growth factor and ignores inhibitory signals. Also, it is immortal and can grow indefinitely, even after it makes contact with neighboring cells. It may escape from the epithelium and ultimately from the primary tumor. Then, the escaped cell can cross the endothelium of a blood vessel and get transported by the bloodstream to colonize a new organ, forming deadly metastasis. Although there are some genetic predispositions in a small fraction of cancers, the major fraction is due to a set of new genetic mutations that originally appear and accumulate in one or a small number of cells that will divide to form the tumor and are not transmitted to the progeny (somatic mutations). The most frequent mutations are a loss of function of p53 protein, a tumor suppressor, or in the p53 pathway, and gain of function mutations in the Ras proteins, or in other oncogenes. Research methods DNA can be manipulated in the laboratory. Restriction enzymes are commonly used enzymes that cut DNA at specific sequences, producing predictable fragments of DNA. DNA fragments can be visualized through use of gel electrophoresis, which separates fragments according to their length.The use of ligation enzymes allows DNA fragments to be connected. By binding ("ligating") fragments of DNA together from different sources, researchers can create recombinant DNA, the DNA often associated with genetically modified organisms. Recombinant DNA is commonly used in the context of plasmids: short circular DNA molecules with a few genes on them. In the process known as molecular cloning, researchers can amplify the DNA fragments by inserting plasmids into bacteria and then culturing them on plates of agar (to isolate clones of bacteria cells). "Cloning" can also refer to the various means of creating cloned ("clonal") organisms.DNA can also be amplified using a procedure called the polymerase chain reaction (PCR). By using specific short sequences of DNA, PCR can isolate and exponentially amplify a targeted region of DNA. Because it can amplify from extremely small amounts of DNA, PCR is also often used to detect the presence of specific DNA sequences. DNA sequencing and genomics DNA sequencing, one of the most fundamental technologies developed to study genetics, allows researchers to determine the sequence of nucleotides in DNA fragments. The technique of chain-termination sequencing, developed in 1977 by a team led by Frederick Sanger, is still routinely used to sequence DNA fragments. Using this technology, researchers have been able to study the molecular sequences associated with many human diseases.As sequencing has become less expensive, researchers have sequenced the genomes of many organisms using a process called genome assembly, which uses computational tools to stitch together sequences from many different fragments. These technologies were used to sequence the human genome in the Human Genome Project completed in 2003. New high-throughput sequencing technologies are dramatically lowering the cost of DNA sequencing, with many researchers hoping to bring the cost of resequencing a human genome down to a thousand dollars.Next-generation sequencing (or high-throughput sequencing) came about due to the ever-increasing demand for low-cost sequencing. These sequencing technologies allow the production of potentially millions of sequences concurrently. The large amount of sequence data available has created the subfield of genomics, research that uses computational tools to search for and analyze patterns in the full genomes of organisms. Genomics can also be considered a subfield of bioinformatics, which uses computational approaches to analyze large sets of biological data. A common problem to these fields of research is how to manage and share data that deals with human subject and personally identifiable information. Society and culture On 19 March 2015, a group of leading biologists urged a worldwide ban on clinical use of methods, particularly the use of CRISPR and zinc finger, to edit the human genome in a way that can be inherited. In April 2015, Chinese researchers reported results of basic research to edit the DNA of non-viable human embryos using CRISPR. See also References Further reading External links Quotations related to Genetics at Wikiquote Genetics at Wikibooks Library resources in your library and in other libraries about Genetics Genetics on In Our Time at the BBC Genetics at Curlie

Genevestigator is an application consisting of a gene expression database and tools to analyse the data. It exists in two versions, biomedical and plant, depending on the species of the underlying microarray and RNAseq as well as single-cell RNA-sequencing data. It was started in January 2004 by scientists from ETH Zurich and is currently developed and commercialized by Nebion AG. Researchers and scientists from academia and industry use it to identify, characterize and validate novel drug targets and biomarkers, identify appropriate research models and in general to understand how gene expression changes with different treatments. Gene expression database The Genevestigator database comprises transciptomic data from numerous public repositories including GEO, Array Express and renowned cancer research projects as TCGA. Depending on the license agreement, it may also contain data from private gene expression studies. All data are manually curated, quality-controlled and enriched for sample and experiment descriptions derived from corresponding scientific publications. The number of species from where the samples are derived is constantly increasing. Currently, the biomedical version contains data from human, mouse, and rat used in biomedical research. Gene expression studies are from various research areas including oncology, immunology, neurology, dermatology and cardiovascular diseases. Samples comprise tissue biopsies and cell lines. The plant version (no longer available) contained both, widely used model species such as arabidopsis and medicago as well as major crop species such as maize, rice, wheat and soybean. After the acquisition of Nebion AG by Immunai Inc. in July 2021, plant data began to be phased out as the biotech company prioritized their focus on biopharma data. As of 2023, the plant data is being maintained on a separate server for remaining users with a license to the plant version of Genevestigator. Gene expression tools More than 60,000 scientists from academia and industry use Genevestigator for their work in molecular biology, toxicogenomics, biomarker discovery and target validation. The original scientific publication has been cited over 3,500 times. The analysis tools are divided into three major sets: CONDITION SEARCH tools: find conditions such as a tissue, disease, treatment or genetic background that regulate the gene(s) of interest GENE SEARCH tools: find genes that are specifically expressed in the condition(s) of interest SIMILARITY SEARCH tools: find genes or conditions that show a similar gene expression pattern See also Spatiotemporal gene expression References Prasad A, Suresh Kumar S, Dessimoz C, Bleuler S, Laule O, Hruz T, Gruissem W, and P Zimmermann (2013) Global regulatory architecture of human, mouse and rat tissue transcriptomes. BMC Genomics 2013, 14:716. Hruz T, Wyss M, Lucas C, Laule O, von Rohr P, Zimmermann P, and S Bleuler (2013) A Multilevel Gamma-Clustering Layout Algorithm for Visualization of Biological Networks. Advances in Bioinformatics, vol. 2013, Article ID 920325, 10 pages, 2013. doi:10.1155/2013/920325. Hruz T, Wyss M, Docquier M, Pfaffl MW, Masanetz S, Borghi L, Verbrugge P, Kalaydjieva L, Bleuler S, Laule O, Descombes P, Gruissem W and P Zimmermann (2011) RefGenes: identification of reliable and condition specific reference genes for RT-qPCR data normalization. BMC Genomics 2011, 12:156. Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, Oertle L, Widmayer P, Gruissem W and P Zimmermann (2008) Genevestigator V3: a reference expression database for the meta-analysis of transcriptomes. Advances in Bioinformatics 2008, 420747 Grennan AK (2006) Genevestigator. Facilitating web-based gene-expression analysis. Plant Physiology 141(4):1164-6 Laule O, Hirsch-Hoffmann M, Hruz T, Gruissem W, and P Zimmermann (2006) Web-based analysis of the mouse transcriptome using Genevestigator. BMC Bioinformatics 7:311 Zimmermann P, Hennig L and W Gruissem (2005) Gene expression analysis and network discovery using Genevestigator. Trends in Plant Science 9 10, 407-409 Zimmermann P, Hirsch-Hoffmann M, Hennig L and W Gruissem (2004) GENEVESTIGATOR: Arabidopsis Microarray Database and Analysis Toolbox. Plant Physiology 136 1, 2621-2632 Zimmermann P, Schildknecht B, Garcia-Hernandez M, Gruissem W, Craigon D, Mukherjee G, May S, Parkinson H, Rhee S, Wagner U and L Hennig (2006) MIAME/Plant - adding value to plant microarray experiments. Plant Methods 2, 1

Genome India Project (GIP) is a research initiative led by the Bangalore-based Indian Institute of Science's Centre for Brain Research and involves over 20 universities across the country in an effort to gather samples, compile data, conduct research, and create an ‘Indian reference genome' grid. Background The initiative is funded by Department of Biotechnology (DBT) to sequence at least 10,000 Indian genomes in phase 1. The goal of the research is to develop predictive diagnostic indicators for several high-priority diseases and other uncommon and genetic disorders. In phase 2, the project would collect genetic samples from patients with three broad categories - cardiovascular diseases, mental illness, and cancer. Participating institutions The list includes; All India Institute of Medical Sciences, Jodhpur Centre for Cellular and Molecular Biology Centre for DNA Fingerprinting and Diagnostics Institute of Genomics and Integrative Biology Gujarat Biotechnology Research Centre, Gandhinagar Indian Institute of Information Technology, Allahabad Indian Institute of Science Education and Research, Pune Indian Institute of Technology, Madras Indian Institute of Technology, Delhi Indian Institute of Technology Jodhpur Institute of Bioresources And Sustainable Development, Imphal Institute of Life Sciences, Bhubhaneswar Mizoram University National Centre for Biological Sciences National Institute of Biomedical Genomics National Institute of Mental Health and Neurosciences Rajiv Gandhi Centre for Biotechnology Sher-i-Kashmir Institute of Medical Sciences == References ==

Genopolitics is the study of the genetic basis of political behavior and attitudes. It combines behavior genetics, psychology, and political science and it is closely related to the emerging fields of neuropolitics (the study of the neural basis of political attitudes and behavior) and political physiology (the study of biophysical correlates of political attitudes and behavior). In 2008, The Chronicle of Higher Education reported on the increase in academicians' recognition of and engagement in genopolitics as a discrete field of study, and New York Times Magazine included genopolitics in its "Eighth Annual Year in Ideas" for the same year, noting that the term was originally coined by James Fowler. Critics of genopolitics have argued that it is "a fundamentally misguided undertaking", and that it is inconsistent with evidence in the fields of genetics, neuroscience, and evolutionary biology. Twin studies of political attitudes Psychologists and behavior geneticists began using twin studies in the 1980s to study variation in social attitudes, and these studies suggested that both genes and environment played a role. In particular, Nick Martin and his colleagues published an influential twin study of social attitudes in Proceedings of the National Academy of Sciences in 1986.However, this early work did not specifically analyze whether or not political orientations were heritable, and political scientists remained mostly unaware of the heritability of social attitudes until 2005. In that year, the American Political Science Review published a reanalysis of political questions on Martin's social attitude survey of twins in that the suggested liberal and conservative ideology is heritable. The article sparked considerable debate between critics, the authors and their defenders. Twin studies of political behavior Initial twin studies suggested that predispositions toward espousal of certain political ideas are heritable, but they said little about political behavior (patterns of voting and/or activism) or predispositions toward it. A 2008 article published in the American Political Science Review matched publicly available voter registration records to a twin registry in Los Angeles, analyzed self-reported voter turnout in the National Longitudinal Study of Adolescent Health (Add Health), and studied other forms of political participation. In all three cases, both genes and environment contributed significantly to variation in political behavior.However, other studies showed that the decision to affiliate with any political party and the strength of this attachment are significantly influenced by genes. Gene association studies Candidate genes Scholars therefore recently turned their attention to specific genes that might be associated with political behaviors and attitudes. In the first-ever research to link specific genes to political phenotypes, a direct association was established between voter turnout and monoamine oxidase A (MAO-A) and a gene–environment interaction between turnout and the serotonin transporter (5HTT) gene among those who frequently participated in religious activities. In other research scholars have also found an association between voter turnout and a dopamine receptor (DRD2) gene that is mediated by a significant association between that gene and the tendency to affiliate with a political party. More recent studies show an interaction between friendships and the dopamine receptor (DRD4) gene that is associated with political ideology. Although this work is preliminary and needs replication, it suggests that neurotransmitter function has an important effect on political behavior. The candidate genes approach to genopolitics received substantial criticism in a 2012 article, published in the American Political Science Review, which argued that many of the candidate genes identified in the above research are associated with innumerable traits and behaviors. The degree to which these genes are associated with so many outcomes thus undermines the apparent important of evidence linking a gene to any particular outcome. Linkage analysis Employing a more general approach, researchers used genome-wide linkage analysis to identify chromosomal regions associated with political attitudes assessed using scores on a liberalism-conservativism scale. Their analysis identified several significant linkage peaks and the associated chromosomal regions implicate a possible role for NMDA and glutamate related receptors in forming political attitudes. However, this role is speculative as linkage analysis cannot identify the effect of individual genes. Other explanations Associations between genetic markers and political behavior are often assumed to predict a causal connection between the two. Scholars have little incentive to be skeptical of this presumed causal link. Yet it is possible that a confounding factor exists which makes the genetic relationship with politics purely correlative. For instance work on Irish parties, which shows some evidence of a genetic basis for the otherwise inexplicable distinction between the historically two main parties there, is also and more easily explained by socialization. See also Biology and political science, sometimes called biopolitics Biology and political orientation Notes Further reading Fowler, James H.; Darren Schreiber (7 November 2008). "Biology, Politics, and the Emerging Science of Human Nature" (PDF). Science. 322 (5903): 912–914. Bibcode:2008Sci...322..912F. doi:10.1126/science.1158188. PMID 18988845. S2CID 206512952. "The Biology of Ideology". Wall Street Journal. May 27, 2008. "It's the Genes Stupid". New York Times. Sep 4, 2008. "The Genetics of Politics". Scientific American. November 2007. "Are Politics Rooted in Your Genes?". CNN. February 11, 2008. Carey, Benedict (June 21, 2005). "Some Politics May Be Etched in the Genes". New York Times. Retrieved May 3, 2010. Hatemi, P. K.; McDermott, R. (2012). "The genetics of politics: Discovery, challenges, and progress". Trends in Genetics. 28 (10): 525–533. doi:10.1016/j.tig.2012.07.004. PMID 22951140. Byrne, Kevin P.; Eoin O’Malley (2012). "Politics with Hidden Bases: Unearthing the Deep Roots of Party Systems" (PDF). British Journal of Politics and International Relations. 14 (4): 613–629. doi:10.1111/j.1467-856X.2011.00478.x. S2CID 49524008.

A genosome (also known as a lipoplex) is a lipid and DNA complex that is used to deliver genes. It can be a form of non-viral gene therapy as the complex does not require any components of a virus in order to transport genetic material. In presence of CT-DNA, genosomes can form through surface electrostatic interaction. See also Vectors in gene therapy § Lipoplexes == References ==

Genotropism is defined as the reciprocal attraction between carriers of the same or related latent recessive genes. Developed by the Hungarian psychiatrist Léopold Szondi in the 1930s, the theory concludes that instinct is biological and genetic in origin. Szondi believed that these genes regulated the "possibilities of fate" and was the working principle of the familial unconscious. Overview Genotropism consists of the theory that genes influence human behavior. While identified as entities, genes exist in groups because evolution favors cooperation. Within each gene group, it is possible to detect specific needs that function as mechanisms of screening and natural selection. Szondi arrived a sort of genetic determinism, a philosophical theory of predestination. "The latent hereditary factors in human beings, the recessive genes, do not remain dormant or inactive within the human organism, but exert a very important and even decisive influence upon its behavior. This latent or recessive gene theory claims that these non-dominant hereditary factors determine the Object selection, voluntary and involuntary, of the individual. The drives resulting from these latent genes, therefore, direct the individual's selection of love objects, friendships, occupations, diseases, and forms of death. Hence, from the very beginning of the human's existence there is a hidden plan of life guided by 'Instinctual drives'." Instinctual drives In Szondi's theory, each "need" (a link between genes and behavior) comprises a polarity of positive and negative tendencies. Needs also group together in polarities to form larger wholes called "instinctual drives." Together, behavior tendencies, needs, and drives combine to form patterned wholes. Szondi created a drive theory that determines that every drive has at least four genes. "The four Szondian drives are (1) contact, (2) sexual, (3) paroxysmal, and (4) ego. They are implicated in their corresponding psychiatric disorders and equivalents: (1) manic-depression, (2) sexual abnormality, (3) epilepsy and hysteria, and (4) schizophrenia." By locating mental disorders in biological drives, one can illustrate that illness is a disharmony of basic needs. The Familial unconscious Genotropism is the working principle of the familial unconscious, the quantitative sharing of genes across the generations of family. Offspring may inherit several genes from both parents, while others receive fewer genes and exhibit spectrum conditions. (For example, while one child is diagnosed with epilepsy, the other only shows various symptoms over a period of time). Szondi observed that when families pass down genes for specific diseases, the same family transmits defenses against those disorders. Known to Szondi as heterosis, it is currently known as "balancing selection." Szondi concluded that genetic traits confer needs and tendencies that shape decision making. "Genetic tendencies can be decoded by constructing genealogies, indicating recurrent patterns of marriage, friendship, and vocational choices in relation to types of illness and modes of death. Destiny comprises all of the hereditary tendencies in the familial unconscious which are expressed primarily through marriage and vocational selections." Basically, the needs and tendencies in which humans exhibit will guide similar genes to one another. The Oedipus complex While Szondi accepted the Oedipus complex, he found that it existed only under the following conditions: when the mother sees her father or brother represented in her son, or when the father sees his mother or sister in his daughter. Therefore, the son takes after the genes represented in his maternal grandfather or uncles, and the daughter after her paternal grandmother or aunt. Current application Although it was mostly abandoned by psychologists in the years after Szondi's death, recent discoveries in evolutionary psychology might be bringing it back in a revised form, through the study of homogamy and psychopathology. References Schicksalsanalyse and Religion Studies [1] The Szondi Test [2] The Szondi Forum [3] Schicksalsanalyse and Religion Studies [4] Schicksalsanalyse and Religion Studies [5]

The genotype of an organism is its complete set of genetic material. Genotype can also be used to refer to the alleles or variants an individual carries in a particular gene or genetic location. The number of alleles an individual can have in a specific gene depends on the number of copies of each chromosome found in that species, also referred to as ploidy. In diploid species like humans, two full sets of chromosomes are present, meaning each individual has two alleles for any given gene. If both alleles are the same, the genotype is referred to as homozygous. If the alleles are different, the genotype is referred to as heterozygous. Genotype contributes to phenotype, the observable traits and characteristics in an individual or organism. The degree to which genotype affects phenotype depends on the trait. For example, the petal color in a pea plant is exclusively determined by genotype. The petals can be purple or white depending on the alleles present in the pea plant. However, other traits are only partially influenced by genotype. These traits are often called complex traits because they are influenced by additional factors, such as environmental and epigenetic factors. Not all individuals with the same genotype look or act the same way because appearance and behavior are modified by environmental and growing conditions. Likewise, not all organisms that look alike necessarily have the same genotype. The term genotype was coined by the Danish botanist Wilhelm Johannsen in 1903. Phenotype Any given gene will usually cause an observable change in an organism, known as the phenotype. The terms genotype and phenotype are distinct for at least two reasons: To distinguish the source of an observer's knowledge (one can know about genotype by observing DNA; one can know about phenotype by observing outward appearance of an organism). Genotype and phenotype are not always directly correlated. Some genes only express a given phenotype in certain environmental conditions. Conversely, some phenotypes could be the result of multiple genotypes. The genotype is commonly mixed up with the phenotype which describes the end result of both the genetic and the environmental factors giving the observed expression (e.g. blue eyes, hair color, or various hereditary diseases).A simple example to illustrate genotype as distinct from phenotype is the flower colour in pea plants (see Gregor Mendel). There are three available genotypes, PP (homozygous dominant), Pp (heterozygous), and pp (homozygous recessive). All three have different genotypes but the first two have the same phenotype (purple) as distinct from the third (white). A more technical example to illustrate genotype is the single-nucleotide polymorphism or SNP. A SNP occurs when corresponding sequences of DNA from different individuals differ at one DNA base, for example where the sequence AAGCCTA changes to AAGCTTA. This contains two alleles : C and T. SNPs typically have three genotypes, denoted generically AA Aa and aa. In the example above, the three genotypes would be CC, CT and TT. Other types of genetic marker, such as microsatellites, can have more than two alleles, and thus many different genotypes. Penetrance is the proportion of individuals showing a specified genotype in their phenotype under a given set of environmental conditions. Mendelian inheritance Traits that are determined exclusively by genotype are typically inherited in a Mendelian pattern. These laws of inheritance were described extensively by Gregor Mendel, who performed experiments with pea plants to determine how traits were passed on from generation to generation. He studied phenotypes that were easily observed, such as plant height, petal color, or seed shape. He was able to observe that if he crossed two true-breeding plants with distinct phenotypes, all the offspring would have the same phenotype. For example, when he crossed a tall plant with a short plant, all the resulting plants would be tall. However, when he self-fertilized the plants that resulted, about 1/4 of the second generation would be short. He concluded that some traits were dominant, such as tall height, and others were recessive, like short height. Though Mendel was not aware at the time, each phenotype he studied was controlled by a single gene with two alleles. In the case of plant height, one allele caused the plants to be tall, and the other caused plants to be short. When the tall allele was present, the plant would be tall, even if the plant was heterozygous. In order for the plant to be short, it had to be homozygous for the recessive allele.One way this can be illustrated is using a Punnett square. In a Punnett square, the genotypes of the parents are placed on the outside. An uppercase letter is typically used to represent the dominant allele, and a lowercase letter is used to represent the recessive allele. The possible genotypes of the offspring can then be determined by combining the parent genotypes. In the example on the right, both parents are heterozygous, with a genotype of Bb. The offspring can inherit a dominant allele from each parent, making them homozygous with a genotype of BB. The offspring can inherit a dominant allele from one parent and a recessive allele from the other parent, making them heterozygous with a genotype of Bb. Finally, the offspring could inherit a recessive allele from each parent, making them homozygous with a genotype of bb. Plants with the BB and Bb genotypes will look the same, since the B allele is dominant. The plant with the bb genotype will have the recessive trait. These inheritance patterns can also be applied to hereditary diseases or conditions in humans or animals. Some conditions are inherited in an autosomal dominant pattern, meaning individuals with the condition typically have an affected parent as well. A classic pedigree for an autosomal dominant condition shows affected individuals in every generation. Other conditions are inherited in an autosomal recessive pattern, where affected individuals do not typically have an affected parent. Since each parent must have a copy of the recessive allele in order to have an affected offspring, the parents are referred to as carriers of the condition. In autosomal conditions, the sex of the offspring does not play a role in their risk of being affected. In sex-linked conditions, the sex of the offspring affects their chances of having the condition. In humans, females inherit two X chromosomes, one from each parent, while males inherit an X chromosome from their mother and a Y chromosome from their father. X-linked dominant conditions can be distinguished from autosomal dominant conditions in pedigrees by the lack of transmission from fathers to sons, since affected fathers only pass their X chromosome to their daughters. In X-linked recessive conditions, males are typically affected more commonly because they are hemizygous, with only one X chromosome. In females, the presence of a second X chromosome will prevent the condition from appearing. Females are therefore carriers of the condition and can pass the trait on to their sons.Mendelian patterns of inheritance can be complicated by additional factors. Some diseases show incomplete penetrance, meaning not all individuals with the disease-causing allele develop signs or symptoms of the disease. Penetrance can also be age-dependent, meaning signs or symptoms of disease are not visible until later in life. For example, Huntington disease is an autosomal dominant condition, but up to 25% of individuals with the affected genotype will not develop symptoms until after age 50. Another factor that can complicate Mendelian inheritance patterns is variable expressivity, in which individuals with the same genotype show different signs or symptoms of disease. For example, individuals with polydactyly can have a variable number of extra digits. Non-Mendelian inheritance Many traits are not inherited in a Mendelian fashion, but have more complex patterns of inheritance. Incomplete dominance For some traits, neither allele is completely dominant. Heterozygotes often have an appearance somewhere in between those of homozygotes. For example, a cross between true-breeding red and white Mirabilis jalapa results in pink flowers. Codominance Codominance refers to traits in which both alleles are expressed in the offspring in approximately equal amounts. A classic example is the ABO blood group system in humans, where both the A and B alleles are expressed when they are present. Individuals with the AB genotype have both A and B proteins expressed on their red blood cells. Epistasis Epistasis is when the phenotype of one gene is affected by one or more other genes. This is often through some sort of masking effect of one gene on the other. For example, the "A" gene codes for hair color, a dominant "A" allele codes for brown hair, and a recessive "a" allele codes for blonde hair, but a separate "B" gene controls hair growth, and a recessive "b" allele causes baldness. If the individual has the BB or Bb genotype, then they produce hair and the hair color phenotype can be observed, but if the individual has a bb genotype, then the person is bald which masks the A gene entirely. Polygenic traits A polygenic trait is one whose phenotype is dependent on the additive effects of multiple genes. The contributions of each of these genes are typically small and add up to a final phenotype with a large amount of variation. A well studied example of this is the number of sensory bristles on a fly. These types of additive effects is also the explanation for the amount of variation in human eye color. Genotyping Genotyping refers to the method used to determine an individual's genotype. There are a variety of techniques that can be used to assess genotype. The genotyping method typically depends on what information is being sought. Many techniques initially require amplification of the DNA sample, which is commonly done using PCR. Some techniques are designed to investigate specific SNPs or alleles in a particular gene or set of genes, such as whether an individual is a carrier for a particular condition. This can be done via a variety of techniques, including allele specific oligonucleotide (ASO) probes or DNA sequencing. Tools such as multiplex ligation-dependent probe amplification can also be used to look for duplications or deletions of genes or gene sections. Other techniques are meant to assess a large number of SNPs across the genome, such as SNP arrays. This type of technology is commonly used for genome-wide association studies. Large-scale techniques to assess the entire genome are also available. This includes karyotyping to determine the number of chromosomes an individual has and chromosomal microarrays to assess for large duplications or deletions in the chromosome. More detailed information can be determined using exome sequencing, which provides the specific sequence of all DNA in the coding region of the genome, or whole genome sequencing, which sequences the entire genome including non-coding regions. Genotype encoding In linear models, the genotypes can be encoded in different manners. Let us consider a biallelic locus with two possible alleles, encoded by A {\textstyle A} and a {\displaystyle a} . We consider a {\displaystyle a} to correspond to the dominant allele to the reference allele A {\textstyle A} . The following table details the different encoding. See also Endophenotype Genotype–phenotype distinction Nucleic acid sequence Phenotype Sequence (biology) References External links Genetic nomenclature

The genotype–phenotype map is a conceptual model in genetic architecture. Coined in a 1991 paper by Pere Alberch, it models the interdependency of genotype (an organism's full hereditary information) with phenotype (an organism's actual observed properties). Application The map visualises a relationship between genotype & phenotype which, crucially: is of greater complexity than a straightforward one-to-one mapping of genotype to/from phenotype. accommodates a parameter space, along which at different points a given phenotype is said to be more or less stable. accommodates transformational boundaries in the parameter space, which divide phenotype states from one another. accounts for different polymorphism and/or polyphenism in populations, depending on their area of parameter space they occupy. == References ==

Germline mosaicism, also called gonadal mosaicism, is a type of genetic mosaicism where more than one set of genetic information is found specifically within the gamete cells; conversely, somatic mosaicism is a type of genetic mosaicism found in somatic cells. Germline mosaicism can be present at the same time as somatic mosaicism or individually, depending on when the conditions occur. Pure germline mosaicism refers to mosaicism found exclusively in the gametes and not in any somatic cells. Germline mosaicism can be caused either by a mutation that occurs after conception, or by epigenetic regulation, alterations to DNA such as methylation that do not involve changes in the DNA coding sequence. A mutation in an allele acquired by a somatic cell early in its development can be passed on to its daughter cells, including those that later specialize to gametes. With such mutation within the gamete cells, a pair of medically typical individuals may have repeated succession of children who suffer from certain genetic disorders such as Duchenne muscular dystrophy and osteogenesis imperfecta because of germline mosaicism. It is possible for parents unaffected by germline mutations to produce an offspring with an autosomal dominant (AD) disorder due to a random new mutation within one’s gamete cells known as sporadic mutation; however, if these parents produce more than one child with an AD disorder, germline mosaicism is more likely the cause than a sporadic mutation. In the first documented case of its kind, two offspring of a French woman who had no phenotypic expression of the AD disorder hypertrophic cardiomyopathy, inherited the disease. Inheritance Germline mosaicism disorders are usually inherited in a pattern that suggests that the condition is dominant in either or both of the parents. That said, diverging from Mendelian gene inheritance patterns, a parent with a recessive allele can produce offspring expressing the phenotype as dominant through germline mosaicism. A situation may also arise in which the parents have milder phenotypic expression of a mutation yet produce offspring with more expressive phenotypic variance and a more frequent sibling recurrences of the mutation.Diseases caused by germline mosaicism can be difficult to diagnose as genetically-inherited because the mutant alleles are not likely to be present in the somatic cells. Somatic cells are more commonly used for genetic analysis because they are easier to obtain than gametes. If the disease is a result of pure germline mosaicism, then the disease causing mutant allele would never be present in the somatic cells. This is a source of uncertainty for genetic counselling. An individual may still be a carrier for a certain disease even if the disease causing mutant allele is not present in the cells that were analyzed because the causative mutation could still exist in some of the individual's gametes.Germline mosaicism may contribute to the inheritance of many genetic conditions. Conditions that are inherited by means of germline mosaicism are often mistaken as being the result of de novo mutations. Various diseases are now being re-examined for presence of mutant alleles in the germline of the parents in order to further our understanding of how they can be passed on. The frequency of germline mosaicism is not known due to the sporadic nature of the mutations causing it and the difficulty in obtaining the gametes that must be tested to diagnose it. Diagnosis Autosomal dominant or X-linked familial disorders often prompt prenatal testing for germline mosaicism. This diagnosis may involve minimally invasive procedures, such as blood sampling or amniotic fluid sampling. Collected samples can be sequenced via common DNA testing methods, such as Sanger Sequencing, MLPA, or Southern Blot analysis, to look for variations on relevant genes connected to the disorder. Recurrence rate The recurrence rate of conditions caused by germline mosaicism varies greatly between subjects. Recurrence is proportional to the number of gamete cells that carry the particular mutation with the condition. If the mutation occurred earlier on in the development of the gamete cells, then the recurrence rate would be higher because a greater number of cells would carry the mutant allele. Case studies A Moroccan family consisting of two healthy unrelated parents and three offspring—including two with Noonan syndrome, a rare autosomal dominant disorder with varying expression and genetic heterogeneity—underwent genetic testing revealing that both of the siblings with NS share the same PTPN11 haplotype from both parents, while a distinct paternal and maternal haplotype was inherited by the unaffected sibling. In the paper Germline and somatic mosaicism in transgenic mice published in 1986, Thomas M.Wilkie, Ralph L.Brinster, and Richard D.Palmiter analyzed a germline mosaicism experiment done on 262 transgenic mice and concluded that 30% of founder transgenic mice are mosaic in the germline. == Notes ==

Haploidisation is the process of halving the chromosomal content of a cell, producing a haploid cell. Within the normal reproductive cycle, haploidisation is one of the major functional consequences of meiosis, the other being a process of chromosomal crossover that mingles the genetic content of the parental chromosomes. Usually, haploidisation creates a monoploid cell from a diploid progenitor, or it can involve halving of a polyploid cell, for example to make a diploid potato plant from a tetraploid lineage of potato plants. If haploidisation is not followed by fertilisation, the result is a haploid lineage of cells. For example, experimental haploidisation may be used to recover a strain of haploid Dictyostelium from a diploid strain. It sometimes occurs naturally in plants when meiotically reduced cells (usually egg cells) develop by parthenogenesis. Haploidisation was one of the procedures used by Japanese researchers to produce Kaguya, a mouse which had same-sex parents; two haploids were then combined to make the diploid mouse. Haploidisation commitment is a checkpoint in meiosis which follows the successful completion of premeiotic DNA replication and recombination commitment. See also Polyploidy Ploidy == References ==

Haploinsufficiency in genetics describes a model of dominant gene action in diploid organisms, in which a single copy of the wild-type allele at a locus in heterozygous combination with a variant allele is insufficient to produce the wild-type phenotype. Haploinsufficiency may arise from a de novo or inherited loss-of-function mutation in the variant allele, such that it yields little or no gene product (often a protein). Although the other, standard allele still produces the standard amount of product, the total product is insufficient to produce the standard phenotype. This heterozygous genotype may result in a non- or sub-standard, deleterious, and (or) disease phenotype. Haploinsufficiency is the standard explanation for dominant deleterious alleles.In the alternative case of haplosufficiency, the loss-of-function allele behaves as above, but the single standard allele in the heterozygous genotype produces sufficient gene product to produce the same, standard phenotype as seen in the homozygote. Haplosufficiency accounts for the typical dominance of the "standard" allele over variant alleles, where the phenotypic identity of genotypes heterozygous and homozygous for the allele defines it as dominant, versus a variant phenotype produced only by the genotype homozygous for the alternative allele, which defines it as recessive. Mechanism The alteration in the gene dosage, which is caused by the loss of a functional allele, is also called allelic insufficiency. Haploinsufficiency in humans About 3,000 human genes cannot tolerate loss of one of the two alleles.An example of this is seen in the case of Williams syndrome, a neurodevelopmental disorder caused by the haploinsufficiency of genes at 7q11.23. The haploinsufficiency is caused by the copy-number variation (CNV) of 28 genes led by the deletion of ~1.6 Mb. These dosage-sensitive genes are vital for human language and constructive cognition.Another example is the haploinsufficiency of telomerase reverse transcriptase which leads to anticipation in autosomal dominant dyskeratosis congenita. It is a rare inherited disorder characterized by abnormal skin manifestations, which results in bone marrow failure, pulmonary fibrosis and an increased predisposition to cancer. A null mutation in motif D of the reverse transcriptase domain of the telomerase protein, hTERT, leads to this phenotype. Thus telomerase dosage is important for maintaining tissue proliferation.A variation of haploinsufficiency exists for mutations in the gene PRPF31, a known cause of autosomal dominant retinitis pigmentosa. There are two wild-type alleles of this gene—a high-expressivity allele and a low-expressivity allele. When the mutant gene is inherited with a high-expressivity allele, there is no disease phenotype. However, if a mutant allele and a low-expressivity allele are inherited, the residual protein levels falls below that required for normal function, and disease phenotype is present.Copy number variation (CNV) refers to the differences in the number of copies of a particular region of the genome. This leads to too many or too few of the dosage sensitive genes. The genomic rearrangements, that is, deletions or duplications, are caused by the mechanism of non-allelic homologous recombination (NAHR). In the case of the Williams Syndrome, the microdeletion includes the ELN gene. The hemizygosity of the elastin is responsible for supravalvular aortic stenosis, the obstruction in the left ventricular outflow of blood in the heart.Other examples include: Some cancers 1q21.1 deletion syndrome 5q- syndrome in myelodysplastic syndrome (MDS) 22q11.2 deletion syndrome CHARGE syndrome Cleidocranial dysostosis Ehlers–Danlos syndrome Frontotemporal dementia caused by mutations in progranulin GLUT1 deficiency (DeVivo syndrome) Haploinsufficiency of A20 Haploinsufficiency of PRR12 Holoprosencephaly caused by haploinsufficiency in the Sonic Hedgehog gene Holt–Oram syndrome Marfan syndrome Phelan–McDermid syndrome Polydactyly Dravet Syndrome ZTTK FOXP1 Syndrome NR4A2-related syndrome Methods of detection The most direct method to detect haploinsufficiency is the heterozygous deletion of one allele in a model organism. This can be done in tissue culture cells or in single-celled organisms such as yeast (Saccharomyces cerevisiae). References Further reading Ebert, BL; et al. (2008). "Identification of RPS14 as a 5q- syndrome gene by RNA interference screen". Nature. 451 (451): 335–340. Bibcode:2008Natur.451..335E. doi:10.1038/nature06494. PMC 3771855. PMID 18202658. Griffiths, Anthony J.; et al. (200). Introduction to Genetic Analysis (8th ed.). W.H. Freeman. ISBN 0-7167-4939-4.

The Hayflick limit, or Hayflick phenomenon, is the number of times a normal somatic, differentiated human cell population will divide before cell division stops. However, this limit does not apply to stem cells.The concept of the Hayflick limit was advanced by American anatomist Leonard Hayflick in 1961, at the Wistar Institute in Philadelphia, Pennsylvania. Hayflick demonstrated that a normal human fetal cell population will divide between 40 and 60 times in cell culture before entering a senescence phase. This finding refuted the contention by Alexis Carrel that normal cells are immortal. Each time a cell undergoes mitosis, the telomeres on the ends of each chromosome shorten slightly. Cell division will cease once telomeres shorten to a critical length. Hayflick interpreted his discovery to be aging at the cellular level. The aging of cell populations appears to correlate with the overall physical aging of an organism.Macfarlane Burnet coined the name "Hayflick limit" in his book Intrinsic Mutagenesis: A Genetic Approach to Ageing, published in 1974. History The belief in cell immortality Prior to Leonard Hayflick's discovery, it was believed that vertebrate cells had an unlimited potential to replicate. Alexis Carrel, a Nobel prize-winning surgeon, had stated "that all cells explanted in tissue culture are immortal, and that the lack of continuous cell replication was due to ignorance on how best to cultivate the cells". He claimed to have cultivated fibroblasts from the hearts of chickens (which typically live 5 to 10 years) and to have kept the culture growing for 34 years.However, other scientists have been unable to replicate Carrel's results, and they are suspected to be due to an error in experimental procedure. To provide required nutrients, embryonic stem cells of chickens may have been re-added to the culture daily. This would have easily allowed the cultivation of new, fresh cells in the culture, so there was not an infinite reproduction of the original cells. It has been speculated that Carrel knew about this error, but he never admitted it.Also, it has been theorized that the cells Carrel used were young enough to contain pluripotent stem cells, which, if supplied with a supporting telomerase-activation nutrient, would have been capable of staving off replicative senescence, or even possibly reversing it. Cultures not containing telomerase-active pluripotent stem cells would have been populated with telomerase-inactive cells, which would have been subject to the 50 ± 10 mitosis event limit until cellular senescence occurs as described in Hayflick's findings. Experiment and discovery Hayflick first became suspicious of Carrel's claims while working in a lab at the Wistar Institute. Hayflick noticed that one of his cultures of embryonic human fibroblasts had developed an unusual appearance and that cell division had slowed. Initially, he brushed this aside as an anomaly caused by contamination or technical error. However, he later observed other cell cultures exhibiting similar manifestations. Hayflick checked his research notebook and was surprised to find that the atypical cell cultures had all been cultured to approximately their 40th doubling while younger cultures never exhibited the same problems. Furthermore, conditions were similar between the younger and older cultures he observed — same culture medium, culture containers, and technician. This led him to doubt that the manifestations were due to contamination or technical error.Hayflick next set out to prove that the cessation of normal cell replicative capacity that he observed was not the result of viral contamination, poor culture conditions or some unknown artifact. Hayflick teamed with Paul Moorhead for the definitive experiment to eliminate these as causative factors. As a skilled cytogeneticist, Moorhead was able to distinguish between male and female cells in culture. The experiment proceeded as follows: Hayflick mixed equal numbers of normal human male fibroblasts that had divided many times (cells at the 40th population doubling) with female fibroblasts that had divided fewer times (cells at the 15th population doubling). Unmixed cell populations were kept as controls. After 20 doublings of the mixed culture, only female cells remained. Cell division ceased in the unmixed control cultures at the anticipated times; when the male control culture stopped dividing, only female cells remained in the mixed culture. This suggested that technical errors or contaminating viruses were unlikely explanations as to why cell division ceased in the older cells, and proved that unless the virus or artifact could distinguish between male and female cells (which it could not) then the cessation of normal cell replication was governed by an internal counting mechanism.These results disproved Carrel's immortality claims and established the Hayflick limit as a credible biological theory. Unlike Carrel's experiment, Hayflick's have been successfully repeated by other scientists. Cell phases Hayflick describes three phases in the life of normal cultured cells. At the start of his experiment he named the primary culture "phase one". Phase two is defined as the period when cells are proliferating; Hayflick called this the time of "luxuriant growth". After months of doubling the cells eventually reach phase three, a phenomenon he named "senescence", where cell replication rate slows before halting altogether. Telomere length The Hayflick limit has been found to correlate with the length of the telomeric region at the end of chromosomes. During the process of DNA replication of a chromosome, small segments of DNA within each telomere are unable to be copied and are lost. This occurs due to the uneven nature of DNA replication, where leading and lagging strands are not replicated symmetrically. The telomeric region of DNA does not code for any protein; it is simply a repeated code on the end region of linear eukaryotic chromosomes. After many divisions, the telomeres reach a critical length and the cell becomes senescent. It is at this point that a cell has reached its Hayflick limit.Hayflick was the first to report that only cancer cells are immortal. This could not have been demonstrated until he had demonstrated that normal cells are mortal. Cellular senescence does not occur in most cancer cells due to expression of an enzyme called telomerase. This enzyme extends telomeres, preventing the telomeres of cancer cells from shortening and giving them infinite replicative potential. A proposed treatment for cancer is the usage of telomerase inhibitors that would prevent the restoration of the telomere, allowing the cell to die like other body cells. Organismal aging Hayflick suggested that his results in which normal cells have a limited replicative capacity may have significance for understanding human aging at the cellular level.It has been reported that the limited replicative capability of human fibroblasts observed in cell culture is far greater than the number of replication events experienced by non-stem cells in vivo during a normal postnatal lifespan. In addition, it has been suggested that no inverse correlation exists between the replicative capacity of normal human cell strains and the age of the human donor from which the cells were derived, as previously argued. It is now clear that at least some of these variable results are attributable to the mosaicism of cell replication numbers at different body sites where cells were taken.Comparisons of different species indicate that cellular replicative capacity may correlate primarily with species body mass, but more likely to species lifespan. Thus, the limited capacity of cells to replicate in culture may be directly relevant to organismal aging. See also Ageing Apoptosis Biological immortality HeLa cells Induced stem cells References Further reading Watts, Geoff (2011). "Leonard Hayflick and the limits of ageing". The Lancet. 377 (9783): 2075. doi:10.1016/S0140-6736(11)60908-2. PMID 21684371. S2CID 205963134. Harley, Calvin B.; Futcher, A. Bruce; Greider, Carol W. (1990). "Telomeres shorten during ageing of human fibroblasts". Nature. 345 (6274): 458–60. Bibcode:1990Natur.345..458H. doi:10.1038/345458a0. PMID 2342578. S2CID 1145492. Gavrilov LA, Gavrilova NS (1991). The Biology of Life Span: A Quantitative Approach. New York: Harwood Academic Publisher. ISBN 3-7186-4983-7. Gavrilov LA, Gavrilova NS (1993). "How many cell divisions in 'old' cells?". Int. J. Geriatr. Psychiatry. 8 (6): 528. Wang, Richard C.; Smogorzewska, Agata; De Lange, Titia (2004). "Homologous Recombination Generates T-Loop-Sized Deletions at Human Telomeres". Cell. 119 (3): 355–68. doi:10.1016/j.cell.2004.10.011. PMID 15507207. S2CID 10686288. Watson, J. M.; Shippen, D. E. (2006). "Telomere Rapid Deletion Regulates Telomere Length in Arabidopsis thaliana". Molecular and Cellular Biology. 27 (5): 1706–15. doi:10.1128/MCB.02059-06. PMC 1820464. PMID 17189431.

Heredity, also called inheritance or biological inheritance, is the passing on of traits from parents to their offspring; either through asexual reproduction or sexual reproduction, the offspring cells or organisms acquire the genetic information of their parents. Through heredity, variations between individuals can accumulate and cause species to evolve by natural selection. The study of heredity in biology is genetics. Overview In humans, eye color is an example of an inherited characteristic: an individual might inherit the "brown-eye trait" from one of the parents. Inherited traits are controlled by genes and the complete set of genes within an organism's genome is called its genotype.The complete set of observable traits of the structure and behavior of an organism is called its phenotype. These traits arise from the interaction of the organism's genotype with the environment. As a result, many aspects of an organism's phenotype are not inherited. For example, suntanned skin comes from the interaction between a person's genotype and sunlight; thus, suntans are not passed on to people's children. However, some people tan more easily than others, due to differences in their genotype: a striking example is people with the inherited trait of albinism, who do not tan at all and are very sensitive to sunburn.Heritable traits are known to be passed from one generation to the next via DNA, a molecule that encodes genetic information. DNA is a long polymer that incorporates four types of bases, which are interchangeable. The Nucleic acid sequence (the sequence of bases along a particular DNA molecule) specifies the genetic information: this is comparable to a sequence of letters spelling out a passage of text. Before a cell divides through mitosis, the DNA is copied, so that each of the resulting two cells will inherit the DNA sequence. A portion of a DNA molecule that specifies a single functional unit is called a gene; different genes have different sequences of bases. Within cells, the long strands of DNA form condensed structures called chromosomes. Organisms inherit genetic material from their parents in the form of homologous chromosomes, containing a unique combination of DNA sequences that code for genes. The specific location of a DNA sequence within a chromosome is known as a locus. If the DNA sequence at a particular locus varies between individuals, the different forms of this sequence are called alleles. DNA sequences can change through mutations, producing new alleles. If a mutation occurs within a gene, the new allele may affect the trait that the gene controls, altering the phenotype of the organism.However, while this simple correspondence between an allele and a trait works in some cases, most traits are more complex and are controlled by multiple interacting genes within and among organisms. Developmental biologists suggest that complex interactions in genetic networks and communication among cells can lead to heritable variations that may underlie some of the mechanics in developmental plasticity and canalization.Recent findings have confirmed important examples of heritable changes that cannot be explained by direct agency of the DNA molecule. These phenomena are classed as epigenetic inheritance systems that are causally or independently evolving over genes. Research into modes and mechanisms of epigenetic inheritance is still in its scientific infancy, but this area of research has attracted much recent activity as it broadens the scope of heritability and evolutionary biology in general. DNA methylation marking chromatin, self-sustaining metabolic loops, gene silencing by RNA interference, and the three dimensional conformation of proteins (such as prions) are areas where epigenetic inheritance systems have been discovered at the organismic level. Heritability may also occur at even larger scales. For example, ecological inheritance through the process of niche construction is defined by the regular and repeated activities of organisms in their environment. This generates a legacy of effect that modifies and feeds back into the selection regime of subsequent generations. Descendants inherit genes plus environmental characteristics generated by the ecological actions of ancestors. Other examples of heritability in evolution that are not under the direct control of genes include the inheritance of cultural traits, group heritability, and symbiogenesis. These examples of heritability that operate above the gene are covered broadly under the title of multilevel or hierarchical selection, which has been a subject of intense debate in the history of evolutionary science. Relation to theory of evolution When Charles Darwin proposed his theory of evolution in 1859, one of its major problems was the lack of an underlying mechanism for heredity. Darwin believed in a mix of blending inheritance and the inheritance of acquired traits (pangenesis). Blending inheritance would lead to uniformity across populations in only a few generations and then would remove variation from a population on which natural selection could act. This led to Darwin adopting some Lamarckian ideas in later editions of On the Origin of Species and his later biological works. Darwin's primary approach to heredity was to outline how it appeared to work (noticing that traits that were not expressed explicitly in the parent at the time of reproduction could be inherited, that certain traits could be sex-linked, etc.) rather than suggesting mechanisms.Darwin's initial model of heredity was adopted by, and then heavily modified by, his cousin Francis Galton, who laid the framework for the biometric school of heredity. Galton found no evidence to support the aspects of Darwin's pangenesis model, which relied on acquired traits.The inheritance of acquired traits was shown to have little basis in the 1880s when August Weismann cut the tails off many generations of mice and found that their offspring continued to develop tails. History Scientists in Antiquity had a variety of ideas about heredity: Theophrastus proposed that male flowers caused female flowers to ripen; Hippocrates speculated that "seeds" were produced by various body parts and transmitted to offspring at the time of conception; and Aristotle thought that male and female fluids mixed at conception. Aeschylus, in 458 BC, proposed the male as the parent, with the female as a "nurse for the young life sown within her".Ancient understandings of heredity transitioned to two debated doctrines in the 18th century. The Doctrine of Epigenesis and the Doctrine of Preformation were two distinct views of the understanding of heredity. The Doctrine of Epigenesis, originated by Aristotle, claimed that an embryo continually develops. The modifications of the parent's traits are passed off to an embryo during its lifetime. The foundation of this doctrine was based on the theory of inheritance of acquired traits. In direct opposition, the Doctrine of Preformation claimed that "like generates like" where the germ would evolve to yield offspring similar to the parents. The Preformationist view believed procreation was an act of revealing what had been created long before. However, this was disputed by the creation of the cell theory in the 19th century, where the fundamental unit of life is the cell, and not some preformed parts of an organism. Various hereditary mechanisms, including blending inheritance were also envisaged without being properly tested or quantified, and were later disputed. Nevertheless, people were able to develop domestic breeds of animals as well as crops through artificial selection. The inheritance of acquired traits also formed a part of early Lamarckian ideas on evolution.During the 18th century, Dutch microscopist Antonie van Leeuwenhoek (1632–1723) discovered "animalcules" in the sperm of humans and other animals. Some scientists speculated they saw a "little man" (homunculus) inside each sperm. These scientists formed a school of thought known as the "spermists". They contended the only contributions of the female to the next generation were the womb in which the homunculus grew, and prenatal influences of the womb. An opposing school of thought, the ovists, believed that the future human was in the egg, and that sperm merely stimulated the growth of the egg. Ovists thought women carried eggs containing boy and girl children, and that the gender of the offspring was determined well before conception.An early research initiative emerged in 1878 when Alpheus Hyatt led an investigation to study the laws of heredity through compiling data on family phenotypes (nose size, ear shape, etc.) and expression of pathological conditions and abnormal characteristics, particularly with respect to the age of appearance. One of the projects aims was to tabulate data to better understand why certain traits are consistently expressed while others are highly irregular. Gregor Mendel: father of genetics The idea of particulate inheritance of genes can be attributed to the Moravian monk Gregor Mendel who published his work on pea plants in 1865. However, his work was not widely known and was rediscovered in 1901. It was initially assumed that Mendelian inheritance only accounted for large (qualitative) differences, such as those seen by Mendel in his pea plants – and the idea of additive effect of (quantitative) genes was not realised until R.A. Fisher's (1918) paper, "The Correlation Between Relatives on the Supposition of Mendelian Inheritance" Mendel's overall contribution gave scientists a useful overview that traits were inheritable. His pea plant demonstration became the foundation of the study of Mendelian Traits. These traits can be traced on a single locus. Modern development of genetics and heredity In the 1930s, work by Fisher and others resulted in a combination of Mendelian and biometric schools into the modern evolutionary synthesis. The modern synthesis bridged the gap between experimental geneticists and naturalists; and between both and palaeontologists, stating that: All evolutionary phenomena can be explained in a way consistent with known genetic mechanisms and the observational evidence of naturalists. Evolution is gradual: small genetic changes, recombination ordered by natural selection. Discontinuities amongst species (or other taxa) are explained as originating gradually through geographical separation and extinction (not saltation). Selection is overwhelmingly the main mechanism of change; even slight advantages are important when continued. The object of selection is the phenotype in its surrounding environment. The role of genetic drift is equivocal; though strongly supported initially by Dobzhansky, it was downgraded later as results from ecological genetics were obtained. The primacy of population thinking: the genetic diversity carried in natural populations is a key factor in evolution. The strength of natural selection in the wild was greater than expected; the effect of ecological factors such as niche occupation and the significance of barriers to gene flow are all important.The idea that speciation occurs after populations are reproductively isolated has been much debated. In plants, polyploidy must be included in any view of speciation. Formulations such as 'evolution consists primarily of changes in the frequencies of alleles between one generation and another' were proposed rather later. The traditional view is that developmental biology ('evo-devo') played little part in the synthesis, but an account of Gavin de Beer's work by Stephen Jay Gould suggests he may be an exception.Almost all aspects of the synthesis have been challenged at times, with varying degrees of success. There is no doubt, however, that the synthesis was a great landmark in evolutionary biology. It cleared up many confusions, and was directly responsible for stimulating a great deal of research in the post-World War II era. Trofim Lysenko however caused a backlash of what is now called Lysenkoism in the Soviet Union when he emphasised Lamarckian ideas on the inheritance of acquired traits. This movement affected agricultural research and led to food shortages in the 1960s and seriously affected the USSR.There is growing evidence that there is transgenerational inheritance of epigenetic changes in humans and other animals. Common genetic disorders Fragile X syndrome Sickle cell disease Phenylketonuria (PKU) Haemophilia Types The description of a mode of biological inheritance consists of three main categories: 1. Number of involved loci Monogenetic (also called "simple") – one locus Oligogenic – few loci Polygenetic – many loci2. Involved chromosomesAutosomal – loci are not situated on a sex chromosome Gonosomal – loci are situated on a sex chromosome X-chromosomal – loci are situated on the X-chromosome (the more common case) Y-chromosomal – loci are situated on the Y-chromosome Mitochondrial – loci are situated on the mitochondrial DNA3. Correlation genotype–phenotype Dominant Intermediate (also called "codominant") Recessive Overdominant UnderdominantThese three categories are part of every exact description of a mode of inheritance in the above order. In addition, more specifications may be added as follows: 4. Coincidental and environmental interactionsPenetrance Complete Incomplete (percentual number) Expressivity Invariable Variable Heritability (in polygenetic and sometimes also in oligogenetic modes of inheritance) Maternal or paternal imprinting phenomena (also see epigenetics)5. Sex-linked interactionsSex-linked inheritance (gonosomal loci) Sex-limited phenotype expression (e.g., cryptorchism) Inheritance through the maternal line (in case of mitochondrial DNA loci) Inheritance through the paternal line (in case of Y-chromosomal loci)6. Locus–locus interactions Epistasis with other loci (e.g., overdominance) Gene coupling with other loci (also see crossing over) Homozygotous lethal factors Semi-lethal factorsDetermination and description of a mode of inheritance is also achieved primarily through statistical analysis of pedigree data. In case the involved loci are known, methods of molecular genetics can also be employed. Dominant and recessive alleles An allele is said to be dominant if it is always expressed in the appearance of an organism (phenotype) provided that at least one copy of it is present. For example, in peas the allele for green pods, G, is dominant to that for yellow pods, g. Thus pea plants with the pair of alleles either GG (homozygote) or Gg (heterozygote) will have green pods. The allele for yellow pods is recessive. The effects of this allele are only seen when it is present in both chromosomes, gg (homozygote). This derives from Zygosity, the degree to which both copies of a chromosome or gene have the same genetic sequence, in other words, the degree of similarity of the alleles in an organism. See also References External links Stanford Encyclopedia of Philosophy entry on Heredity and Heritability ""Experiments in Plant Hybridization" (1866), by Johann Gregor Mendel", by A. Andrei at the Embryo Project Encyclopedia

Heterogamy is a term applied to a variety of distinct phenomena in different scientific domains. Usually having to do with some kind of difference, "hetero", in reproduction, "gamy". See below for more specific senses. Science Reproductive biology In reproductive biology, heterogamy is the alternation of differently organized generations, applied to the alternation between parthenogenetic and a sexual generation. This type of heterogamy occurs for example in some aphids. Alternately, heterogamy or heterogamous is often used as a synonym of heterogametic, meaning the presence of two unlike chromosomes in a sex. For example, XY males and ZW females are called the heterogamous sex. Cell biology In cell biology, heterogamy is a synonym of anisogamy, the condition of having differently sized male and female gametes produced by different sexes or mating types in a species. Botany In botany, a plant is heterogamous when it carries at least two different types of flowers in regard to their reproductive structures, for example male and female flowers or bisexual and female flowers. Stamens and carpels are not regularly present in each flower or floret. Social science In sociology, heterogamy refers to a marriage between two individuals that differ in a certain criterion, and is contrasted with homogamy for a marriage or union between partners that match according to that criterion. For example, ethnic heterogamy refers to marriages involving individuals of different ethnic groups. Age heterogamy refers to marriages involving partners of significantly different ages. Heterogamy and homogamy are also used to describe marriage or union between people of unlike and like sex (or gender) respectively. See also Heterogametic Homogametic == References ==

Hypoxia inducible lipid droplet-associated (Hilpda, also known as C7orf68 and HIG-2) is a protein that in humans is encoded by the HILPDA gene. Discovery HILPDA was originally discovered in a screen to identify new genes that are activated by low oxygen pressure (hypoxia) in human cervical cancer cells. The protein consists of 63 amino acids in humans and 64 amino acids in mice. Expression HILPDA is produced by numerous cells and tissues, including cancer cells, immune cells, fat cells, and liver cells. Low oxygen pressure (hypoxia), fatty acids, and beta-adrenergic agonists stimulate HILPDA expression. Function Nearly all cells have the ability to store excess energy as fat in special structures in the cell called lipid droplets. The formation and breakdown of lipid droplets is controlled by various enzymes and lipid droplet-associated proteins. One of the lipid droplet-associated proteins is HILPDA. HILPDA acts as a regulatory signal that blocks the breakdown of the fat stores in cells when the external fat supply is high or the availability of oxygen is low. In cells, HILPDA is located in the endoplasmic reticulum and around lipid droplets. Gain and loss-of-function studies have shown that HILPDA promotes fat storage in cancer cells, macrophages and liver cells. This effect is at least partly achieved by suppressing triglyceride breakdown by inhibiting the enzyme adipose triglyceride lipase. The binding of HILPDA to adipose triglyceride lipase occurs via the conserved N-terminal portion of HILPDA, which is similar to a region in the G0S2 protein. Clinical significance The deficiency of HILPDA in mice that are prone to develop atherosclerosis led to a reduction in atherosclerotic plaques, suggesting that HILPDA may be a potential therapeutic target for atherosclerosis. In addition, HILPDA may be targeted for the treatment of non-alcoholic fatty liver disease. == References ==

Hovlinc RNA is a self-cleaving ribozyme of about 168 nucleotides found in a very long noncoding RNA (vlincRNA) in humans, chimpanzees, and gorillas. The word "hovlinc" comes from "hominin vlincRNA-located" RNA. Hovlinc is only a fourth known case of a ribozyme in human. Self-cleavage activity of Hovlinc has been shown in human, chimpanzees and bonobos, but is absent in gorillas, raising questions about Hovlinc's biological function and evolution. There are only a few known examples of ribozymes in human, including Hovlinc, Mammalian CPEB3 ribozyme, Hammerhead ribozyme (HH9 and HH10) and B2 SINE ribozyme. Presumably Hovlinc acquired its self-cleaving activity about 10 to 13 million of years ago, which coincides with the last common ancestor of humans, gorillas, and chimpanzees. Hovlinc presents catalytic activity in hominids but not in gorillas where a mutation abolished the self-cleavage activity. Hovlinc is a very structured RNA that contains four stem loops joined in a central loop, it also features large pseudoknots that help to bring together the second and fourth helices, which helps the RNA to get the more compacted structure that allows catalytic activity. References External links Hovlinc family in Rfam

Human germline engineering is the process by which the genome of an individual is edited in such a way that the change is heritable. This is achieved by altering the genes of the germ cells, which then mature into genetically modified eggs and sperm. For safety, ethical, and social reasons, there is broad agreement among the scientific community and the public that germline editing for reproduction is a red line that should not be crossed at this point in time. There are differing public sentiments, however, on whether it may be performed in the future depending on whether the intent would be therapeutic or non-therapeutic.Using germline editing for reproduction is prohibited by law in more than 70 countries and by a binding international treaty of the Council of Europe. However, in November 2015, a group of Chinese scientists used the gene-editing technique CRISPR/Cas9 to edit single-celled, non-viable embryos to see the effectiveness of this technique. This attempt was rather unsuccessful; only a small fraction of the embryos successfully incorporated the new genetic material and many of the embryos contained a large number of random mutations. The non-viable embryos that were used contained an extra set of chromosomes, which may have been problematic. In 2016, another similar study was performed in China which also used non-viable embryos with extra sets of chromosomes. This study showed very similar results to the first; there were successful integrations of the desired gene, yet the majority of the attempts failed, or produced undesirable mutations. In November 2018, researcher He Jiankui claimed that he had created the first human genetically edited babies, known by their pseudonyms, Lulu and Nana. In May 2019, lawyers in China reported, in light of the purported creation by He Jiankui of the first gene-edited humans, the drafting of regulations that anyone manipulating the human genome by gene-editing techniques, like CRISPR, would be held responsible for any related adverse consequences. Techniques CRISPR-Cas9 In general, CRISPR-Cas9 is the most effective gene-editing technique to date. The CRISPR-Cas9 system consists of an enzyme called Cas9 and a special piece of guide RNA (gRNA). Cas9 acts as a pair of ‘molecular scissors’ that can cut the DNA at a specific location in the genome so that DNA can be added or removed. The guide RNA is a piece of RNA with complementary bases to those at the target location, so that it will only bind there and no other regions of the genome. The Cas9 follows the guide RNA to the same location in the DNA sequence and makes a cut across both strands of the DNA. At this stage, the cell recognizes that the DNA is damaged and tries to repair it. Scientists can use the DNA repair machinery to introduce changes to one or more genes in the genome of a cell of interest. Although the CRISPR/Cas9 can be used in humans, it is more commonly used by scientists in other animal models or cell culture systems, including in experiments to learn more about genes that could be involved in human diseases. Clinical trials are being conducted on somatic cells, but CRISPR could make it possible to modify the DNA of spermatogonial stem cells. This could be used to eliminate certain diseases in humans, or at least significantly decrease a disease's frequency until it eventually disappears over generations. Cancer survivors theoretically would be able to have their genes modified by the CRISPR/Cas9 so that certain diseases or mutations will not be passed down to their offspring. This could possibly eliminate cancer predispositions in humans. Researchers hope that they can use the system in the future to treat currently incurable diseases by altering the genome altogether. PGD Another way to modify the human genome involves analyzing human embryos to identify genes associated with disease, and selecting embryos that have the desired genetic makeup. This is called PGD, or Preimplantation Genetic Diagnosis. IVF, or in vitro fertilization, is often used to obtain embryos for evaluation of the genome – alternatively, oocytes can be screened prior to fertilization. The technique was first used in 1989. PGD is used primarily to select embryos for implantation when there are possible genetic defects, allowing mutated or disease-related alleles to be identified and excluded from selection. It is especially useful when one or both parents carry a heritable genetic disease. PGD can also be used to select for embryos of a certain sex, which is useful to avoid sex-linked genetic disorders like hemophilia, which is more common in males. Infants born with traits selected by PGD are sometimes considered to be designer babies.One application of PGD is the selection of ‘savior siblings’, children who are born to provide a transplant (of an organ or group of cells) to a sibling with a usually life-threatening disease. Savior siblings are conceived through IVF and then screened using PGD to analyze genetic similarity to the child needing a transplant, in order to reduce the risk of rejection. Detailed description Embryos for PGD are obtained from IVF procedures in which the oocyte is artificially fertilized by sperm. Oocytes from the woman are harvested following controlled ovarian hyper stimulation (COH), which involves fertility treatments to induce production of multiple oocytes. After harvesting the oocytes, they are fertilized in vitro, either during incubation with multiple sperm cells in culture, or via intracytoplasmic sperm injection (ICSI), where sperm is directly injected into the oocyte. Such tests include amniocentesis, ultrasounds, and other preimplantation genetic diagnostic tests. These tests are quite common, and reliable, as we talk about them today; however, in the past when they were first introduced, they too were scrutinized. The resulting embryos are usually cultured for 3–6 days, allowing them to reach the blastomere or blastocyst stage. Once embryos reach the desired stage of development, cells are biopsied and genetically screened. The screening procedure varies based on the nature of the disorder being investigated. Polymerase chain reaction (PCR) is a process in which DNA sequences are amplified to produce many more copies of the same segment, allowing screening of large samples and identification of specific genes. The process is often used when screening for monogenic disorders, such as cystic fibrosis. Another screening technique, fluorescent in situ hybridization (FISH) uses fluorescent probes which specifically bind to highly complementary sequences on chromosomes, which can then be identified using fluorescence microscopy. FISH is often used when screening for chromosomal abnormalities such as aneuploidy, making it a useful tool when screening for disorders such as Down syndrome.Following screening, embryos with the desired trait (or lacking an undesired trait such as a mutation) are transferred into the mother's uterus, then allowed to develop naturally. Conceivable uses Human germline engineering could be used to heritably cure genetic disorders and other diseases, and to give specific traits to human babies. For example, The Berlin Patient has a genetic mutation in the CCR5 gene (which codes for a protein on the surface of white blood cells, targeted by the HIV virus) that deactivates the expression of CCR5, conferring innate resistance to HIV. HIV/AIDS carries a large disease burden and is incurable (see Epidemiology of HIV/AIDS). One proposal is to genetically modify human embryos to give the CCR5 Δ32 allele to people. Another use would be to cure genetic disorders. In the first study published regarding human germline engineering, the researchers attempted to edit the HBB gene which codes for the human β-globin protein. Mutations in the HBB gene result in the disorder β-thalassaemia, which can be fatal. Perfect editing of the genome in patients who have these HBB mutations would result in copies of the gene which do not possess any mutations, effectively curing the disease. If the germline could be edited, this normal copy of the HBB genes could be passed on to future generations. Designer babies The non-therapeutic use of human germline engineering would be eugenic modifications to humans which would result in what are known as "designer babies". The concept of a "designer baby" is that its entire genetic composition could be selected for. In an extreme case, people would be able to effectively create the offspring that they want, with a genotype of their choosing. Not only does human germline engineering allow for the selection of specific traits, but it also allows for enhancement of these traits. Using human germline editing for selection and enhancement is currently very heavily scrutinized, and the main driving force behind the movement of trying to ban human germline engineering.In a 2019 animal study with Liang Guang Small Spotted pigs, increased muscle mass was achieved with precise editing of the myostatin signal peptide. Myostatin is a negative regulator of muscle growth, so through mutating the signal peptide regions of the gene, muscle growth could be promoted in the experimental pigs. The Myostatin genes in 955 pig embryos were mutated at several locations with CRISPR and implanted into five surrogates, resulting in 16 piglets. It was found that only specific mutations to the myostatin signal peptide resulted in increased muscle mass in the piglets mainly due to an increase in muscle fibers. A similar animal study created a knockout in the myostatin gene in mice, which also increased their muscle mass. This showed that muscle mass could be increased with germline editing, which is likely applicable to humans because humans also have the myostatin gene to regulate muscle growth. Human germline engineering may then result in intentionally increased muscle mass, with applications such as gene doping. State of research Human germline engineering is a widely debated topic, and in more than 40 countries, it is formally outlawed. While there is no current legislation explicitly prohibiting germline engineering in the United States, the Consolidated Appropriation Act of 2016 bans the use of US FDA funds to engage in research regarding human germline modification. In April 2015, a research team published an experiment in which they used CRISPR to edit a gene that is associated with blood disease in non-living human embryos. This experiment was unsuccessful, but gene editing tools are used in labs. Scientists using the CRISPR/Cas9 system to modify genetic materials have run into issues when it comes to mammalian alterations due to the complex diploid cells. Studies have been done in microorganisms regarding loss of function genetic screening and some studies have been done using mice as a subject. Because RNA processes differ between bacteria and mammalian cells, scientists have had difficulties coding for mRNA's translated data without the interference of RNA. Studies have been done using the Cas9 nuclease that uses a single guide RNA to allow for larger knockout regions in mice, and this was successful. Altering the genetic sequence of mammals is also widely debated, and this creates a difficult FDA regulation standard for such studies. Lack of clear international regulation The lack of clear international regulation has led to researchers across the globe attempting to create an international framework of ethical guidelines. Current framework lacks the requisite treaties among nations to create a mechanism for international enforcement. At the first International Summit on Human Gene Editing in December 2015 the collaboration of scientists issued the first international guidelines on genetic research. These guidelines allow for the pre-clinical research into the editing of genetic sequences in human cells granted the embryos are not used to implant pregnancy. Genetic alteration of somatic cells for therapeutic proposes was also considered an ethically acceptable field of research in part due to the lack of ability of somatic cells to transfer genetic material to subsequent generations. However citing the lack of social consensus, and the risk of inaccurate gene editing the conference called for restraint on any germline modifications on implanted embryos intended for pregnancy. With the international outcry in response to the first recorded case of human germ line edited embryos being implanted by researcher He Jiankui, scientists have continued discussion on the best possible mechanism for enforcement of an international framework. On March 13, 2019 researchers Eric Lander, Françoise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul Bergfrom along with others across the globe published a call for a framework that does not foreclose any outcome but includes a voluntary pledge by nations along with a coordinating body to monitor the application of pledged nations in a moratorium on human germline editing with an attempt to reach social consensus before moving forward into further research. The World Health Organization announced on December 18, 2018 plans to convene an intentional committee on clinical germline editing. He Jiankui controversy and research On 25 November 2018, two days before the Second International Summit on Human Genome Editing in Hong Kong, He Jiankui, a Chinese researcher of the Southern University of Science and Technology, released a video on YouTube announcing that he and his colleagues have “created” the world's first genetically altered babies, Lulu and Nana. He explained the details of his experiment in his address at the Hong Kong conference. He and his team had recruited eight couples through an HIV volunteer group named Baihualin (BHL) China League (one couple later withdrew from the research). All the male participants are HIV-positive, and all female participants are HIV-negative. The participants' sperm was “washed off” to get rid of HIV and then injected into eggs collected from the female participants. By using clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9, a gene editing technique, they disabled a gene called CCR5 in the embryos, aiming to close the protein doorway that allows HIV to enter a cell and make the subjects immune to the HIV virus. The process led to at least one successful pregnancy and the birth of the twin baby girls, Lulu and Nana. Researcher Alcino J. Silva has discovered an impact the CCR5 gene has on the memory function the brain.A major concern has been that He Jiankui's attempts to cripple CCR5, the gene for a protein on immune cells that HIV uses to infect the cells, also made “off-target” changes elsewhere in the girls' genomes. Those changes could cause cancer or other problems. He contends that the babies have no such off-target mutations, although some scientists are skeptical of the evidence offered so far.People inherit two copies of CCR5, one from each parent. He chose the gene as a target because he knew that about 1% of Northern European populations are born with both copies missing 32 base pairs, resulting in a truncated protein that does not reach the cell surface. These people, known as CCR5Δ32 homozygotes, appear healthy and are highly resistant to HIV infection. In the embryos, He's team designed CRISPR to cut CCR5 at the base pair at one end of the natural deletion. The error-prone cell-repair mechanism, which CRISPR depends on to finish knocking out genes, then deleted 15 base pairs in one of Lulu's copies of the gene, but none in the other. With one normal CCR5, she is expected to have no protection from HIV. Nana, according to the data He presented in a slide at an international genome-editing summit held in November 2018 in Hong Kong, China, had bases added to one CCR5 copy and deleted from the other, which likely would cripple both genes and provide HIV resistance. He added the genes for the CRISPR machinery almost immediately after each embryo was created through in vitro fertilization, but several researchers who closely studied the slide caution that it may have done its editing after Nana's embryo was already past the one-cell stage. That means she could be a genetic “mosaic” who has some unaffected cells with normal CCR5—and ultimately might have no protection from HIV. Aside from the primary HIV concerns, the gene edits may have inadvertently altered cognitive function. Researchers showed in 2016 that knocking out one or both CCR5s in mice enhances their memory and cognition. A subsequent study that crippled CCR5 in mice found that, compared with control animals, the mutants recovered from strokes more quickly and had improved motor and cognitive functions following traumatic brain injury. The later study, in the 21 February issue of Cell, also included an analysis of 68 stroke patients who had one copy of CCR5 with the HIV resistance mutation; it concluded they had improved recovery, too. On the night of November 26, 122 Chinese scientists issued a statement strongly condemning He's action as unethical. They stated that while CRISPR-Cas is not a new technology, it involves serious off-target risks and associated ethical considerations, and so should not be used to produce gene-altered babies. They described He's experiment as “crazy” and “a huge blow to the global reputation and development of Chinese science”. The Scientific Ethics Committee of the Academic Divisions of the Chinese Academy of Sciences posted a statement declaring their opposition to any clinical use of genome editing on human embryos, noting that “the theory is not reliable, the technology is deficient, the risks are uncontrollable, and ethics and regulations prohibit the action”. The Chinese Academy of Engineering released a statement on November 28, calling on scientists to improve self-discipline and self-regulation, and to abide by corresponding ethical principles, laws, and regulations. Finally, the Chinese Academy of Medical Sciences published a correspondence in The Lancet, stating that they are “opposed to any clinical operation of human embryo genome editing for reproductive purposes." Major studies of influence The first known publication of research into human germline editing was by a group of Chinese scientists in April 2015 in the Journal "Protein and Cell". The scientists used tripronuclear (3PN) zygotes, zygotes fertilized by two sperm and therefore non-viable, to investigate CRISPR/Cas9-mediated gene editing in human cells, something that had never been attempted before. The scientists found that while CRISPR/Cas9 could effectively cleave the β-globin gene (HBB), the efficiency of homologous recombination directed repair of HBB was highly inefficient and did not do so in a majority of the trials. Problems arose such as off target cleavage and the competitive recombination of the endogenous delta-globin with the HBB led to unexpected mutation. The results of the study indicated that repair of HBB in the embryos occurred preferentially through alternative pathways. In the end only 4 of the 54 zygotes carried the intended genetic information, and even then the successfully edited embryos were mosaics containing the preferential genetic code and the mutation. The conclusion of the scientists was that further effort was needed in to improve the precision and efficiency of CRISPR/Cas9 gene editing.In March 2017, a group of Chinese scientists claimed to have edited three normal viable human embryos out of six total in the experiment. The study showed that CRISPR/Cas9 is could effectively be used as a gene-editing tool in human 2PN zygotes, which could lead potentially pregnancy viable if implanted. The scientists used injection of Cas9 protein complexed with the relevant sgRNAs and homology donors into human embryos. The scientists found homologous recombination-mediated alteration in HBB and G6PD. The scientists also noted the limitations of their study and called for further research.In August 2017, a group of scientists from Oregon published an article in Nature journal detailing the successful use of CRISPR to edit out a mutation responsible for congenital heart disease. The study looked at heterozygous MYBPC3 mutation in human embryos. The study claimed precise CRISPR/Cas9 and homology-directed repair response with high accuracy and precision. Double-strand breaks at the mutant paternal allele were repaired using the homologous wild-type gene. By modifying the cell cycle stage at which the DSB was induced, they were able to avoid mosaicism, which had been seen in earlier similar studies, in cleaving embryos and achieve a large percentage of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of unintended mutations. The scientists concluded that the technique may be used for the correction of mutations in human embryos. The claims of this study were however pushed back on by critics who argued the evidence was overall unpersuasive.In June 2018, a group of scientists published and article in "Nature" journal indicating a potential link for edited cells having increased potential turn cancerous. The scientists reported that genome editing by CRISPR/Cas9 induced DNA damage response and the cell cycle stopped. The study was conducted in human retinal pigment epithelial cells, and the use of CRISPR led to a selection against cells with a functional p53 pathway. The conclusion of the study would suggest that p53 inhibition might increase efficiency of human germline editing and that p53 function would need to be watched when developing CRISPR/Cas9 based therapy.In November 2018, a group of Chinese scientists published research in the journal "Molecular Therapy" detailing their use of CRISPR/Cas9 technology to correct a single mistaken amino acid successfully in 16 out of 18 attempts in a human embryo. The unusual level of precision was achieved by the use of a base editor (BE) system which was constructed by fusing the deaminase to the dCas9 protein. The BE system efficiently edits the targeted C to T or G to A without the use of a donor and without DBS formation. The study focused on the FBN1 mutation that is causative for Marfan syndrome. The study provides proof positive for the corrective value of gene therapy for the FBN1 mutation in both somatic cells and germline cells. The study is noted for its relative precision which is a departure from past results of CRISPR/Cas9 studies. Ethical and moral debates As early in the history of biotechnology as 1990, there have been scientists opposed to attempts to modify the human germline using these new tools, and such concerns have continued as technology progressed. In March 2015, with the advent of new techniques like CRISPR, a group of scientists urged a worldwide moratorium on clinical use of gene editing technologies to edit the human genome in a way that can be inherited. In April 2015, researchers reported results of basic research to edit the DNA of non-viable human embryos using CRISPR, creating controversy.A committee of the American National Academy of Sciences and National Academy of Medicine gave support to human genome editing in 2017 once answers have been found to safety and efficiency problems "but only for serious conditions under stringent oversight." The American Medical Association's Council on Ethical and Judicial Affairs stated that "genetic interventions to enhance traits should be considered permissible only in severely restricted situations: (1) clear and meaningful benefits to the fetus or child; (2) no trade-off with other characteristics or traits; and (3) equal access to the genetic technology, irrespective of income or other socioeconomic characteristics."Several religious positions have been published with regards to human germline engineering. According to them, many see germline modification as being more moral than the alternative, which would be either discarding of the embryo, or birth of a diseased human. The main conditions when it comes to whether or not it is morally and ethically acceptable lie within the intent of the modification, and the conditions in which the engineering is done.Ethical claims about germline engineering include beliefs that every fetus has a right to remain genetically unmodified, that parents hold the right to genetically modify their offspring, and that every child has the right to be born free of preventable diseases. For parents, genetic engineering could be seen as another child enhancement technique to add to diet, exercise, education, training, cosmetics, and plastic surgery. Another theorist claims that moral concerns limit but do not prohibit germline engineering. Consent One issue related to human genome editing relates to the impact of the technology on future individuals whose genes are modified without their consent. Clinical ethics accepts the idea that parents are, almost always, the most appropriate surrogate medical decision makers for their children until the children develop their own autonomy and decision-making capacity. This is based on the assumption that, except under rare circumstances, parents have the most to lose or gain from a decision and will ultimately make decisions that reflects the future values and beliefs of their children. According to this assumption, it could be assumed that parents are the most appropriate decision makers for their future children as well. However, there are anecdotal reports of children and adults who disagree with the medical decisions made by a parent during pregnancy or early childhood, such as when death was a possible outcome. There are also published patient stories by individuals who feel that they would not wish to change or remove their own medical condition if given the choice and individuals who disagree with medical decisions made by their parents during childhood.Other scientists and philosophers have noted that the issue of the lack of prior consent applies as well to individuals born via traditional sexual reproduction. Philosopher David Pearce further argues that “old-fashioned sexual reproduction is itself an untested genetic experiment”, often compromising a child's wellbeing and pro-social capacities even if the child grows in a healthy environment. According to Pearce, “the question of [human germline engineering] comes down to an analysis of risk-reward ratios - and our basic ethical values, themselves shaped by our evolutionary past.” Bioethicist Julian Savulescu in turn proposes the principle of procreative beneficence, according to which “couples (or single reproducers) should select the child, of the possible children they could have, who is expected to have the best life, or at least as good a life as the others, based on the relevant, available information”. Some ethicists argue that the principle of procreative beneficence would justify or even require genetically enhancing one's children.A relevant issue concerns “off target effects”, large genomes may contain identical or homologous DNA sequences, and the enzyme complex CRISPR/Cas9 may unintentionally cleave these DNA sequences causing mutations that may lead to cell death. The mutations can cause important genes to be turned on or off, such as genetic anti-cancer mechanisms, that could speed up disease exasperation. Unequal distribution of benefits The other ethical concern is the potential for “designer babies”, or the creation of humans with "perfect", or "desirable" traits. There is a debate as to if this is morally acceptable as well. Such debate ranges from the ethical obligation to use safe and efficient technology to prevent disease to seeing some actual benefit in genetic disabilities. There are concerns that the introduction of desirable traits in a certain part of the population (instead of the entire population) could cause economic inequalities (“positional” good). However, this is not the case if a same desirable trait would be introduced over the entire population (similar to vaccines).Another ethical concern pertains to potential unequal distribution of benefits, even in the case of genome editing being inexpensive. For example, corporations may be able to take unfair advantage of patent law or other ways of restricting access to genome editing and thereby may increase the inequalities. There are already disputes in the courts where CRISPR-Cas9 patents and access issues are being negotiated. Therapeutic and non-therapeutic use There remains debate on if the permissibility of human germline engineering for reproduction is dependent on the use, being either a therapeutic or non-therapeutic application. In a survey by the UK's Royal Society, 76% of participants in the UK supported therapeutic human germline engineering to prevent or correct disease, however for non-therapeutic edits such as enhancing intelligence or altering eye or hair color in embryos, there was only 40% and 31% support, respectively. There was a similar result in a study at the University of Bogota, Colombia, where students as well as professors generally agreed that therapeutic genome editing is acceptable, while non-therapeutic genome editing is not.There is also debate on if there can be a defined distinction between therapeutic and non-therapeutic germline editing. An example would be if two embryos are predicted to grow up to be very short in height. Boy 1 will be short because of a mutation in his Human Growth Hormone gene, while boy 2 will be short because his parents are very short. Editing the embryo of boy 1 to make him of average height would be a therapeutic germline edit, while editing the embryo of boy 2 to be of average height would be a non-therapeutic germline edit. In both cases with no editing of the boys' genomes they would both grow up to be very short, which would decrease their wellbeing in life. Likewise editing both of the boys' genomes would allow them to grow up to be of average height. In this scenario, editing for the same phenotype for being of average height falls under both therapeutic and non-therapeutic germline engineering. Current global policy There is distinction in some country policies, including but not limited to official regulation and legislation, between human germline engineering for reproductive use and for laboratory research. As of October 2020, there are 96 countries that have policies involving the use of germline engineering in human cells. Reproductive use Reproductive use of human germline engineering involves implanting the edited embryo to be born. 70 countries currently explicitly prohibit the use of human germline engineering for use in reproduction, while 5 countries prohibit it for reproduction with exceptions. No countries permit the use of human germline engineering for reproduction.Countries that explicitly prohibit any use of human germline engineering for reproduction are: Albania, Argentina, Australia, Austria, Bahrain, Belarus, Benin, Bosnia and Herzegovina, Brazil, Bulgaria, Burundi, Canada, Chile, China, Congo, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, India, Iran, Ireland, Israel, Japan, Kenya, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Montenegro, Netherlands, New Zealand, Nigeria, North Macedonia, Norway, Oman, Pakistan, Poland, Portugal, Qatar, Romania, Russia, San Marino, Saudi Arabia, Serbia, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, the United Kingdom, the United States, Uruguay, and the VaticanCountries that explicitly prohibit (with exceptions) the use of human germline engineering for reproduction are: Belgium, Colombia, Italy, Panama, and the United Arab Emirates Laboratory research Laboratory research use involves human germline engineering restricted to in vitro use, where edited cells will not be implanted to be born. 19 countries currently explicitly prohibit any use of human germline engineering for in vitro use, while 4 prohibit it with exceptions, and 11 permit it.Countries that explicitly prohibit any use of germline engineering for in vitro use are: Albania, Austria, Bahrain, Belarus, Brazil, Canada, Costa Rica, Croatia, Germany, Greece, Lebanon, Malaysia, Malta, Pakistan, Saudi Arabia, Sweden, Switzerland, Uruguay, and the VaticanCountries that explicitly prohibit (with exceptions) the use of germline engineering for in vitro use are: Colombia, Finland, Italy, and PanamaCountries that explicitly permit the use of germline engineering for in vitro use are: Burundi, China, Congo, India, Iran, Ireland, Japan, Norway, Thailand, the United Kingdom, and the United States See also Human genetic engineering Gene therapy Germinal choice technology Human genetic enhancement CRISPR Designer Baby References Further reading Enriquez, Juan; Gullans, Steve (2015). Evolving Ourselves: How Unnatural Selection is Changing Life on Earth. One World Publications. ISBN 978-1780748412. Metzl, Jamie (2020). Hacking Darwin: Genetic Engineering and the Future of Humanity. Naperville, IL: Sourcebooks. "Special Issue: Human Germline Editing". Bioethics. 34 (1). 2020. Venter, Craig (2014). Life at the Speed of Light: From the Double Helix to the Dawn of Digital Life. United Kingdom: Penguin Books. ISBN 978-0143125907.

Hybrizyme is a term coined to indicate novel or normally rare gene variants (or alleles) that are associated with hybrid zones, geographic areas where two related taxa (e.g. species or subspecies) meet, mate, and produce hybrid offspring. The hybrizyme phenomenon is widespread and these alleles occur commonly, if not in all hybrid zones. Initially considered to be caused by elevated rates of mutation in hybrids, the most probable hypothesis infers that they are the result of negative (purifying) selection. Namely, in the center of the hybrid zone, negative selection purges alleles against hybrid disadvantage (e.g. hybrid inviability or infertility). Stated differently, any allele that will decrease reproductive isolation is favored and any linked alleles (genetic markers) also increase their frequency by genetic hitchhiking. If the linked alleles used to be rare variants in the parental taxa, they will become more common in the area where the hybrids are formed. Etymology Originally hybrizymes were defined as "unexpected allelic electromorphs associated with hybrid zones", a formal term proposed by renowned conservation geneticist and biogeographer David S. Woodruff in 1988. By suggesting a new definition for a phenomenon that had been previously widely observed Woodruff's interpretation bypasses the etiological connotation of alternative terms and avoids inappropriate context. Namely, previous studies referred to allozymes that were observed at high frequency in hybrid zones, but are absent or rare in parental taxa as "the rare allele phenomenon". These alleles can have increased frequencies up to a point of the allele becoming the most common one in the hybrid zone, rendering the term "the rare allele phenomenon" deceptive. Despite this, these two terms have been used interchangeably in literature. Widespread phenomenon Hybrid populations display the hybrizyme phenomenon by having increased frequencies of certain alleles that are rare or non-existent outside of the hybrid zone. The hybrizyme phenomenon is widespread in hybrid zones of species of snails, crickets, lizards, salamanders, rodents, fish and birds. Intriguingly, the increased frequency of some of these alleles can have a pronounced effect making them 3-20 times more common in hybrids than in non-hybrid populations.Early studies focused on detecting electromorphs for loci that code regulatory and non-regulatory enzymes from several functional classes using allozyme electrophoresis and usually involved loci that were polymorphic in parental populations. The phenomenon has also been detected in a broad range of genetic markers such as intron haplotypes, microsatellites, ribosomal DNA spacer variants, and anonymous SNPs. Mutational origin Multiple hypotheses have been proposed to explain the mutational (molecular) origin of hybrizymes. They include gene conversion, transposable element activity, post-translational modification, mutations. and intragenic recombination. Some of these hypotheses are rejected by research in the past couple of years, but there is an unambiguous explanation for the mutational origin of hybrizymes. The two hypotheses most often discussed are increased mutation rates and intragenic recombination. Mutation Under the mutational hypothesis, hybrizymes likely arise due to simple point mutations. Sequencing data have indicated this and imply low likelihood that hybrizymes arise as a result of transposition or recombination. Research on pocket gophers and Japanese freshwater crabs confirms that the phenomenon is possibly caused by simple nucleotide substitutions. However, the hypothesis has several weaknesses. It does not explain why normally rare alleles are restricted to a hybrid zone, why polymorphic loci are affected more or offers a mechanism that explains the high frequency of even the rarest variants. Intragenic recombination Intragenic recombination, under certain circumstances, might create new allelic variants at rates higher than the ones associated with regular mutational processes. Under this hypothesis the variant allele would be a mosaic of the parental alleles. The likelihood of this hypothesis was disputed, through sequencing studies. Although there is yet no specific explanation for hybrizymes, it is not excluded that hybrizymes are generated by the combined effect of recombination and mutation events, with any recombination trace concealed by succeeding mutations. However, research on Acer species implies that high recombination rates are possible due to acceleration of genetic variation after hybridization. Furthermore, results are found that indicate that recurrent mutation is unlikely and that support the hypothesis of recombination. Cause of maintenance Several hypotheses have been proposed to account the high frequency of hybrizymes in hybrid zones such as genetic drift, elevated rates of nucleotide substitutions. or positive selection on alleles which are mildly deleterious in parental taxa. Still, some faced a certain degree of unpredictability; specifically under the mutational hypothesis the overall substitution rates are elevated and many variants are expected versus having only one allele reaching high frequency and, at the same time, positive selection on deleterious alleles seems ambiguous. Selection does not need to be directed to the hybrizyme, but to other genes with which the hybrizyme is linked, placing genetic hitchhiking in perspective. In other words, hybrid zones are maintained primarily by balance between gene flow and hybrid inferiority. In the centre of hybrid zones, the process of constant creation of low-fitness recombinant genotypes will favor any allele that will decrease reproductive isolation, consequently elevating the hybrid fitness. So, a likely mechanism would be negative or purifying selection against poorly fit multilocus genotypes. Therefore, the hybrizymes that increase in frequency could be modifier alleles or genetic markers that increase via hitchhiking. It is not excluded that the targets of selection are the barrier loci, loci that resist homogenization with the other genome during gene flow among diverging species, making them the most different parts of the genome between divergent populations.If allelic variation at these loci is considered, there might be alleles that have differential effect on reproductive isolation or hybrid disadvantage, leading to selection of those who have lower severity. The exact origin and mechanism that maintains these alleles at a high frequency is still a subject of debate and additional studies, such as Next Generation Sequencing analysis of the genomic regions involved in the phenomenon as a more trustworthy pathway to identify genes that impact the level of reproductive isolation. Adaptive novelty Hybridization might expand the prospect of adaptive radiation to the point where positive selection on recombinant hybrid genotypes surpasses the intrinsic selection against them. Therefore, the selection schemes in hybrid swarms ensures that relatively strong endogenous selection would not quench such potential. Additionally, partial postzygotic reproductive isolation usually involves multiple genes and segregation and recombination of genes creates broadly varying reproductive compatibility in hybrid populations. Consequently, there will be recurrent removal of disadvantageous alleles for reproductive isolation and relative stabilization of hybrid zones, possibly slowing down the path of complete speciation by reinforcement.With the continual selection against hybrid disadvantage, crossing-over might, over time, interrupt existing linkages and establish new. This generates a shift in selection pressure on loci which are in linkage with these genes and will contribute to further changes in allele frequencies on a genome scale. The "rare allele phenomenon" might be an indication of this process. Even with the continuous effect of relatively strong endogenous selection against hybrids, a hybrid population might be an example where selection against reproductive isolation results in creating variable recombinant genotypes. Sometimes, this phenomenon might assist in creating a complex of adaptive traits that lead to adaptive novelty. == References ==

Hypervariable may refer to: Hypervariable sequence, a segment of a chromosome characterised by considerable variation in the number of tandem repeats at one or more loci Hypervariable locus, a locus with many alleles; especially those whose variation is due to variable numbers of tandem repeats Hypervariable region (HVR), a chromosomal segment characterized by multiple alleles within a population for a single genetic locus

Integrons are genetic mechanisms that allow bacteria to adapt and evolve rapidly through the stockpiling and expression of new genes. These genes are embedded in a specific genetic structure called gene cassette (a term that is lately changing to integron cassette) that generally carries one promoterless open reading frame (ORF) together with a recombination site (attC). Integron cassettes are incorporated to the attI site of the integron platform by site-specific recombination reactions mediated by the integrase. Discovery Integrons were initially discovered on conjugative plasmids through their role in antibiotic resistance. Indeed, these mobile integrons, as they are now known, can carry a variety of cassettes containing genes that are almost exclusively related to antibiotic resistance. Further studies have come to the conclusion that integrons are chromosomal elements, and that their mobilisation onto plasmids has been fostered by transposons and selected by the intensive use of antibiotics. The function of the majority of cassettes found in chromosomal integrons remains unknown. Integron function Cassette maintenance requires that they be integrated within a replicative element (chromosome, plasmids). The integrase encoded by the integron preferentially catalyses two types of recombination reaction: 1) attC x attC, which results in cassette excision, 2) attI x attC, which allows integration of the cassette at the attI site of the integron. Once inserted, the cassette is maintained during cell division. Successive integrations of gene cassettes result in the formation of a series of cassettes. The cassette integrated last is then the one closest to the Pc promoter at the attI site. The IntI-catalysed mode of recombination involves structured single-stranded DNA and gives the attC site recognition mode unique characteristics. The integration of gene cassettes within an integron also provides a Pc promoter that allows expression of all cassettes in the array, much like an operon. The level of gene expression of a cassette is then a function of the number and nature of the cassettes that precede it. In 2009, Didier Mazel and his team showed that the expression of the IntI integrase was controlled by the bacterial SOS response, thus coupling this adaptive apparatus to the stress response in bacteria. Structure An integron is minimally composed of: a gene encoding for a site-specific recombinase: intI, belonging to the integrase family a proximal recombination site: attI, which is recognized by the integrase and at which gene cassettes may be inserted a promoter: Pc, which directs transcription of cassette-encoded genes Gene cassettes Additionally, an integron will usually contain one or more gene cassettes that have been incorporated into it. The gene cassettes may encode genes for antibiotic resistance, although most genes in integrons are uncharacterized. An attC sequence (also called 59-be) is a repeat that flanks cassettes and enables cassettes to be integrated at the attI site, excised and undergo horizontal gene transfer. Occurrence Integrons may be found as part of mobile genetic elements such as plasmids and transposons. Integrons can also be found in chromosomes. Terminology The term super-integron was first applied in 1998 (but without definition) to the integron with a long cassette array on the small chromosome of Vibrio cholerae. The term has since been used for integrons of various cassette array lengths or for integrons on bacterial chromosomes (versus, for example, plasmids). Use of "super-integron" is now discouraged since its meaning is unclear.In more modern usage, an integron located on a bacterial chromosome is termed a sedentary chromosomal integron, and one associated with transposons or plasmids is called a mobile integron. References Medical terms Further reading Collis, CM; Kim, MJ; Partridge, SR; Stokes, HW; Hall, RM (2002). "Characterization of the Class 3 Integron and the Site-Specific Recombination System It Determines". Journal of Bacteriology. 184 (11): 3017–3026. doi:10.1128/jb.184.11.3017-3026.2002. PMC 135066. PMID 12003943. Tosini, F; Visca, P; Luzzi, I; Dionisi, AM; Pezzella, C; Petrucca, A; Carattoli, A (1998). "Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype typhimurium". Antimicrob Agents Chemother. 42 (12): 3053–8. doi:10.1128/aac.42.12.3053. PMC 105998. PMID 9835490. Mazel, D (2006). "Integrons: agents of bacterial evolution". Nature Reviews Microbiology. 4 (8): 608–620. doi:10.1038/nrmicro1462. PMID 16845431. S2CID 4407151. External links IntegronFinder - A tool to detect integrons in bacterial genomes INTEGRALL - The Integron Database

Interleukin 17F (IL-17F) is signaling protein that is in human is encoded by the IL17F gene and is considered a pro-inflammatory cytokine. This protein belongs to the interleukin 17 family and is mainly produced by the T helper 17 cells after their stimulation with interleukin 23. However, IL-17F can be also produced by a wide range of cell types, including innate immune cells and epithelial cells.The IL17F gene is located on chromosome 6p12 and was discovered in 2001. This cytokine can be secreted as disulfide-linked homodimer or heterodimer. Function and signaling IL-17F is involved in the development of inflammation and host defense against infection by inducing the expression of genes that encode other proinflammatory cytokines, such as tumor necrosis factor, interleukin 1, interleukin 6 and some members of the colony-stimulating factor family. IL-17F can also induce expression of chemokines, such as CXCL1, CXCL5, interleukin 8, CCL7 and others, thereby promoting inflammation and neutrophil recruitment. IL-17F signaling can also lead to antimicrobial peptide and matrix metalloproteinase production. The target cells of IL-17F are epithelial cells, fibroblasts, keratinocytes, synoviocytes and endothelial cells. These cells express IL-17RA and IL-17RC, which are the receptors IL-17F binds. IL-17F shows a broad tissue expression pattern, including the lungs, where it may be associated with the pathogenesis of asthma. IL-17F employs Act1 and TRAF6 as its signal transducers to induce the expression of the pro-inflammatory cytokines and chemokines in many different cell types. IL-17F signaling also activates the MAP kinase pathway and leads to the activation of NF-κB, MAPK-AP-1 and C/EBP.IL-17F is highly (55%) homologous to interleukin-17A (IL-17A). These two molecules bind to the same receptors and are very likely to have similar biological functions. IL-17A and IL-17F are often co-expressed. However, IL-17F is a weaker inducer of pro-inflammatory cytokine expression and is produced by a wider range of cell types than IL-17A. Another difference lies in the binding affinities for their receptors: IL-17A binds more strongly to IL-17RA, IL-17F to IL-17RC.The interleukin 17 family members are among the effector cytokines of Th17 immune response. This immune response protects hosts from pathogens at epithelial and mucosal tissues including the skin, lung, and intestine. The Th17-type immune response is directed primarily against extracellular bacteria. IL-17F as an effector cytokine of Th17 cells is involved in host defense against bacterial infections. It has many mechanisms by which it helps resist bacteria. IL-17F has the ability to stimulate the production of defensins and other antimicrobial peptides; it can also resist bacteria through production of pro-inflammatory cytokines and chemokines that attract neutrophils and other effector cells. Clinical significance IL-17F is a proinflammatory cytokine associated with many diseases. It very often plays crucial role in autoimmune diseases. One of the diseases associated with IL-17F is psoriasis. Levels of IL-17F, as well as the levels of IL-17A, are increased in psoriatic skin and in synovial cells in psoriatic arthritis. IL-17F is capable of inducing cartilage matrix release and can inhibit the synthesis of new cartilage matrix. The monoclonal antibody bimekizumab against IL-17A and IL-17F is approved in Europe for the treatment of psoriasis; it may also be useful in the treatment of ankylosing spondylitis.IL-17F plays an important role in asthma and allergic airway inflammation. IL-17F has been well characterized both in vitro and in vivo to have a pro-inflammatory role in asthma. IL-17F was originally found in bronchoalveolar lavage cells from patients with allergic asthma upon ragweed allergen stimulation. The expression level of IL-17F correlates with the severity of the disease. Overexpression of this cytokine in the airway is associated with neutrophilia, secretion of many cytokines, increased airway activity and mucus hypersecretion.IL-17F is also involved in the pathogenesis of intestinal inflammation. Expression of IL-17F in colon is associated with inflammatory bowel disease, and this inducible IL-17F expression is significantly higher in Crohn's disease than in ulcerative colitis.Increased expression of IL-17F is also found in neuronal inflammation—specifically, in active lesion sites in experimental autoimmune encephalitis, an animal model of multiple sclerosis. IL-17F together with IL-17A contributes to chronic inflammation.IL-17F may also be involved in tumorigenesis and associated with the tumor microenvironment (TME), as pro-tumor and anti-tumor functions have been ascribed to the related protein IL-17A has. However, a role for IL-17F in tumor development has not been well described. == References ==

Island Conservation is a non-profit organization with the mission to prevent extinctions by removing invasive species from islands. Island Conservation has therefore focused its efforts on islands with species categorized as Critically Endangered and Endangered on the IUCN's Red List. Working in partnership with local communities, government management agencies, and conservation organizations, Island Conservation develops plans and implements the removal of invasive alien species, and conducts field research to document the benefits of the work and to inform future projects. Island Conservation's approach is now being shown to have a wider beneficial effect on the marine systems surrounding its project areas. In addition, invasive vertebrate eradication has now been shown to have many benefits besides conservation of species. Specifically, the approach has been found to align with 13 UN Sustainable Development Goals and 42 associated targets encompassing marine and terrestrial biodiversity conservation, promotion of local and global partnerships, economic development, climate change mitigation, human health and sanitation and sustainable production and consumption.To date Island Conservation has deployed teams to protect 1,195 populations of 487 species and subspecies on 64 islands.The work of Island Conservation is not without controversy, This is documented in the book Battle at the End of Eden. Restoring islands requires removing whole populations of an invasive species. There is an ethical question of whether humankind has the right to remove one species to save others. However, a 2019 study suggests that if eradications of invasive animals were conducted on just 169 islands, the survival prospects of 9.4% of the Earth's most highly threatened terrestrial insular vertebrates would be improved. History Island Conservation was founded by Bernie Tershy and Don Croll, both Professors at UCSC's Long Marine Lab. These scientists learned about the story of Clipperton Island which had been visited by ornithologist Ken Stager of the Los Angeles County Museum in 1958. Appalled at the depredations visited by feral pigs upon the island's brown booby and masked booby colonies (reduced to 500 and 150 birds, respectively), Stager procured a shotgun and removed all 58 pigs. By 2003, the colonies numbered 25,000 brown boobies and 112,000 masked boobies, the world's second-largest brown booby colony and largest masked booby colony.Much of organization's early focus was working in Mexico in conjunction with its sister organization, Grupo de Ecología y Conservación de Islas, in the Gulf of California and off the Pacific Coast. Subsequently, Island Conservation expanded its geographic scope to the Channel Islands of California, Pacific Coast of Canada, The Aleutians Islands, Hawaiian Islands, and finally to the Pacific, Caribbean, and South America. Island Conservation has a strong scientific grounding. Over 160 peer-reviewed publications in major journals such as Biological Conservation, Conservation Biology and Proceedings of the National Academy of Sciences have been authored or co-authored by Island Conservation staff and contractors. Partnerships As Island Conservation does not have management responsibility over any islands itself, all projects are in partnership with the island owner/manager, island users, local communities and regulatory authorities. Since its founding in 1994, the organization has developed partnerships with over 100 organizations. Partners include conservation organizations, government agencies, regulatory agencies, scientific institutions, and international conservation consortiums. Island Conservation is a member of the International Union for Conservation of Nature (IUCN), Alliance for Zero Extinction, and has a Memorandum of Understanding with the US Fish & Wildlife Service, and BirdLife International, amongst others. Advisory Council The organization's founding Advisory Board is composed of prominent scientists, practitioners, and authors in the fields of conservation biology and invasive species including Paul Ehrlich, José Sarukhán Kermez, Russell Mittermeier, Harold Mooney, David Quammen, Peter Raven, Michael Soulé, and Edward O. Wilson. Programs North America In this region, Island Conservation currently works in the United States and Canada. In the United States, the Anacapa Island Restoration Project was completed in 2002 and benefited the Scripps's murrelet, Cassin's auklet, and Anacapa Deer Mouse. The Lehua Island Restoration Project was completed in 2006 which benefited Newell's shearwater and black-footed albatross. Subsequently, projects completed include the Hawadax Island Restoration Project in 2008, the San Nicolas Island Project in 2010, and the Palmyra Island Restoration Project in 2011. Key federal government partnerships in North America include in the US Department of Interior, USFWS, NPS, the US Department of Agriculture-APHIS, National Wildlife Research Center, NOAA, Parks Canada Agency, and Environment and Climate Change Canada. Island Conservation is working with the following non-governmental organizations: Coastal Conservation Association (CA), Bird Studies Canada, American Bird Conservancy, The Nature Conservancy, and Grupo de Ecología y Conservación de Islas. Pacific Since 2010, Island Conservation has contributed to the development and implementation of island restoration projects in Australia (Lord Howe Island and Norfolk Island), French Polynesia (Tetiꞌaroa Restoration Project in 2022, Acteon-Gambier Archipelago Restoration Project in 2015), Tonga (Late Island and numerous small islets), Republic of Palau (including within the Rock Islands Southern Lagoon World Heritage Area), Federated States of Micronesia (Ulithi Lagoon), and New Caledonia (Walpole Island). Island Conservation is an active member of the Pacific Invasives Partnership. Other key partnerships include Invasive Species Council, BirdLife International, New Zealand Department of Conservation, SPREP and the Ornithological Society of French Polynesia. Caribbean In this region, Island Conservation works primarily in Puerto Rico, The Commonwealth of The Bahamas, and the Dominican Republic. In May 2012, Island Conservation and the Bahamas National Trust worked together to remove invasive house mice from Allen Cay to protect native species including the Allen Cays rock iguana and Audubon's shearwater. Since 2008, Island Conservation and the US Fish and Wildlife Service (USFWS) have worked together to remove invasive vertebrates from Desecheo National Wildlife Refuge in Puerto Rico, primarily benefiting the Higo Chumbo cactus, three endemic reptiles, two endemic invertebrates, and to recover globally significant seabird colonies of brown boobies, red footed boobies, and bridled terns. Future work will focus on important seabird populations, key reptile groups including West Indian Rock Iguanas, and the restoration of Mona Island, Alto Velo, and offshore cays in the Puerto Rican Bank and The Bahamas. Key partnerships include the USFWS, Puerto Rico DNER, the Bahamas National Trust, and the Dominican Republic Ministry of Environment and Natural Resources. South America In this region, Island Conservation works primarily in Ecuador and Chile. In Ecuador, the Rábida Island Restoration Project was completed in 2010. A gecko (Phyllodactylus sp.) found during monitoring in late 2012 was only recorded from subfossils estimated at more than 5,700 years old. Live Rábida Island endemic land snails (Bulimulus (Naesiotus) rabidensis), not seen since collected over 100 years ago, were also collected in late 2012. This was followed in 2012 by the Pinzon and Plaza Sur Island Restoration Project primarily benefiting the Pinzón giant tortoise, Opuntia galapageia, Galápagos land iguana. As a result of the project, Pinzon Giant Tortoise hatched from eggs and were surviving in the wild for the first time in more than 150 years In 2019, The Directorate of Galápagos National Park with Island Conservation used drones to eradicate invasive rats from North Seymour Island - this was the first time such an approach has been used on vertebrates in the wild. The expectation is that this innovation will pave the way for cheaper invasive species eradications in the future on small and mid-sized islands. The current focus in Ecuador is Floreana Island with 55 IUCN threatened species present and 13 extirpated species that could be reintroduced after invasive mammals are eradicated. Partners include: The Leona M. and Harry B. Helmsley Charitable Trust, Ministry of Environment (Galápagos National Park Directorate, Galápagos Biosecurity Agency), the Ministry of Agriculture, the Floreana Parish Council and the Galapagos Government Council. In 2009 Chile, Island Conservation initiated formal collaborations with CONAF, the country's protected areas agency, to further restoration of islands under their administration. In January 2014, the Choros Island Restoration Project was completed benefiting the Humboldt penguin, Peruvian diving petrel, and the local eco-tourism industry. The focus of future work includes the Humboldt Penguin National Reserve and the Juan Fernández Archipelago. Conservation Innovation From its earliest days, Island Conservation has prided itself on innovating its tools and approach to eradication projects. Island Conservation implemented its first helicopter-based aerial broadcast eradication on Anacapa Island in 2001 refining technology developed in New Zealand for agriculture and pest control, this has been replicated on more than 10 international island restoration projects since. Island Conservation has developed practices for holding native species in captivity for re-release and mitigating risks to species, including the successful capture and release of endemic mice on Anacapa and hawks on Pinzon.In 2010, Island Conservation partnered with the U.S. Humane Society to remove feral cats from San Nicolas Island for relocation to a sanctuary on the mainland California. New tools including a remote trap monitoring system, digital data collection system, and statistical decision support tools improved the humanness of removal methods, reduced project cost, and reduced time to declare success.Following a series of failed eradication attempts in 2012, Island Conservation led a group of international experts to identify challenges on tropical islands resulting in recommend practices for tropical rodent eradications. Applying these lessons following a failed attempt on Desecheo island 2017 resulted in success. Island Conservation led a horizon scan in 2015 that identified drones, genetic biocontrol, and conflict transformation as critical innovations to increase the scale, scope, and pace of rodent eradications. Since this exercise, Island Conservation formed the Genetic Biocontrol for Invasive Rodents (GBIRd) partnership to cautiously explore the development of safe and ethical genetic technologies to prevent extinctions, supported sustainable community-driven approaches to conservation projects, and implemented the world’s first drone-powered rat eradication. The current focus of the Conservation Innovation program is to advance methods that increase safety, reduce cost, and improve the feasibility of eradicating invasive vertebrates from islands. References External links Official website Grupo de Ecología y Conservación de Islas (GECI) Database of Island Invasive Species Eradications (DIISE) Threatened Island Biodiversity database (TIB) Genetic Biocontrol for Invasive Rodents (GBIRd)

The Jena Declaration is a scientific statement that questions and refutes the concept of human "races in a biological sense". It was published in September 2019 at the 112th Annual Meeting of the German Zoological Society (Deutsche Zoologische Gesellschaft) in Jena. The statement was written by leading scientists from the fields of evolutionary research, genetics and zoology, and was instrumental in influencing the legislative amendment to remove the term "Rasse" (roughly "race in a biological sense") from the German constitution. With this statement, the Institute for Zoology and Evolutionary Research at Friedrich Schiller University Jena explicitly distances itself from its 20th century predecessors, especially from the controversial scholar and evolutionary biologist Ernst Haeckel, who was closely associated with the University of Jena and whose ideas of racism and eugenics are today considered scientifically untenable and morally reprehensible. Content The authors of the statement, Martin S. Fischer, Uwe Hoßfeld, Johannes Krause and Stefan Richter examined the issue of alleged human "races" from a biological perspective. They clarified that this concept has no scientific justification. Scientific studies of genetic variation within and between human populations showed that the biological concept of "race" was a typological construct based on arbitrarily selected physical characteristics and did not reflect the actual genetic diversity of the human species.The Jena Declaration affirms that there are no "races" in the biological sense in humans, since the genetic variation within human populations is often greater than the genetic variation between these populations. Only in domestic animals the genetic similarity within a breed is actually greater than between breeds. Moreover, genetic differences between populations are continuous, as humans travelled long before major explorations and voyages of conquest by Europeans, creating links between populations that were geographically distant from each other. External characteristics such as skin colour, used for typological classifications or in everyday racism, are very superficial and rapidly changing biological adaptations to local conditions. In the human genome, for example, there is not a single difference among the 3.2 billion base pairs that separates Africans from non-Africans. So not only is there not a single gene that accounts for "racial" differences, there is not even a single base pair.The authors conclude that the concept of human "races" is the result of racism and not its precondition. Its use in scientific literature and social discourse often leads to misunderstandings and reinforces prejudice and discrimination. They therefore call for the term "race" to be discontinued in relation to people, except in historical or socio-political contexts where it should be understood as a social construction rather than a biological reality. They argue that the use of the term in relation to people creates a false idea of genetically separate groups and that it is important to debunk this myth in order to combat racism. They conclude the statement with an appeal to educational institutions, media, authorities and all citizens to reconsider the German term "Rasse" and emphasise genetic diversity and humanity instead of artificial and harmful categorisations. Impact In Germany, the Declaration had a considerable impact on public debate and legislation, especially on the discussion about removing the term "Rasse" from the German constitution.The Jena Declaration also led to a number of publications in the field of education and learning. In the book "Den Begriff 'Rasse' überwinden: die 'Jenaer Erklärung' in der (Hoch-)Schulbildung" (Overcoming the Concept of Race: The Jena Declaration in (Higher) School Education), a variety of ideas and concepts for overcoming the concept of "race" are offered. In this publication, the Jena Declaration serves as an impulse for a nationwide reorientation of (high) school education. Another example is the publication "Die Jenaer Erklärung gegen Rassismus' und ihre Anwendung im Unterricht" (The Jena Declaration against Racism and its Application in the Classroom), which presents concrete examples of the application of the Jena Declaration in the classroom. IQWiG (The independent Institute for Quality and Efficiency in Health Care) also backs the "Jena Declaration" by ceasing to translate the term "race" as "Rasse" in its evaluations.The Institute no longer translates the term "race" as "Rasse" in its assessments. References External links Jena Declaration The Jena Declaration: Jena, Haeckel and the Question of Human Races, or, Racism Creates Races

Jan Klein (January 18, 1936 – May 7, 2023) was a Czech–American immunologist. Professional life Jan Klein was a Czech-American immunologist, best known for his work on the major histocompatibility complex (MHC). He was born in 1936 in Stemplovec, Opava, Czech Republic. He graduated from the Charles University at Prague, in 1955, and received his M.S. (magna cum laude) in botany from the same school in 1958. He was a teacher at the Neruda High School in Prague from 1958 to 1961. He received his Ph.D. in genetics from the Czechoslovak Academy of Sciences in 1965, and moved to Stanford University as a postdoctoral fellow the same year. He became assistant professor in 1969, and associate professor in 1973 at the University of Michigan. He assumed the position of professor at the University of Texas Southwestern Medical School in 1975. From 1977 to his retirement in 2004, he was the director of the Max-Planck-Institut für Biologie at Tübingen, Germany. From 2004 to his passing in 2023, he was a Frances R. and Helen M. Pentz Visiting Professor of Science and adjunct professor of biology at the Pennsylvania State University. Research interests Klein's scientific output encompasses 600 publications in scientific journals and a dozen of books, which he either authored or edited. It spans three major disciplines: genetics, immunology, and evolutionary biology, as well as one interface discipline: immunogenetics. His major research focus was on the major histocompatibility complex, (MHC or Mhc), which comprises series of genes, which play a critical part in the initiation of the adaptive immune response (AIS), exemplified by the production of antibodies specific for different pathogens. Major accomplishments Redefinition of Immunology In his textbooks and other writings, Klein introduced a new concept of immunology, in which he conceived the discipline as a branch of biological sciences, rather than as a narrow province of medical studies, as it had been represented traditionally. He defined immunology as the science of self-nonself discrimination, concerned not just with the human species and its animal models (mouse, rabbit, and others), but with all organisms; and not just with issues of human health, but with normal physiological functions, executed with specialized body systems. He was the first to include in an immunology textbook sections emphasizing the importance of the so-called non-adaptive immune system (NAIS; he preferred to call it non-anticipatory). He also gave immunology a logical internal structure. Instead of organizing his textbooks into sections such as immunochemistry, immunobiology, immunogenetics, immunopathology, and so on, as was then customary (i.e., according to immunology’s interfaces with other disciplines and leaving very little for immunology itself), he presented it as a self-contained science. He organized it as a science operating with specialized organs, cells, genes, molecules, mechanisms, phenotypes, and functions. Redefinition of Immunogenetics In his experimental work, his 25 years as a director of the Immunogenetics Division of the Max Planck Institute of Biology, and nearly the same period of time at the helm of the journal Immunogenetics, Klein strived to redefine the immunogenetics discipline. Immunogenetics emerged in the 1930s as the study of genes controlling antigens (such as those of the various blood group systems) detected by antibodies. This was a very artificial delineation of a discipline, based essentially on a method, rather than on an internal content. In Klein's conception, immunogenetics was to deal with what immunology and genetics have in common—a set of genes that control and effect immune responses of any kind. Discovery of Class II Genes and the Concept of Mhc In the adaptive immune system, the three preeminent sets of genes are those that code for the Mhc, T-cell receptor (Tcr), and B-cell receptor (Bcr, the antibodies) proteins. Klein contributed to the study of all three systems, but his primary interest was in the Mhc system. He developed the modern concept of the Mhc as consisting of two principal kinds of gene, for which he coined the designations class I and class II genes. The class I genes were discovered in 1936 (the year Jan Klein was born) as coding for blood group (red blood cell) antigens, which, however, were also responsible for the rejection of incompatible grafts. Klein, with his coworker Vera Hauptfeld and his wife Dagmar Klein, were the first to describe the product of the class II genes and identify them as the molecules that control level of antibodies synthesized in response to foreign antigens. Earlier, Hugh O. McDevitt and his coworkers mapped an Immune response-1 (Ir-1) locus influencing the level of antibody production against the synthetic polypeptide (T,G)-L—A into the Mhc. Klein and his coworkers, finding their locus inseparable from the postulated Ir-1 locus, concluded that the class II antigens they demonstrated on the surfaces of lymphocytes were the product of the Ir-1 locus. Later studies confirmed this interpretation. Genetic mapping of the loci controlling the class I and class II antigens of the mouse showed them to be part of a cluster, which Klein mapped to the chromosome 17 and for which he championed the name major histocompatibility locus, Mhc. The name referred to the fact that the genes were part of a set that controlled tissue compatibility and in this set one cluster had the strongest (major) effect. George D. Snell named the tissue compatibility genes histocompatibility 1, 2, 3, etc., in the order of discovery, and since the H2 genes happened to be strongest of the set, they became the first Mhc known. All other histocompatibility genes came to be called minor. Initially, genetic mapping of the mouse class I antigens suggested the existence of multiple class I loci in the H2 complex. Soon, however, inconsistencies in the assignment of certain antigens to loci signaled that something was amiss with the H2 maps, as they were then drawn. Klein and Donald C. Shreffler solved the problem by demonstrating that a given antigen could be present on molecules controlled by different loci. Taking this finding into account, they were able to reduce the number of the class I loci to two, H2K and H2D. This "two-locus model" played a n important part in subsequent interpretations of the Mhc. The model was also consistent with the results of earlier Klein's PhD work, in which he discovered that immune selection for a loss of certain H2 antigens on somatic cells was accompanied by the loss of some but not other unselected antigens. In this respect, the antigens fell into two groups as if carried by two different molecules. The discovery of the class II genes had been fitted into the model by the demonstration that they mapped between the H2K and the H2D. Shreffler also demonstrated the existence of another locus mapping between the two class I loci. It coded for what he called the "serum serological" or Ss protein, present in a soluble form in the blood fluid phase, in contrast to the class I and class II antigens, which were expressed on cell surfaces. At that stage, the H2 complex could be divided into four regions: class I (H2K)...Class II (Ir-1)...Ss...Class I (H2D). These developments alerted immunologists on the one hand and transplantation biologists on the other of the Mhc’s potential importance for their respective disciplines. The consequence was a proliferation of reports describing association of a variety of phenomena with the complex. The associations were demonstrated by testing the responses of congenic strains differing at the H2 complex and mapping the genes controlling the responses within the H2 complex with the help of strains carrying H2 haplotypes derived by intra-H2 recombinations. These strains were developed by George D. Snell, Jack H. Stimpfling, Donald C. Shreffler, and Jan Klein. The phenomena included control of antibody response to a variety of antigens, both natural and synthetic; suppression of immune response by special suppressor cells or soluble factors; proliferation of lymphocytes in an in vitro culture challenged with H2-incompatible stimulating cell (the so-called mixed lymphocyte reaction, MLR); killing of H2-icompatible target cells by sensitized lymphocytes (cell-mediated lymphocytotoxicity, CML); response of transplanted immune cell against the tissues of the host (graft versus host reaction, GVHR); rejection of H2-incompatible grafts (skin, heart, bone marrow, etc.) by the recipients; and others. All these phenomena appeared to be controlled by different loci within the Mhc. As a result, the H2 complex appeared to expand by the addition of new loci (regions). Klein's group, however, challenged this interpretation and in a series of carefully controlled studies demonstrated that the new loci were in reality mirages generated by various forms of interaction involving the established class I and class II loci. In this manner, Klein contracted the H2 complex back to the version established by the serological methods, and propounded the view that the various responses (MLR, CML, etc.) were controlled by the class I and class II loci, rather than by separate loci. Later, other loci were again mapped within the H2 complex and these were no phantoms. They were real but, as Klein argued, they were unrelated to the class I and class II loci and ended up in the region by chance. The general opinion was, however, that they represented the class III region of the Mhc, that they were functionally related to the Mhc by being involved in immune response, and that the complex functioned as an immune supergene. The first of these class III loci was the Ss locus, which was later identified as coding for complement component 4. The C4 protein was indeed involved in immunity by being one in a series of protein molecules that attach to a cell-bound antibody to puncture a hole in it and thus kill it. But nobody could come up with a reason why it had to be linked to the class I or class II genes to function properly. Similar arguments could be applied to the other class III genes. Later, Klein's view received a strong support when his group discovered that in the fishes, which comprise more than half of jawed vertebrates, not even the class I and class II genes were in a single cluster and the class III genes were scattered all over the genome. Ultimately, the modern concept prevailed against the tendencies to make the Mhc unnecessarily nonparsimonious. Nature of the Mhc-controlled Immune Response The control of antibody response by the Mhc raised many question. The one on the top of immunologists’ agenda was: Why were some individuals carrying a certain H2 haplotype high responders to a given antigen, while others, carrying certain other haplotype were low responders or nonresponders? The phenomenon could be reproduced in vitro by the exposure to the antigen. Lymphocytes isolated from the high responder proliferated to a much higher degree than those isolated from a low responder individual. The assay required, in addition to the thymus-derived (T) lymphocytes, also "macrophages" or antigen-presenting cells (APCs) from the same individual. In this set-up the question reduced itself to: Are the T lymphocytes or the APCs responsible for the difference in responsiveness? Many immunologists were inclined to put the blame on the APCs, but the Klein-Nagy group, in a series of elegant experiments, falsified this hypothesis and explained why T lymphocytes bearing different Mhc haplotypes might differ in their response to specific antigens. The receptors of the T lymphocytes recognize an antigen in association with their own Mhc molecules. The different specificities of the Tcrs born by the individual T cells are generated by a special mechanism during the lymphocyte development from precursor cells in the thymus. The generation is entirely random, so that receptors arise against all possible antigens, including those borne by the individual in which the differentiation takes place (the self-molecules). The cells with receptors for self-molecules must be eliminated to prevent an immune reaction against the individual's own components. The eliminated Tcrs might, however, by chance have had the capability of recognizing certain foreign antigens (nonself) in association with the nonresponder’ own Mhc molecules. The T-cell repertoire thus has "blind spots", making an individual nonresponsive not only to self but also against certain foreign antigens. Mhc Polymorphism, Variation in Chromosome Numbers, and t-haplotypes Typing of inbred strains suggested that the Mhc might manifest unusually high variability (polymorphism). Inbred strains were, however, not suited for determining polymorphism, because assessing it required measuring gene frequencies in populations. There were all sorts of problems associated with such an effort, most of which could, however, be alleviated by transferring a sample of H2 haplotypes from wild mice onto inbred (C57BL/10 or B10) background and thus producing a set of congenic B10.W lines. These lines proved to be essential for the complete characterization of the new haplotypes; for the identification of natural intra-H2 recombinants; and for their use as a tool for mapping H2-associated traits. Using a variety of methods, Klein and his colleagues were able to characterize H2 polymorphism in populations of wild mice from different parts of the world. The studies revealed that the polymorphism was indeed staggering, both in the number of alleles and haplotypes (a haplotype being a particular combination of alleles borne by a particular chromosomal segment) that occurred in appreciable frequencies in the populations. Exceptions from the high polymorphism were found only in certain island populations and in populations that have passed recently through a bottleneck phase. The H2 polymorphism, in combination with other markers, could then be used to characterize a population. H2- typing of the global wild mice population revealed it to be fragmented into a large number of small subpopulations (demes), which differed in the presence and frequencies of alleles at the individual loci. Skin grafting and other methods indicated inbreeding within the demes, but sharing of certain alleles between the demes suggested a continuous gene flow between demes. These findings were supported by analyses of other markers, primarily chromosomal polymorphism and t-haplotypes. The karyotype of the house mouse normally consists of 40 telocentric chromosomes, but in certain regions in Europe, mice with karyotypes containing fewer than 40 chromosomes can be found. The reduction in chromosome number is due to centric fusion (Robertsonian translocation) of two telocentrics into a single metacentric. Klein's group found populations with metacentric chromosomes in different regions of Europe, but concentrated its effort on the system of metacentrics in southern Germany. An in-depth study of these populations revealed subdivision into subpopulations, which correlated with that established by the studies of H2 polymorphism. A t-haplotype is a designation for a chromosomal region adjacent to or encompassing the H2 complex. Three features characterize the t region: suppression of recombination over the entire length of a complete t-haplotype; segregation distortion (t/+ males transmit the t-chromosome into more than 90 percent of their progeny); and frequent presence of homozygous lethal genes. Klein group's combined t and H2 studies on wild mice from all over the world led to the identification and characterization of a number of new t-haplotypes. Their characterization demonstrated that all the haplotypes were derived from a single ancestral haplotype; that the ancestral haplotype originated in the western European Mus domesticus; that it arose recently; and that from M. domesticus a single t-haplotype introgressed into the eastern European M. musculus, where it then underwent limited diversification. Trans-species Polymorphism Dictionaries define genetic polymorphism as the presence, in appreciable frequencies, of two or more alleles at a locus in a species. Hence H2 polymorphism was expected to have arisen by an unusually high mutation (evolutionary) rate in the house mouse after its divergence from its nearest relative. There was, however, no indication that this was the case. On the contrary, Klein and his co-workers found, by the methods then available, indistinguishable alleles in the two European house mouse species, Mus domesticus and M. musculus, which diverged from each other some 1–2 million years (my) ago. Similarly, in M. domesticus populations, whose divergence times could be dated, they found no new variants. Klein's group could also not find any new Mhc (HLA) variants in isolated human populations such as those of the South American Indians and the indigenous populations of Siberia. These and other observations led Klein to the formulation of the trans-species polymorphism (TSP) hypothesis positing that the divergence of similar Mhc alleles predates the divergence of the species in which they occur. The original detection of trans-species polymorphism relied on serological (antibody-based) identification of antigenic molecules. Later, however, the identity of alleles in different species could be confirmed by peptide-mapping analysis of the antigenic proteins. Ultimately, DNA-sequencing not only confirmed the results obtained with the earlier methods, but also introduced a new dimension into the TSP studies. The tests revealed that closely related species such as M. domesticus and M. musculus, the many haplochromine fish species in East African lakes and rivers, or Darwin's finches on the Galapagos Islands, shared many alleles at not only the Mhc, but also at some of the non-Mhc loci. In more distantly related species, such as human and chimpanzee or the house mouse and the Norwegian rat, sharing of identical alleles could no longer be demonstrated, but shared related alleles were clearly in evidence. This finding led to the concept of allelic lineages, in which members of a given lineage in one species were more similar to members of the same lineage in another species than they were to other alleles in either of the two species, TSP of Mhc and other loci has since been documented in many species and found applications to a variety of issues in evolutionary biology. Applications of the TSP Concept in Evolutionary Biology The essence of the TSP concept is that a certain number of alleles at a locus must pass through the speciation phase from the ancestral to the descendant species to assure the retention of the ancestral polymorphism in the new species. If this number is known, the size of the founding population of the emerging species can be estimated. The TSP thus provides a window into the otherwise poorly accessible phase of evolution. Klein's group used the TSP concept to estimate the founding population sizes of several species. For the human species, the size estimated from the HLA polymorphism was 10,000 breeding individuals. Similarly large founding populations had to be postulated for the two lineages from which most of the hundreds of species inhabiting Lake Victoria in East Africa had diverged. And even for Darwin's finches, widely believed to have arisen from a single pair of founders, Vincek and his colleagues came to the conclusion that the founding flock was at least 30 heads strong. These studies became Klein's bridge to evolutionary biology. He crossed this bridge in a series of investigations into the nature of the speciation process in Darwin's finches and in haplochromine fishes of East Africa. With Akie Sato and collaborators, they provided molecular evidence that the 14 extant species of Darwin's finches on the Galapagos Islands and the one species on the Cocos Island were all derived from a single ancestral species that arrived on the islands some 5 my ago. They identified the ancestral species as being related to Tiaris obscura, a species now inhabiting Ecuador and other parts of the South American continent. Using DNA markers they were able to determine phylogenetic relationships among the extant Darwin's finches, except for the group of Ground finches. In the latter, the morphologically poorly distinguishable species were indistinguishable at the molecular level. This result could mean either that the species diverged quite recently and that the polymorphisms of their genomes have not have had enough time to sort themselves out among the species, or that the species continue exchanging genes. Haplochromines are one of two main groups of cichlid fishes in East Africa; the other group being the tilapiine fishes. Klein and his associates studied both groups and using a variety of molecular markers contributed to the resolution of their phylogenetic relationships. They then focused on the haplochromines of both the lakes, large and small, and the rivers. The studies revealed degree of relatedness between the various groups that correlated roughly with their geographical distribution. The main focus of Klein's group became Lake Victoria, however. The lake is the youngest of all the large lakes in East Africa, its latest refill after a desiccation dated to 14,600 years ago. The lake is inhabited with more 200 haplochromine species distinguishable morphologically and behaviorally. Contrary to earlier claims, Klein's group demonstrated that the species are not monophyletic and are by no means pauperized in their genetic polymorphism. They fall into at least two lineages, which separated from each other 41,500 years ago, presumably outside of the lake. The lineages diverged from haplochromines inhabiting smaller lakes west of Lake Victoria more than 80,000 years ago. As in the case of the Ground finches of the Galapagos Islands, the haplochromine species of Lake Victoria are not distinguishable by any molecular markers Klein's group used in their studies. All population genetics methods used to compute genetic distances showed no significant difference between species and between populations of the same species. In this case, however, Klein's group was able to rule out insufficient separation time as the explanation of the data and to argue that the explanation lies in the continuation of a gene flow between the incipient species. They argue further that speciation is a protracted affair during which the arising species diverge in a few genes responsible for phenotypic differences, but continue exchanging genes until the emergence of a reproductive barrier stops the process. They argue furthermore that because of this phenomenon, many phylogenies of so-called adaptive radiations will remain unresolved. One such case is the radiation that gave rise to the tetrapods in the evolution of jawed vertebrates. In this case, Klein's group has demonstrated that increasing the number of genes in the input database does not improve the resolution power of the output phylogenetic trees. Evolution of the Mhc Three critical assumptions underlie the study of Mhc evolution: First, the Mhc is absent in all non-vertebrates. Second, jawless vertebrates (Agnatha) are monophyletic and are a sister group of jawed vertebrates (Gnathostoma). And third, jawless vertebrates lack the Mhc, which is present in all the jawed vertebrates. Klein's group contributed significantly to the current general acceptance of these suppositions. The absence of the Mhc in non-vertebrates became apparent when scrutiny of non-vertebrate genomes failed to identify homologs of Mhc genes. Klein's group provided strong support for agnathan monophyly by cloning, sequencing, and analyzing long DNA stretches of the representative agnathan and gnathostome species. And they isolated, in collaboration with Max Cooper's group, lymphocyte-like cells, cloned, sequenced, and analyzed genes expressed in these cells, and found no evidence for expressed Mhc gene homologs. They did find, however, evidence for gradual evolution of the adaptive immune system. They could demonstrate the presence in jawless vertebrates of several auxiliary components and pathways, which the AIS co-opted when the three central receptors (Mhc, Tcr, and Bcr) emerged in the jawed vertebrates. They also contributed evidence for the omnipresence of Mhc genes in jawed vertebrates by identifying such genes in a wide range of species from bony fishes [zebrafish (Danio rerio), cichlid Aulonocara hansbaenschi, tilapia (Oreochromis niloticus), carp (Cyprinus carpio), guppy (Poecilia reticulata), threespine stickleback (Gasterosteus aculeatus), swordtail (Xiphophorus)]; through coelacanth (Latimeria chalumnae), African lungfish (Protopterus aethiopicus); birds [Bengalese finch (Lonchura striata), Darwin's finches and their South American relatives]; to metatherian mammals [red-necked wallaby (Macropus rufogriseus) and eutherian mammal [rodents such as the mole rat (Spalax ehrenbergi)] and a variety of primates including prosimians, New World monkeys (NWM, Platyrrhini), Old World monkeys (OWM, Catarrhini) and apes]. In several of these species they worked out also the organization of the Mhcs, most notably in the zebrafish. As for the evolution of the Mhc genes themselves, Klein's group contributed significantly to the description of its general outline. In collaboration with Yoko Satta and Naoyuki Takahata, they developed a method for estimating the evolutionary rates of the Mhc genes and demonstrated that the rate was close to the average rate of most non-Mhc genes, and they provided evidence that the Mhc genes are subject to balancing selection. They also provided evidence that the selection leads to the independent, repeated emergence of similar or identical short sequence motifs by convergent evolution. Klein himself has long championed the view that this mechanism and mechanisms similar to it, rather than the generally favored "gene conversion", explained the origin of the motifs. Klein's group demonstrated that during its evolution, the Mhc undergoes repeated rounds of expansion and contraction by gene duplications and deletions –in Klein's terminology, an accordion mode of evolution. Thus, for example, they showed that in each of the three major primate lineages – the prosimians, the NWM and the OWM – evolution of some of the class II gene families started anew after a contraction to a single ancestral gene. And on the example of two "class III" genes, C4 and CYP21, they illustrated a mechanism by which the accordion might be expanding and contracting. The C4 gene, as already stated, codes for a component of the complement system; the CYP21gene codes for a key enzyme in the synthesis of glucocorticoid and mineralcorticoid hormones. The two genes are thus unrelated to each other and to the class I and class II genes, but they are accidentally hooked together into a module, which has been found to duplicate or triplicate as a unit during primate evolution. The hook-up seems to have arisen, when an identical short sequence motif arose by chance at both flanks of the initial C4-CYP21 doublet. Since then, an occasional misalignment of the opposite flanks has led to an unequal crossing-over and so to duplications or deletion of the module. Honors and awards 2018 Neuron Prize for Lifelong Contribution to Science – Biology 2004 Gregor Johann Mendel Medal, Moravian Museum, Brno 1994 Jan Evangelista Purkyne Medal 1990 Glaxo Prize for Medical Writing 1986 James W. Mclaughlin Medal 1986 6th J.F. Heremans Memorial Lecture, Institute of Cellular and Molecular Pathology 1985-1990 Member, Institute Scientific Council, ICP 1985 5th Maude L. Menten Lecturer, University of Pittsburgh School of Medicine 1985 Culpepper Lecturer, University of North Carolina 1985 Francois 1er Fonde le College de France Medal 1981 Rabbi Shai Shacknai Memorial Prize in Immunology and Cancer Research, Hebrew University of Jerusalem 1979 Elisabeth Goldschmid Memorial Lecture, Hebrew University of Jerusalem Memberships 1997–1998, Immunogenetics honorary editor 1991, International Mammalian Genome Society founding member 1990–1993, Mammalian Genome, editor-in-chief 1989–Present, Folia Biologica, member, editorial board 1989–1991, EMBO Journal, member, editorial board 1988–1995, Cambridge Studies in Evolutionary Biology, member, editorial board 1987–1995, Molecular Biology and Evolution, associate editor 1987, CRC Critical Reviews in Immunology, member, editorial board 1987, National Institutes of Health, member, National Advisory Council of Immunology 1985–1990, Mouse Newsletter, member, editorial board 1984–1991, International Reviews of Immunology, member, editorial board 1984–1990, Bioscience Research Reports, Immunology Series, member, editorial board 1983–1997, EOS, Journal of Immunology and Immunopharmacology, member, editorial board 1983–1996, Immunological Reviews, member, editorial board 1983–1987, Cell, member, editorial board 1982–Present, Scandinavian Journal of Immunology, member, editorial board 1981–1990, Journal of Craniofacial Genetics and Developmental Biology, member, editorial board 1981–1987, Transplantation Society, councilor 1977–1991, European Journal of Immunology, member, editorial board 1977–1983, Developmental and Comparative Immunology, member, editorial board 1977–1980, Current Topics in Microbiology and Immunology, member, editorial board 1974–1997, Immunogenetics, editor-in-chief 1974–1978, National Institutes of Health, member, Immunology Study Section 1974–1976, Transplantation, member, editorial board 1974–1975, Journal of Immunology, member, editorial board 1982, European Molecular Biology Organization, member American Association of Immunologists, honorary member Scandinavian Society of Immunology, honorary member French Society of Immunology, honorary member American Association for Advancement of Science, Fellow Member American Association for the Advancement of Science, Fellow American Association of Immunologists, honorary member Societas Scientarum Bohemica, honorary member Books Klein, J. and Klein, N. Solitude of a Humble Genius - Gregor Johann Mendel: Volume 1, Springer-Verlag Berlin Heidelberg 2013 Klein, J. and Takahata, N. Where Do We Come From? Springer-Verlag, Heidelberg 2002 Klein, J. and Horejsi, V. Immunology. 2nd edn. Blackwell Science, Oxford 1997. Blancher, A., Klein, J., and Socha, W.W. (eds.). Molecular Biology and Evolution of Blood Group and MHC antigens in Primates. Springer-Verlag, Berlin 1997. Klein, J. and Klein, D. (eds.) Molecular Biology of the Major Histocompatibility Complex. Springer-Verlag, Heidelberg 1991 Klein, J. Immunology. Blackwell, Oxford 1990. Klein, J. Natural History of the Major Histocompatibility Complex. Wiley, New York 1986. Klein, J. Immunology. The Science of Self-Nonself Discrimination. Wiley, New York 1982. Klein, J. Biology of the Mouse Histocompatibility-2 Complex. Principles of Immunogenetics Applied to a Single System. Springer-Verlag, New York 1975. Klein, J., Vojtíšková, M., and Zelený, V. (eds.) Genetic Variations in Somatic Cells. Academia, Praha 1966. Klein, J. Molekulární základy dedicnosti (Molecular Basis of Heredity). Orbis, Praha 1964 (in Czech). Klein, J. The Use of Tissue Incompatibility in the Genetics of the Somatic Cell. Academia, Praha 1966 (in Czech). References External links Jan Klein telling his life story at Web of Stories Jan Klein at timms Jan Klein Laureate Neuron Prize for Lifelong Contribution to Science 2018 – Biology

Macrosatellites are the largest of the tandem DNA repeats. Each macrosatellite repeat typically is several kilobases in length, and the entire repeat array often spans hundreds of kilobases. Reduced number of repeats on chromosome 4 (D4Z4 repeats) causes euchromatization of local DNA and is the predominant cause of facioscapulohumeral muscular dystrophy (FSHD). Other macrosatellites are RS447, NBL2 and DXZ4, although RS447 is also commonly referred to as a "megasatellite." See also Microsatellite Minisatellite Satellite DNA == References ==

Magnetogenetics is a medical research technique whereby magnetic fields are used to affect cell function. History The development of genetic technologies that can modulate cellular processes has greatly contributed to biological research. A representative example is the development of optogenetics, which is a neuromodulation tool kit that involves light-sensitive proteins such as opsins. This progress provided the grounds for a breakthrough in linking the causal relationship between neuronal activity and behavioral outcome. The foremost strength of the genetic toolkits used in neuromodulation is that it can provide either spatially or temporally, or both, precise modulation of the brain nervous system. To date, several technologies are adapted with genetics (e.g. optogenetics, chemogenetics, etc.), and each technology has strengths and limits. For example, optogenetics has advantages in that it can provide temporally and spatially precise manipulation of neurons. On the other hand, it involves light stimulation, which cannot penetrate tissues effectively and requires implanted optical devices, limiting its applications for in vivo live animal studies Techniques that rely on the magnetic control of cellular process are relatively new. This technique may provide an approach that does not require implantation of invasive electrodes or optical devices. This method will allow penetration in to the deeper region of the brain, and may have lower response latency. In 1980, Young and colleagues have shown that magnetic fields with magnitudes in millitesla range are able to penetrate into the brain without attenuation of the signal or side effects because of the negligible magnetic susceptibility and low conductivity of biological tissue. Early attempts to manipulate electrical signaling within brain using magnetic fields was performed by Baker et al., who later developed devices for transcranial magnetic stimulation (TMS) in 1985. To apply magnetogenetics in biological and neuroscientific research, fusing TRPV class receptors with a paramagnetic protein (typically ferritin) was suggested. These paramagnetic proteins, which typically contain iron or have iron-containing cofactors, are then magnetically stimulated. How this technique can modulate neuronal activity remains unclear but it is thought that the ion channels are activated and opened either by mechanical force exerted by the paramagnetic proteins, or by heating of these via magnetic stimulation. However, availability of such paramagnetic proteins as a transducer for magnetic field to mechanical or temperature stimuli is controversial. On the other hand, nanoparticles have been suggested as possible candidates that can function as the transducer of magnetic field to the stimulus cue. Based on this concept, next generation of magnetogenetics technique is being developed. In 2010, Arnd Pralle and colleges showed that the first in vivo magneto-thermal stimulation of heat sensitive ion channel TRPV1 that employs magnetic nanoparticles as a transducer in C. elegans. In 2012, Seung Chan Kim showed gene expression profile change of total human genome approximately 30,000 genes using 0.2T static magnetic fields. In 2015, Polina Anikeeva's research group demonstrated that similar concept can enhance the neuronal signals in mammalian brain. In 2021, Jinwoo Cheon's research group has successfully developed the magneto-mechanical genetics which uses magnetic stimulation derived mechanical force in mammalian. In this study, magnetic torque by rotating magnetic field was employed to activate the mechanosensitive cation channel Piezo1. Results of this study show that remote, in vivo manipulation of behavior of mice can be done using magnetogenetics. Issues Physical limitation of the ferritin One of the main issues in magnetogenetics is related the physical properties of the ferritin. The ferritin is composed of 24 subunits of protein complex and a small iron oxide core. The core of the ferritin is in the form of ferric hydroxide which has antiferromagnetic properties. Some researchers have reported that ferritin has remnant magnetization due to their intrinsic defect and impurities. However, even with optimistic calculations, the magnetic interaction energy for heat or force generation is several orders below than thermal fluctuation energy. Recently, other researchers hypothesized that there are other possible mechanisms for activate the ion channels, but these studies remain inconclusive. See also Deep brain stimulation Magnetic nanoparticles Regenerative medicine Tissue engineering Transcranial magnetic stimulation == References ==

Intragenomic conflict refers to the evolutionary phenomenon where genes have phenotypic effects that promote their own transmission in detriment of the transmission of other genes that reside in the same genome. The selfish gene theory postulates that natural selection will increase the frequency of those genes whose phenotypic effects cause their transmission to new organisms, and most genes achieve this by cooperating with other genes in the same genome to build an organism capable of reproducing and/or helping kin to reproduce. The assumption of the prevalence of intragenomic cooperation underlies the organism-centered concept of inclusive fitness. However, conflict among genes in the same genome may arise both in events related to reproduction (a selfish gene may "cheat" and increase its own presence in gametes or offspring above the expected according to fair Mendelian segregation and fair gametogenesis) and altruism (genes in the same genome may disagree on how to value other organisms in the context of helping kin because coefficients of relatedness diverge between genes in the same genome). Nuclear genes Autosomic genes usually have the same mode of transmission in sexually reproducing species due to the fairness of Mendelian segregation, but conflicts among alleles of autosomic genes may arise when an allele cheats during gametogenesis (segregation distortion) or eliminates embryos that don't contain it (lethal maternal effects). An allele may also directly convert its rival allele into a copy of itself (homing endonucleases). Finally, mobile genetic elements completely bypass Mendelian segregation, being able to insert new copies of themselves into new positions in the genome (transposons). Segregation distortion In principle, the two parental alleles have equal probabilities of being present in the mature gamete. However, there are several mechanisms that lead to an unequal transmission of parental alleles from parents to offspring. One example is a gene drive complex, called a segregation distorter, that "cheats" during meiosis or gametogenesis and thus is present in more than half of the functional gametes. The most studied examples are sd in Drosophila melanogaster (fruit fly), t haplotype in Mus musculus (mouse) and sk in Neurospora spp. (fungus). Possible examples have also been reported in humans. Segregation distorters that are present in sexual chromosomes (as is the case with the X chromosome in several Drosophila species) are denominated sex-ratio distorters, as they induce a sex-ratio bias in the offspring of the carrier individual. Killer and target The simplest model of meiotic drive involves two tightly linked loci: a Killer locus and a Target locus. The segregation distorter set is composed by the allele Killer (in the Killer locus) and the allele Resistant (in the Target locus), while its rival set is composed by the alleles Non-killer and Non-resistant. So, the segregation distorter set produces a toxin to which it is itself resistant, while its rival is not. Thus, it kills those gametes containing the rival set and increases in frequency. The tight linkage between these loci is crucial, so these genes usually lie on low-recombination regions of the genome. True meiotic drive Other systems do not involve gamete destruction, but rather use the asymmetry of meiosis in females: the driving allele ends up in the oocyte instead of in the polar bodies with a probability greater than one half. This is termed true meiotic drive, as it does not rely on a post-meiotic mechanism. The best-studied examples include the neocentromeres (knobs) of maize, as well as several chromosomal rearrangements in mammals. The general molecular evolution of centromeres is likely to involve such mechanisms. Lethal maternal effects The Medea gene causes the death of progeny from a heterozygous mother that do not inherit it. It occurs in the flour beetle (Tribolium castaneum). Maternal-effect selfish genes have been successfully synthesized in the lab. Transposons Transposons are autonomous replicating genes that encode the ability to move to new positions in the genome and therefore accumulate in the genomes. They replicate themselves in spite of being detrimental to the rest of the genome. They are often called 'jumping genes' or parasitic DNA and were discovered by Barbara McClintock in 1944. Homing endonuclease genes Homing endonuclease genes (HEG) convert their rival allele into a copy of themselves, and are thus inherited by nearly all meiotic daughter cells of a heterozygote cell. They achieve this by encoding an endonuclease which breaks the rival allele. This break is repaired by using the sequence of the HEG as template.HEGs encode sequence-specific endonucleases. The recognition sequence (RS) is 15–30 bp long and usually occurs once in the genome. HEGs are located in the middle of their own recognition sequences. Most HEGs are encoded by self-splicing introns (group I & II) and inteins. Inteins are internal protein fragments produced from protein splicing and usually contain endonuclease and splicing activities. The allele without the HEGs are cleaved by the homing endonuclease and the double-strand break are repaired by homologous recombination (gene conversion) using the allele containing HEGs as template. Both chromosomes will contain the HEGs after repair. B-chromosome B-chromosomes are nonessential chromosomes; not homologous with any member of the normal (A) chromosome set; morphologically and structurally different from the A's; and they are transmitted at higher-than-expected frequencies, leading to their accumulation in progeny. In some cases, there is strong evidence to support the contention that they are simply selfish and that they exist as parasitic chromosomes. They are found in all major taxonomic groupings of both plants and animals. Cytoplasmic genes Since nuclear and cytoplasmic genes usually have different modes of transmission, intragenomic conflicts between them may arise. Mitochondria and chloroplasts are two examples of sets of cytoplasmic genes that commonly have exclusive maternal inheritance, similar to endosymbiont parasites in arthropods, like Wolbachia. Males as dead-ends to cytoplasmic genes Anisogamy generally produces zygotes that inherit cytoplasmic elements exclusively from the female gamete. Thus, males represent dead-ends to these genes. Because of this fact, cytoplasmic genes have evolved a number of mechanisms to increase the production of female descendants and eliminate offspring not containing them. Feminization Male organisms are converted into females by cytoplasmic inherited protists (Microsporidia) or bacteria (Wolbachia), regardless of nuclear sex-determining factors. This occurs in amphipod and isopod Crustacea and Lepidoptera. Male-killing Male embryos (in the case of cytoplasmic inherited bacteria) or male larvae (in the case of Microsporidia) are killed. In the case of embryo death, this diverts investment from males to females who can transmit these cytoplasmic elements (for instance, in ladybird beetles, infected female hosts eat their dead male brothers, which is positive from the viewpoint of the bacterium). In the case of microsporidia-induced larval death, the agent is transmitted out of the male lineage (through which it cannot be transmitted) into the environment, where it may be taken up again infectiously by other individuals. Male-killing occurs in many insects. In the case of male embryo death, a variety of bacteria have been implicated, including Wolbachia. Male-sterility In some cases anther tissue (male gametophyte) is killed by mitochondria in monoecious angiosperms, increasing energy and material spent in developing female gametophytes. This leads to a shift from monoecy to gynodioecy, where part of the plants in the population are male-sterile. Parthenogenesis induction In certain haplodiploid Hymenoptera and mites, in which males are produced asexually, Wolbachia and Cardinium can induce duplication of the chromosomes and thus convert the organisms into females. The cytoplasmic bacterium forces haploid cells to go through incomplete mitosis to produce diploid cells which therefore will be female. This produces an entirely female population. If antibiotics are administered to populations which have become asexual in this way, they revert to sexuality instantly, as the cytoplasmic bacteria forcing this behaviour upon them are removed. Cytoplasmic incompatibility In many arthropods, zygotes produced by sperm of infected males and ova of non-infected females can be killed by Wolbachia or Cardinium. Evolution of sex Conflict between chromosomes has been proposed as an element in the evolution of sex. See also Green-beard effect References == Further reading ==

Memetics is a theory of the evolution of culture based on Darwinian principles with the meme as the unit of culture. The term "meme" was coined by biologist Richard Dawkins in his 1976 book The Selfish Gene, to illustrate the principle that he later called "Universal Darwinism". All evolutionary processes depend on information being copied, varied, and selected, a process also known as variation with selective retention. The information that is copied is called the replicator, and genes are the replicator for biological evolution. Dawkins proposed that the same process drives cultural evolution, and he called this second replicator the "meme". He gave as examples, tunes, catchphrases, fashions, and technologies. Like genes, memes are selfish replicators and have causal efficacy; in other words, their properties influence their chances of being copied and passed on. Some succeed because they are valuable or useful to their human hosts while others are more like viruses. Just as genes can work together to form co-adapted gene complexes, so groups of memes acting together form co-adapted meme complexes or memeplexes. Memeplexes include (among many other things) languages, traditions, scientific theories, financial institutions, and religions. Dawkins famously referred to religions as "viruses of the mind".Among proponents of memetics are psychologist Susan Blackmore, author of The Meme Machine, who argues that when our ancestors began imitating behaviours, they let loose a second replicator and co-evolved to become the "meme machines" that copy, vary, and select memes in culture. Philosopher Daniel Dennett develops memetics extensively, notably in his books Darwin's Dangerous Idea, and From Bacteria to Bach and Back. He describes the units of memes as "the smallest elements that replicate themselves with reliability and fecundity." and claims that "Human consciousness is itself a huge complex of memes." In The Beginning of Infinity, physicist David Deutsch contrasts static societies that depend on anti-rational memes suppressing innovation and creativity, with dynamic societies based on rational memes that encourage enlightenment values, scientific curiosity, and progress. Criticisms of memetics include claims that memes do not exist, that the analogy with genes is false, that the units cannot be specified, that culture does not evolve through imitation, and that the sources of variation are intelligently designed rather than random. Critics of memetics include biologist Stephen Jay Gould who calls memetics a "meaningless metaphor". Philosopher Dan Sperber argues against memetics as a viable approach to cultural evolution because cultural items are not directly copied or imitated but are reproduced. Anthropologist Robert Boyd and biologist Peter Richerson work within the alternative, and more mainstream, field of cultural evolution theory and gene-culture coevolution. Dual inheritance theory has much in common with memetics but rejects the idea that memes are replicators. From this perspective, memetics is seen as just one of several approaches to cultural evolution and one that is generally considered less useful than the alternatives of gene-culture coevolution or dual inheritance theory. The main difference is that dual inheritance theory ultimately depends on biological advantage to genes, whereas memetics treats memes as a second replicator in its own right. Memetics also extends to the analysis of Internet culture and Internet memes. History In his book The Selfish Gene (1976), the evolutionary biologist Richard Dawkins used the term meme to describe a unit of human cultural transmission analogous to the gene, arguing that replication also happens in culture, albeit in a different sense. While cultural evolution itself is a much older topic, with a history that dates back at least as far as Darwin's era, Dawkins (1976) proposed that the meme is a unit of culture residing in the brain and is the mutating replicator in human cultural evolution. After Dawkins, many discussed this unit of culture as evolutionary "information" which replicates with rules analogous to Darwinian selection. A replicator is a pattern that can influence its surroundings – that is, it has causal agency – and can propagate. This proposal resulted in debate among anthropologists, sociologists, biologists, and scientists of other disciplines. Dawkins himself did not provide a sufficient explanation of how the replication of units of information in the brain controls human behaviour and ultimately culture (the principal topic of the book was genetics). Dawkins apparently did not intend to present a comprehensive theory of memetics in The Selfish Gene, but rather coined the term meme in a speculative spirit. Accordingly, different researchers came to define the term "unit of information" in different ways. The evolutionary model of cultural information transfer is based on the concept that memes—units of information—have an independent existence, are self-replicating, and are subject to selective evolution through environmental forces. Starting from a proposition put forward in the writings of Dawkins, this model has formed the basis of a new area of study, one that looks at the self-replicating units of culture. It has been proposed that just as memes are analogous to genes, memetics is analogous to genetics. The modern memetics movement dates from the mid-1980s. A January 1983 "Metamagical Themas" column by Douglas Hofstadter, in Scientific American, was influential – as was his 1985 book of the same name. "Memeticist" was coined as analogous to "geneticist" – originally in The Selfish Gene. Later Arel Lucas suggested that the discipline that studies memes and their connections to human and other carriers of them be known as "memetics" by analogy with "genetics". Dawkins' The Selfish Gene has been a factor in attracting the attention of people of disparate intellectual backgrounds. Another stimulus was the publication in 1991 of Consciousness Explained by Tufts University philosopher Daniel Dennett, which incorporated the meme concept into a theory of the mind. In his 1991 essay "Viruses of the Mind", Richard Dawkins used memetics to explain the phenomenon of religious belief and the various characteristics of organised religions. By then, memetics had also become a theme appearing in fiction (e.g. Neal Stephenson's Snow Crash). The idea of language as a virus had already been introduced by William S. Burroughs as early as 1962 in his fictional book The Ticket That Exploded, and continued in The Electronic Revolution, published in 1970 in The Job. The foundation of memetics in its full modern incarnation was launched by Douglas Rushkoff's Media Virus: Hidden Agendas in Popular Culture in 1995, and was accelerated with the publication in 1996 of two more books by authors outside the academic mainstream: Virus of the Mind: The New Science of the Meme by former Microsoft executive turned motivational speaker and professional poker-player Richard Brodie, and Thought Contagion: How Belief Spreads Through Society by Aaron Lynch, a mathematician and philosopher who worked for many years as an engineer at Fermilab. Lynch claimed to have conceived his theory totally independently of any contact with academics in the cultural evolutionary sphere, and apparently was not aware of The Selfish Gene until his book was very close to publication.Around the same time as the publication of the books by Lynch and Brodie the e-journal Journal of Memetics – Evolutionary Models of Information Transmission (published electronically from 1997 to 2005) first appeared. It was first hosted by the Centre for Policy Modelling at Manchester Metropolitan University. The e-journal soon became the central point for publication and debate within the nascent memeticist community. (There had been a short-lived paper-based memetics publication starting in 1990, the Journal of Ideas edited by Elan Moritz.) In 1999, Susan Blackmore, a psychologist at the University of the West of England, published The Meme Machine, which more fully worked out the ideas of Dennett, Lynch, and Brodie and attempted to compare and contrast them with various approaches from the cultural evolutionary mainstream, as well as providing novel (and controversial) memetics-based theories for the evolution of language and the human sense of individual selfhood. Etymology The term meme derives from the Ancient Greek μιμητής (mimētḗs), meaning "imitator, pretender". The similar term mneme was used in 1904, by the German evolutionary biologist Richard Semon, best known for his development of the engram theory of memory, in his work Die mnemischen Empfindungen in ihren Beziehungen zu den Originalempfindungen, translated into English in 1921 as The Mneme. Until Daniel Schacter published Forgotten Ideas, Neglected Pioneers: Richard Semon and the Story of Memory in 2000, Semon's work had little influence, though it was quoted extensively in Erwin Schrödinger’s 1956 Tarner Lecture “Mind and Matter”. Richard Dawkins (1976) apparently coined the word meme independently of Semon, writing this: "'Mimeme' comes from a suitable Greek root, but I want a monosyllable that sounds a bit like 'gene'. I hope my classicist friends will forgive me if I abbreviate mimeme to meme. If it is any consolation, it could alternatively be thought of as being related to 'memory', or to the French word même."David Hull (2001) pointed out Dawkins's oversight of Semon's work. Hull suggests this early work as an alternative origin to memetics by which Dawkins's memetic theory and classicist connection to the concept can be negotiated."Why not date the beginnings of memetics (or mnemetics) as 1904 or at the very least 1914? If [Semon's] two publications are taken as the beginnings of memetics, then the development of memetics [...] has been around for almost a hundred years without much in the way of conceptual or empirical advance!"Despite this, Semon's work remains mostly understood as distinct to memetic origins even with the overt similarities accounted for by Hull. Internalists and externalists The memetics movement split almost immediately into two. The first group were those who wanted to stick to Dawkins' definition of a meme as "a unit of cultural transmission". Gibron Burchett, a memeticist responsible for helping to research and co-coin the term memetic engineering, along with Leveious Rolando and Larry Lottman, has stated that a meme can be defined, more precisely, as "a unit of cultural information that can be copied, located in the brain". This thinking is more in line with Dawkins' second definition of the meme in his book The Extended Phenotype. The second group wants to redefine memes as observable cultural artifacts and behaviors. However, in contrast to those two positions, the article "Consciousness in meme machines" by Susan Blackmore rejects neither movement.These two schools became known as the "internalists" and the "externalists." Prominent internalists included both Lynch and Brodie; the most vocal externalists included Derek Gatherer, a geneticist from Liverpool John Moores University, and William Benzon, a writer on cultural evolution and music. The main rationale for externalism was that internal brain entities are not observable, and memetics cannot advance as a science, especially a quantitative science, unless it moves its emphasis onto the directly quantifiable aspects of culture. Internalists countered with various arguments: that brain states will eventually be directly observable with advanced technology, that most cultural anthropologists agree that culture is about beliefs and not artifacts, or that artifacts cannot be replicators in the same sense as mental entities (or DNA) are replicators. The debate became so heated that a 1998 Symposium on Memetics, organised as part of the 15th International Conference on Cybernetics, passed a motion calling for an end to definitional debates. McNamara demonstrated in 2011 that functional connectivity profiling using neuroimaging tools enables the observation of the processing of internal memes, "i-memes", in response to external "e-memes". This was developed further in a paper "Memetics and Neural Models of Conspiracy Theories" by Duch, where a model of memes as a quasi-stable neural associative memory attractor network is proposed, and a formation of Memeplex leading to conspiracy theories illustrated with the simulation of a self-organizing network.An advanced statement of the internalist school came in 2002 with the publication of The Electric Meme, by Robert Aunger, an anthropologist from the University of Cambridge. Aunger also organised a conference in Cambridge in 1999, at which prominent sociologists and anthropologists were able to give their assessment of the progress made in memetics to that date. This resulted in the publication of Darwinizing Culture: The Status of Memetics as a Science, edited by Aunger and with a foreword by Dennett, in 2001. Decline In 2005, the Journal of Memetics ceased publication and published a set of articles on the future of memetics. The website states that although "there was to be a relaunch... after several years nothing has happened". Susan Blackmore left the University of the West of England to become a freelance science-writer and now concentrates more on the field of consciousness and cognitive science. Derek Gatherer moved to work as a computer programmer in the pharmaceutical industry, although he still occasionally publishes on memetics-related matters. Richard Brodie is now climbing the world professional poker rankings. Aaron Lynch disowned the memetics community and the words "meme" and "memetics" (without disowning the ideas in his book), adopting the self-description "thought contagionist". He died in 2005. Susan Blackmore (2002) re-stated the definition of meme as: whatever is copied from one person to another person, whether habits, skills, songs, stories, or any other kind of information. Further she said that memes, like genes, are replicators in the sense as defined by Dawkins. That is, they are information that is copied. Memes are copied by imitation, teaching and other methods. The copies are not perfect: memes are copied with variation; moreover, they compete for space in our memories and for the chance to be copied again. Only some of the variants can survive. The combination of these three elements (copies; variation; competition for survival) forms precisely the condition for Darwinian evolution, and so memes (and hence human cultures) evolve. Large groups of memes that are copied and passed on together are called co-adapted meme complexes, or memeplexes. In Blackmore's definition, the way that a meme replicates is through imitation. This requires brain capacity to generally imitate a model or selectively imitate the model. Since the process of social learning varies from one person to another, the imitation process cannot be said to be completely imitated. The sameness of an idea may be expressed with different memes supporting it. This is to say that the mutation rate in memetic evolution is extremely high, and mutations are even possible within each and every iteration of the imitation process. It becomes very interesting when we see that a social system composed of a complex network of microinteractions exists, but at the macro level an order emerges to create culture.Many researchers of cultural evolution regard memetic theory of this time a failed paradigm superseded by dual inheritance theory. Others instead suggest it is not superseded but rather holds a small but distinct intellectual space in cultural evolutionary theory. "Internet Memetics" A new framework of Internet Memetics initially borrowed Blackmore's conceptual developments but is effectively a data-driven approach, focusing on digital artifacts. This was led primarily by conceptual developments Colin Lankshear and Michele Knobel (2006) and Limor Shifman and Mike Thelwall (2009). Shiman, in particular, followed Susan Blackmore in rejecting the internalist and externalist debate, however did not offer a clear connection to prior evolutionary frameworks. Later in 2014, she rejected the historical relevance of "information" to memetics. Instead of memes being units of cultural information, she argued information is exclusively delegated to be "the ways in which addressers position themselves in relation to [a meme instance's] text, its linguistic codes, the addressees, and other potential speakers." This is what she called stance, which is analytically distinguished from the content and form of her meme. As such, Shifman's developments can be seen as critical to Dawkins's meme, but also as a somewhat distinct conceptualization of the meme as a communicative system dependent on the internet and social media platforms. By introducing memetics as an internet study there has been a rise in empirical research. That is, memetics in this conceptualization has been notably testable by the application of social science methodologies. It has been popular enough that following Lankshear and Knobel's (2019) review of empirical trends, they warn those interested in memetics that theoretical development should not be ignored, concluding that, "[R]ight now would be a good time for anyone seriously interested in memes to revisit Dawkins’ work in light of how internet memes have evolved over the past three decades and reflect on what most merits careful and conscientious research attention."As Lankshear and Knobel show, the Internet Memetic reconceptualization is limited in addressing long-standing memetic theory concerns. It is not clear that existing Internet Memetic theory's departure from conceptual dichotomies between internalist and externalist debate are compatible with most earlier concerns of memetics. Internet Memetics might be understood as a study without an agreed upon theory, as present research tends to focus on empirical developments answering theories of other areas of cultural research. It exists more as a set of distributed studies than a methodology, theory, field, or discipline, with a few exceptions such as Shifman and those closely following her motivating framework. Criticisms Critics contend that some of the proponents' assertions are "untested, unsupported or incorrect." Most of the history of memetic criticism has been directed at Dawkins' earlier theory of memetics framed in The Selfish Gene. There have been some serious criticisms of memetics. Namely, there are a few key points on which most criticisms focus: mentalism, cultural determinism, Darwinian reduction, a lack of academic novelty, and a lack of empirical evidence of memetic mechanisms. Luis Benitez-Bribiesca points to the lack of memetic mechanisms. He refers to the lack of a code script for memes which would suggest a genuine analogy to DNA in genes. He also suggests the meme mutation mechanism is too unstable which would render the evolutionary process chaotic. That is to say that the "unit of information" which traverses across minds is perhaps too flexible in meaning to be a realistic unit. As such, he calls memetics "a pseudoscientific dogma" and "a dangerous idea that poses a threat to the serious study of consciousness and cultural evolution" among other things. Another criticism points to memetic triviality. That is, some have argued memetics is derivative of more rich areas of study. One of these cases comes from Peircian semiotics, (e.g., Deacon, Kull) stating that the concept of meme is a less developed Sign. Meme is thus described in memetics as a sign without its triadic nature. Charles Sanders Peirce's semiotic theory involves a triadic structure: a sign (a reference to an object), an object (the thing being referred to), and an interpretant (the interpreting actor of a sign). For Deacon and Kull, the meme is a degenerate sign, which includes only its ability of being copied. Accordingly, in the broadest sense, the objects of copying are memes, whereas the objects of translation and interpretation are signs. Others have pointed to the fact that memetics reduces genuine social and communicative activity to genetic arguments, and this cannot adequately describe cultural interactions between people. For example, Henry Jenkins, Joshua Green, and Sam Ford, in their book Spreadable Media (2013), criticize Dawkins' idea of the meme, writing that "while the idea of the meme is a compelling one, it may not adequately account for how content circulates through participatory culture." The three authors also criticize other interpretations of memetics, especially those which describe memes as "self-replicating", because they ignore the fact that "culture is a human product and replicates through human agency." In doing so, they align more closely with Shifman's notion of Internet Memetics and her addition of the human agency of stance to describe participatory structure. Mary Midgley criticizes memetics for at least two reasons: Like other critics, Maria Kronfeldner has criticized memetics for being based on an allegedly inaccurate analogy with the gene; alternately, she claims it is "heuristically trivial", being a mere redescription of what is already known without offering any useful novelty. New developments Alternative definitions Dawkins, in A Devil's Chaplain, expanded his definition of meme by saying there are actually two different types of memetic processes (controversial and informative). The first is a type of cultural idea, action, or expression, which does have high variance; for instance, a student of his who had inherited some of the mannerisms of Wittgenstein. The second type is a self-correcting meme that is highly resistant to mutation. As an example of this, he gives origami patterns taught to elementary students– the meme is either passed on in the exact sequence of instructions, or (in the case of a forgetful child) terminates. The self-correcting meme tends to not evolve, and to experience profound mutations in the rare event that it does. Another definition, given by Hokky Situngkir, tried to offer a more rigorous formalism for the meme, memeplexes, and the deme, seeing the meme as a cultural unit in a cultural complex system. It is based on the Darwinian genetic algorithm with some modifications to account for the different patterns of evolution seen in genes and memes. In the method of memetics as the way to see culture as a complex adaptive system, he describes a way to see memetics as an alternative methodology of cultural evolution. DiCarlo (2010) developed the definition of meme further to include the idea of 'memetic equilibrium', which describe a culturally compatible state with biological equilibrium. In "How Problem Solving and Neurotransmission in the Upper Paleolithic led to The Emergence and Maintenance of Memetic Equilibrium in Contemporary World Religions", DiCarlo argues that as human consciousness evolved and developed, so too did our ancestors' capacity to consider and attempt to solve environmental problems in more conceptually sophisticated ways. When a satisfactory solution is found, the feeling of environmental stability, or memetic equilibrium, is achieved. The relationship between a gradually emerging conscious awareness and sophisticated languages in which to formulate representations combined with the desire to maintain biological equilibrium, generated the necessity for equilibrium to fill in conceptual gaps in terms of understanding three very important aspects in the Upper Paleolithic: causality, morality, and mortality. The desire to explain phenomena in relation to maintaining survival and reproductive stasis, generated a normative stance in the minds of our ancestors—Survival/Reproductive Value (or S-R Value). Limor Shifman (2014) defines Internet memes, memes in digitally mediated contexts, to be (a) a group of digital items sharing common characteristics of content, form, and/or stance, which (b) were created with awareness of each other, and (c) were circulated, imitated, and/or transformed via the Internet by many users. Further, she outlines content as "both ideas and ideologies", form as "the physical incarnation of the message", and stance as "the information memes convey about their own communication." Stance is about how actors (e.g. people) position themselves in relation to content and form of the media as well as those who might be addressed by the message. Over a decade after Kull's and Deacon's semiotic critique, Sara Cannizzaro offered her own development to redeem memes as fully formed cybersemiotic signs which has had limited success among those adjacent to Internet Memetics. In particular, she translates many of the neo-Darwinian conceptualizations of evolution to biosemiotic evolutionary concepts. This approach was theoretically integrated with an empirical investigation of information in Alexander O. Smith and Jeff Hemsley's development. They suggested under the influence of Cannizzaro's work that memes are "an information transmission network of documents connected through their differences among similarities and is interpreted as a semiotic system". Memetic analysis The possibility of quantitative analysis of memes using neuroimaging tools and the suggestion that such studies have already been done was given by McNamara (2011). This author proposes hyperscanning (concurrent scanning of two communicating individuals in two separate MRI machines) as a key tool in the future for investigating memetics. Velikovsky (2013) proposed the "holon" as the structure of the meme, synthesizing the major theories on memes of Richard Dawkins, Mihaly Csikszentmihalyi, E. O. Wilson, Frederick Turner (poet) and Arthur Koestler. Proponents of memetics as described in the Journal of Memetics (out of print since 2005) believe that 'memetics' has the potential to be an important and promising analysis of culture using the framework of evolutionary concepts. Keith Henson in Memetics and the Modular-Mind (Analog Aug. 1987) makes the case that memetics needs to incorporate evolutionary psychology to understand the psychological traits of a meme's host. The primary analytic approaches of internet memetics has been more in association with visual culture and communication methodologies. These researchers justify the existence of memes by way of culturally association, social networks or networked artifacts, most notably online image artifacts. Applications Research methodologies that apply memetics go by many names: Viral marketing, cultural evolution, the history of ideas, social analytics, and more. Many of these applications do not make reference to the literature on memes directly but are built upon the evolutionary lens of idea propagation that treats semantic units of culture as self-replicating and mutating patterns of information that are assumed to be relevant for scientific study. For example, the field of public relations is filled with attempts to introduce new ideas and alter social discourse. One means of doing this is to design a meme and deploy it through various media channels. One historic example of applied memetics is the PR campaign conducted in 1991 as part of the build-up to the first Gulf War in the United States.The application of memetics to a difficult complex social system problem, environmental sustainability, has recently been attempted at thwink.org Using meme types and memetic infection in several stock and flow simulation models, Jack Harich has demonstrated several interesting phenomena that are best, and perhaps only, explained by memes. One model, The Dueling Loops of the Political Powerplace, argues that the fundamental reason corruption is the norm in politics is due to an inherent structural advantage of one feedback loop pitted against another. Another model, The Memetic Evolution of Solutions to Difficult Problems, uses memes, the evolutionary algorithm, and the scientific method to show how complex solutions evolve over time and how that process can be improved. The insights gained from these models are being used to engineer memetic solution elements to the sustainability problem. Another application of memetics in the sustainability space is the crowdfunded Climate Meme Project conducted by Joe Brewer and Balazs Laszlo Karafiath in the spring of 2013. This study was based on a collection of 1000 unique text-based expressions gathered from Twitter, Facebook, and structured interviews with climate activists. The major finding was that the global warming meme is not effective at spreading because it causes emotional duress in the minds of people who learn about it. Five central tensions were revealed in the discourse about [climate change], each of which represents a resonance point through which dialogue can be engaged. The tensions were Harmony/Disharmony (whether or not humans are part of the natural world), Survival/Extinction (envisioning the future as either apocalyptic collapse of civilization or total extinction of the human race), Cooperation/Conflict (regarding whether or not humanity can come together to solve global problems), Momentum/Hesitation (about whether or not we are making progress at the collective scale to address climate change), and Elitism/Heretic (a general sentiment that each side of the debate considers the experts of its opposition to be untrustworthy).Ben Cullen, in his book Contagious Ideas, brought the idea of the meme into the discipline of archaeology. He coined the term "Cultural Virus Theory", and used it to try to anchor archaeological theory in a neo-Darwinian paradigm. Archaeological memetics could assist the application of the meme concept to material culture in particular. Francis Heylighen of the Center Leo Apostel for Interdisciplinary Studies has postulated what he calls "memetic selection criteria". These criteria opened the way to a specialized field of applied memetics to find out if these selection criteria could stand the test of quantitative analyses. In 2003 Klaas Chielens carried out these tests in a Masters thesis project on the testability of the selection criteria. In Selfish Sounds and Linguistic Evolution, Austrian linguist Nikolaus Ritt has attempted to operationalise memetic concepts and use them for the explanation of long term sound changes and change conspiracies in early English. It is argued that a generalised Darwinian framework for handling cultural change can provide explanations where established, speaker centred approaches fail to do so. The book makes comparatively concrete suggestions about the possible material structure of memes, and provides two empirically rich case studies. Australian academic S.J. Whitty has argued that project management is a memeplex with the language and stories of its practitioners at its core. This radical approach sees a project and its management as an illusion; a human construct about a collection of feelings, expectations, and sensations, which are created, fashioned, and labeled by the human brain. Whitty's approach requires project managers to consider that the reasons for using project management are not consciously driven to maximize profit, and are encouraged to consider project management as naturally occurring, self-serving, evolving process which shapes organizations for its own purpose. Swedish political scientist Mikael Sandberg argues against "Lamarckian" interpretations of institutional and technological evolution and studies creative innovation of information technologies in governmental and private organizations in Sweden in the 1990s from a memetic perspective. Comparing the effects of active ("Lamarckian") IT strategy versus user–producer interactivity (Darwinian co-evolution), evidence from Swedish organizations shows that co-evolutionary interactivity is almost four times as strong a factor behind IT creativity as the "Lamarckian" IT strategy. Terminology Memeplex – (an abbreviation of meme-complex) is a collection or grouping of memes that have evolved into a mutually supportive or symbiotic relationship. Simply put, a meme-complex is a set of ideas that reinforce each other. Meme-complexes are roughly analogous to the symbiotic collection of individual genes that make up the genetic codes of biological organisms. An example of a memeplex would be a religion. Meme pool – a population of interbreeding memes. Memetic engineering – The process of deliberately creating memes, using engineering principles. Memetic algorithms – an approach to evolutionary computation that attempts to emulate cultural evolution in order to solve optimization problems. Memotype – the actual information-content of a meme. Memeoid – a neologism for people who have been taken over by a meme to the extent that their own survival becomes inconsequential. Examples include kamikazes, suicide bombers and cult members who commit mass suicide. The term was apparently coined by H. Keith Henson in "Memes, L5 and the Religion of the Space Colonies," L5 News, September 1985 pp. 5–8, and referenced in the expanded second edition of Richard Dawkins' book The Selfish Gene (p. 330). In The Electronic Revolution William S. Burroughs writes: "the word has not been recognised as a virus because it has achieved a state of stable symbiosis with the host." Memetic equilibrium – the cultural equivalent of species biological equilibrium. It is that which humans strive for in terms of personal value with respect to cultural artefacts and ideas. The term was coined by Christopher diCarlo. Metamemetic thinking - coined by Diego Fontanive, is the thinking skill & cognitive training capable of making individuals acknowledge illogical memes. Eumemics - the belief and practice of deliberately improving the quality of the meme pool. Memocide - intentional action to eradicate a meme or memeplex from the population, either by killing its carriers or by censorship. See also References Sources Apter, Emily (2019). Alphabetic Memes: Caricature, Satire, and Political Literacy in the Age of Trump (PDF). OCTOBER Journal 170, Fall 2019, MIT Press Journal Botz-Bornstein, Thorsten (2008). "Can Memes Play Games? Memetics and the Problem of Space" in T. Botz-Bornstein (ed.): Culture, Nature, Memes: Dynamic Cognitive Theories (Newcastle: Cambridge Scholars Press), pp. 142–156. Boyd, Robert & Richerson, Peter J. (1985). Culture and the Evolutionary Process. University of Chicago Press. ISBN 978-0-226-06933-3 Boyd, Rob & Richerson, Peter J. (2005). Not by Genes Alone: How Culture Transformed Human Evolution. Chicago University Press. ISBN 0-226-71284-2 Boyles, Robert James M. (2011), "The Enemy: A Thought Experiment on Patriarchies, Feminisms and Memes" (PDF), Feminista: Gender, Race, and Class in the Philippines, Philippines: Anvil Publishing, Inc.: 53–64, ISBN 978-971-27-2594-4 DiCarlo, Christopher W. 2010. "How Problem Solving and Neurotransmission in the Upper Paleolithic led to The Emergence and Maintenance of Memetic Equilibrium in Contemporary World Religions." Politics and Culture. https://politicsandculture.org/2010/04/27/how-problem-solving-and-neurotransmission-in-the-upper-paleolithic-led-to-the-emergence-and-maintenance-of-memetic-equilibrium-in-contemporary-world-religions/ Archived 2021-08-23 at the Wayback Machine Cloak, F.T. (1975). "Is a cultural ethology possible?". Human Ecology. 3 (3): 161–182. doi:10.1007/bf01531639. S2CID 144333714. Edmonds, Bruce. 2002. "Three challenges for the survival of memetics." Journal of Memetics - Evolutionary Models of Information Transmission, 6. http://cfpm.org/jom-emit/2002/vol6/edmonds_b_letter.html Archived 2011-05-03 at the Wayback Machine Edmonds, Bruce. 2005. "The revealed poverty of the gene-meme analogy – why memetics per se has failed." Journal of Memetics - Evolutionary Models of Information Transmission, 9. http://cfpm.org/jom-emit/2005/vol9/edmonds_b.html Archived 2021-07-17 at the Wayback Machine Heylighen F. & Chielens K. (2009): Evolution of Culture, Memetics, in: Encyclopedia of Complexity and Systems Science, ed. B. Meyers (Springer) Houben, Jan E.M. "Memetics of Vedic Ritual, Morphology of the Agnistoma." Powerpoint presentation first presented at the Third International Vedic Workshop, Leiden 2002 www.academia.edu/7090834 Houben, Jan E.M. "A Tradição Sânscrita entre Memética Védica e Cultura Literária." (In Portuguese) Revista Linguagem & Ensino, vol. 17 n. 2 (2014), p. 441-469. www.rle.ucpel.tche.br/index.php/rle/article/view/1089/783 The Selfish Gene by Richard Dawkins, Oxford University Press, 1976, 2nd edition, December 1989, hardcover, 352 pages, ISBN 0-19-217773-7; April 1992, ISBN 0-19-857519-X; trade paperback, September 1990, 352 pages, ISBN 0-19-286092-5 Aunger, Robert. The Electric Meme: A New Theory of How We Think. New York: Free Press, 2002. ISBN 978-0-7432-0150-6 The Meme Machine by Susan Blackmore, Oxford University Press, 1999, hardcover ISBN 0-19-850365-2, trade paperback ISBN 0-9658817-8-4, May 2000, ISBN 0-19-286212-X The Ideology of Cybernetic Totalist Intellectuals an essay by Jaron Lanier which is very strongly critical of "meme totalists" who assert memes over bodies. Culture as Complex Adaptive System by Hokky Situngkir – formal interplays between memetics and cultural analysis. Journal of Memetics – Evolutionary Models of Information Transmission Brodie, Richard. Virus of the Mind: The New Science of the Meme. Seattle, Wash: Integral Press, 1996. ISBN 978-0-9636001-1-0 Cultural Software: A Theory of Ideology by Jack Balkin which uses memetics to explain the growth and spread of ideology. Can we Measure Memes? by Adam McNamara which presents neuroimaging tools to measure memes. Convivere con la memetica (in Italian) by Francesco Somigli, 2011 Lulu.com External links "What’s in a Meme?" – Richard Dawkins Foundation

A microsatellite is a tract of repetitive DNA in which certain DNA motifs (ranging in length from one to six or more base pairs) are repeated, typically 5–50 times. Microsatellites occur at thousands of locations within an organism's genome. They have a higher mutation rate than other areas of DNA leading to high genetic diversity. Microsatellites are often referred to as short tandem repeats (STRs) by forensic geneticists and in genetic genealogy, or as simple sequence repeats (SSRs) by plant geneticists.Microsatellites and their longer cousins, the minisatellites, together are classified as VNTR (variable number of tandem repeats) DNA. The name "satellite" DNA refers to the early observation that centrifugation of genomic DNA in a test tube separates a prominent layer of bulk DNA from accompanying "satellite" layers of repetitive DNA.They are widely used for DNA profiling in cancer diagnosis, in kinship analysis (especially paternity testing) and in forensic identification. They are also used in genetic linkage analysis to locate a gene or a mutation responsible for a given trait or disease. Microsatellites are also used in population genetics to measure levels of relatedness between subspecies, groups and individuals. History Although the first microsatellite was characterised in 1984 at the University of Leicester by Weller, Jeffreys and colleagues as a polymorphic GGAT repeat in the human myoglobin gene, the term "microsatellite" was introduced later, in 1989, by Litt and Luty. The name "satellite" DNA refers to the early observation that centrifugation of genomic DNA in a test tube separates a prominent layer of bulk DNA from accompanying "satellite" layers of repetitive DNA. The increasing availability of DNA amplification by PCR at the beginning of the 1990s triggered a large number of studies using the amplification of microsatellites as genetic markers for forensic medicine, for paternity testing, and for positional cloning to find the gene underlying a trait or disease. Prominent early applications include the identifications by microsatellite genotyping of the eight-year-old skeletal remains of a British murder victim (Hagelberg et al. 1991), and of the Auschwitz concentration camp doctor Josef Mengele who escaped to South America following World War II (Jeffreys et al. 1992). Structures, locations, and functions A microsatellite is a tract of tandemly repeated (i.e. adjacent) DNA motifs that range in length from one to six or up to ten nucleotides (the exact definition and delineation to the longer minisatellites varies from author to author), and are typically repeated 5–50 times. For example, the sequence TATATATATA is a dinucleotide microsatellite, and GTCGTCGTCGTCGTC is a trinucleotide microsatellite (with A being Adenine, G Guanine, C Cytosine, and T Thymine). Repeat units of four and five nucleotides are referred to as tetra- and pentanucleotide motifs, respectively. Most eukaryotes have microsatellites, with the notable exception of some yeast species. Microsatellites are distributed throughout the genome. The human genome for example contains 50,000–100,000 dinucleotide microsatellites, and lesser numbers of tri-, tetra- and pentanucleotide microsatellites. Many are located in non-coding parts of the human genome and therefore do not produce proteins, but they can also be located in regulatory regions and coding regions. Microsatellites in non-coding regions may not have any specific function, and therefore might not be selected against; this allows them to accumulate mutations unhindered over the generations and gives rise to variability that can be used for DNA fingerprinting and identification purposes. Other microsatellites are located in regulatory flanking or intronic regions of genes, or directly in codons of genes – microsatellite mutations in such cases can lead to phenotypic changes and diseases, notably in triplet expansion diseases such as fragile X syndrome and Huntington's disease.Telomeres are linear sequences of DNA that sit at the very ends of chromosomes and protect the integrity of genomic material (not unlike an aglet on the end of a shoelace) during successive rounds of cell division due to the "end replication problem". In white blood cells, the gradual shortening of telomeric DNA has been shown to inversely correlate with ageing in several sample types. Telomeres consist of repetitive DNA, with the hexanucleotide repeat motif TTAGGG in vertebrates. They are thus classified as minisatellites. Similarly, insects have shorter repeat motifs in their telomeres that could arguably be considered microsatellites. Mutation mechanisms and mutation rates Unlike point mutations, which affect only a single nucleotide, microsatellite mutations lead to the gain or loss of an entire repeat unit, and sometimes two or more repeats simultaneously. Thus, the mutation rate at microsatellite loci is expected to differ from other mutation rates, such as base substitution rates. The mutation rate at microsatellite loci depends on the repeat motif sequence, the number of repeated motif units and the purity of the canonical repeated sequence. A variety of mechanisms for mutation of microsatellite loci have been reviewed, and their resulting polymorphic nature has been quantified. The actual cause of mutations in microsatellites is debated. One proposed cause of such length changes is replication slippage, caused by mismatches between DNA strands while being replicated during meiosis. DNA polymerase, the enzyme responsible for reading DNA during replication, can slip while moving along the template strand and continue at the wrong nucleotide. DNA polymerase slippage is more likely to occur when a repetitive sequence (such as CGCGCG) is replicated. Because microsatellites consist of such repetitive sequences, DNA polymerase may make errors at a higher rate in these sequence regions. Several studies have found evidence that slippage is the cause of microsatellite mutations. Typically, slippage in each microsatellite occurs about once per 1,000 generations. Thus, slippage changes in repetitive DNA are three orders of magnitude more common than point mutations in other parts of the genome. Most slippage results in a change of just one repeat unit, and slippage rates vary for different allele lengths and repeat unit sizes, and within different species. If there is a large size difference between individual alleles, then there may be increased instability during recombination at meiosis.Another possible cause of microsatellite mutations are point mutations, where only one nucleotide is incorrectly copied during replication. A study comparing human and primate genomes found that most changes in repeat number in short microsatellites appear due to point mutations rather than slippage. Microsatellite mutation rates Direct estimates of microsatellite mutation rates have been made in numerous organisms, from insects to humans. In the desert locust Schistocerca gregaria, the microsatellite mutation rate was estimated at 2.1 × 10−4 per generation per locus. The microsatellite mutation rate in human male germ lines is five to six times higher than in female germ lines and ranges from 0 to 7 × 10−3 per locus per gamete per generation. In the nematode Pristionchus pacificus, the estimated microsatellite mutation rate ranges from 8.9 × 10−5 to 7.5 × 10−4 per locus per generation.Microsatellite mutation rates vary with base position relative to the microsatellite, repeat type, and base identity. Mutation rate rises specifically with repeat number, peaking around six to eight repeats and then decreasing again. Increased heterozygosity in a population will also increase microsatellite mutation rates, especially when there is a large length difference between alleles. This is likely due to homologous chromosomes with arms of unequal lengths causing instability during meiosis. Biological effects of microsatellite mutations Many microsatellites are located in non-coding DNA and are biologically silent. Others are located in regulatory or even coding DNA – microsatellite mutations in such cases can lead to phenotypic changes and diseases. A genome-wide study estimates that microsatellite variation contributes 10–15% of heritable gene expression variation in humans. Effects on proteins In mammals, 20–40% of proteins contain repeating sequences of amino acids encoded by short sequence repeats. Most of the short sequence repeats within protein-coding portions of the genome have a repeating unit of three nucleotides, since that length will not cause frame-shifts when mutating. Each trinucleotide repeating sequence is transcribed into a repeating series of the same amino acid. In yeasts, the most common repeated amino acids are glutamine, glutamic acid, asparagine, aspartic acid and serine. Mutations in these repeating segments can affect the physical and chemical properties of proteins, with the potential for producing gradual and predictable changes in protein action. For example, length changes in tandemly repeating regions in the Runx2 gene lead to differences in facial length in domesticated dogs (Canis familiaris), with an association between longer sequence lengths and longer faces. This association also applies to a wider range of Carnivora species. Length changes in polyalanine tracts within the HOXA13 gene are linked to hand-foot-genital syndrome, a developmental disorder in humans. Length changes in other triplet repeats are linked to more than 40 neurological diseases in humans, notably trinucleotide repeat disorders such as fragile X syndrome and Huntington's disease. Evolutionary changes from replication slippage also occur in simpler organisms. For example, microsatellite length changes are common within surface membrane proteins in yeast, providing rapid evolution in cell properties. Specifically, length changes in the FLO1 gene control the level of adhesion to substrates. Short sequence repeats also provide rapid evolutionary change to surface proteins in pathenogenic bacteria; this may allow them to keep up with immunological changes in their hosts. Length changes in short sequence repeats in a fungus (Neurospora crassa) control the duration of its circadian clock cycles. Effects on gene regulation Length changes of microsatellites within promoters and other cis-regulatory regions can change gene expression quickly, between generations. The human genome contains many (>16,000) short sequence repeats in regulatory regions, which provide 'tuning knobs' on the expression of many genes.Length changes in bacterial SSRs can affect fimbriae formation in Haemophilus influenzae, by altering promoter spacing. Dinucleotide microsatellites are linked to abundant variation in cis-regulatory control regions in the human genome. Microsatellites in control regions of the Vasopressin 1a receptor gene in voles influence their social behavior, and level of monogamy.In Ewing sarcoma (a type of painful bone cancer in young humans), a point mutation has created an extended GGAA microsatellite which binds a transcription factor, which in turn activates the EGR2 gene which drives the cancer. In addition, other GGAA microsatellites may influence the expression of genes that contribute to the clinical outcome of Ewing sarcoma patients. Effects within introns Microsatellites within introns also influence phenotype, through means that are not currently understood. For example, a GAA triplet expansion in the first intron of the X25 gene appears to interfere with transcription, and causes Friedreich's ataxia. Tandem repeats in the first intron of the Asparagine synthetase gene are linked to acute lymphoblastic leukaemia. A repeat polymorphism in the fourth intron of the NOS3 gene is linked to hypertension in a Tunisian population. Reduced repeat lengths in the EGFR gene are linked with osteosarcomas.An archaic form of splicing preserved in zebrafish is known to use microsatellite sequences within intronic mRNA for the removal of introns in the absence of U2AF2 and other splicing machinery. It is theorized that these sequences form highly stable cloverleaf configurations that bring the 3' and 5' intron splice sites into close proximity, effectively replacing the spliceosome. This method of RNA splicing is believed to have diverged from human evolution at the formation of tetrapods and to represent an artifact of an RNA world. Effects within transposons Almost 50% of the human genome is contained in various types of transposable elements (also called transposons, or 'jumping genes'), and many of them contain repetitive DNA. It is probable that short sequence repeats in those locations are also involved in the regulation of gene expression. Applications Microsatellites are used for assessing chromosomal DNA deletions in cancer diagnosis. Microsatellites are widely used for DNA profiling, also known as "genetic fingerprinting", of crime stains (in forensics) and of tissues (in transplant patients). They are also widely used in kinship analysis (most commonly in paternity testing). Also, microsatellites are used for mapping locations within the genome, specifically in genetic linkage analysis to locate a gene or a mutation responsible for a given trait or disease. As a special case of mapping, they can be used for studies of gene duplication or deletion. Researchers use microsatellites in population genetics and in species conservation projects. Plant geneticists have proposed the use of microsatellites for marker assisted selection of desirable traits in plant breeding. Cancer diagnosis In tumour cells, whose controls on replication are damaged, microsatellites may be gained or lost at an especially high frequency during each round of mitosis. Hence a tumour cell line might show a different genetic fingerprint from that of the host tissue, and, especially in colorectal cancer, might present with loss of heterozygosity. Microsatellites analyzed in primary tissue therefore been routinely used in cancer diagnosis to assess tumour progression. Genome Wide Association Studies (GWAS) have been used to identify microsatellite biomarkers as a source of genetic predisposition in a variety of cancers. Forensic and medical fingerprinting Microsatellite analysis became popular in the field of forensics in the 1990s. It is used for the genetic fingerprinting of individuals where it permits forensic identification (typically matching a crime stain to a victim or perpetrator). It is also used to follow up bone marrow transplant patients.The microsatellites in use today for forensic analysis are all tetra- or penta-nucleotide repeats, as these give a high degree of error-free data while being short enough to survive degradation in non-ideal conditions. Even shorter repeat sequences would tend to suffer from artifacts such as PCR stutter and preferential amplification, while longer repeat sequences would suffer more highly from environmental degradation and would amplify less well by PCR. Another forensic consideration is that the person's medical privacy must be respected, so that forensic STRs are chosen which are non-coding, do not influence gene regulation, and are not usually trinucleotide STRs which could be involved in triplet expansion diseases such as Huntington's disease. Forensic STR profiles are stored in DNA databanks such as the UK National DNA Database (NDNAD), the American CODIS or the Australian NCIDD. Kinship analysis (paternity testing) Autosomal microsatellites are widely used for DNA profiling in kinship analysis (most commonly in paternity testing). Paternally inherited Y-STRs (microsatellites on the Y chromosome) are often used in genealogical DNA testing. Genetic linkage analysis During the 1990s and the first several years of this millennium, microsatellites were the workhorse genetic markers for genome-wide scans to locate any gene responsible for a given phenotype or disease, using segregation observations across generations of a sampled pedigree. Although the rise of higher throughput and cost-effective single-nucleotide polymorphism (SNP) platforms led to the era of the SNP for genome scans, microsatellites remain highly informative measures of genomic variation for linkage and association studies. Their continued advantage lies in their greater allelic diversity than biallelic SNPs, thus microsatellites can differentiate alleles within a SNP-defined linkage disequilibrium block of interest. Thus, microsatellites have successfully led to discoveries of type 2 diabetes (TCF7L2) and prostate cancer genes (the 8q21 region). Population genetics Microsatellites were popularized in population genetics during the 1990s because as PCR became ubiquitous in laboratories researchers were able to design primers and amplify sets of microsatellites at low cost. Their uses are wide-ranging. A microsatellite with a neutral evolutionary history makes it applicable for measuring or inferring bottlenecks, local adaptation, the allelic fixation index (FST), population size, and gene flow. As next generation sequencing becomes more affordable the use of microsatellites has decreased, however they remain a crucial tool in the field. Plant breeding Marker assisted selection or marker aided selection (MAS) is an indirect selection process where a trait of interest is selected based on a marker (morphological, biochemical or DNA/RNA variation) linked to a trait of interest (e.g. productivity, disease resistance, stress tolerance, and quality), rather than on the trait itself. Microsatellites have been proposed to be used as such markers to assist plant breeding. Analysis Repetitive DNA is not easily analysed by next generation DNA sequencing methods, for some technologies struggle with homopolymeric tracts. A variety of software approaches have been created for the analysis or raw nextgen DNA sequencing reads to determine the genotype and variants at repetitive loci. Microsatellites can be analysed and verified by established PCR amplification and amplicon size determination, sometimes followed by Sanger DNA sequencing. In forensics, the analysis is performed by extracting nuclear DNA from the cells of a sample of interest, then amplifying specific polymorphic regions of the extracted DNA by means of the polymerase chain reaction. Once these sequences have been amplified, they are resolved either through gel electrophoresis or capillary electrophoresis, which will allow the analyst to determine how many repeats of the microsatellites sequence in question there are. If the DNA was resolved by gel electrophoresis, the DNA can be visualized either by silver staining (low sensitivity, safe, inexpensive), or an intercalating dye such as ethidium bromide (fairly sensitive, moderate health risks, inexpensive), or as most modern forensics labs use, fluorescent dyes (highly sensitive, safe, expensive). Instruments built to resolve microsatellite fragments by capillary electrophoresis also use fluorescent dyes. Forensic profiles are stored in major databanks. The British data base for microsatellite loci identification was originally based on the British SGM+ system using 10 loci and a sex marker. The Americans increased this number to 13 loci. The Australian database is called the NCIDD, and since 2013 it has been using 18 core markers for DNA profiling. Amplification Microsatellites can be amplified for identification by the polymerase chain reaction (PCR) process, using the unique sequences of flanking regions as primers. DNA is repeatedly denatured at a high temperature to separate the double strand, then cooled to allow annealing of primers and the extension of nucleotide sequences through the microsatellite. This process results in production of enough DNA to be visible on agarose or polyacrylamide gels; only small amounts of DNA are needed for amplification because in this way thermocycling creates an exponential increase in the replicated segment. With the abundance of PCR technology, primers that flank microsatellite loci are simple and quick to use, but the development of correctly functioning primers is often a tedious and costly process. Design of microsatellite primers If searching for microsatellite markers in specific regions of a genome, for example within a particular intron, primers can be designed manually. This involves searching the genomic DNA sequence for microsatellite repeats, which can be done by eye or by using automated tools such as repeat masker. Once the potentially useful microsatellites are determined, the flanking sequences can be used to design oligonucleotide primers which will amplify the specific microsatellite repeat in a PCR reaction. Random microsatellite primers can be developed by cloning random segments of DNA from the focal species. These random segments are inserted into a plasmid or bacteriophage vector, which is in turn implanted into Escherichia coli bacteria. Colonies are then developed, and screened with fluorescently–labelled oligonucleotide sequences that will hybridize to a microsatellite repeat, if present on the DNA segment. If positive clones can be obtained from this procedure, the DNA is sequenced and PCR primers are chosen from sequences flanking such regions to determine a specific locus. This process involves significant trial and error on the part of researchers, as microsatellite repeat sequences must be predicted and primers that are randomly isolated may not display significant polymorphism. Microsatellite loci are widely distributed throughout the genome and can be isolated from semi-degraded DNA of older specimens, as all that is needed is a suitable substrate for amplification through PCR. More recent techniques involve using oligonucleotide sequences consisting of repeats complementary to repeats in the microsatellite to "enrich" the DNA extracted (microsatellite enrichment). The oligonucleotide probe hybridizes with the repeat in the microsatellite, and the probe/microsatellite complex is then pulled out of solution. The enriched DNA is then cloned as normal, but the proportion of successes will now be much higher, drastically reducing the time required to develop the regions for use. However, which probes to use can be a trial and error process in itself. ISSR-PCR ISSR (for inter-simple sequence repeat) is a general term for a genome region between microsatellite loci. The complementary sequences to two neighboring microsatellites are used as PCR primers; the variable region between them gets amplified. The limited length of amplification cycles during PCR prevents excessive replication of overly long contiguous DNA sequences, so the result will be a mix of a variety of amplified DNA strands which are generally short but vary much in length. Sequences amplified by ISSR-PCR can be used for DNA fingerprinting. Since an ISSR may be a conserved or nonconserved region, this technique is not useful for distinguishing individuals, but rather for phylogeography analyses or maybe delimiting species; sequence diversity is lower than in SSR-PCR, but still higher than in actual gene sequences. In addition, microsatellite sequencing and ISSR sequencing are mutually assisting, as one produces primers for the other. Limitations Repetitive DNA is not easily analysed by next generation DNA sequencing methods, which struggle with homopolymeric tracts. Therefore, microsatellites are normally analysed by conventional PCR amplification and amplicon size determination. The use of PCR means that microsatellite length analysis is prone to PCR limitations like any other PCR-amplified DNA locus. A particular concern is the occurrence of 'null alleles': Occasionally, within a sample of individuals such as in paternity testing casework, a mutation in the DNA flanking the microsatellite can prevent the PCR primer from binding and producing an amplicon (creating a "null allele" in a gel assay), thus only one allele is amplified (from the non-mutated sister chromosome), and the individual may then falsely appear to be homozygous. This can cause confusion in paternity casework. It may then be necessary to amplify the microsatellite using a different set of primers. Null alleles are caused especially by mutations at the 3' section, where extension commences. In species or population analysis, for example in conservation work, PCR primers which amplify microsatellites in one individual or species can work in other species. However, the risk of applying PCR primers across different species is that null alleles become likely, whenever sequence divergence is too great for the primers to bind. The species may then artificially appear to have a reduced diversity. Null alleles in this case can sometimes be indicated by an excessive frequency of homozygotes causing deviations from Hardy-Weinberg equilibrium expectations. See also References Further reading External links All known disease-causing short tandem repeats MicroSatellite DataBase Search tools: FireMuSat2+ Archived 2014-02-21 at the Wayback Machine IMEx Archived 2013-09-14 at the Wayback Machine Imperfect SSR Finder Archived 2021-07-23 at the Wayback Machine—find perfect or imperfect SSRs in FASTA sequences. JSTRING—Java Search for Tandem Repeats In Genomes Microsatellite repeats finder MISA—MIcroSAtellite identification tool MREPATT Mreps Phobos—a tandem repeat search tool for perfect and imperfect repeats—the maximum pattern size depends only on computational power Poly SciRoKo SSR Finder STAR Tandem Repeats Finder TandemSWAN TRED TROLL Zebrafish Repeats Archived 2019-09-12 at the Wayback Machine

In human genetics the midparent value of a trait is defined as the average of the trait value of the father and a scaled version of that of the mother. This value can be used in a study to analyze the data set without heeding sex effects. Studying quantitative traits in heritability studies may be complicated by sex differences observed for the trait. Well-known examples include studies of humans' height, whose midparent value hmp is given by: h m p = h f + ( 1.08 × h m ) 2 {\displaystyle h_{mp}={\frac {h_{f}+(1.08\times h_{m})}{2}}} where hf is the father's height, and hm the mother's. The coefficient 1.08 serves as a scaling factor. After the 1.08 scaling, the mean of the mother's height is the same as that of the father's, and the variance is closer to the father's; in this way, sex difference can be ignored. == References ==

A minichromosome is a small chromatin-like structure resembling a chromosome and consisting of centromeres, telomeres and replication origins but little additional genetic material. They replicate autonomously in the cell during cellular division. Minichromosomes may be created by natural processes as chromosomal aberrations or by genetic engineering. Structure Minichromosomes can be either linear or circular pieces of DNA. By minimizing the amount of unnecessary genetic information on the chromosome and including the basic components necessary for DNA replication (centromere, telomeres, and replication sequences), molecular biologists aim to construct a chromosomal platform which can be utilized to insert or present new genes into a host cell. Production Producing minichromosomes by genetic engineering techniques involves two primary methods, the de novo (bottom-up) and the top-down approach. De novo The minimum constituent parts of a chromosome (centromere, telomeres, and DNA replication sequences) are assembled by using molecular cloning techniques to construct the desired chromosomal contents in vitro. Next, the desired contents of the minichromosome must be transformed into a host which is capable of assembling the components (typically yeast or mammalian cells) into a functional chromosome. This approach has been attempted for the introduction of minichromosomes into maize for the possibility of genetic engineering, but success has been limited and questionable. In general, the de novo approach is more difficult than the top-down method due to species incompatibility issues and the heterochromatic nature of centromeric regions. Top-down This method utilizes the mechanism of telomere-mediated chromosomal truncation (TMCT). This process is the generation of truncation by selective transformation of telomeric sequences into a host genome. This insertion causes the generation of more telomeric sequences and eventual truncation. The newly synthesized truncated chromosome can then be altered through the insertion of new genes for desired traits. The top-down approach is generally considered as the more plausible means of generating extra-numerary chromosomes for the use of genetic engineering of plants. In particular it is useful because their stability during cell division has been demonstrated. The limitation of this approach is that it is labor-intensive. Role in genetic engineering Unlike traditional methods of genetic engineering, minichromosomes can be used to transfer and express multiple sets of genes onto one engineered chromosome package. Traditional methods which involve the insertion of novel genes into existing sequences may result in the disruption of endogenous genes and thus negatively affect the host cell. Additionally, with traditional gene insertion methods, scientists have had less ability to control where the newly inserted genes are located on the host cell chromosomes, which makes it difficult to predict inheritance of multiple genes from generation to generation. Minichromosome technology allows for the stacking of genes side-by-side on the same chromosome thus reducing likelihood of segregation of novel traits. Plants In 2006, scientists demonstrated the successful use of telomere truncation in maize plants to produce minichromosomes that could be utilized as a platform for inserting genes into the plant genome. In plants, the telomere sequence is conserved, which implies that this strategy can be utilized to successfully construct additional minichromosomes in other plant species.In 2007, scientists reported success in assembling minichromosomes in vitro using the de novo method.The use of minichromosomes as a means for generating more desirable crop traits is actively being explored. Major advantages include the ability to introduce genetic information which is highly compatible with the host genome. This eliminates the risk of disrupting various important processes such as cell division and gene expression. With continued development, the future for use of minichromosomes may make a huge impact on the productivity of major crops. Other organisms Minichromosomes have also been successfully inserted into yeast and animal cells. These minichromosomes were constructed using the de novo approach. See also Minichromosome maintenance proteins Microchromosome Y chromosome, §Degeneration == References ==

The mobilome is the entire set of mobile genetic elements in a genome. Mobilomes are found in eukaryotes, prokaryotes, and viruses. The compositions of mobilomes differ among lineages of life, with transposable elements being the major mobile elements in eukaryotes, and plasmids and prophages being the major types in prokaryotes. Virophages contribute to the viral mobilome. Mobilome in eukaryotes Transposable elements are elements that can move about or propagate within the genome, and are the major constituents of the eukaryotic mobilome. Transposable elements can be regarded as genetic parasites because they exploit the host cell's transcription and translation mechanisms to extract and insert themselves in different parts of the genome, regardless of the phenotypic effect on the host.Eukaryotic transposable elements were first discovered in maize (Zea mays) in which kernels showed a dotted color pattern. Barbara McClintock described the maize Ac/Ds system in which the Ac locus promotes the excision of the Ds locus from the genome, and excised Ds elements can mutate genes responsible for pigment production by inserting into their coding regions.Other examples of transposable elements include: yeast (Saccharomyces cerevisiae) Ty elements, a retrotransposon which encodes a reverse transcriptase to convert its mRNA transcript into DNA which can then insert into other parts of the genome; and fruit fly (Drosophila melanogaster) P-elements, which randomly inserts into the genome to cause mutations in germ line cells, but not in somatic cells. Mobilome in prokaryotes Plasmids were discovered in the 1940s as genetic materials outside of bacterial chromosomes. Prophages are genomes of bacteriophages (a type of virus) that are inserted into bacterial chromosomes; prophages can then be spread to other bacteria through the lytic cycle and lysogenic cycle of viral replication.While transposable elements are also found in prokaryotic genomes, the most common mobile genetic elements in the prokaryotic genome are plasmids and prophages.Plasmids and prophages can move between genomes through bacterial conjugation, allowing horizontal gene transfer. Plasmids often carry genes that are responsible for bacterial antibiotic resistance; as these plasmids replicate and pass from one genome to another, the whole bacterial population can quickly adapt to the antibiotic. Prophages can loop out of bacterial chromosomes to produce bacteriophages that go on to infect other bacteria with the prophages; this allows prophages to propagate quickly among the bacterial population, to the harm of the bacterial host. Mobilome in viruses Discovered in 2008 in a strain of Acanthamoeba castellanii mimivirus, virophages are an element of the virus mobilome. Virophages are viruses that replicate only when host cells are co-infected with helper viruses. Following co-infection, helper viruses exploit the host cell's transcription/translation machinery to produce their own machinery; virophages replicate through the machinery of either the host cell or the viruses. The replication of virophages can negatively impact the replication of helper viruses.Sputnik and mavirus are examples of virophages. == References ==

Molecular Cytogenetics is a continuous, open access, peer-reviewed journal covering research into cytogenetics and its applications throughout the fields of biology and medicine. It was established in 2008 and is published by BioMed Central. The editors-in-chief are Thomas Liehr (Institute of Human Genetics), Henry Heng (Wayne State University School of Medicine), and Yuri Yurov (National Research Center of Mental Health). According to the Journal Citation Reports, the journal has a 2015 impact factor of 1.506. References External links Official website

In human mitochondrial genetics, Haplogroup Z is a human mitochondrial DNA (mtDNA) haplogroup. Origin Haplogroup Z is believed to have arisen in Central Asia, and is a descendant of haplogroup CZ. Distribution The greatest clade diversity of haplogroup Z is found in East Asia and Central Asia. However, its greatest frequency appears in some peoples of Russia, such as Evens from Kamchatka (8/39 Z1a2a, 3/39 Z1a3, 11/39 = 28.2% Z total) and from Berezovka, Srednekolymsky District, Sakha Republic (3/15 Z1a3, 1/15 Z1a2a, 4/15 = 26.7% Z total), and among the Saami people of northern Scandinavia. With the exception of three Khakasses who belong to Z4, two Yakut who belong to Z3a1, two Yakut, a Yakutian Evenk, a Buryat, and an Altai Kizhi who belong to Z3(xZ3a, Z3c), and the presence of the Z3c clade among populations of Altai Republic, nearly all members of haplogroup Z in North Asia and Europe belong to subclades of Z1. The TMRCA of Z1 is 20,400 [95% CI 7,400 <-> 34,000] ybp according to Sukernik et al. 2012, 20,400 [95% CI 7,800 <-> 33,800] ybp according to Fedorova et al. 2013, or 19,600 [95% CI 12,500 <-> 29,300] ybp according to YFull. Among the members (Z1, Z2, Z3, Z4, and Z7) of haplogroup Z, Nepalese populations were characterized by rare clades Z3a1a and Z7, of which Z3a1a was the most frequent sub-clade in Newar, with a frequency of 16.5%. Z3, found in East Asia, North Asia, and MSEA, is the oldest member of haplogroup Z with an estimated age of ~ 25.4 Kya. Haplogroup Z3a1a is also detected in other Nepalese populations, such as Magar (5.4%), Tharu, Kathmandu (mixed population) and Nepali-other (mixed population from Kathmandu and Eastern Nepal). S6). Z3a1a1 detected in Tibet, Myanmar, Nepal, India, Thai-Laos and Vietnam trace their ancestral roots to China with a coalescent age of ~ 8.4 KyaFedorova et al. 2013 have reported finding Z*(xZ1a, Z3, Z4) in 1/388 Turks and 1/491 Kazakhs. These individuals should belong to Z1* (elsewhere observed in a Tofalar), Z2 (observed in Japanese), Z7 (observed in the Himalaya), Z5 (observed in Japanese), or basal Z* (observed in a Blang individual in Northern Thailand). Subclades Tree This phylogenetic tree of haplogroup Z subclades is based on the paper by Mannis van Oven and Manfred Kayser Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation and subsequent published research. CZ Z Z* – Thailand (Blang in Chiang Rai Province) Z5 – Japan (Aichi) Z-T152C! (TMRCA 24,300 [95% CI 19,300 <-> 30,300] ybp) Z-T152C!* – Hong Kong Z1 (TMRCA 18,600 [95% CI 10,900 <-> 29,500] ybp) Z1a – Koryak, Buryat, Kalmyk, Mongol (Hinggan, Hulunbuir, Xilingol), Khakas, Shor, Altai Kizhi, Kazakh, Kyrgyz, Uyghur, Turk, Arab (Uzbekistan) (TMRCA 7,600 [95% CI 5,100 <-> 10,900] ybp) Z1a1 – Italy, Hungary (ancient Avar), Germany, Sweden, Kazakh, Uyghur, Buryat (TMRCA 5,600 [95% CI 2,500 <-> 10,900] ybp) Z1a1a – Khakas, Nogai, Udmurt, Russia (Krasnodar Krai, etc.), Abazin, Cherkessian, Finland, Norway, Sweden, Estonia, UkrainianZ1a1a* – Norway (Vest-Agder, Aust-Agder), Finland, Sami (Västerbotten, Norrbotten), Komi, Russia (Chelyabinsk Oblast), Ket (lower Yenisey River basin) Z1a1a1 – Russia (Chelyabinsk Oblast) Z1a1a2 – Udmurt Z1a1a3 – Russia (Chelyabinsk Oblast, Novgorod Oblast), Poland Z1a1a4 – Finland (Eastern Finland Province), Estonia (Rapla County) Z1a1b – Evenk (Sakha Republic), DolganZ1a1b* – Nganasan (Taimyr Peninsula), Yukaghir (lower Indigirka River basin), Even (Sakkyryyr, Eveno-Bytantaysky National district or Momsky district of Sakha Republic), Evenk (Iengra River basin, Nyukzha river basin) Z1a1b1 Z1a1b1* – Buryat (Irkutsk Oblast) Z1a1b1a – Uyghur Z1a2 (TMRCA 5,400 [95% CI 2,400 <-> 10,400] ybp) Z1a2* – Ulchi (lower Amur River basin) Z1a2a – Itelmen, KoryakZ1a2a* – Even (Kamchatka), Yukaghir (upper Anadyr River basin) Z1a2a1 Z1a2a1* – Even (Kamchatka, Berezovka) Z1a2a1a – Even (Kamchatka), Evenk (village of Nelkan by the Maya River in the Okhotsk Region) Z1a3 (TMRCA 3,600 [95% CI 1,850 <-> 6,500] ybp) Z1a3* – Yukaghir (upper Anadyr River basin), Even (Tompo District, Eveno-Bytantaysky National district or Momsky district of Sakha Republic), Evenk (Nyukzha River basin), Yakut (central Yakutia) Z1a3a Z1a3a* – Even (Kamchatka) Z1a3a1 – Yukaghir (lower Kolyma River basin), Even (Berezovka) Z1a3b – Even (Berezovka), Yakut Z1a4 (TMRCA 5,500 [95% CI 3,200 <-> 9,000] ybp) Z1a4* – Uyghur, Tubalar, Buryat (Irkutsk Oblast) Z1a4a – Uyghur Z1b – Tofalar Z2 – Japan (Tokyo, Aichi, etc.) (TMRCA 3,900 [95% CI 1,450 <-> 8,400] ybp) Z3 – Japan (Tokyo), South Korea, China, Singapore, Malaysia, Thailand (Lao Isan in Chaiyaphum Province), Vietnam, Uyghur, Evenk (Sakha Republic), Mongol (Hohhot, Tongliao, Chaoyang, Chifeng, Jiangsu), Buryat, Altai Kizhi, Kyrgyz, Kazakh, Tajik, Azerbaijan, North Ossetian, Romania, USA (TMRCA 21,000 [95% CI 17,200 <-> 25,300] ybp) Z3a – China (Mongol, Xibo, Deng, etc.), Kazakh (TMRCA 12,900 [95% CI 9,000 <-> 18,000] ybp) Z3a1 Z3a1a Z3a1a - Nepal (Newar, Magar, Tharu, Eastern Nepal, Kathmandu) Z3a1a* – Lachungpa, Lepcha Z3a1a1 – China Z3a1a2 – Gallong, Dirang Monpa, Thailand (Khon Mueang in Mae Hong Son Province), Vietnam (Hà Nhì) Z3a1b – Yakut Z3a2 – LachungpaZ3a2a – Lachungpa Z3a3 – Thailand (Palaung in Chiang Mai Province, Lawa in Mae Hong Son Province) Z3b – Deng, Gallong (TMRCA 8,400 [95% CI 2,300 <-> 21,500] ybp) Z-G709A – Yakut, China (Han from Beijing) Z3c – Altaian, Altai Kizhi, Iran, Kyrgyz (Tashkurgan), Mongol (Tongliao), Japan (Tokyo), Vietnam Z3d – China (Han from Beijing, etc.), Taiwan (Minnan, etc.), Mongol (Inner Mongolia), Korea Z3e – China, KoreaZ3e1 - China Z3f – China, She people (China), Korea, Hazara Z3g - Uyghur (China), Hazara (Pakistan) Z4 – China (Suzhou, Mongol in Shandong, etc.), Thailand (Phuan in Suphan Buri Province), Philippines, Uzbekistan, Kazakhstan, Kalmyk, Khakas, Karanogai (TMRCA 14,900 [95% CI 9,200 <-> 22,800] ybp) Z4a – China (Han from Hunan and Denver, Mongol from Inner Mongolia, Liaoning, Heilongjiang, Hebei, Henan, Shandong, etc.), Uyghur, Daur, Japan (Tokyo) Z4a1 – China (Han from Wuhan, Mongol from Baotou and Xilingol) Z4a1a – China (Han from Hunan and Yunnan), Vietnam Z4a1a1 – Japan (Tokyo, etc.), South Korea Z7 – Dirang Monpa, Tibet (Tingri, Shannan) (TMRCA 1,750 [95% CI 275 <-> 6,200] ybp), Nepal (Newar) Z8* – Nepal (Newar) See also Genealogical DNA test Genetic genealogy Human mitochondrial genetics Population genetics Human mitochondrial DNA haplogroups References External links General Mannis van Oven's Phylotree Haplogroup Z Ian Logan's Mitochondrial DNA Site: Haplogroup Z Ian Logan's Mitochondrial DNA Site: Haplogroup Z2 Ian Logan's Mitochondrial DNA Site: Haplogroup Z3 Ian Logan's Mitochondrial DNA Site: Haplogroup Z4 Ian Logan's Mitochondrial DNA Site: Haplogroup Z7 Spread of Haplogroup Z, from National Geographic

Museomics is the study of genomic data obtained from ancient DNA (aDNA) and historic DNA (hDNA) specimens in museum collections. Early research in this area focused on short sequences of DNA from mitochondrial genes, but sequencing of whole genomes has become possible.Next-generation sequencing (NGS) and high-throughput sequencing (HTS) methods can be applied to the analysis of genetic datasets extracted from collections materials. Such techniques have been described as a "third revolution in sequencing technology". Like radiocarbon dating, the techniques of museomics are a transformative technology. Results are revising and sometimes overturning previously accepted theories about a wide variety of topics such as the domestication of the horse.Museum collections contain unique resources such as natural history specimens, which can be used for genome-scale examinations of species, their evolution, and their responses to environmental change. Ancient DNA provides a unique window into genetic change over time. It enables scientists to directly study evolutionary and ecological processes, comparing ancient and modern populations, identifying distinct populations, and revealing patterns of change such as extinctions and migrations. Research may be used to identify isolated populations and inform conservation priorities.However, museum specimens can be poorly preserved and are subject to degradation and contamination. Genomic analyses face considerable challenges as a result of the highly degraded DNA typical of museum specimens. DNA from such samples is often subject to post-mortem nucleotide damage such as the hydrolytic deamination of cytosine (C) to uracil (U) residues. PCR amplification of damaged templates can further substitute uracils with thymine (T), completing a C to T substitution path. Such errors tend to occur towards the ends of molecules, accumulate with time, and can be significant in specimens a century-old or later. Robust genomic and statistical techniques are needed to rigorously detect and avoid errors and genotyping uncertainties when carrying out analyses based on museum collections. Optimal methods for working with hDNA and aDNA can differ as a result of differences in their DNA degradation history.Museomics also involves destructive sampling, irreversibly removing parts of sometimes rare specimens to obtain DNA. This can be contentious for curators and collection staff, involving a variety of ethical issues around the handling and destruction of objects, colonial acquisition and repatriation practices, and present-day social and political implications of research. Museums, universities and journals are increasingly developing ethics statements, best practices and guidelines for such work. See also Genomics Proteomics List of omics topics in biology == References ==

The mutation accumulation theory of aging was first proposed by Peter Medawar in 1952 as an evolutionary explanation for biological aging and the associated decline in fitness that accompanies it. Medawar used the term 'senescence' to refer to this process. The theory explains that, in the case where harmful mutations are only expressed later in life, when reproduction has ceased and future survival is increasingly unlikely, then these mutations are likely to be unknowingly passed on to future generations. In this situation the force of natural selection will be weak, and so insufficient to consistently eliminate these mutations. Medawar posited that over time these mutations would accumulate due to genetic drift and lead to the evolution of what is now referred to as aging. Background and history Despite Charles Darwin's completion of his theory of biological evolution in the 19th century, the modern logical framework for evolutionary theories of aging wouldn't emerge until almost a century later. Though August Weismann did propose his theory of programmed death, it was met with criticism and never gained mainstream attention. It wasn't until 1930 that Ronald Fisher first noted the conceptual insight which prompted the development of modern aging theories. This concept, namely that the force of natural selection on an individual decreases with age, was analysed further by J. B. S. Haldane, who suggested it as an explanation for the relatively high prevalence of Huntington's disease despite the autosomal dominant nature of the mutation. Specifically, as Huntington's only presents after the age of 30, the force of natural selection against it would have been relatively low in pre-modern societies. It was based on the ideas of Fisher and Haldane that Peter Medawar was able to work out the first complete model explaining why aging occurs, which he presented in a lecture in 1951 and then published in 1952 Mechanism of action Amongst almost all populations, the likelihood that an individual will reproduce is related directly to their age. Starting at 0 at birth, the probability increases to its maximum in young adulthood once sexual maturity has been reached, before gradually decreasing with age. This decrease is caused by the increasing likelihood of death due to external pressures such as predation or illness, as well as the internal pressures inherent to organisms that experience senescence. In such cases deleterious mutations which are expressed early on are strongly selected against due to their major impact on the number of offspring produced by that individual. Mutations that present later in life, by contrast, are relatively unaffected by selective pressure, as their carriers have already passed on their genes, assuming they survive long enough for the mutation to be expressed at all. The result, as predicted by Medawar, is that deleterious late-life mutations will accumulate and result in the evolution of aging as it is known colloquially. This concept is portrayed graphically by Medawar through the concept of a "selection shadow". The shaded region represents the 'shadow' of time during which selective pressure has no effect. Mutations that are expressed within this selection shadow will remain as long as reproductive probability within that age range remains low. Evidence supporting the mutation accumulation theory Predation and Delayed Senescence In populations where extrinsic mortality is low, the drop in reproductive probability after maturity is less severe than in other cases. The mutation accumulation theory therefore predicts that such populations would evolve delayed senescence. One such example of this scenario can be seen when comparing birds to organisms of equivalent size. It has been suggested that their ability to fly, and therefore lower relative risk of predation, is the cause of their longer than expected life span. The implication that flight, and therefore lower predation, increases lifespan is further born out by the fact that bats live on average 3 times longer than similarly sized mammals with comparable metabolic rates. Providing further evidence, insect populations are known to experience very high rates of extrinsic mortality, and as such would be expected to experience rapid senescence and short life spans. The exception to this rule, however, is found in the longevity of eusocial insect queens. As expected when applying the mutation accumulation theory, established queens are at almost no risk of predation or other forms of extrinsic mortality, and consequently age far more slowly than others of their species. Age-specific reproductive success of Drosophila Melanogaster In the interest of finding specific evidence for the mutation accumulation theory, separate from that which also supports the similar antagonistic pleiotropy hypothesis, an experiment was conducted involving the breeding of successive generations of Drosophila Melanogaster. Genetic models predict that, in the case of mutation accumulation, elements of fitness, such as reproductive success and survival, will show age-related increases in dominance, homozygous genetic variance and additive variance. Inbreeding depression will also increase with age. This is because these variables are proportional to the equilibrium frequencies of deleterious alleles, which are expected to increase with age under mutation accumulation but not under the antagonistic pleiotropy hypothesis. This was tested experimentally by measuring age specific reproductive success in 100 different genotypes of Drosophila Melanogaster, with findings ultimately supporting the mutation accumulation theory of aging. Criticisms of the mutation accumulation theory Under most assumptions, the mutation accumulation theory predicts that mortality rates will reach close to 100% shortly after reaching post-reproductive age. Experimental populations of Drosophila Melanogaster, and other organisms, however, exhibit age-specific mortality rates that plateau well before reaching 100%, making mutation accumulation alone an insufficient explanation. It is suggested instead that mutation accumulation is only one factor among many, which together form the cause of aging. In particular, the mutation accumulation theory, the antagonistic pleiotropy hypothesis and the disposable soma theory of aging are all believed to contribute in some way to senescence. == References ==

The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity, also known as the Nagoya Protocol on Access and Benefit Sharing (ABS), is a 2010 supplementary agreement to the 1992 Convention on Biological Diversity (CBD). Its aim is the implementation of one of the three objectives of the CBD: the fair and equitable sharing of benefits arising out of the utilization of genetic resources, thereby contributing to the conservation and sustainable use of biodiversity. It sets out obligations for its contracting parties to take measures in relation to access to genetic resources, benefit-sharing and compliance. The protocol was adopted on 29 October 2010 in Nagoya, Japan, and entered into force on 12 October 2014. As of April 2022 it has been ratified by 137 parties, which includes 136 UN member states and the European Union. Concerns have been expressed that the added bureaucracy and legislation could be damaging to the monitoring and collection of biodiversity, to conservation, to the international response to infectious diseases, and to research. Aims and scope The Nagoya Protocol applies to genetic resources that are covered by the CBD, and to the benefits arising from their utilization. The protocol also covers traditional knowledge associated with genetic resources that are covered by the CBD and the benefits arising from its utilization. Its aim is the implementation of one of the three objectives of the CBD: the fair and equitable sharing of benefits arising out of the utilization of genetic resources, thereby contributing to the conservation and sustainable use of biodiversity. Adoption and ratification The protocol was adopted on 29 October 2010 in Nagoya, Japan, at the tenth meeting of the Conference of the Parties, held from 18 to 29 October 2010 and entered into force on 12 October 2014. As of April 2022 it has been ratified by 137 parties, which includes 136 UN member states and the European Union. Obligations The Nagoya Protocol sets out obligations for its contracting parties to take measures in relation to access to genetic resources, benefit-sharing and compliance. Access obligations Domestic-level access measures aim to: Create legal certainty, clarity, and transparency Provide fair and non-arbitrary rules and procedures Establish clear rules and procedures for prior informed consent and mutually agreed on terms Provide for issuance of a permit or equivalent when access is granted Create conditions to promote and encourage research contributing to biodiversity conservation and sustainable use Pay due regard to cases of present or imminent emergencies that threaten human, animal, or plant health Consider the importance of genetic resources for food and agriculture for food security Benefit-sharing obligations Domestic-level benefit-sharing measures aim to provide for the fair and equitable sharing of benefits arising from the utilization of genetic resources with the contracting party providing genetic resources. Utilization includes research and development on the genetic or biochemical composition of genetic resources, as well as subsequent applications and commercialization. Sharing is subject to mutually agreed terms. Benefits may be monetary or non-monetary such as royalties and the sharing of research results. Compliance obligations Specific obligations to support compliance with the domestic legislation or regulatory requirements of the contracting party providing genetic resources, and contractual obligations reflected in mutually agreed terms, are a significant innovation of the Nagoya Protocol.Contracting parties are to: Take measures providing that genetic resources utilized within their jurisdiction have been accessed in accordance with prior informed consent, and that mutually agreed terms have been established, as required by another contracting party Cooperate in cases of an alleged violation of another contracting party's requirements Encourage contractual provisions on dispute resolution in mutually agreed terms Ensure an opportunity is available to seek recourse under their legal systems when disputes arise from mutually agreed terms (MAT) Take measures regarding access to justice Monitor the use of genetic resources after they leave a country by designating effective checkpoints at every stage of the value chain: research, development, innovation, pre-commercialization, or commercialization Implementation The Nagoya Protocol's success will require effective implementation at the domestic level. A range of tools and mechanisms provided by the Nagoya Protocol will assist contracting parties including: Establishing national focal points (NFPs) and competent national authorities (CNAs) to serve as contact points for information, grant access, or compliance An Access and Benefit-sharing Clearing-House to share information, such as domestic regulatory ABS requirements or information on NFPs and CNAs Capacity-building to support key aspects of implementation.Based on a country's self-assessment of national needs and priorities, capacity-building may help to: Develop domestic ABS legislation to implement the Nagoya Protocol Negotiate mutually-agreed terms Develop in-country research capability and institutions Raise awareness Transfer technology Target financial support for capacity-building and development initiatives through the GEF Relationship to other international agreements A growing number of Preferential Trade Agreements (PTAs) include provisions related to access to genetic resources or to the sharing of the benefits that arise out of their utilization. Indeed, some recent trade agreements, originating notably from Latin American countries, provide specific measures designed to facilitate the implementation of the ABS provisions contained in the Nagoya Protocol, including measures related to technical assistance, transparency and dispute settlement. Criticism However, there are concerns that the added bureaucracy and legislation will, overall, be damaging to the monitoring and collection of biodiversity, to conservation, to the international response to infectious diseases, and to research.Many scientists have voiced concern over the protocol, fearing the increased red tape will hamper disease prevention and conservation efforts, and that the threat of possible imprisonment of scientists will have a chilling effect on research. Non-commercial biodiversity researchers and institutions such as natural history museums fear maintaining biological reference collections and exchanging material between institutions will become difficult. See also Animal Genetic Resources for Food and Agriculture Bermuda Principles Cartagena Protocol on Biosafety, another supplementary protocol adopted by the CBD References Further reading Smith, David; da Silva, Manuela; Jackson, Julian; Lyal, Christopher (1 March 2017). "Explanation of the Nagoya Protocol on Access and Benefit Sharing and its implication for microbiology". Microbiology. Microbiology Society. 163 (3): 289–296. doi:10.1099/mic.0.000425. ISSN 1350-0872. PMID 28086069. Golan, Jacob; Athayde, Simone; Olson, Elizabeth; McAlvay, Alex (3 April 2019). "Intellectual Property Rights and Ethnobiology: An Update to Posey's Call to Action". Journal of Ethnobiology. Society of Ethnobiology. 39 (1): 90–109. doi:10.2993/0278-0771-39.1.90. ISSN 0278-0771. S2CID 198150482. External links About the Nagoya Protocol (CBD website) "Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity: Nagoya, 29 October 2010". United Nations Treaty Collection. Chapter XXVII: Environment.

Necrofauna are species that were previously extinct and have been biologically revived or recreated by the process of de-extinction. Necrofauna are proxies or imitations of their former species and not identical replicas. Due to a number of technological, biological and environmental factors, they are considered a new type organism altogether. Revive & Restore, a nonprofit organization that supports pursuing de-extinction research with transparency to the public, describes the creation of necrofauna as a result of “transfer[ing] the genes that define the extinct species into the genome of the related species, effectively converting it into a living version of the extinct creature."While the existence of necrofauna is still largely hypothetical, a Pyrenean ibex was the first and only animal to have undergone the de-extinction process with moderate success. The "unextinct" or revived animal was born, but then died several minutes later due to a lung defect.Necrofauna and the de-extinction movement are highly controversial within conservation and scientific circles. Many conservationists argue that creating necrofauna could potentially distract from the urgency of saving endangered species that are still alive. Concerns have also been raised pertaining to the possible damaging impacts ecology could face in the wake of introducing a new species into an environment. Etymology The term necrofauna is a portmanteau consisting of two morphemes. The first morpheme, “necro,” comes from the Greek prefix necro, meaning death. “Fauna,” meanwhile, refers to the animals that inhabit a particular time period or environment and is derived from the Greek name Fauna, the Roman goddess of earth and fertility. Alex Steffen is referred to as the first person to coin the neologism “necrofauna” in Jason Mark’s Earth Island Journal article titled “Back From the Dead.” The word was used in the context of describing the phenomenon of "charismatic necrofauna," which expresses the possibility that only certain charismatic species may be chosen as candidates for de-extinction based on human preferences, or that such resurrection efforts could distract from helping less "charismatic" species that are currently endangered. == References ==

Neofunctionalization, one of the possible outcomes of functional divergence, occurs when one gene copy, or paralog, takes on a totally new function after a gene duplication event. Neofunctionalization is an adaptive mutation process; meaning one of the gene copies must mutate to develop a function that was not present in the ancestral gene. In other words, one of the duplicates retains its original function, while the other accumulates molecular changes such that, in time, it can perform a different task. The process The process of neofunctionalization begins with a gene duplication event, which is thought to occur as a defense mechanism against the accumulation of deleterious mutations. Following the gene duplication event there are two identical copies of the ancestral gene performing exactly the same function. This redundancy allows one the copies to take on a new function. In the event that the new function is advantageous, natural selection positively selects for it and the new mutation becomes fixed in the population. The occurrence of neofunctionalization can most often be attributed to changes in the coding region or changes in the regulatory elements of a gene. It is much more rare to see major changes in protein function, such as subunit structure or substrate and ligand affinity, as a result of neofunctionalization. Selective constraints Neofunctionalization is also commonly referred to as "mutation during non-functionality" or "mutation during redundancy". Regardless of if the mutation arises after non-functionality of a gene or due to redundant gene copies, the important aspect is that in both scenarios one copy of the duplicated gene is freed from selective constraints and by chance acquires a new function which is then improved by natural selection. This process is thought to occur very rarely in evolution for two major reasons. The first reason is that functional changes typically require a large number of amino acid changes; which has a low probability of occurrence. Secondly, because deleterious mutations occur much more frequently than advantageous mutations in evolution. This makes the likelihood that gene function is lost over time (i.e. pseudogenization) far greater than the likelihood of the emergence of a new gene function. Walsh discovered that the relative probability of neofunctionalization is determined by the selective advantage and the relative rate of advantageous mutations. This was proven in his derivation of the relative probability of neofunctionalization to pseudogenization, which is given by: ρ S − 1 1 − e s {\displaystyle {\frac {\rho \,\!S-1}{1-e^{s}}}} where ρ is the ratio of advantageous mutation rate to null mutation rate and S is the population selection 4NeS (Ne: effective population size S: selection intensity). Classical model In 1936, Muller originally proposed neofunctionalization as a possible outcome of a gene duplication event. In 1970, Ohno suggested that neofunctionalization was the only evolutionary mechanism that gave rise to new gene functions in a population. He also believed that neofunctionalization was the only alternative to pseudogenization. Ohta (1987) was among the first to suggest that other mechanisms may exist for the preservation of duplicated genes in the population. Today, subfunctionalization is a widely accepted alternative fixation process for gene duplicates in the population and is currently the only other possible outcome of functional divergence. Neosubfunctionalization Neosubfunctionalization occurs when neofunctionalization is the end result of subfunctionalization. In other words, once a gene duplication event occurs forming paralogs that after an evolutionary period subfunctionalize, one gene copy continues on this evolutionary journey and accumulates mutations that give rise to a new function. Some believe that neofunctionalization is the end stage for all subfunctionalized genes. For instance, according to Rastogi and Liberles "Neofunctionalization is the terminal fate of all duplicate gene copies retained in the genome and subfunctionlization merely exist as a transient state to preserve the duplicate gene copy." The results of their study become punctuated as population size increases. Examples The evolution of the antifreeze protein in the Antarctic zoarcid fish L. dearborni provides a prime example of neofunctionalization after gene duplication. In the case of the Antarctic zoarcid fish type III antifreeze protein gene (AFPIII; P12102) diverged from a paralogous copy of sialic acid synthase (SAS) gene. The ancestral SAS gene was found to have both sialic acid synthase and rudimentary ice-binding functionalities. After duplication one of the paralogs began to accumulate mutations that lead to the replacement of SAS domains of the gene allowing for further development and optimization of the antifreeze functionality. The new gene is now capable of noncolligative freezing-point depression, and thus is neofunctionalized. This specialization allows Antarctic zoarcid fish to survive in the frigid temperatures of the Antarctic Seas. Model limitations Limitations exist in neofunctionalization as a model for functional divergence primarily because: the amount of nucleotide changes giving rise to a new function must be very minimal; making the probability for pseudogenization much higher than neofunctionalization after a gene duplication event. After a gene duplication event both copies may be subjected to selective pressure equivalent to that constraining the ancestral gene; meaning that neither copy is available for neofunctionalization. In many cases positive Darwinian selection presents a more parsimonious explanation for the divergence of multigene families. See also Subfunctionalization == References ==

Neurocriminology is an emerging sub-discipline of biocriminology and criminology that applies brain imaging techniques and principles from neuroscience to understand, predict, and prevent crime. Concept While crime is partially a social and environmental problem, the main idea behind neurocriminology (also known as neurolaw) is that the condition of an individual's brain often needs to be included in the analysis for a complete understanding. This can include conditions such as brain tumors, psychoses, sociopathy, sleepwalking, and many more. Deviant brain theories have always been part of biocriminology, which explains crime with biological reasons. Neurocriminology has become mainstream during the past two decades, since contemporary biocriminologists focus almost exclusively on brain due to significant advances in neuroscience. Even though neurocriminology is still at odds with traditional sociological theories of crime, it is becoming more popular in the scientific community. Origins The origins of neurocriminology go back to one of the founders of modern criminology, 19th-century Italian psychiatrist and prison doctor Cesare Lombroso, whose beliefs that the crime originated from brain abnormalities were partly based on phrenological theories about the shape and size of the human head. Lombroso conducted a postmortem on a serial killer and rapist, who had an unusual indentation at the base of the skull. Lombroso discovered a hollow part in the killer's brain where the cerebellum would be. Lombroso's theory was that crime originated in part from abnormal brain physiology and that violent criminals where throwbacks to less evolved human types identifiable by ape-like physical characteristics. Criminals, he believed, could be identified by physical traits, such as a large jaw and sloping forehead. The contemporary neuroscientists further developed his idea that physiology and traits of the brain underlie all crime. The term “neurocriminology” was first introduced by James Hilborn (Cognitive Centre of Canada) and adopted by the leading researcher in the field, Dr. Adrian Raine, the chair of the Criminology Department at University of Pennsylvania. He was the first to conduct brain imaging study on violent criminals. Major studies Many recent studies have revealed that sometimes structural and functional abnormalities are so striking that anyone can see them. Some violent offenders, however, have subtle structural or functional abnormalities and even highly experienced neuroradiologists cannot detect these irregularities right away. Yet, the abnormalities can be detected using brain imaging and state-of-the-art analytic tools. Neurophysiological studies Studies on structural deficiencies suggest that people consistently behaving antisocially have structurally impaired brains. The abnormalities can be either of general character or affect specific regions of the brain that control emotions, aggression or are responsible for ethical decisions: Low number of neurons in the prefrontal cortex. A study in 2000 determined that people with a history of persistent antisocial behavior had an 11 percent reduction in the volume of gray matter in the prefrontal cortex, while white matter volume was normal. Similarly, A 2009 meta-analysis study, which pooled together the findings of 12 anatomical brain-imaging studies conducted on offender populations, found that the prefrontal cortex of the brain is indeed structurally impaired in offenders.Underdeveloped amygdalae. Two studies found that both the left and especially the right amygdalae are impaired in psychopaths. The psychopaths had on average 18 percent reduction in the volume of the right amygdala.Cavum septi pellucidi maldevelopment. A study in 2010 suggested that people with cavum septi pellucidi were prone to psychopathy, antisocial personality disorder, and had more charges and convictions for criminal offenses. This brain maldevelopment was especially linked to lifelong antisocial behavior, i.e. a reckless disregard for self and others, lack of remorse, and aggression.Bigger right hippocampus. A 2004 study suggested that the psychopaths’ right hippocampus that partially controls emotions and regulates aggression was significantly bigger than the left. This asymmetry was also true in normal people, but it was much more noticeable in psychopaths.Increase in the volume of the striatum. A study in 2010 found that psychopathic individuals showed a 10 percent increase in the volume of the striatum.Damage by foreign objects. A large number of studies on structural damage by foreign objects convincingly shows that adults suffering head injuries damaging the prefrontal cortex show impulsive and antisocial behavior that does not conform to the norms of society. There is a number of famous life stories showing the same causal connection. For example, P. Gage was a well-respected, well-liked, and responsible gentleman. In 1848 because of a construction accident he suffered a serious damage to his brain when a metal rod propelled by an explosive entered his lower left cheek and exited from the top-middle part of his head. Gage healed quickly. After that accident, however, he became erratic, disrespectful, and vulgar. Gage had been transformed from a well-controlled, well-respected person to an individual with psychopathic traits.Damage by tumors. There is also a number of famous U.S. criminal cases showing that damage of the brain by tumors can result in the same transformation as the damage by foreign objects. Charles Whitman, for instance, was a young man who studied architectural engineering at the University of Texas. Whitman had no history of violence or crime. As a child, he scored 138 on the Stanford-Binet IQ test, placing in the 99th percentile. He was an Eagle Scout, volunteered as a scoutmaster, and served in Marine Corps. In 1966 Whitman unexpectedly killed his mother as well as wife, ascended the belltower of the University of Texas, Austin, and fired a rifle at students below. He killed 15 people and wounding 31 more before police officers shot him. Whitman in his final note complained of inability to control his thoughts and requested an autopsy, which revealed a brain tumor in the hypothalamus region of his brain, a growth that, some hypothesized, put pressure on his amygdala.Another example would be Michael Oft. Oft was a teacher in Virginia who had no prior psychiatric nor deviant behavior history. At the age of forty, his behavior suddenly changed. He began to frequent massage parlors, collect child pornography, abuse his step-daughter, and was soon found guilty of child molestation. Mr. Oft opted for a treatment program for pedophiles, but still couldn't resist soliciting sexual favors from staff and other clients at the rehabilitation center. A neurologist advised a brain scan, which showed a tumor growing at the base of his orbitofrontal cortex, compressing the right prefrontal region of his brain. After the tumor was removed, Mr. Oft's emotion, behavior and sexual activity returned to normal. But after several months of normal behavior Mr. Oft again began to collect child pornography. Neurologists rescanned his brain and found that the tumor had grown back. After the second surgery removing the tumor, his behavior has been totally appropriate. Neurofunctional studies Similarly to neurophysiological studies neurofunctional showed that brains of criminals and psychopaths not only are structures differently but also operate in a different way. As you can see below, both structural and functional abnormalities tend to affect the same areas of the brain. These are the major abnormalities found: Lack of Activation in the Prefrontal Cortex. A number of studies replicated the observance that violent criminals’ brains showed a significant reduction in prefrontal glucose metabolism.Reduced Activity In The Amygdala. A study found that individuals with high psychopathy scores showed reduced activity in the amygdala during emotional, personal moral decision-making.Dysfunctional Posterior Cingulate. Two studies found that posterior cingulate functions poorly in adult criminal psychopaths and aggressive patients.Reduced Cerebral Blood Flow in Angular Gyrus. A couple of studies found reduced cerebral blood flow in angular gyrus of murderers and impulsive, violent criminals.Higher Activation of Subcortical Limbic Regions. A 1998 study showed higher activation of subcortical limbic regions of two groups of reactive and proactive murderers, especially in the more “emotional” right hemisphere of the brain.Functional Disturbances of the Hippocampus and Its Parahippocampal Gyrus. A number of studies suggest that this region of the brain is not working properly in murders and violent offenders in general. Free will Unlike the founding father of criminology, Cesare Lombroso, who thought that crime was fundamentally biological in its origin and criminals lacked free will altogether, contemporary neurocriminologists seem to take the middle ground approach. They do not argue that biological factors alone cause behavioral problems, but recognize that behavior results from interaction between biology and environment. Some authors, however, are more determinist in their views. As Stanford neuroscientist David Eagleman writes: "Free will may exist (it may simply be beyond our current science), but one thing seems clear: if free will does exist, it has little room in which to operate. It can at best be a small factor riding on top of vast neural networks shaped by genes and environment. In fact, free will may end up being so small that we eventually think about bad decision-making in the same way we think about any physical process, such as diabetes or lung disease." Legal use US legal defense teams increasingly use brain scans as mitigating evidence in trials of violent criminals and sex offenders. See Neurolaw for more. Here are some of the most famous cases: Herbert Weinstein In 1991, a sixty-five-year-old advertising executive with no prior history of crime or violence after an argument strangled his wife, opened the window and threw her out of their 12th-floor apartment. His defense team had a structural brain scan done using MRI and PET scan. The images showed a big piece missing from the prefrontal cortex of the brain, i.e., a subarachnoid cyst was growing in his left frontal lobe. The defense team used these images to argue that Weinstein had an impaired ability to regulate his emotions and make rational decisions. The team went with an insanity defense, and the prosecution and defense agreed to a plea of manslaughter. As a result, Weinstein was given a seven-year sentence in contrast to the twenty-five-year sentence he would have served if he had been convicted of second-degree murder. He ended up serving until 2006. Antonio Bustamante Bustamante was a well-behaved teenager who suddenly at the age of 22 became a career criminal. His crimes included theft, breaking and entering, drug offenses, and robbery. In 1990 Bustamante was charged with a homicide. The defense team discovered that the client had suffered a head injury from a crowbar at the age of twenty. Bustamante's behavior changed fundamentally after that, transforming him from a normal individual into an impulsive and emotionally labile criminal. The defense team had his client's brain scanned, which revealed malfunctioning of the prefrontal cortex. At the end the jury believed that Bustamante's brain was not normal and spared him from the death penalty. Donta Page In 1999, Page robbed, raped and killed a female student in Denver. He later was found guilty of first-degree murder and was a candidate for the death penalty. Professor A. Raine from the University of Pennsylvania was an expert witness for defense and brought Page into a laboratory to assess his brain function. Brain imaging scans revealed a distinct lack of activation in the ventral prefrontal cortex. Professor Raine argued for a deep-rooted biological explanation for Mr. Page's violence, who escaped death penalty partly on the basis of his brain pathology. Crime prevention Even though currently there are no preventive programs in place utilizing the recent discoveries in neurocriminology, there are a number of offender rehabilitation programs (Cognitive Centre of Canada). Decisions based on brain imaging Some scientists propose using brain imaging to help decide which soon-to-be-released offenders are at greater risk for reoffending. The brain imaging data would be used along with common factors like age, prior arrests, and marital status. To support this idea, in a 2013 study, Professor Kent Kiehl from the University of New Mexico studying the population of 96 male offenders in the state's prisons found that offenders with low activity in the anterior cingulate cortex where twice as likely to commit an offense in the four years after their release as those who had high activity in this region. Similarly, Dustin Pardini conducted that which shows that men with a smaller amygdala are three times more likely to commit violence three years after their release. Neurochemistry Trials demonstrated the efficacy of a number of medications, i.e. stimulants antipsychotics, antidepressants and mood stabilizers, in diminishing aggression in adolescents and children. Even a simple omega-3 supplements in the diets of young offenders reduces offending and aggression. Meditation Meditation can also affect brains, and even change them permanently. In 2003 Professor Richie Davidson from the University of Wisconsin performed a revolutionary study. People were randomly selected into either a mindfulness training group or a control group that was put on a waiting list for training. Davidson showed that even eight weekly sessions of meditation enhanced left frontal EEG functioning. Similar study was later replicated by Professor Holzel. See also Criminology Social neuroscience Neurolaw Neuropsychiatry == References ==

Neurogenetics studies the role of genetics in the development and function of the nervous system. It considers neural characteristics as phenotypes (i.e. manifestations, measurable or not, of the genetic make-up of an individual), and is mainly based on the observation that the nervous systems of individuals, even of those belonging to the same species, may not be identical. As the name implies, it draws aspects from both the studies of neuroscience and genetics, focusing in particular how the genetic code an organism carries affects its expressed traits. Mutations in this genetic sequence can have a wide range of effects on the quality of life of the individual. Neurological diseases, behavior and personality are all studied in the context of neurogenetics. The field of neurogenetics emerged in the mid to late 20th century with advances closely following advancements made in available technology. Currently, neurogenetics is the center of much research utilizing cutting edge techniques. History The field of neurogenetics emerged from advances made in molecular biology, genetics and a desire to understand the link between genes, behavior, the brain, and neurological disorders and diseases. The field started to expand in the 1960s through the research of Seymour Benzer, considered by some to be the father of neurogenetics. His pioneering work with Drosophila helped to elucidate the link between circadian rhythms and genes, which led to further investigations into other behavior traits. He also started conducting research in neurodegeneration in fruit flies in an attempt to discover ways to suppress neurological diseases in humans. Many of the techniques he used and conclusions he drew would drive the field forward.Early analysis relied on statistical interpretation through processes such as LOD (logarithm of odds) scores of pedigrees and other observational methods such as affected sib-pairs, which looks at phenotype and IBD (identity by descent) configuration. Many of the disorders studied early on including Alzheimer's, Huntington's and amyotrophic lateral sclerosis (ALS) are still at the center of much research to this day. By the late 1980s new advances in genetics such as recombinant DNA technology and reverse genetics allowed for the broader use of DNA polymorphisms to test for linkage between DNA and gene defects. This process is referred to sometimes as linkage analysis. By the 1990s ever advancing technology had made genetic analysis more feasible and available. This decade saw a marked increase in identifying the specific role genes played in relation to neurological disorders. Advancements were made in but not limited to: Fragile X syndrome, Alzheimer's, Parkinson's, epilepsy and ALS. Neurological disorders While the genetic basis of simple diseases and disorders has been accurately pinpointed, the genetics behind more complex, neurological disorders is still a source of ongoing research. New developments such as the genome wide association studies (GWAS) have brought vast new resources within grasp. With this new information genetic variability within the human population and possibly linked diseases can be more readily discerned. Neurodegenerative diseases are a more common subset of neurological disorders, with examples being Alzheimer's disease and Parkinson's disease. Currently no viable treatments exist that actually reverse the progression of neurodegenerative diseases; however, neurogenetics is emerging as one field that might yield a causative connection. The discovery of linkages could then lead to therapeutic drugs, which could reverse brain degeneration. Gene sequencing One of the most noticeable results of further research into neurogenetics is a greater knowledge of gene loci that show linkage to neurological diseases. The table below represents a sampling of specific gene locations identified to play a role in selected neurological diseases based on prevalence in the United States. Methods of research Statistical analysis Logarithm of odds (LOD) is a statistical technique used to estimate the probability of gene linkage between traits. LOD is often used in conjunction with pedigrees, maps of a family's genetic make-up, in order to yield more accurate estimations. A key benefit of this technique is its ability to give reliable results in both large and small sample sizes, which is a marked advantage in laboratory research.Quantitative trait loci (QTL) mapping is another statistical method used to determine the chromosomal positions of a set of genes responsible for a given trait. By identifying specific genetic markers for the genes of interest in a recombinant inbred strain, the amount of interaction between these genes and their relation to the observed phenotype can be determined through complex statistical analysis. In a neurogenetics laboratory, the phenotype of a model organisms is observed by assessing the morphology of their brain through thin slices. QTL mapping can also be carried out in humans, though brain morphologies are examined using nuclear magnetic resonance imaging (MRI) rather than brain slices. Human beings pose a greater challenge for QTL analysis because the genetic population cannot be as carefully controlled as that of an inbred recombinant population, which can result in sources of statistical error. Recombinant DNA Recombinant DNA is an important method of research in many fields, including neurogenetics. It is used to make alterations to an organism's genome, usually causing it to over- or under-express a certain gene of interest, or express a mutated form of it. The results of these experiments can provide information on that gene's role in the organism's body, and it importance in survival and fitness. The hosts are then screened with the aid of a toxic drug that the selectable marker is resistant to. The use of recombinant DNA is an example of a reverse genetics, where researchers create a mutant genotype and analyze the resulting phenotype. In forward genetics, an organism with a particular phenotype is identified first, and its genotype is then analyzed. Animal research Model organisms are an important tool in many areas of research, including the field of neurogenetics. By studying creatures with simpler nervous systems and with smaller genomes, scientists can better understand their biological processes and apply them to more complex organisms, such as humans. Due to their low-maintenance and highly mapped genomes, mice, Drosophila, and C. elegans are very common. Zebrafish and prairie voles have also become more common, especially in the social and behavioral scopes of neurogenetics. In addition to examining how genetic mutations affect the actual structure of the brain, researchers in neurogenetics also examine how these mutations affect cognition and behavior. One method of examining this involves purposely engineering model organisms with mutations of certain genes of interest. These animals are then classically conditioned to perform certain types of tasks, such as pulling a lever in order to gain a reward. The speed of their learning, the retention of the learned behavior, and other factors are then compared to the results of healthy organisms to determine what kind of an effect – if any – the mutation has had on these higher processes. The results of this research can help identify genes that may be associated with conditions involving cognitive and learning deficiencies. Human research Many research facilities seek out volunteers with certain conditions or illnesses to participate in studies. Model organisms, while important, cannot completely model the complexity of the human body, making volunteers a key part to the progression of research. Along with gathering some basic information about medical history and the extent of their symptoms, samples are taken from the participants, including blood, cerebrospinal fluid, and/or muscle tissue. These tissue samples are then genetically sequenced, and the genomes are added to current database collections. The growth of these data bases will eventually allow researchers to better understand the genetic nuances of these conditions and bring therapy treatments closer to reality. Current areas of interest in this field have a wide range, spanning anywhere from the maintenance of circadian rhythms, the progression of neurodegenerative disorders, the persistence of periodic disorders, and the effects of mitochondrial decay on metabolism. Genome-wide association studies Such databases are used in genome-wide association studies (GWAS). Examples of phenotypes investigated by notable neurogenetics GWAS include: Language-related skills: a meta-analysis of GWAS reported genetic factors of, the so far uniquely human, language-related capabilities, in particular factors of differences in skill-levels of five tested traits. It also used neuroanatomy/neuroimaging data. Behavioral neurogenetics Advances in molecular biology techniques and the species-wide genome project have made it possible to map out an individual's entire genome. Whether genetic or environmental factors are primarily responsible for an individual's personality has long been a topic of debate. Thanks to the advances being made in the field of neurogenetics, researchers have begun to tackle this question by beginning to map out genes and correlate them to different personality traits. There is little to no evidence to suggest that the presence of a single gene indicates that an individual will express one style of behavior over another; rather, having a specific gene could make one more predisposed to displaying this type of behavior. It is starting to become clear that most genetically influenced behaviors are due to the effects of many variants within many genes, in addition to other neurological regulating factors like neurotransmitter levels. Due to fact that many behavioral characteristics have been conserved across species for generations, researchers are able to use animal subjects such as mice and rats, but also fruit flies, worms, and zebrafish, to try to determine specific genes that correlate to behavior and attempt to match these with human genes. Cross-species gene conservation While it is true that variation between species can appear to be pronounced, at their most basic they share many similar behavior traits which are necessary for survival. Such traits include mating, aggression, foraging, social behavior and sleep patterns. This conservation of behavior across species has led biologists to hypothesize that these traits could possibly have similar, if not the same, genetic causes and pathways. Studies conducted on the genomes of a plethora of organisms have revealed that many organisms have homologous genes, meaning that some genetic material has been conserved between species. If these organisms shared a common evolutionary ancestor, then this might imply that aspects of behavior can be inherited from previous generations, lending support to the genetic causes – as opposed to the environmental causes – of behavior. Variations in personalities and behavioral traits seen amongst individuals of the same species could be explained by differing levels of expression of these genes and their corresponding proteins. Aggression There is also research being conducted on how an individual's genes can cause varying levels of aggression and aggression control. Throughout the animal kingdom, varying styles, types and levels of aggression can be observed leading scientists to believe that there might be a genetic contribution that has conserved this particular behavioral trait. For some species varying levels of aggression have indeed exhibited direct correlation to a higher level of Darwinian fitness. Development A great deal of research has been done on the effects of genes and the formation of the brain and the central nervous system. The following wiki links may prove helpful: Neural development Neurogenesis The Brain Neural tubeThere are many genes and proteins that contribute to the formation and development of the central nervous system, many of which can be found in the aforementioned links. Of particular importance are those that code for BMPs, BMP inhibitors and SHH. When expressed during early development, BMP's are responsible for the differentiation of epidermal cells from the ventral ectoderm. Inhibitors of BMPs, such as NOG and CHRD, promote differentiation of ectoderm cells into prospective neural tissue on the dorsal side. If any of these genes are improperly regulated, then proper formation and differentiation will not occur. BMP also plays a very important role in the patterning that occurs after the formation of the neural tube. Due to the graded response the cells of the neural tube have to BMP and Shh signaling, these pathways are in competition to determine the fate of preneural cells. BMP promotes dorsal differentiation of pre-neural cells into sensory neurons and Shh promotes ventral differentiation into motor neurons. There are many other genes that help to determine neural fate and proper development include, RELN, SOX9, WNT, Notch and Delta coding genes, HOX, and various cadherin coding genes like CDH1 and CDH2.Some recent research has shown that the level of gene expression changes drastically in the brain at different periods throughout the life cycle. For example, during prenatal development the amount of mRNA in the brain (an indicator of gene expression) is exceptionally high, and drops to a significantly lower level not long after birth. The only other point of the life cycle during which expression is this high is during the mid- to late-life period, during 50–70 years of age. While the increased expression during the prenatal period can be explained by the rapid growth and formation of the brain tissue, the reason behind the surge of late-life expression remains a topic of ongoing research. Current research Neurogenetics is a field that is rapidly expanding and growing. The current areas of research are very diverse in their focuses. One area deals with molecular processes and the function of certain proteins, often in conjunction with cell signaling and neurotransmitter release, cell development and repair, or neuronal plasticity. Behavioral and cognitive areas of research continue to expand in an effort to pinpoint contributing genetic factors. As a result of the expanding neurogenetics field a better understanding of specific neurological disorders and phenotypes has arisen with direct correlation to genetic mutations. With severe disorders such as epilepsy, brain malformations, or mental retardation a single gene or causative condition has been identified 60% of the time; however, the milder the intellectual handicap the lower chance a specific genetic cause has been pinpointed. Autism for example is only linked to a specific, mutated gene about 15–20% of the time while the mildest forms of mental handicaps are only being accounted for genetically less than 5% of the time. Research in neurogenetics has yielded some promising results, though, in that mutations at specific gene loci have been linked to harmful phenotypes and their resulting disorders. For instance a frameshift mutation or a missense mutation at the DCX gene location causes a neuronal migration defect also known as lissencephaly. Another example is the ROBO3 gene where a mutation alters axon length negatively impacting neuronal connections. Horizontal gaze palsy with progressive scoliosis (HGPPS) accompanies a mutation here. These are just a few examples of what current research in the field of neurogenetics has achieved. See also Neurogenomics Neuropsychology Behavioral genetics Psychiatric genetics Cognitive genomicsInternational Behavioural and Neural Genetics SocietyJournalsGenes, Brain and Behavior Journal of Neurogenetics Neurogenetics == References ==

Neurogenomics is the study of how the genome of an organism influences the development and function of its nervous system. This field intends to unite functional genomics and neurobiology in order to understand the nervous system as a whole from a genomic perspective. The nervous system in vertebrates is made up of two major types of cells – neuroglial cells and neurons. Hundreds of different types of neurons exist in humans, with varying functions – some of them process external stimuli; others generate a response to stimuli; others organize in centralized structures (brain, spinal ganglia) that are responsible for cognition, perception, and regulation of motor functions. Neurons in these centralized locations tend to organize in giant networks and communicate extensively with each other. Prior to the availability of expression arrays and DNA sequencing methodologies, researchers sought to understand the cellular behaviour of neurons (including synapse formation and neuronal development and regionalization in the human nervous system) in terms of the underlying molecular biology and biochemistry, without any understanding of the influence of a neuron's genome on its development and behaviour. As our understanding of the genome has expanded, the role of networks of gene interactions in the maintenance of neuronal function and behaviour has garnered interest in the neuroscience research community. Neurogenomics allows scientists to study the nervous system of organisms in the context of these underlying regulatory and transcriptional networks. This approach is distinct from neurogenetics, which emphasizes the role of single genes without a network-interaction context when studying the nervous system. Approaches Advent of high-throughput biology In 1999, Cirelli & Tononi first reported the association of genome-wide brain gene expression profiling (using microarrays) with a behavioural phenotype in mice. Since then, global brain gene expression data, derived from microarrays, has been aligned to various behavioural quantitative trait loci (QTLs) and reported in several publications. However, microarray based approaches have their own problems that confound analysis – probe saturation can result in very small measurable variance of gene expression between genetically unique individuals, and the presence of single nucleotide polymorphisms (SNPs) can result in hybridization artifacts. Furthermore, due to their probe-based nature, microarrays can miss out on many types of transcripts (ncRNAs, miRNAs, and mRNA isoforms). Probes can also have species-specific binding affinities that can confound comparative analysis. Notably, the association between behavioural patterns and high penetrance single gene loci falls under the purview of neurogenetics research, wherein the focus is to identify a simple causative relationship between a single, high penetrance gene and an observed function/behaviour. However, it has been shown that several neurological diseases tend to be polygenic, being influenced by multiple different genes and regulatory regions instead of one gene alone. There has hence been a shift from single gene approaches to network approaches for studying neurological development and diseases, a shift that has been greatly propelled by the advent of next generation sequencing methodologies. Next-generation sequencing approaches Twin studies have revealed that schizophrenia, bipolar disorder, autism spectrum disorder (ASD), and attention deficit hyperactivity disorder (ADHD) are highly heritable, genetically complex psychiatric disorders. However, linkage studies have largely failed at identifying causative variants for psychiatric disorders such as these, primarily because of their complex genetic architecture. Multiple low penetrance risk variants can be aggregated in affected individuals and families, and sets of causative variants could vary across families. Studies along these lines have determined a polygenic basis for several psychiatric disorders. Several independently occurring de novo mutations in patients Alzheimer's disease have been found to disrupt a shared set of functional pathways involved with neuronal signalling, for example. The quest to understand the causative biology of psychiatric disorders is hence greatly assisted by the ability to analyse entire genomes of affected and unaffected individuals in an unbiased manner.With the availability of massively parallel next generation sequencing methodologies, scientists have been able to look beyond the probe based captures of expressed genes. RNA-seq, for example, identifies 25-60% more expressed genes than microarrays do. In the upcoming field of neurogenomics, it is hoped that by understanding the genomic profiles of different parts of the brain, we might be able to improve our understanding of how the interactions between genes and pathways influence cellular function and development. This approach is expected to be able to identify the secondary gene networks that are disrupted in neurological disorders, subsequently assisting drug development stratagems for brain diseases. The BRAIN initiative launched in 2013, for example, seeks to "inform the development of future treatments for brain disorders, including Alzheimer’s disease, epilepsy, and traumatic brain injury" . Rare variant association studies (RVAS) have highlighted the role of de novo mutations in several congenital and early-childhood-onset disorders like autism. Several of these protein disrupting mutations have been able to be identified only with the aid of whole genome sequencing efforts, and validated with RNA-Seq. Additionally, these mutations are not statistically enriched in individual genes, but rather, exhibit patterns of statistical enrichment in groups of genes associated with networks regulating neurological development and maintenance. Such a discovery would have been impossible with prior gene-centric approaches (neurogenetics, behavioural neuroscience). Neurogenomics allows for a high-throughput system-based approach for understanding the polygenic basis of neuropsychiatric disorders. Imaging studies and optical mapping When autism was identified as a distinct biological disorder in the 1980s, researchers found that autistic individuals showed a brain growth abnormality in the cerebellum in their early developmental years. Subsequent research has indicated that 90% of autistic children have a larger brain volume than their peers by 2 to 4 years of age, and show an expansion in the white and gray matter content in the cerebrum. The white and gray matter in the cerebrum is associated with learning and cognition respectively, and the formation of amyloid plaques in the white matter has been associated with Alzheimer's disease. These findings highlighted the influence of structural variance in the brain on psychiatric disorders, and have motivated the use of imaging technologies to map regions of divergence between healthy and diseased brains. Furthermore, while it may not always be possible to retrieve biological specimens from different areas live human brains, neuroimaging techniques offer a noninvasive means to understanding the biological basis of neurological disorders. It is hoped that an understanding of localization patterns of different psychiatric diseases could in turn inform network analysis studies in neurogenomics. MRI Structural Magnetic Resonance Imaging (MRI) can be used to identify the structural composition of the brain. Particularly in the context of neurogenomics, MRI has played an extensive role in the study of Alzheimer's disease over the past four decades. It was initially used to rule out other causes of dementia, but recent studies indicated the presence of characteristic changes in patients with Alzheimer's disease. As a result, MRI scans are currently being used as a neuroimaging tool to help identify the temporal and spatial pathophysiology of Alzheimer's disease, such as specific cerebral alterations and amyloid imaging.The ease and non-invasive nature of MRI scans has motivated research projects that trace the development and onset of psychiatric diseases in the brain. Alzheimer disease has become a key candidate in this topographical approach to psychiatric diseases. For example, MRI scans are currently being used to track the resting and task-dependent functional profiles of brains in children with autosomal dominant Alzheimer disease. These studies have found indications of early onset brain alterations in at-risk individuals for Alzheimer's disease. The Autism Center of Excellence at University of California, San Diego, is also conducting MRI studies with children between 12 and 42 months, in the hopes of characterizing brain development abnormalities in children who present behavioural symptoms of autism.Additional research has indicated that there are specifics patterns of atrophy in the cerebrum (as a repercussion of neurodegeneration) in different neurological disorders and diseases. These disease-specific patterns of progression of atrophy can be identified with MRI scans, and provide a clinical phenotype context to neurogenomic research. The temporal information about disease progression provided by this approach can also potentially inform the interpretation of gene network-level perturbations in psychiatric diseases. Optical mapping One prohibitive feature of 2nd generation sequencing methodologies is the upper limit on the genomic range accessible by mate-pairing. Optical mapping is an emerging methodology used to span large-scale variants that cannot usually be detected using paired end reads. This approach has been successfully applied to detect structural variants in oligodendroglioma, a type of brain cancer. Recent work has also highlighted the versatility of optical maps in improving existing genome assemblies. Chromosomal rearrangements, microdeletions, and large-scale translocations have been associated with impaired neurological and cognitive function, for example in hereditary neuropathy and neurofibromatosis. Optical mapping can significantly improve variant detection and inform gene interaction network models for the diseased state in neurological disorders. Studying other brain diseases Apart from neurological disorders, there are additional diseases that manifest in the brain and have formed exemplar use-case scenarios for the application of brain imaging in network analysis. In a classic example of imaging-genomic analyses, a research study in 2012 compared MRI scans and gene expression profiles of 104 glioma patients in order to distinguish treatment outcomes and identify novel targetable genomic pathways in Glioblastoma Multiforme (GBM). Researchers found two distinct groups of patients with significantly different organization of white matter (invasive vs non-invasive). Subsequent pathway analysis of the gene expression data indicated mitochondrial dysfunction as the top canonical pathway in an aggressive, low-mortality GBM phenotype.Expansion of brain imaging approaches to other diseases can be used to rule out other medical illnesses while diagnosing psychiatric disorders, but cannot be used to inform the presence or absence of a psychiatric disorder. Research developmental models In humans The current approaches in collecting gene expression data in human brains are to use either microarrays or RNA-seq. Currently, it is rare to gather "live" brain tissue – only when treatments involve brain surgery is there a chance that brain tissue is collected during the procedure. This is the case with epilepsy. Currently, gene expression data is usually collected on post mortem brains and this is often a barrier to neurogenomics research in humans. After death, the amount of time between death and when the data from the post mortem brain is collected is known as the post mortem interval (PMI). Since RNA degrades after death, a fresh brain is optimal – but not always available. This in turn can influence a variety of downstream analyses. Consideration should be taken of the following factors when working with 'omics data collected from post-mortem brains: Ideally, human brains should be controlled for PMIs for a given study. The cause of death is also an important variable to consider in the collection of human brain samples for the purposes of neurogenomics research. For example, brain samples of individuals with clinical depression are often collected after suicide. Certain conditions of death, such as drug overdose or self-inflicted gunshot, will alter the expression of the brain. Another issue with studying gene expression in brains is the cellular heterogeneity of brain tissue samples. Bulk brain samples may vary in proportions of specific cell populations from case to case. This can impact the gene expression signatures and may significantly change differential expression analysis. One approach to address this issue is to use single cell RNA-seq. This would control for a specific cell type. However, this solution is only applicable where studies are not cell-type specific.Differential diagnosis also remains a critical pre-analytical confounder of cohort-wide studies of spectrum neurological disorders. Specifically, this has been noted to be a problem for Alzheimer's disease and autism spectrum disorder studies. Furthermore, as our understanding of the diverse symptoms and genomic underpinnings of various neurogenomic disorders improves, the diagnostic criteria itself undergoes rearrangements and review. Animal models Ongoing genomics research in neurological disorders tends to use animal models (and corresponding gene homologs) to understand the network interactions underlying a particular disorder due to ethical issues surrounding the retrieval of biological specimens from live human brains. This, too, is not without its roadblocks. Neurogenomic research with a model organism is contingent on the availability of a fully sequenced and annotated reference genome. Additionally, the RNA profiles (miRNA, ncRNA, mRNA) of the model organism need to be well catalogued, and any inferences applied from them to humans must have a basis in functional/sequence homology. Zebrafish Zebrafish development relies on gene networks that are highly conserved among all vertebrates. Additionally, with an extremely well annotated set of 12,000 genes and 1,000 early development mutants that are actually visible in the optically clear zebrafish embryos and larvae, zebrafish offer a sophisticated system for mutagenesis and real-time imaging of developing pathologies. This early development model has been employed to study the nervous system at cellular resolution. The zebrafish model system has already been used to study neuroregeneration and severe polygenic human diseases like cancer and heart disease. Several zebrafish mutants with behavioural variations in response to cocaine and alcohol dosage have been isolated and can also form a basis for studying the pathogenesis of behavioural disorders. Rodent Rodent models have been preeminent in studying human disorders. These models have been extensively annotated with gene homologs of several monogenic disorders in humans. Knockout studies of these homologs have led to expansion of our understanding of network interactions of genes in human tissues. For example, the FMR1 gene has been implicated with autism from a number of network studies. Using a knockout of FMR1 in mice creates the model for Fragile X Syndrome, one of the disorders in the Autism spectrum.Mice xenografts are particularly useful for drug discovery, and were extremely important in the discovery of early anti-psychotic drugs. The development of animal models for complex psychiatric diseases has also improved over the last few years. Rodent models have demonstrated behavioural phenotype changes resembling a positive schizophrenia state, either after genetic manipulation or after treatment with drugs that target the areas of the brain suspected to influence hyperactivity or neurodevelopment. Interest has been generated in identifying the network disruptions mediated by these laboratory manipulations, and collection of genomic data from rodent studies has contributed significantly to a better understanding of the genomics of psychiatric diseases. The first mouse brain transcriptome was generated in 2008. Since then, extensive work has been done with building social-stress mice models to study the pathway level expression signatures of various psychiatric diseases. A recent paper simulated features of Post Traumatic Stress Disorder (PTSD) in mice, and profiled the entire transcriptome of these mice. The authors found differential regulation in many biological pathways, some of which were implicated in anxiety disorders (hyperactivity, fear response), mood disorders, and impaired cognition. These findings are backed by extensive transcriptomic analyses of anxiety disorders, and expression level changes in biological pathways involved with fear learning and memory are thought to contribute to the behavioural manifestations of these disorders. It is thought that functional enrichment of genes involved in long term synaptic potentiation, depression, and plasticity has an important role to play in the acquisition, consolidation, and maintenance of traumatic memories underlying anxiety disorders. Experimental mice models for psychiatric disorders A common approach to using a mouse model is to apply an experimental treatment to a pregnant mouse in order to affect a whole litter. However, a key issue in the field is the treatment of litters in a statistical analysis. Most studies consider the total number of offspring produced as that may lead to an increase in statistical power. However, the correct way is to count by the number of litters and to normalize based on litter size. It was found that several autism studies incorrectly performed their statistical analyses based on total number of offspring instead of number of litters.Several anxiety disorders such as post-traumatic stress disorder (PTSD) involve heterogeneous changes in several different brain regions, such as the hippocampus, amygdala, and nucleus accumbens. The cellular encoding of traumatic events and the behavioral responses triggered by such events has been shown to lie primarily in changes in signaling molecules associated with synaptic transmission. Global gene expression profiling of the various gene regions implicated in fear and anxiety processing, using mice models, has led to the identification of temporally and spatially distinct sets of differentially expressed genes. Pathway analysis of these genes has indicated possible roles in neurogenesis and anxiety-related behavioural responses, alongside other functional and phenotypic observations.Mice models for brain research have contributed significantly to drug development and increased our understanding of the genomic underpinnings of several neurological diseases in the last generation. Chlorpromazine, the first antipsychotic drug (discovered in 1951), was identified as a viable treatment option after it was shown to suppress response to aversive stimuli in rats in a behavioural screen. Challenges The modelling and assessment of latent symptoms (thoughts, verbal learning, social interactions, cognitive behaviour) remains a challenge when using model organisms to study psychiatric disorders with a complex genetic pathology. For example, a given genotype+phenotype in a mouse model must imitate the genomic underpinnings of a phenotype observed in a human. This is a particularly crucial item of consideration in spectrum disorders such as autism. Autism is a disorder whose symptoms can be divided into two categories: (i) deficits of social interactions and (ii) repetitive behaviours and restricted interests. Since mice tend to be more social creatures amongst all members of the order Rodentia currently being used as model organisms, mice are generally used to model human psychiatric disorders as closely as possible. Particularly for autism, the following work-arounds are currently in place to emulate human behavioural symptoms: For the first diagnostic category of impaired social behaviour, mice are subject to a social assay intended to represent typical autistic social deficits. Normal social behaviour for mice includes sniffing, following, physical contact and allogrooming. Vocal communication could be used as well. There are a number of ways the second diagnostic category can be observed in mice. Examples of repetitive behaviours can include excessive circling, self-grooming and excessive digging. Usually these behaviours would be performed consistently within a long measurement of time (i.e. self-grooming for 10 minutes).While repetitive behaviours are easily observable, it is difficult to characterize actual restricted interests of mice. One aspect of restricted interests of autistic individuals is the "insistence of sameness"—the concept that autistic individuals require their environment to remain consistent. If that environment should change, the individual would experience stress and anxiety. There has been reported success in confirming a mouse model of autism by changing the mouse's environment.In any of these experiments, the ‘autistic’ mice have a ‘normal’ socializing partner and the scientists observing the mice are unaware ("blind") to the genotypes of the mice. Gene expression in the brain The gene expression profile of the central nervous system (CNS) is unique. Eighty percent of all human genes are expressed in the brain; 5,000 of these genes are solely expressed in the CNS. The human brain has the highest amount of gene expression of all studied mammalian brains. In comparison, tissues outside of the brain will have more similar expression levels in comparison to their mammalian counterparts. One source of the increased expression levels in the human brain is from the non-protein coding region of the genome. Numerous studies have indicated that the human brain have a higher level of expression in regulatory regions in comparison to other mammalian brains. There is also notable enrichment for more alternative splicing events in the human brain. Spatial differences Gene expression profiles also vary within specific regions of the brain. A microarray study showed that the transcriptome profile of the CNS clusters together based on region. A different study characterized the regulation of gene expression across 10 different regions based on their eQTL signals. The cause of the varying expression profiles relates to function, neuron migration and cellular heterogeneity of the region. Even the three layers of the cerebral cortex have distinct expression profiles.A study completed at Harvard Medical School in 2014 was able to identify developmental lineages stemming from single base neuronal mutations. The researchers sequenced 36 neurons from the cerebral cortex of three normal individuals, and found that highly expressed genes, and neural associated genes, were significantly enriched for single-neuron SNVs. These SNVs, in turn, were found to be correlated with chromatin markers of transcription from fetal brain. Development patterns in humans Gene expression of the brain changes throughout the different phases of life. The most significant levels of expression are found during early development, with the rate of gene expression being highest during fetal development. This results from the rapid growth of neurons in the embryo. Neurons at this stage are undergoing neuronal differentiation, cell proliferation, migration events and dendritic and synaptic development. Gene expression patterns shift closer towards specialized functional profiles during embryonic development, however, certain developmental steps are still ongoing at parturition. Consequently, gene expression profiles of the two brain hemispheres appear asymmetrical at birth. At birth, gene expression profiles appear asymmetrical between brain hemispheres. As development continues, the gene expression profiles become similar between the hemispheres. Given a healthy adult, expression profiles stay relatively consistent from the late twenties into the late forties. From the fifties onwards, there is significant decrease in the expression of genes important for regular function. Despite this, there is an increase in the diversity of genes being expressed across the brain. This age related change in expression may be correlated with GC content. At later stages of life, there is an increase in the induction of low GC-content pivotal genes as well as an increase in the repression of high GC-content pivotal genes. Another cause of the shift in gene diversity is the accumulation of mutations and DNA damage. Gene expression studies show that genes that accrue these age-related mutations are consistent between individuals in the aging population. Genes that are highly expressed at development decrease significantly at late stages in life, whereas genes that are highly repressed at development increase significantly at the late stages. Evolution of the mammalian brain The evolution of Homo sapiens since the divergence from the primate common ancestor has shown a marked expansion in the size and complexity of the brain, especially in the cerebral cortex. In comparison to primates, the human cerebral cortex has a larger surface area but differs only slightly in thickness. Many large scale studies in understanding the differences of the human brain from other species have indicated expansion of gene families and changes in alternative splicing to be responsible for the corollary increase in cognitive capabilities and cooperative behaviour in humans. However, we are yet to determine the exact phenotypic consequences of all these changes. One difficulty is that only primates have developed subdivisions in their cerebral cortex, making the modeling of human specific neurological problems difficult to mimic in rodents.Sequence data is used to understand the evolutionary genetic changes which led to the development of the human CNS. We can then understand how the neurological phenotypes differ between species. Comparative genomics entails comparison of sequence data across a phylogeny to pinpoint the genotypic changes that occur within specific lineages, and understand how these changes might have arisen. The increase in high quality mammalian reference sequences generally makes comparative analysis better as it increases statistical power. However, the increase in number of species in a phylogeny does risk adding unnecessary noise as the alignments of the orthologous sequences usually decrease in quality. Furthermore, different classes of species will have significant differences in their phenotypes.Despite this, comparative genomics has allowed us to connect the genetic changes found in a phylogeny to specific pathways. In order to determine this, lineages are tested for the functional changes that accrue over time. This is often measured as a ratio of nonsynonymous substitutions to synonymous substitutions or the dN/dS ratio (sometimes, further abbreviated to ω). When the dN/dS ratio is greater than 1, this indicates positive selection. A dN/dS ratio equal to 1 is evidence of no selective pressures. A dN/dS ratio less than 1 indicates negative selection. For example, the conserved regions of the genome will generally have a dN/dS ratio of less than 1 since any changes to those positions will likely be detrimental. Of the genes expressed in the human brain, it is estimated that 342 of them have a dN/dS ratio greater than 1 in the human lineage in comparison to other primate lineages. This indicates positive selection on the human lineage for brain phenotypes. Understanding the significance of the positive selection is generally the next step. For example, ASPM, CDK5RAP2 and NIN are genes that are positively selected for on the human lineage and have been directly correlated with brain size. This finding may help elucidate why human brains are larger than other mammalian brains. Network level expression differences between species It is thought that gene expression changes, being the ultimate response for any genetic changes, are a good proxy for understanding phenotypic differences within biological samples. Comparative studies have revealed a range of differences in the transcriptional controls between primates and rodents. For example, the gene CNTNAP2 is specifically enriched for in the prefrontal cortex. The mouse homolog of CNTNAP2 is not expressed in the mouse brain. CNTNAP2 has been implicated in cognitive functions of language as well as neurodevelopmental disorders such as Autism Spectrum Disorder. This suggests that the control of expression plays a significant role in the development in unique human cognitive function. As a consequence, a number of studies have investigated the brain specific enhancers. Transcription factors such as SOX5 have been found to be positively selected for on the human lineage. Gene expression studies in humans, chimpanzees and rhesus macaques, have identified human specific co-expression networks, and an elevation in gene expression in the human cortex in comparison to primates. Disorders Neurogenomic disorders manifest themselves as neurological disorders with a complex genetic architecture and a non-Mendelian-like pattern of inheritance. Some examples of these disorders include Bipolar disorder and Schizophrenia. Several genes may be involved in the manifestation of the disorder, and mutations in such disorders are generally rare and de novo. Hence it becomes extremely unlikely to observe the same (potentially causative) variant in two unrelated individuals affected with the same neurogenomic disorder. Ongoing research has implicated several de novo exonic variations and structural variations in Autism Spectrum Disorder (ASD), for example. The allelic spectrum of the rare and common variants in neurogenomic disorders therefore necessitates a need for large cohort studies in order to effectively exclude low effect variants and identify the overarching pathways frequently mutated in the different disorders, rather than specific genes and specific high penetrance mutations. Whole genome sequencing (WGS) and whole exome sequencing (WES) has been used in Genome Wide Association Studies (GWAS) to characterize genetic variants associated with neurogenomic disorders. However, the impact of these variants cannot always be verified because of the non-Mendelian inheritance patterns observed in several of these disorders. Another prohibitive feature in network analysis is the lack of large-scale datasets for many psychiatric (neurogenomic) diseases. Since several diseases with neurogenomic underpinnings tend to have a polygenic basis, several nonspecific, rare, and partially penetrant de novo mutations in different patients can contribute to the same observed range of phenotypes, as is the case with Autism Spectrum Disorder and schizophrenia. Extensive research in alcohol dependence has also highlighted the need for high-quality genomic profiling of large sample sets when studying polygenic, spectrum disorders. The 1000 Genomes Project was a successful demonstration of how a concerted effort to acquire representative genomic data from the broad spectrum of humans can result in identification of actionable biological insights for different diseases. However, a large-scale initiative like this is still lacking in the field of neurogenomic disorders specifically. Modelling psychiatric disorders in neurogenomics research – issues One major GWAS study identified 13 new risk loci for schizophrenia. Studying the impact of these candidates would ideally demonstrate a schizophrenia phenotype in animal models, which is usually difficult to observe due to its manifestation as a latent personality. This approach is able to determine the molecular impact the candidate gene. Ideally the candidate genes would have a neurological impact, which in turn would suggest that it plays a role in the neurological disorder. For example, in the aforementioned schizophrenia GWAS study, Ripke and colleagues determined that these candidate genes were all involved in calcium signalling. Alternatively, one can study these variants in model organisms in the context of affected neurological function. It is important to note that the high penetrance variants of these disorders tend to be de novo mutations. A further complication to studying neurogenomic disorders is the heterogeneous nature of the disorder. In many of these disorders, the mutations observed from case to case do not stay consistent. In autism, an affected individual may experience a large amount of deleterious mutations in gene X. A different affected individual may not have any significant mutations on gene X but have a large amount of mutations in gene Y. The alternative is to determine if gene X and gene Y impact the same biochemical pathway—one that influences a neurological function. A bioinformatics network analysis is one approach to this problem. Network analyses methodologies provide a generalized, systems overview of a molecular pathway. One final complication to consider is the comorbidity of neurogenomic genes. Several disorders, especially at the more severe ends of the spectrum tend to be comorbid with each other. For example, more severe cases of ASD tend to be associated with intellectual disability (ID). This raises the question of whether or not there are true, unique ASD genes and unique ID genes or if there are just genes just associated with neurological function that can be mutated into an abnormal phenotype. One confounding factor may be the actual diagnostic category and methods of the spectrum disorders as symptoms between severe disorders may be similar. One study investigated the comorbid symptoms between groups of ID and ASD, and found no significant difference between the symptoms of ID children, ASD children with ID and ASD children without ID. Future research may help establish a more stringent genetic basis for the diagnoses of these disorders. Network analysis The main goal of network analysis in neurogenomics is to identify statistically significant nonrandom associations between genes that contain risk variants. While several algorithm implementations of this approach already exist, the general steps for network analysis remain the same. The analytical process starts out with the identification of a biological network based on experimental validation. This can be a gene co-expression network, or a protein-protein interaction (PPI) network. The nodes of the network will be clustered. Subsequently, a specific list of genes with known associations to a particular phenotype of interest is generated. This list could be determined by experimental data, agnostic of genetic studies in psychiatric disorders. This is referred to as a 'hit list'. Genes that belong to the hit list as well as the biological network selected in the first step are marked as such. This is followed by a guilt-by-association (GBA) step. This means that clusters within the biological network that have a significant amount of genes from the hit list are investigated further using functional enrichment tools and database querying for the pathways in which these high scoring cluster genes participate Thus the biological associations of the high-scoring, experimentally implicated cluster members are investigated, expanding the search area from beyond the initial hit list to include gene members of additional pathways that may have significant association with the initial biological network under consideration. This results in a set of candidate genes.The underlying principle of this approach is that the genes that cluster together, will also jointly affect the same molecular pathway. Again, they would ideally be part of a neurological function. The candidate genes can then be used to prioritize variants for wet lab validation. Neuropharmacology Historically, due to the behavioural stimulation manifested as a symptom in several the neurogenomic disorders, the therapies would rely mostly on anti-psychotics or antidepressants. These classes of medications would suppress common symptoms of the disorders, but with questionable efficacy. The biggest barrier to neruopharmacogenomic research was the cohort sizes. Given newly available large-cohort sequencing data, there has been a recent push to expand therapeutic options. The heterogenous nature of neurological diseases is the key motivation for personalized medicine approaches to their therapies. It is rare to find single high penetrance causative genes in neurological diseases. The genomic profiles understandably vary between cases, and logically, the therapies would need to vary between cases. Further complicating the issue is that many of these disorders are spectrum disorders. Their genetic etiology will vary within this spectrum. For example, severe ASD is associated with high penetrance de novo mutations. Milder forms of ASD is usually associated with a mixture of common variants. The key issue then is the translation of these newly identified genetic variants (from Copy Number Variant studies, candidate gene sequencing and high throughput sequencing technologies) into an intervention for patients with neurogenomic disorders. One aspect will be if the neurological disorder are medically actionable (i.e. is there a simple metabolic pathway that a therapy can target). For example, specific cases of ASD have been associated with microdeletions on TMLHE gene. This gene codes for the enzyme of carnitine biosynthesis. Supplements to elevate carnitine levels appeared to alleviate certain ASD symptoms but the study was confounded by many influencing factors. As mentioned earlier, using a gene network approach will help identify relevant pathways of interest. Many neuropharmacogenomic approaches have focused on targeting the downstream products of these pathways. Blood brain barrier Studies in animal models for several brain diseases has shown that the blood brain barrier (BBB) undergoes modification at many levels; for example, the surface glycoprotein composition can influence the types of HIV-1 strains transported by the BBB. The BBB has been found to be key in the onset of Alzheimer's disease. It is extremely difficult, however, to be able to study this in humans due to obvious restrictions with accessing the brain and retrieving biological specimens for sequencing or morphological analysis. Mice models of the BBB and models of disease states have served well in conceptualizing the BBB as a regulatory interface between disease and good health in the brain. Personalized neurobiology The heterogenous nature of neurological diseases is the key motivation for personalized medicine approaches to their therapies. Genomic samples of individual patients could be used to identify predictive factors, or to better understand the specific prognosis of a neurogenomic disease, and use this information to guide treatment options. While there is a clear clinical utility to this approach, the adaptation of this approach is still nonexistent. There are various issues prohibiting the application of personalized genomics to the assessment, diagnosis, and treatment of psychiatric disorders. Firstly, the causative network biology of several spectrum disorders with neurogenomic underpinnings is not fully understood yet, in spite of extensive studies conducted with disorders like Autism Spectrum and schizophrenia. Thus, the analytical validity of standing hypotheses concerning the etiology of neurogenomic disorders has still not been fully established and is subject to debate and controversy. The clinical validity of genetic variants that have shown to be highly correlated with specific neurogenomic disorders is often a major cause of concern. The interpretation of these test results, and subsequent decision making, are a complicated undertaking given the polygenic nature of many of these disorders. Complicating things further, it has been shown that pre-emptive intervention in major psychiatric disorders does not always reduce the risk for the disorder. Such intervention might not even be available for at-risk offspring of affected adults, thereby limiting the 'medical actionability' of the data. Ethical concerns have also been raised regarding the safeguarding of personal genomic information, and how best to approach the burden of incidental findings and family risk assessment. Consanguinity and in-breeding can lead to selective enrichment of rare, otherwise low penetrance genetic mutations attributed to various symptoms of neurogenomic disorders. Thus, the interpretation of family-specific genetic mutations and/or network-level disruptions in the onset of a rare psychiatric disorder requires careful consideration of the motivations of participants included in the study. That said, these issues can be addressed by effective education and counseling, and collection of genomic data from patients with psychiatric disorders should not be disqualified solely on this basis. The data itself serves as a dynamic health resource and can significantly further our understanding of the genomic basis of several psychiatric disorders. See also Neuroinformatics 1000 Genomes Project Genome-wide association study == References ==

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate properly during cell division (mitosis/meiosis). There are three forms of nondisjunction: failure of a pair of homologous chromosomes to separate in meiosis I, failure of sister chromatids to separate during meiosis II, and failure of sister chromatids to separate during mitosis. Nondisjunction results in daughter cells with abnormal chromosome numbers (aneuploidy). Calvin Bridges and Thomas Hunt Morgan are credited with discovering nondisjunction in Drosophila melanogaster sex chromosomes in the spring of 1910, while working in the Zoological Laboratory of Columbia University. Types In general, nondisjunction can occur in any form of cell division that involves ordered distribution of chromosomal material. Higher animals have three distinct forms of such cell divisions: Meiosis I and meiosis II are specialized forms of cell division occurring during generation of gametes (eggs and sperm) for sexual reproduction, mitosis is the form of cell division used by all other cells of the body. Meiosis II Ovulated eggs become arrested in metaphase II until fertilization triggers the second meiotic division. Similar to the segregation events of mitosis, the pairs of sister chromatids resulting from the separation of bivalents in meiosis I are further separated in anaphase of meiosis II. In oocytes, one sister chromatid is segregated into the second polar body, while the other stays inside the egg. During spermatogenesis, each meiotic division is symmetric such that each primary spermatocyte gives rise to 2 secondary spermatocytes after meiosis I, and eventually 4 spermatids after meiosis II. Meiosis II-nondisjunction may also result in aneuploidy syndromes, but only to a much smaller extent than do segregation failures in meiosis I. Mitosis Division of somatic cells through mitosis is preceded by replication of the genetic material in S phase. As a result, each chromosome consists of two sister chromatids held together at the centromere. In the anaphase of mitosis, sister chromatids separate and migrate to opposite cell poles before the cell divides. Nondisjunction during mitosis leads to one daughter receiving both sister chromatids of the affected chromosome while the other gets none. This is known as a chromatin bridge or an anaphase bridge. Mitotic nondisjunction results in somatic mosaicism, since only daughter cells originating from the cell where the nondisjunction event has occurred will have an abnormal number of chromosomes. Nondisjunction during mitosis can contribute to the development of some forms of cancer, e.g., retinoblastoma (see below). Chromosome nondisjunction in mitosis can be attributed to the inactivation of topoisomerase II, condensin, or separase. Meiotic nondisjunction has been well studied in Saccharomyces cerevisiae. This yeast undergoes mitosis similarly to other eukaryotes. Chromosome bridges occur when sister chromatids are held together post replication by DNA-DNA topological entanglement and the cohesion complex. During anaphase, cohesin is cleaved by separase. Topoisomerase II and condensin are responsible for removing catenations. Molecular mechanisms Central role of the spindle assembly checkpoint The spindle assembly checkpoint (SAC) is a molecular safe-guarding mechanism that governs proper chromosome segregation in eukaryotic cells. SAC inhibits progression into anaphase until all homologous chromosomes (bivalents, or tetrads) are properly aligned to the spindle apparatus. Only then, SAC releases its inhibition of the anaphase promoting complex (APC), which in turn irreversibly triggers progression through anaphase. Sex-specific differences in meiosis Surveys of cases of human aneuploidy syndromes have shown that most of them are maternally derived. This raises the question: Why is female meiosis more error prone? The most obvious difference between female oogenesis and male spermatogenesis is the prolonged arrest of oocytes in late stages of prophase I for many years up to several decades. Male gametes on the other hand quickly go through all stages of meiosis I and II. Another important difference between male and female meiosis concerns the frequency of recombination between homologous chromosomes: In the male, almost all chromosome pairs are joined by at least one crossover, while more than 10% of human oocytes contain at least one bivalent without any crossover event. Failures of recombination or inappropriately located crossovers have been well documented as contributors to the occurrence of nondisjunction in humans. Age-related loss of cohesin ties Due to the prolonged arrest of human oocytes, weakening of cohesive ties holding together chromosomes and reduced activity of the SAC may contribute to maternal age-related errors in segregation control. The cohesin complex is responsible for keeping together sister chromatids and provides binding sites for spindle attachment. Cohesin is loaded onto newly replicated chromosomes in oogonia during fetal development. Mature oocytes have only limited capacity for reloading cohesin after completion of S phase. The prolonged arrest of human oocytes prior to completion of meiosis I may therefore result in considerable loss of cohesin over time. Loss of cohesin is assumed to contribute to incorrect microtubule-kinetochore attachment and chromosome segregation errors during meiotic divisions. Consequences The result of this error is a cell with an imbalance of chromosomes. Such a cell is said to be aneuploid. Loss of a single chromosome (2n-1), in which the daughter cell(s) with the defect will have one chromosome missing from one of its pairs, is referred to as a monosomy. Gaining a single chromosome, in which the daughter cell(s) with the defect will have one chromosome in addition to its pairs is referred to as a trisomy. In the event that an aneuploidic gamete is fertilized, a number of syndromes might result. Monosomy The only known survivable monosomy in humans is Turner syndrome, where the affected individual is monosomic for the X chromosome (see below). Other monosomies are usually lethal during early fetal development, and survival is only possible if not all the cells of the body are affected in case of a mosaicism (see below), or if the normal number of chromosomes is restored via duplication of the single monosomic chromosome ("chromosome rescue"). Turner syndrome (X monosomy) (45, X0) Complete loss of an entire X chromosome accounts for about half the cases of Turner syndrome. The importance of both X chromosomes during embryonic development is underscored by the observation that the overwhelming majority (>99%) of fetuses with only one X chromosome (karyotype 45, X0) are spontaneously aborted. Autosomal trisomy The term autosomal trisomy means that a chromosome other than the sex chromosomes X and Y is present in 3 copies instead of the normal number of 2 in diploid cells. Down syndrome (trisomy 21) Down syndrome, a trisomy of chromosome 21, is the most common anomaly of chromosome number in humans. The majority of cases result from nondisjunction during maternal meiosis I. Trisomy occurs in at least 0.3% of newborns and in nearly 25% of spontaneous abortions. It is the leading cause of pregnancy wastage and is the most common known cause of intellectual disability. It is well documented that advanced maternal age is associated with greater risk of meiotic nondisjunction leading to Down syndrome. This may be associated with the prolonged meiotic arrest of human oocytes potentially lasting for more than four decades. Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13) Human autosomal trisomies compatible with live birth, other than Down syndrome (trisomy 21), are Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13). Complete trisomies of other chromosomes are usually not viable and represent a relatively frequent cause of miscarriage. Only in rare cases of a mosaicism, the presence of a normal cell line, in addition to the trisomic cell line, may support the development of a viable trisomy of the other chromosomes. Sex chromosome aneuploidy The term sex chromosome aneuploidy summarizes conditions with an abnormal number of sex chromosomes, i.e., other than XX (female) or XY (male). Formally, X chromosome monosomy (Turner syndrome, see above) can also be classified as a form of sex chromosome aneuploidy. Klinefelter syndrome (47, XXY) Klinefelter syndrome is the most common sex chromosome aneuploidy in humans. It represents the most frequent cause of hypogonadism and infertility in men. Most cases are caused by nondisjunction errors in paternal meiosis I. About eighty percent of individuals with this syndrome have one extra X chromosome resulting in the karyotype XXY. The remaining cases have either multiple additional sex chromosomes (48,XXXY; 48,XXYY; 49,XXXXY), mosaicism (46,XY/47,XXY), or structural chromosome abnormalities. XYY Male (47, XYY) The incidence of XYY syndrome is approximately 1 in 800–1000 male births. Many cases remain undiagnosed because of their normal appearance and fertility, and the absence of severe symptoms. The extra Y chromosome is usually a result of nondisjunction during paternal meiosis II. Trisomy X (47,XXX) Trisomy X is a form of sex chromosome aneuploidy where females have three instead of two X chromosomes. Most patients are only mildly affected by neuropsychological and physical symptoms. Studies examining the origin of the extra X chromosome observed that about 58–63% of cases were caused by nondisjunction in maternal meiosis I, 16–18% by nondisjunction in maternal meiosis II, and the remaining cases by post-zygotic, i.e., mitotic, nondisjunction. Uniparental disomy Uniparental disomy denotes the situation where both chromosomes of a chromosome pair are inherited from the same parent and are therefore identical. This phenomenon most likely is the result of a pregnancy that started as a trisomy due to nondisjunction. Since most trisomies are lethal, the fetus only survives because it loses one of the three chromosomes and becomes disomic. Uniparental disomy of chromosome 15 is, for example, seen in some cases of Prader-Willi syndrome and Angelman syndrome. Mosaicism syndromes Mosaicism syndromes can be caused by mitotic nondisjunction in early fetal development. As a consequence, the organism evolves as a mixture of cell lines with differing ploidy (number of chromosomes). Mosaicism may be present in some tissues, but not in others. Affected individuals may have a patchy or asymmetric appearance. Examples of mosaicism syndromes include Pallister-Killian syndrome and Hypomelanosis of Ito. Mosaicism in malignant transformation Development of cancer often involves multiple alterations of the cellular genome (Knudson hypothesis). Human retinoblastoma is a well studied example of a cancer type where mitotic nondisjunction can contribute to malignant transformation: Mutations of the RB1 gene, which is located on chromosome 13 and encodes the tumor suppressor retinoblastoma protein, can be detected by cytogenetic analysis in many cases of retinoblastoma. Mutations of the RB1 locus in one copy of chromosome 13 are sometimes accompanied by loss of the other wild-type chromosome 13 through mitotic nondisjunction. By this combination of lesions, affected cells completely lose expression of functioning tumor suppressor protein. Diagnosis Preimplantation genetic diagnosis Pre-implantation genetic diagnosis (PGD or PIGD) is a technique used to identify genetically normal embryos and is useful for couples who have a family history of genetic disorders. This is an option for people choosing to procreate through IVF. PGD is considered difficult due to it being both time consuming and having success rates only comparable to routine IVF. Karyotyping Karyotyping involves performing an amniocentesis in order to study the cells of an unborn fetus during metaphase 1. Light microscopy can be used to visually determine if aneuploidy is an issue. Polar body diagnosis Polar body diagnosis (PBD) can be used to detect maternally derived chromosomal aneuploidies as well as translocations in oocytes. The advantage of PBD over PGD is that it can be accomplished in a short amount of time. This is accomplished through zona drilling or laser drilling. Blastomere biopsy Blastomere biopsy is a technique in which blastomeres are removed from the zona pellucida. It is commonly used to detect aneuploidy. Genetic analysis is conducted once the procedure is complete. Additional studies are needed to assess the risk associated with the procedure. Lifestyle/environmental hazards Exposure of spermatozoa to lifestyle, environmental and/or occupational hazards may increase the risk of aneuploidy. Cigarette smoke is a known aneugen (aneuploidy inducing agent). It is associated with increases in aneuploidy ranging from 1.5 to 3.0-fold. Other studies indicate factors such as alcohol consumption, occupational exposure to benzene, and exposure to the insecticides fenvalerate and carbaryl also increase aneuploidy. == References ==

Nucleomodulins are a family of bacterial proteins that enter the nucleus of eukaryotic cells.This term comes from the contraction between "nucleus" and "modulins", which are microbial molecules that modulate the behaviour of eukaryotic cells. Nucleomodulins are produced by pathogenic or symbiotic bacteria. They act on various processes in the nucleus: remodelling of the chromatin structure, transcription, splicing of pre-messenger RNA, cell division.The identification of nucleomodulins in several species of bacterial pathogens of humans, animals and plants has led to the emergence of the concept that direct control of the nucleus is one of the most sophisticated strategies used by microbes to bypass host defences. Nucleomodulins can be directly secreted into the intracellular medium after entry of the bacteria into the cell, like Listeria monocytogenes, or they can be injected from the extracellular medium or intracellular organelles using a type III or IV bacterial secretion system, also known as a "molecular syringe".More recently, it has been shown that some of them, such as YopM from Yersinia pestis and IpaH9.8 from Shigella flexneri, can autonomously penetrate eukaryotic cells thanks to a membrane transduction domain.The diversity of molecular mechanisms triggered by nucleomodulins is a source of inspiration for new biotechnologies. They are true nano-machines capable of hijacking a multitude of nuclear processes. In research, nucleomodulins are the subject of in-depth studies that have led to the discovery of new human nuclear regulators, such as the epigenetic regulator BAHD1. Examples Agrobacterium tumefaciens, responsible for crown gall disease, produces an arsenal of Vir proteins, including VirD2 and VirE2, enabling the precise integration of a piece of its DNA, called T-DNA, into that of the host plant Listeria monocytogenes, responsible for listeriosis, can modulate the expression of immunity genes. One of the mechanisms at play involves the bacterial protein LntA, which inhibits the function of the epigenetic regulator BAHD1. The action of this nucleomodulin is associated with chromatin decompaction and activation of an interferon response genes.Shigella flexneri, responsible for shigellosis, secretes the IpaH9.8 protein targeting a mRNA splicing protein that disrupts the production of protein isoforms and the inflammatory response in humans.Legionella pneumophila, responsible for legionellosis, secretes an enzyme with histone methyltransferase activity capable of methylating histones at different chromosome loci or at the level of ribosomal DNA (rDNA) in the nucleolus. == References ==

Oogenesis, ovogenesis, or oögenesis is the differentiation of the ovum (egg cell) into a cell competent to further develop when fertilized. It is developed from the primary oocyte by maturation. Oogenesis is initiated in the embryonic stage. Oogenesis in non-human mammals In mammals, the first part of oogenesis starts in the germinal epithelium, which gives rise to the development of ovarian follicles, the functional unit of the ovary. Oogenesis consists of several sub-processes: oocytogenesis, ootidogenesis, and finally maturation to form an ovum (oogenesis proper). Folliculogenesis is a separate sub-process that accompanies and supports all three oogenetic sub-processes. Oogonium —(Oocytogenesis)—> Primary Oocyte —(Meiosis I)—> First Polar body (Discarded afterward) + Secondary oocyte —(Meiosis II)—> Second Polar Body (Discarded afterward) + Ovum Oocyte meiosis, important to all animal life cycles yet unlike all other instances of animal cell division, occurs completely without the aid of spindle-coordinating centrosomes. The creation of oogonia The creation of oogonia traditionally does not belong to oogenesis proper, but, instead, to the common process of gametogenesis, which, in the female human, begins with the processes of folliculogenesis, oocytogenesis, and ootidogenesis. Oogonia enter meiosis during embryonic development, becoming oocytes. Meiosis begins with DNA replication and meiotic crossing over. It then stops in early prophase. Maintenance of meiotic arrest Mammalian oocytes are maintained in meiotic prophase arrest for a very long time—months in mice, years in humans. Initially the arrest is due to lack of sufficient cell cycle proteins to allow meiotic progression. However, as the oocyte grows, these proteins are synthesized, and meiotic arrest becomes dependent on cyclic AMP. The cyclic AMP is generated by the oocyte by adenylyl cyclase in the oocyte membrane. The adenylyl cyclase is kept active by a constitutively active G-protein-coupled receptor known as GPR3 and a G-protein, Gs, also present in the oocyte membrane.Maintenance of meiotic arrest also depends on the presence of a multilayered complex of cells, known as a follicle, that surrounds the oocyte. Removal of the oocyte from the follicle causes meiosis to progress in the oocyte. The cells that comprise the follicle, known as granulosa cells, are connected to each other by proteins known as gap junctions, that allow small molecules to pass between the cells. The granulosa cells produce a small molecule, cyclic GMP, that diffuses into the oocyte through the gap junctions. In the oocyte, cyclic GMP prevents the breakdown of cyclic AMP by the phosphodiesterase PDE3, and thus maintains meiotic arrest. The cyclic GMP is produced by the guanylyl cyclase NPR2. Reinitiation of meiosis and stimulation of ovulation by luteinizing hormone As follicles grow, they acquire receptors for luteinizing hormone, a pituitary hormone that reinitiates meiosis in the oocyte and causes ovulation of a fertilizable egg. Luteinizing hormone acts on receptors in the outer layers of granulosa cells of the follicle, causing a decrease in cyclic GMP in the granulosa cells. Because the granulosa cells and oocyte are connected by gap junctions, cyclic GMP also decreases in the oocyte, causing meiosis to resume. Meiosis then proceeds to second metaphase, where it pauses again until fertilization. Luteinizing hormone also stimulates gene expression leading to ovulation. Human oogenesis Oogenesis Oogenesis starts with the process of developing primary oocytes, which occurs via the transformation of oogonia into primary oocytes, a process called oocytogenesis. From one single oogonium, only one mature oocyte will rise, with 3 other cells called polar bodies. Oocytogenesis is complete either before or shortly after birth. Number of primary oocytes It is commonly believed that, when oocytogenesis is complete, no additional primary oocytes are created, in contrast to the male process of spermatogenesis, where gametocytes are continuously created. In other words, primary oocytes reach their maximum development at ~20 weeks of gestational age, when approximately seven million primary oocytes have been created; however, at birth, this number has already been reduced to approximately 1-2 million per ovary. At puberty the number of oocytes decreases even more to reach about 60,000 to 80,000 per ovary, and only about 500 mature oocytes will be produced during a woman's life, the others will undergo atresia (degeneration). Two publications have challenged the belief that a finite number of oocytes are set around the time of birth. The renewal of ovarian follicles from germline stem cells (originating from bone marrow and peripheral blood) has been reported in the postnatal mouse ovary. In contrast, DNA clock measurements do not indicate ongoing oogenesis during human females' lifetimes. Thus, further experiments are required to determine the true dynamics of small follicle formation. Ootidogenesis The succeeding phase of ootidogenesis occurs when the primary oocyte develops into an ootid. This is achieved by the process of meiosis. In fact, a primary oocyte is, by its biological definition, a cell whose primary function is to divide by the process of meiosis.However, although this process begins at prenatal age, it stops at prophase I. In late fetal life, all oocytes, still primary oocytes, have halted at this stage of development, called the dictyate. After menarche, these cells then continue to develop, although only a few do so every menstrual cycle. Meiosis I Meiosis I of ootidogenesis begins during embryonic development, but halts in the diplotene stage of prophase I until puberty. The mouse oocyte in the dictyate (prolonged diplotene) stage actively repairs DNA damage, whereas DNA repair is not detectable in the pre-dictyate (leptotene, zygotene and pachytene) stages of meiosis. For those primary oocytes that continue to develop in each menstrual cycle, however, synapsis occurs and tetrads form, enabling chromosomal crossover to occur. As a result of meiosis I, the primary oocyte has now developed into the secondary oocyte. Meiosis II Immediately after meiosis I, the haploid secondary oocyte initiates meiosis II. However, this process is also halted at the metaphase II stage until fertilization, if such should ever occur. If the egg is not fertilized, it is disintegrated and released (menstruation) and the secondary oocyte does not complete meiosis II (and does not become an ovum). When meiosis II has completed, an ootid and another polar body have now been created. The polar body is small in size. Folliculogenesis Synchronously with ootidogenesis, the ovarian follicle surrounding the ootid has developed from a primordial follicle to a preovulatory one. Maturation into ovum Both polar bodies disintegrate at the end of Meiosis II, leaving only the ootid, which then eventually undergoes maturation into a mature ovum. The function of forming polar bodies is to discard the extra haploid sets of chromosomes that have resulted as a consequence of meiosis. In vitro maturation In vitro maturation (IVM) is the technique of letting ovarian follicles mature in vitro. It can potentially be performed before an IVF. In such cases, ovarian hyperstimulation is not essential. Rather, oocytes can mature outside the body prior to IVF. Hence, no (or at least a lower dose of) gonadotropins have to be injected in the body. Immature eggs have been grown until maturation in vitro at a 10% survival rate, but the technique is not yet clinically available. With this technique, cryopreserved ovarian tissue could possibly be used to make oocytes that can directly undergo in vitro fertilization. In vitro oogenesis By definition it means, to recapitulate mammalian oogenesis and producing fertilizable oocytes in vitro.it is a complex process involving several different cell types, precise follicular cell-oocyte reciprocal interactions, a variety of nutrients and combinations of cytokines, and precise growth factors and hormones depending on the developmental stage. In 2016, two papers published by Morohaku et al. and Hikabe et al. reported in vitro procedures that appear to reproduce efficiently these conditions allowing for the production, completely in a dish, of a relatively large number of oocytes that are fertilizable and capable of giving rise to viable offspring in the mouse. This technique can be mainly benefited in cancer patients where in today's condition their ovarian tissue is cryopreserved for preservation of fertility. Alternatively to the autologous transplantation, the development of culture systems that support oocyte development from the primordial follicle stage represent a valid strategy to restore fertility. Over time, many studies have been conducted with the aim to optimize the characteristics of ovarian tissue culture systems and to better support the three main phases: 1) activation of primordial follicles; 2) isolation and culture of growing preantral follicles; 3) removal from the follicle environment and maturation of oocyte cumulus complexes. While complete oocyte in vitro development has been achieved in mouse, with the production of live offspring, the goal of obtaining oocytes of sufficient quality to support embryo development has not been completely reached into higher mammals despite decades of effort. Ovarian aging BRCA1 and ATM proteins are employed in repair of DNA double-strand break during meiosis. These proteins appear to have a critical role in resisting ovarian aging. However, homologous recombinational repair of DNA double-strand breaks mediated by BRCA1 and ATM weakens with age in oocytes of humans and other species. Women with BRCA1 mutations have lower ovarian reserves and experience earlier menopause than women without these mutations. Even in woman without specific BRCA1 mutations, ovarian aging is associated with depletion of ovarian reserves leading to menopause, but at a slower rate than in those with such mutations. Since older premenopausal women ordinarily have normal progeny, their capability for meiotic recombinational repair appears to be sufficient to prevent deterioration of their germline despite the reduction in ovarian reserve. DNA damages may arise in the germline during the decades long period in humans between early oocytogenesis and the stage of meiosis in which homologous chromosomes are effectively paired (dictyate stage). It has been suggested that such DNA damages may be removed, in large part, by mechanisms dependent on chromosome pairing, such as homologous recombination. Oogenesis in non-mammals Some algae and the oomycetes produce eggs in oogonia. In the brown alga Fucus, all four egg cells survive oogenesis, which is an exception to the rule that generally only one product of female meiosis survives to maturity. In plants, oogenesis occurs inside the female gametophyte via mitosis. In many plants such as bryophytes, ferns, and gymnosperms, egg cells are formed in archegonia. In flowering plants, the female gametophyte has been reduced to an eight-celled embryo sac within the ovule inside the ovary of the flower. Oogenesis occurs within the embryo sac and leads to the formation of a single egg cell per ovule. In ascaris, the oocyte does not even begin meiosis until the sperm touches it, in contrast to mammals, where meiosis is completed in the estrus cycle. In female Drosophila flies, genetic recombination occurs during meiosis. This recombination is associated with formation of DNA double-strand breaks and the repair of these breaks. The repair process leads to crossover recombinants as well as at least three times as many noncrossover recombinants (e.g. arising by gene conversion without crossover). See also Anisogamy Archegonium Evolution of sexual reproduction Female infertility Female reproductive system Meiosis Oncofertility Oogonium Oocyte Origin and function of meiosis Sexual reproduction Spermatogenesis References Cho WK, Stern S, Biggers JD. 1974. Inhibitory effect of dibutyryl cAMP on mouse oocyte maturation in vitro. J Exp Zool.187:383-386 BibliographyManandhar G, Schatten H and Sutovsky P (2005). Centrosome reduction during gametogenesis and its significance. Biol Reprod, 72(1)2-13. External links Reproductive Physiology

Pathogenicity islands (PAIs), as termed in 1990, are a distinct class of genomic islands acquired by microorganisms through horizontal gene transfer. Pathogenicity islands are found in both animal and plant pathogens. Additionally, PAIs are found in both gram-positive and gram-negative bacteria. They are transferred through horizontal gene transfer events such as transfer by a plasmid, phage, or conjugative transposon. Therefore, PAIs contribute to microorganisms' ability to evolve. One species of bacteria may have more than one PAI. For example, Salmonella has at least five.An analogous genomic structure in rhizobia is termed a symbiosis island. Properties Pathogenicity islands (PAIs) are gene clusters incorporated in the genome, chromosomally or extrachromosomally, of pathogenic organisms, but are usually absent from those nonpathogenic organisms of the same or closely related species. They may be located on a bacterial chromosome or may be transferred within a plasmid or can be found in bacteriophage genomes. The GC-content and codon usage of pathogenicity islands often differs from that of the rest of the genome, potentially aiding in their detection within a given DNA sequence, unless the donor and recipient of the PAI have similar GC-content.PAIs are discrete genetic units flanked by direct repeats, insertion sequences or tRNA genes, which act as sites for recombination into the DNA. Cryptic mobility genes may also be present, indicating the provenance as transduction. PAIs are flanked by direct repeats; the sequence of bases at two ends of the inserted sequence are the same. They carry functional genes, such as integrases, transposases, phagocytosis, or part of insertion sequences, to enable insertion into host DNA. PAIs are often associated with tRNA genes, which target sites for this integration event. They can be transferred as a single unit to new bacterial cells, thus conferring virulence to formerly benign strains.PAIs, a type of mobile genetic element, may range from 10-200 kb and encode genes which contribute to the virulence of the respective pathogen. Pathogenicity islands carry genes encoding one or more virulence factors, including, but not limited to, adhesins, secretion systems (like type III secretion system), toxins, invasins, modulins, effectors, superantigens, iron uptake systems, o-antigen synthesis, serum resistance, immunoglobulin A proteases, apoptosis, capsule synthesis, and plant tumorigenesis via Agrobacterium tumefaciens.There are various combinations of regulation involving pathogenicity islands. The first combination is that the pathogenicity island contains the genes to regulate the virulence genes encoded on the PAI. The second combination is that the pathogenicity island contains the genes to regulate genes located outside of the pathogenecity island. Additionally, regulatory genes outside of the PAI may regulate virulence genes in the pathogenicity island. Regulation genes typically encoded on PAIs include AraC-like proteins and two-component response regulators.PAIs can be considered unstable DNA regions as they are susceptible to deletions or mobilization. This may be due to the structure of PAIs, with direct repeats, insertion sequences and association with tRNA that enables deletion and mobilization at higher frequencies. Additionally, deletions of pathogenicity islands inserted in the genome can result in disrupting tRNA and subsequently affect the metabolism of the cell. Examples The P fimbriae island contains virulence factors such as haemolysin, pili, cytotoxic necrosing factor, and uropathogenic specific protein (USP). Yersinia pestis high pathogenicity island I has genes regulating iron uptake and storage. Salmonella SP1 and SP2 sites. Rhodococcus equi virulence plasmid pathogenicity island encodes virulence factors for proliferation in macrophages. The SaPI family of Staphylococcus aureus pathogenicity islands, mobile genetic elements, encode superantigens, including the gene for toxic shock syndrome toxin, and are mobilized at high frequencies by specific bacteriophages. Phage encoded Cholera toxin of Vibrio cholerae, Diphtheria toxin of Corynebacterium diphtheriae, Neurotoxins of Clostridium botulinum and Cytotoxin of Pseudomonas aeruginosa. Helicobacter pylori has two strains, one being more virulent than the other due to the presence of the Cag pathogenicity island. References External links BAC definition of pathogenicity

Patome is a database of biological sequence data of issued patents and/or published applications. See also Patents Gene patent References External links https://web.archive.org/web/20101223004907/http://www.patome.org/

Penetrance in genetics is the proportion of individuals carrying a particular variant (or allele) of a gene (genotype) that also expresses an associated trait (phenotype). In medical genetics, the penetrance of a disease-causing mutation is the proportion of individuals with the mutation that exhibit clinical symptoms among all individuals with such mutation. For example: If a mutation in the gene responsible for a particular autosomal dominant disorder has 75% penetrance, then 75% of those with the mutation will go on to develop the disease, showing its phenotype, whereas 25% will not. Penetrance only refers to whether an individual with a specific genotype exhibits any phenotypic signs or symptoms, and is not to be confused with variable expressivity which is to what extent or degree the symptoms for said disease are shown (the expression of the phenotypic trait). Meaning that, even if the same disease-causing mutation affects separate individuals, the expressivity will vary. Degrees of Penetrance Complete penetrance If 100% of individuals carrying a particular genotype express the associated trait, the genotype is said to show complete penetrance. Neurofibromatosis type 1 (NF1), is an autosomal dominant condition which shows complete penetrance, consequently everyone who inherits the disease-causing variant of this gene will develop some degree of symptoms for NF1. Reduced penetrance The penetrance is said to be reduced if less than 100% of individuals carrying a particular genotype express associated traits, and is likely to be caused by a combination of genetic, environmental and lifestyle factors. BRCA1 is an example of a genotype with reduced penetrance. By age 70, the mutation is estimated to have a breast cancer penetrance of around 65% in women. Meaning that about 65% of women carrying the gene will develop breast cancer by the time they turn 70. Non-penetrance: Within the category of reduced penetrance, individuals carrying the mutation without displaying any signs or symptoms, are said to have a genotype that is non-penetrant. For the BRCA1 example above, the remaining 35% which never develop breast cancer, are therefore carrying the mutation, but it is non-penetrant. This can lead to healthy, unaffected parents carrying the mutation on to future generations that might be affected. Factors affecting penetrance Many factors such as age, sex, environment, epigenetic modifiers, and modifier genes are linked to penetrance. These factors can help explain why certain individuals with a specific genotype exhibit symptoms or signs of disease, whilst others do not. Age-dependent penetrance If clinical signs associated with a specific genotype appear more frequently with increasing age, the penetrance is said to be age dependent. Some diseases are non-penetrant up until a certain age and then the penetrance starts to increase drastically, whilst others exhibit low penetrance at an early age and continue to increase with time. For this reason, many diseases have a different estimated penetrance dependent on the age.A specific hexanucleotide repeat expansion within the C9orf72 gene said to be a major cause for developing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is an example of a genotype with age dependent penetrance. The genotype is said to be non-penetrant until the age of 35, 50% penetrant by the age of 60, and almost completely penetrant by age 80. Gender-related penetrance For some mutations, the phenotype is more frequently present in one sex and in rare cases mutations appear completely non-penetrant in a particular gender. This is called gender-related penetrance or sex-dependent penetrance and may be the result of allelic variation, disorders in which the expression of the disease is limited to organs only found in one sex such as testis or ovaries, or sex steroid-responsive genes. Breast cancer caused by the BRCA2 mutation is an example of a disease with gender-related penetrance. The penetrance is determined to be much higher in women than men. By age 70, around 86% of females in contrast to 6% of males with the same mutation is estimated to develop breast cancer.In cases where clinical symptoms or the phenotype related to a genetic mutation are present only in one sex, the disorder is said to be sex-limited. Familial male-limited precocious puberty (FMPP) caused by a mutation in the LHCGR gene, is an example of a genotype only penetrant in males. Meaning that males with this particular genotype exhibit symptoms of the disease whilst the same genotype is nonpenetrant in females. Genetic modifiers Genetic modifiers are genetic variants or mutations able to modify a primary disease-causing variant's phenotypic outcome without being disease causing themselves. For instance, in single gene disorders there is one gene primarily responsible for development of the disease, but modifier genes inherited separately can affect the phenotype. Meaning that the presence of a mutation located on a loci different from the one with the disease-causing mutation, may either hinder manifestation of the phenotype or alter the mutations effects, and thereby influencing the penetrance. Environmental modifiers Exposure to environmental and lifestyle factors such as chemicals, diet, alcohol intake, drugs and stress are some of the factors that might influence disease penetrance. For example, several studies of BRCA1 and BRCA2 mutations, associated with an elevated risk of breast and ovarian cancer in women, have examined associations with environmental and behavioral modifiers such as pregnancies, history of breast feeding, smoking, diet, and so forth. Epigenetic regulation Sometimes, genetic alterations which can cause genetic disease and phenotypic traits, are not from changes related directly to the DNA sequence, but from epigenetic alterations such as DNA methylation or histone modifications. Epigenetic differences may therefore be one of the factors contributing to reduced penetrance. A study done on a pair of genetically identical monozygotic twins, where one twin got diagnosed with leukemia and later on thyroid carcinoma whilst the other had no registered illnesses, showed that the affected twin had increased methylation levels of the BRCA 1 gene. The research concluded that the family had no known DNA-repair syndrome or any other hereditary diseases in the last four generations, and no genetic differences between the studied pair of monozygotic twins were detected in the BRCA1 regulatory region. This indicates that epigenetic changes caused by environmental or behavioral factors had a key role in the cause of promotor hypermethylation of the BRCA1 gene in the affected twin, which caused the cancer. Determining penetrance It can be challenging to estimate the penetrance of a specific genotype due to all the influencing factors. In addition to the factors mentioned above there are several other considerations that must be taken into account when penetrance is determined: Ascertainment bias Penetrance estimates can be affected by ascertainment bias if the sampling is not systematic. Traditionally a phenotype-driven approach focusing on individuals with a given condition and their family members has been used to determine penetrance. However, it may be difficult to transfer these estimates over to the general population because family members may share other genetic and/or environmental factors that could influence manifestation of said disease, leading to ascertainment bias and an overestimation of the penetrance. Large-scale population-based studies, which use both genetic sequencing and phenotype data from large groups of people, is a different method for determining penetrance. This method offers less upward bias compared to family-based studies and is more accurate the larger the sample population is. These studies may contain a healthy-participant-bias which can lead to lower penetrance estimates. Phenocopies A genotype with complete penetrance will always display the clinical phenotypic traits related to its mutation (taking into consideration the expressivity), but the signs or symptoms displayed by a specific affected individual can often be similar to other unrelated phenotypical traits. Taking into consideration the effect that environmental or behavioral modifiers have, and how they can impact the cause of a mutation or epigenetic alteration, we now have the cause as to how different paths lead to the same phenotypic display. When similar phenotypes can be observed but by different causes, it is called phenocopies. Phenocopies is when environmental and/or behavioral modifiers causes an illness which mimics the phenotype of a genetic inherited disease. Because of phenocopies, determining the degree of penetrance for a genetic disease requires full knowledge of the individuals attending the studies, and the factors that may or may not have caused their illness. For example, new research on Hypertrophic Cardiomyopathy (HCM) based on a technique called Cardiac Magnetic Resonance (CMR), describes how various genetic illnesses that showcase the same phenotypic traits as HCM, are actually phenocopies. Previously these phenocopies were all diagnosed and treated, thought to arrive from the same cause, but because of new diagnostic methods, they can now be separated and treated more efficiently. Subjects not yet covered Allelic heterogeneity Polygenic inheritance Locus heterogeneity References External links Tutorial about the different aspects of genetic penetrance.

A phene is an individual genetically determined characteristic or trait which can be possessed by an organism, such as eye colour, height, behavior, tooth shape or any other observable characteristic. Phene - phenotype - phenome distinction The term 'phene' was evidently coined as an obvious parallel construct to 'gene'. Phene is to Phenotype as Gene is to Genotype, and Similarly Phene is to Phenome as Gene is to Genome. More specifically, a Phene is an abstract concept describing a particular characteristic which can be possessed by an organism. Whereas Phenotype refers to a collection of Phenes possessed by a particular organism, and Phenome refers to the entire set of Phenes that exist within an organism or species. Genome wide association studies use "phenes" or "traits" (symptoms) to distinguish groups in the human population. These groups are then employed to identify associations with genetic alleles that are more common in the symptomatic group than in the asymptomatic control group. Allen et al. report that with respect to Schizophrenia "Research in molecular genetics has focused on detecting multiple genes of small effect" This indicates the importance of discovering individual traits or "phenes" that are governed by single genes. Schizophrenia or bipolar disorder may be described as a phenotype but how many individual traits or "phenes" contribute to these phenotypes? Very large genome wide association studies have not found many significant gene linkages. On the contrary the results of these studies implicate a large number of gene alleles that have a very small effect (phene).It is important to note that the word phenotype was originally used to refer to both the trait/character itself (e.g. the blue eyes phenotype) and the set of traits/characteristics possessed by the organism (clair's eye-colour phenotype is blue). While this definition is still used in many places, the lack of distinction can make in-depth explanations confusing and thus use of the term Phene becomes necessary. Indeed, it is extremely difficult to determine precisely what the fundamental building blocks of a phenome are. Since the term "phenotype" has been used to describe traits and syndromes and population characteristics it is not helpful in the collective search for specific traits that could be a consequence of a single gene or gene–environmental interaction. Phene has emerged as a candidate building block for the phenome. Phene - gene distinction Genes give rise to phenes. Genes are the biochemical instructions encoding what an organism can be, while phenes are what the organism is. In general it takes a combination of particular genes, environmental influences and random variation to give rise to any one phene in an organism. Both phenes and genes are subject to evolution. However, if one defines "genes" as "DNA sequences encoding polypeptides", they are not directly accessible to natural selection; the associated phenes are. Note that some, e.g. Richard Dawkins, have used a wider definition of "gene" than the one used in genetics on occasion, extending it to any DNA sequence with a function. Due to the distinct chemical and physical properties of the nucleotides in the DNA and some mutations being "silent" (that is, not altering gene expression), the DNA primary sequence may also be a phene. For example, A-T and C-G base pairs are differently resistant to heat (see also DNA-DNA hybridization). In a thermophilic microorganism, "silent" mutations may have an effect on DNA stability and thus survival. While being subject to evolution, natural selection affects the primary sequence directly in this case, with or without it being expressed. Consider, for example, a mutation that makes a zygote abort development as a young embryo. This mutation, obviously, will not spread, as it is quickly fatal. It is not the mutated nucleotide that is selected against, but the fact that due to this mutation, the phene (a key enzyme or developmental factor for example) does not get expressed. Compare a (fictional) kind of mutation that breaks the DNA strand in a crucial position and defies all attempts to repair it, leading to cell death. Here, the mutated and unmutated DNA sequences would be phenes themselves; it is the changed primary sequence itself which by failing would cause death, not the corresponding polypeptide. See also Dawkin's concept of extended phenotype. Origin The term has been widely adopted by the academic community and appears in scientific literature. A quick keyword search of titles and abstracts containing "phene" at PubMed returns many articles. It is a valuable concept in the genomic era where "phenes" or "traits" (symptoms) are used to distinguish groups with genetic disorders. Usages "Phene" is used as to refer to relevant phenotypic traits in the OMIA (Online Mendelian Inheritance in Animals) database. One of the objectives of the OMIA is to match genotypes to phenotypes. Lenffer et al. (2006) describe the OMIA as a "comparative biology resource" "(The) OMIA is a comprehensive resource of phenotypic information on heritable animal traits and genes in a strongly comparative context, relating traits to genes where possible. OMIA is modelled on and is complementary to Online Mendelian Inheritance in Man (OMIM)." The term "phene" is equated with "trait". See also Phenotype Phenotypic trait Online Mendelian Inheritance in Man (a database of human phenes) References Porter, Ian H (June 1973). "From gene to phene". J Invest Dermatol. 60 (6): 360–368. doi:10.1111/1523-1747.ep12702133. PMID 4268033. Science Of Biogenetics : Can two Brown eyed parents have blue eyed child

A phenocopy is a variation in phenotype (generally referring to a single trait) which is caused by environmental conditions (often, but not necessarily, during the organism's development), such that the organism's phenotype matches a phenotype which is determined by genetic factors. It is not a type of mutation, as it is non-hereditary. The term was coined by Richard Goldschmidt in 1935. He used it to refer to forms, produced by some experimental procedure, whose appearance duplicates or copies the phenotype of some mutant or combination of mutants. Examples The butterfly genus Vanessa can change phenotype based on the local temperature. If introduced to Lapland they mimic butterflies localised to this area; and if localised to Syria they mimic butterflies of this area. The larvae of Drosophila melanogaster have been found to be particularly vulnerable to environmental factors which produce phenocopies of known mutations; these factors include temperature, shock, radiation, and various chemical compounds. In fruit fly, Drosophila melanogaster, the normal body colour is brownish gray with black margins. A hereditary mutant for this was discovered by T.H. Morgan in 1910 where the body colour is yellow. This was a genotypic character which was constant in both the flies in all environments. However, in 1939, Rapoport discovered that if larvae of normal flies were fed with silver salts, they develop into yellow bodied flies irrespective of their genotype. The yellow bodied flies which are genetically brown is a variant of the original yellow bodied fly. Phenocopy can also be observed in Himalayan rabbits. When raised in moderate temperatures, Himalayan rabbits are white in colour with black tail, nose, and ears, making them phenotypically distinguishable from genetically black rabbits. However, when raised in cold temperatures, Himalayan rabbits show black colouration of their coats, resembling the genetically black rabbits. Hence this Himalayan rabbit is a phenocopy of the genetically black rabbit.Reversible and/or cosmetic modifications such as the use of hair bleach are not considered to be phenocopy, as they are not inherent traits. See also Genocopy == References ==

Phenotypic Integration is a metric for measuring the correlation of multiple functionally-related traits to each other. Complex phenotypes often require multiple traits working together in order to function properly. Phenotypic integration is significant because it provides an explanation as to how phenotypes are sustained by relationships between traits. Every organism's phenotype is integrated, organized, and a functional whole. Integration is also associated with functional modules. Modules are complex character units that are tightly associated, such as a flower. It is hypothesized that organisms with high correlations between traits in a module have the most efficient functions. The fitness of a particular value for one phenotypic trait frequently depends on the value of the other phenotypic traits, making it important for those traits evolve together. One trait can have a direct effect on fitness, and it has been shown that the correlations among traits can also change fitness, causing these correlations to be adaptive, rather than solely genetic. Integration can be involved in multiple aspects of life, not just at the genetic level, but during development, or simply at a functional level. Integration can be caused by genetic, developmental, environmental, or physiological relationships among characters. Environmental conditions can alter or cause integration, i.e. they may be plastic. Correlational selection, a form of natural selection can also produce integration. At the genetic level, integration can be caused by pleiotropy, close linkage, or linkage disequilibrium among unlinked genes. At the developmental level it can be due to cell-cell signaling such as in the development of the ectopic eyes in Drosophila. It is believed that the patterns of genetic covariance helped distinguish certain species. It can create variation among certain phenotypes, and can facilitate efficiency. This is significant because integration may play a huge role in phenotypic evolution. Phenotypic integration and its evolution can not only create large amounts of variety among phenotypes which can cause variation among species. For example, the color patterns on Garter snakes range widely and are caused by the covariance among multiple phenotypes. Origins Shortly after the structure of DNA was uncovered, Everett C. Olson and Robert L. Miller (1958) wrote the first book regarding the topic of phenotypic integration. The term integration was first used in reference to genetics by Olson and Miller, referring to correlations among characters that are influenced by selection. Following Olson and Miller, botanical studies on coherence between characters were done spanning over many years. Its first expansion was in the construction of a morphological integration genetic model constructed by Russell Lande (1980). However, the term "Phenotypic Integration" was first coined by Massimo Pigliucci and Katherine Preston, in their book, Phenotypic Integration, which helped elucidate the observed laws of correlation and some theoretical issues regarding the topic. Natural Selection and Phenotypic Integration Phenotypic Integration can be favorable or unfavorable with respect to natural selection. It has been shown that certain combinations of correlated traits can be unfavorable to an organism. In an ontogenetic study of laboratory rats, certain covariances among developmental characters which produced differing functions in the skull and limb were less favorable than another set that contributed to skull and limb structure. The most common form of selection on phenotypic integration is correlational selection. Correlational selection is a form of natural selection that favors certain combinations of traits (phenotypic integration). It can promote both genetic correlations and high levels of genetic variation. It has even been found that correlational selection may be the most common form of natural selection. Occasionally, this form of selection will favor a group of traits at the expense of others and if it does favor a particular set of traits it will include the most used traits whose functional effectiveness is essential for their ability to work together, and whose successful interaction is needed for the fitness of the individual. Phenotypic integration may be the adaptive product of correlational selection. An example of natural selection favoring integration is in the color patterns and escape mechanisms of the Garter snake, Thamnophis Ordinoides. Another example is in plants that have highly-specific pollinators, natural selection favors plants that have highly specialized flowering to pair with the specific pollinators, and therefore high floral integration. Evolution of Phenotypic Integration Integration can be found at the genetic level due to genetic linkage. Genetic linkage involves multiple genes being inherited together during meiosis because they are close to each other on the same chromosome. Alleles at different loci can be inherited together if they are tightly linked. Large genetic correlations can only be upheld if the loci that influence different characters are tightly linked, or if high levels of inbreeding in the population occur. Even if selection favors the correlations, it will not be maintained unless those conditions are met. Selection will favor tight linkage because it is maintained better. Poorly linked genetic correlations will not last. Transposition allows the loci at different locations on the chromosome to move so that they can become close to each other and be inherited together. This is significant to understanding the relationship between phenotypic integration and evolution because it is one of the mechanisms of how multiple traits that are connected to each other to evolve and change together. For instance, the Papilio dardanus butterflies come in three different forms, each mimicking a different distasteful butterfly species. Multiple loci contribute to these different forms, and a butterfly with alleles for form A at one locus and B at another locus would have poor fitness. However, the multiple loci are tightly linked, so they are inherited together as a single allele. Through transposition, these multiple loci ended up close to each other.Mutations among these linked genes are the nonadaptive fuel which can create evolution. Evolution may also occur because the integration may have an adaptive advantage in a particular environment for an organism. It is also important to recognize that not only can the traits be inherited together, but inherited separately and selected together. Another important example of phenotypic integration evolving over time is the relationship between the neurocranium and the brain. Over the last 150 million years the number of bones in the brain has decreased while the size of the brain in mammals has changed. Integration between the brain and the skull has evolved over this time period to reduce the number of bones in the cranium, while increasing the size of the brain. This relationship between correlated traits has played an important role in the evolution of mammalian cranium structure and brain size. Finally, development is another crucial cause of phenotypic integration that has evolved over time. Cell-signaling pathways which utilize integration in the form of complex interactions among specific cells in the pathway are crucial to proper development in many organisms. The interactions among the cells in the pathway, and the interaction of the pathways with other pathways have evolved over time to create complex structures. Examples Aposematism in poison dart frogs has also shown that phenotypic integration may be involved. Aposematism is the use of warning colors to deter predators because it often conveys the organism being poisonous, and this study found that diet specialization, and chemical defense are integrated and help affect aposematism. In another study regarding the relationship of sexual ornaments and phenotypic integration, there seems to be a paradox where sexual traits are expected to be both less integrated for greater expression, and more integrated to better indicate physiological quality. However, in the case of the house finch, the female house finches select for males based on their likelihood to be a good parent. The females base their choice of male parental behaviors on the elaboration of the male's sexual ornamentation. Thus, female choice favors hormonally controlled integration of male sexual behaviors and male sexual ornamentation.Phylogenetically consistent patterns of phenotypic integration have also been recently reported in leaves, floral morphology, and dry fruits as well as in the morphology of some animal organs. Future work Understanding phenotypic integration will continue as more research and understanding is done with regards to genetic, developmental, and physiological mechanisms, and learn more about the relationship of selection and complex phenotypes. Research of this topic can even be beneficial to modern biomedicine. == References ==

Phylostratum is a set of genes from an organism that coalesce to founder genes having common phylogenetic origin. == References ==

Plant genetic resources describe the variability within plants that comes from human and natural selection over millennia. Their intrinsic value mainly concerns agricultural crops (crop biodiversity). According to the 1983 revised International Undertaking on Plant Genetic Resources for Food and Agriculture of the Food and Agriculture Organization (FAO), plant genetic resources are defined as the entire generative and vegetative reproductive material of species with economical and/or social value, especially for the agriculture of the present and the future, with special emphasis on nutritional plants.In the State of the World’s Plant Genetic Resources for Food and Agriculture (1998) the FAO defined Plant Genetic Resources for Food and Agriculture (PGRFA) as the diversity of genetic material contained in traditional varieties and modern cultivars as well as crop wild relatives and other wild plant species that can be used now or in the future for food and agriculture. History The first use of plant genetic resources dates to more than 10,000 years ago, when farmers selected from the genetic variation they found in wild plants to develop their crops. As human populations moved to different climates and ecosystems, taking the crops with them, the crops adapted to the new environments, developing, for example, genetic traits providing tolerance to conditions such as drought, water logging, frost and extreme heat. These traits - and the plasticity inherent in having wide genetic variability - are important properties of plant genetic resources.In recent centuries, although humans had been prolific in collecting exotic flora from all corners of the globe to fill their gardens, it wasn’t until the early 20th century that the widespread and organized collection of plant genetic resources for agricultural use began in earnest. Russian geneticist Nikolai Vavilov, considered by some as the father of plant genetic resources, realized the value of genetic variability for breeding and collected thousands of seeds during his extensive travels to establish one of the first gene banks. Vavilov inspired the American Jack Harlan to collect seeds from across the globe for the United States Department of Agriculture (USDA). David Fairchild, another botanist at USDA, successfully introduced many important crops (e.g. cherries, soybeans, pistachios) into the United States.It wasn’t until 1967 that the term genetic resources was coined by Otto Frankel and Erna Bennett at the historic International Conference on Crop Plant Exploration and Conservation, organized by the FAO and the International Biological Program (IBP) “The effective utilization of genetic resources requires that they are adequately classified and evaluated” was a key message from the conference. Conservation Plant genetic resource conservation has become increasingly important as more plants have become threatened or rare. At the same time, an exploding world population and rapid climate change have led humans to seek new resilient and nutritious crops. Plant conservation strategies generally combine elements of conservation on farm (as part of the crop production cycle, where it continues to evolve and support farmer needs), ex situ (for example in gene banks or field collections as seed or tissue samples) or in situ (where they grow in the wild or protected areas). Most in situ conservation concerns crop wild relatives, an important source of genetic variation to crop breeding programs.Plant genetic resources that are conserved by any of these methods are often referred to as germplasm, which is a shorthand term meaning "any genetic materials". The term originates from germ plasm, August Weismann's theory that heritable information is transmitted only by germ cells, and which has been superseded by modern insights on inheritance, including epigenetics and non-nuclear DNA. After the Second World War, efforts to conserve plant genetic resources came mainly from breeders’ organizations in the USA and Europe, which led to crop-specific collections primarily located in developed countries (e.g. IRRI, CIMMYT). In the 1960s and 1970s, more focus was put on the collection and conservation of plant genetic resources in face of genetic erosion by organizations such as the Rockefeller Foundation and the European Society of Breeding Research (EUCARPIA).A key event in the conservation of plant genetic resources was the establishment of the International Board for Plant Genetic Resources (IBPGR) (now Bioversity International) in 1974, whose mandate was to promote and assist in the worldwide effort to collect and conserve the plant germplasm needed for future research and production. IBPGR mobilized scientists to create a global network of gene banks, thus marking the international recognition of the importance of plant genetic resources.In 2002, the Global Crop Diversity Trust was established by Bioversity International on behalf of the CGIAR and the FAO through a Crop Diversity Endowment Fund. The goal of the Trust is to provide a secure and sustainable source of funding for the world's most important ex situ crop collections. Policy In response to the growing awareness of the global value of and threat to biological diversity, the United Nations drafted the 1992 Convention on Biological Diversity (CBD), the first global multilateral treaty focused on the conservation and sustainable use of biodiversity. Article 15 of the CBD specified that countries have national sovereignty over their genetic resources, but that there should be facilitated access and benefit sharing (ABS) under mutually agreed terms and with prior informed consent. Going further to protect national sovereignty of plant genetic resources, an instrumental piece of legislation, The International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA), was adopted by the FAO in November 2001 and came into force in 2004.The ITPGRFA established several mechanisms under the Multilateral System, which grants free access and equitable use of 64 of the world’s most important crops (Annex 1 crops) for some uses (research, breeding and training for food and agriculture). The treaty prevents the recipients of genetic resources from claiming intellectual property rights over those resources in the form in which they received them, and ensures that access to genetic resources is consistent with international and national laws. This is facilitated by the Standard Material Transfer Agreement, a mandatory contract between providers and recipients for the exchange of germplasm under the Multilateral System. The Governing Body of the treaty, through FAO as the Third Party Beneficiary, has an interest in the agreements.The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization is a supplementary agreement to the Convention on Biological Diversity that was adopted in 2010 and enforced in 2014. It provides greater legal transparency to policies governing fair and equitable sharing of benefits arising from the utilization of genetic resources. Issues and controversies Due to the high value and complexity of plant genetic resources and the number of parties involved globally, some issues have arisen over their conservation and use. Much of the material for breeding programs was collected from the Southern hemisphere and sent to gene banks in the Northern hemisphere, a concern that led to more emphasis on the national sovereignty of plant genetic resources and instigated policies that addressed the imbalance.The increased use of plant genetic information for research, for example to find genes of interest for drought tolerance, has led to controversy on whether and to what extent the genetic data (separate from the organism) are subject to the international ABS regulations described above.Forest genetic resources represent a specific case of plant genetic resources. See also Internal links Biopiracy Bioprospecting Plant Treaty Convention on Biological Diversity and Nagoya Protocol UPOV Convention on New Varieties of Plants Farmers rights / Peasants' rights Access and Benefit Sharing Agreement Genetic resources (disambiguation) External links Food and Agriculture Organization of the United Nations (FAO) Convention on Biological Diversity (CBD) International Treaty on Plant Genetic Resources for Food and Agriculture (Plant Treaty) International Convention for the Protection of New Varieties of Plants (UPOV Convention) Bioversity International == References ==

A polyphenic trait is a trait for which multiple, discrete phenotypes can arise from a single genotype as a result of differing environmental conditions. It is therefore a special case of phenotypic plasticity. There are several types of polyphenism in animals, from having sex determined by the environment to the castes of honey bees and other social insects. Some polyphenisms are seasonal, as in some butterflies which have different patterns during the year, and some Arctic animals like the snowshoe hare and Arctic fox, which are white in winter. Other animals have predator-induced or resource polyphenisms, allowing them to exploit variations in their environment. Some nematode worms can develop either into adults or into resting dauer larvae according to resource availability. Definition A polyphenism is the occurrence of several phenotypes in a population, the differences between which are not the result of genetic differences. For example, crocodiles possess a temperature-dependent sex determining polyphenism, where sex is the trait influenced by variations in nest temperature.When polyphenic forms exist at the same time in the same panmictic (interbreeding) population they can be compared to genetic polymorphism. With polyphenism, the switch between morphs is environmental, but with genetic polymorphism the determination of morph is genetic. These two cases have in common that more than one morph is part of the population at any one time. This is rather different from cases where one morph predictably follows another during, for instance, the course of a year. In essence the latter is normal ontogeny where young forms can and do have different forms, colours and habits to adults. The discrete nature of polyphenic traits differentiates them from traits like weight and height, which are also dependent on environmental conditions but vary continuously across a spectrum. When a polyphenism is present, an environmental cue causes the organism to develop along a separate pathway, resulting in distinct morphologies; thus, the response to the environmental cue is “all or nothing.” The nature of these environmental conditions varies greatly, and includes seasonal cues like temperature and moisture, pheromonal cues, kairomonal cues (signals released from one species that can be recognized by another), and nutritional cues. Types Sex determination Sex-determining polyphenisms allow a species to benefit from sexual reproduction while permitting an unequal gender ratio. This can be beneficial to a species because a large female-to-male ratio maximizes reproductive capacity. However, temperature-dependent sex determination (as seen in crocodiles) limits the range in which a species can exist, and makes the species susceptible to endangerment by changes in weather pattern. Temperature-dependent sex determination has been proposed as an explanation for the extinction of the dinosaurs.Population-dependent and reversible sex determination, found in animals such as the blue wrasse fish, have less potential for failure. In the blue wrasse, only one male is found in a given territory: larvae within the territory develop into females, and adult males will not enter the same territory. If a male dies, one of the females in his territory becomes male, replacing him. While this system ensures that there will always be a mating couple when two animals of the same species are present, it could potentially decrease genetic variance in a population, for example if the females remain in a single male's territory. Insect castes The caste system of insects enables eusociality, the division of labor between non-breeding and breeding individuals. A series of polyphenisms determines whether larvae develop into queens, workers, and, in some cases soldiers. In the case of the ant, P. morrisi, an embryo must develop under certain temperature and photoperiod conditions in order to become a reproductively-active queen. This allows for control of the mating season but, like sex determination, limits the spread of the species into certain climates. In bees, royal jelly provided by worker bees causes a developing larva to become a queen. Royal jelly is only produced when the queen is aging or has died. This system is less subject to influence by environmental conditions, yet prevents unnecessary production of queens. Seasonal Polyphenic pigmentation is adaptive for insect species that undergo multiple mating seasons each year. Different pigmentation patterns provide appropriate camouflage throughout the seasons, as well as alter heat retention as temperatures change. Because insects cease growth and development after eclosion, their pigment pattern is invariable in adulthood: thus, a polyphenic pigment adaptation would be less valuable for species whose adult form survives longer than one year. Birds and mammals are capable of continued physiological changes in adulthood, and some display reversible seasonal polyphenisms, such as in the Arctic fox, which becomes all white in winter as snow camouflage. Predator-induced Predator-induced polyphenisms allow the species to develop in a more reproductively-successful way in a predator's absence, but to otherwise assume a more defensible morphology. However, this can fail if the predator evolves to stop producing the kairomone to which the prey responds. For example, the midge larvae (Chaoborus) that feed on Daphnia cucullata (a water flea) release a kairomone that Daphnia can detect. When the midge larvae are present, Daphnia grow large helmets that protect them from being eaten. However, when the predator is absent, Daphnia have smaller heads and are therefore more agile swimmers. Resource Organisms with resource polyphenisms show alternative phenotypes that allow differential use of food or other resources. One example is the western spadefoot toad, which maximizes its reproductive capacity in temporary desert ponds. While the water is at a safe level, the tadpoles develop slowly on a diet of other opportunistic pond inhabitants. However, when the water level is low and desiccation is imminent, the tadpoles develop a morphology (wide mouth, strong jaw) that permits them to cannibalize. Cannibalistic tadpoles receive better nutrition and thus metamorphose more quickly, avoiding death as the pond dries up.Among invertebrates, the nematode Pristionchus pacificus has one morph that primarily feeds on bacteria and a second morph that produces large teeth, enabling it to feed on other nematodes, including competitors for bacterial food. In this species, cues of starvation and crowding by other nematodes, as sensed by pheromones, trigger a hormonal signal that ultimately activates a developmental switch gene that specifies formation of the predatory morph. Density-dependent Density-dependent polyphenism allows species to show a different phenotype based on the population density in which it was reared. In Lepidoptera, African armyworm larvae exhibit one of two appearances: the gregarious or solitary phase. Under crowded or "gregarious" conditions, the larvae have black bodies and yellow stripes along their bodies. However, under solitary conditions, they have green bodies with a brown stripe down their backs. The different phenotypes emerge during the third instar and remain until the last instar. Dauer diapause in nematodes Under conditions of stress such as crowding and high temperature, L2 larvae of some free living nematodes such as Caenorhabditis elegans can switch development to the so-called dauer larva state, instead of going the normal molts into a reproductive adult. These dauer larvae are a stress-resistant, non-feeding, long-lived stage, enabling the animals to survive harsh conditions. On return to favorable conditions, the animal resumes reproductive development from L3 stage onwards. Evolution A mechanism has been proposed for the evolutionary development of polyphenisms: A mutation results in a novel, heritable trait. The trait's frequency expands in the population, creating a population on which selection can act. Pre-existing (background) genetic variation in other genes results in phenotypic differences in expression of the new trait. These phenotypic differences undergo selection; as genotypic differences narrow, the trait becomes: Genetically fixed (non-responsive to environmental conditions) Polyphenic (responsive to environmental conditions)Evolution of novel polyphenisms through this mechanism has been demonstrated in the laboratory. Suzuki and Nijhout used an existing mutation (black) in a monophenic green hornworm (Manduca sexta) that causes a black phenotype. They found that if larvae from an existing population of black mutants were raised at 20˚C, then all the final instar larvae were black; but if the larvae were instead raised at 28˚C, the final instar larvae ranged in color from black to green. By selecting for larvae that were black if raised at 20˚C but green if raised at 28˚C, they produced a polyphenic strain after thirteen generations.This fits the model described above because a new mutation (black) was required to reveal pre-existing genetic variation and to permit selection. Furthermore, the production of a polyphenic strain was only possible because of background variation within the species: two alleles, one temperature-sensitive and one stable, were present for a single gene upstream of black (in the pigment production pathway) before selection occurred. The temperature-sensitive allele was not observable because at high temperatures, it caused an increase in green pigment in hornworms that were already bright green. However, introduction of the black mutant caused the temperature-dependent changes in pigment production to become obvious. The researchers could then select for larvae with the temperature-sensitive allele, resulting in a polyphenism. See also Phenotypic switching References External links "Seasonal Polyphenism in Butterfly Wings", article in DevBio, a companion to Developmental Biology, 9th edition, by Scott F. Gilbert

Positional sequencing is a method of sequencing DNA that simultaneously generates information about both identity and location of nucleotide sequences. The method involves detecting the location of sequence specific recognition events (e.g., such as hybridization of probes of known sequence) on single DNA molecules in each read, and generating maps of the location of such events. Multiple reads can be assembled into a consensus map that identifies the multiple locations of a specific sub-sequence. The assembly process is greatly facilitated by knowledge of the location of each sub-sequence, as well as the fact that individual reads produce non-contiguous sequence data over length scales that can be orders of magnitude greater than what can be achieved with Sanger sequencing or nextgen sequencing by synthesis. A collection of maps may be used to reconstruct single-base resolved sequence in a process analogous to sequence reconstruction in sequencing by hybridization. Ambiguities in the reconstruction of sequences are resolved through the knowledge of the relative position of overlapping sequence specific recognition events. By varying the parameters (e.g., length of read, density of recognition events, resolution of the detector) governing a specific implementation of the method, it is possible to query all size scales of DNA variation, from single nucleotide sequence all the way to large structural variants and chromosomal aneuploidies. See also Sequencing by ligation == References ==

In molecular biology, a primosome is a protein complex responsible for creating RNA primers on single stranded DNA during DNA replication. The primosome consists of seven proteins: DnaG primase, DnaB helicase, DnaC helicase assistant, DnaT, PriA, Pri B, and PriC. At each replication fork, the primosome is utilized once on the leading strand of DNA and repeatedly, initiating each Okazaki fragment, on the lagging DNA strand. Initially the complex formed by PriA, PriB, and PriC binds to DNA. Then the DnaB-DnaC helicase complex attaches along with DnaT. This structure is referred to as the pre-primosome. Finally, DnaG will bind to the pre-primosome forming a complete primosome. The primosome attaches 1-10 RNA nucleotides to the single stranded DNA creating a DNA-RNA hybrid. This sequence of RNA is used as a primer to initiate DNA polymerase III. The RNA bases are ultimately replaced with DNA bases by RNase H nuclease (eukaryotes) or DNA polymerase I nuclease (prokaryotes). DNA Ligase then acts to join the two ends together. Assembly of the Escherichia coli primosome requires six proteins, PriA, PriB, PriC, DnaB, DnaC, and DnaT, acting at a primosome assembly site (pas) on an SSBcoated single-stranded (8s) DNA. Assembly is initiated by interactions of PriA and PriB with ssDNA and the pas. PriC, DnaB, DnaC, and DnaT then act on the PriAPriB- DNA complex to yield the primosome.Primosomes are nucleoproteins assemblies that activate DNA replication forks. Their primary role is to recruit the replicative helicase onto single-stranded DNA. The "replication restart" primosome, defined in Escherichia coli, is involved in the reactivation of arrested replication forks. Binding of the PriA protein to forked DNA triggers its assembly. PriA is conserved in bacteria, but its primosomal partners are not. In Bacillus subtilis, genetic analysis has revealed three primosomal proteins, DnaB, DnaD, and DnaI, that have no obvious homologues in E. coli. They are involved in primosome function both at arrested replication forks and at the chromosomal origin. Our biochemical analysis of the DnaB and DnaD proteins unravels their role in primosome assembly. They are both multimeric and bind individually to DNA. Furthermore, DnaD stimulates DnaB binding activities. DnaD alone and the DnaD/DnaB pair interact specifically with PriA of B. subtilis on several DNA substrates. This suggests that the nucleoprotein assembly is sequential in the PriA, DnaD, DnaB order. The preferred DNA substrate mimics an arrested DNA replication fork with unreplicated lagging strand, structurally identical to a product of recombinational repair of a stalled replication fork. == References ==

A prion is a misfolded protein that can induce misfolding of normal variants of the same protein and trigger cellular death. Prions cause prion diseases known as transmissible spongiform encephalopathies (TSEs) that are transmissible, fatal neurodegenerative diseases in humans and animals. The proteins may misfold sporadically, due to genetic mutations, or by exposure to an already misfolded protein. The consequent abnormal three-dimensional structure confers on them the ability to cause misfolding of other proteins. The word prion is derived from the term "proteinaceous infectious particle". The hypothesized role of a protein as an infectious agent stands in contrast to all other known infectious agents such as viroids, viruses, bacteria, fungi, and parasites, all of which contain nucleic acids (DNA, RNA, or both). Most prions are twisted isoforms of the major prion protein (PrP), a natural protein whose normal function is uncertain. They are hypothesized as the cause of transmissible spongiform encephalopathies (TSEs), including scrapie in sheep, chronic wasting disease (CWD) in deer, bovine spongiform encephalopathy (BSE) in cattle (mad cow disease), feline spongiform encephalopathy (FSE) in felines, and Creutzfeldt–Jakob disease (CJD) in humans. All known prion diseases in mammals affect the structure of the brain or other neural tissue; all are progressive, have no known effective treatment, and are always fatal. All known mammalian prion diseases were caused by PrP until 2015, when a prion form of alpha-synuclein was hypothesized to cause multiple system atrophy (MSA).Prions are a type of intrinsically disordered protein, which continuously change their conformation unless they are bound to a specific partner such as another protein. With a prion, two protein chains are stabilized if one binds to another in the same conformation. The probability of this happening is low, but once it does, the combination of the two is very stable. Then more units can get added, making a sort of "fibril". Prions form abnormal aggregates of proteins called amyloids, which accumulate in infected tissue and are associated with tissue damage and cell death. Amyloids are also associated with several other neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.A prion disease is a type of proteopathy, or disease of structurally abnormal proteins. In humans, prions are believed to be the cause of Creutzfeldt–Jakob disease (CJD), its variant (vCJD), Gerstmann–Sträussler–Scheinker syndrome (GSS), fatal familial insomnia (FFI), and kuru. There is also evidence suggesting prions may play a part in the process of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS); these have been termed prion-like diseases. Several yeast proteins have also been identified as having prionogenic properties, as well as a protein involved in modification of synapses during the formation of memories (see Eric Kandel § Molecular changes during learning). Prion replication is subject to epimutation and natural selection just as for other forms of replication, and their structure varies slightly between species.Prion aggregates are stable, and this structural stability means that prions are resistant to denaturation by chemical and physical agents: they cannot be destroyed by ordinary disinfection or cooking. This makes disposal and containment of these particles difficult, and the risk of iatrogenic spread through medical instruments a growing concern. Etymology and pronunciation The word prion, coined in 1982 by Stanley B. Prusiner, is derived from protein and infection, hence prion, and is short for "proteinaceous infectious particle", in reference to its ability to self-propagate and transmit its conformation to other proteins. Its main pronunciation is , although , as the homographic name of the bird (prions or whalebirds) is pronounced, is also heard. In his 1982 paper introducing the term, Prusiner specified that it is "pronounced pree-on". Prion protein Structure The major prion protein (PrP) that prions are made of is found throughout the body, even in healthy people and animals. However, PrP found in infectious material has a different structure and is resistant to proteases, the enzymes in the body that can normally break down proteins. The normal form of the protein is called PrPC, while the infectious form is called PrPSc – the C refers to 'cellular' PrP, while the Sc refers to 'scrapie', the prototypic prion disease, occurring in sheep. PrP can also be induced to fold into other more-or-less well-defined isoforms in vitro; although their relationships to the form(s) that are pathogenic in vivo is often unclear, high-resolution structural analyses have begun to reveal structural features that correlate with prion infectivity. PrPC PrPC is a normal protein found on the membranes of cells, "including several blood components of which platelets constitute the largest reservoir in humans." It has 209 amino acids (in humans), one disulfide bond, a molecular mass of 35–36 kDa and a mainly alpha-helical structure. Several topological forms exist; one cell surface form anchored via glycolipid and two transmembrane forms. The normal protein is not sedimentable; meaning that it cannot be separated by centrifuging techniques. Its function is a complex issue that continues to be investigated. PrPC binds copper (II) ions with high affinity. The significance of this finding is not clear, but it is presumed to relate to PrP structure or function. PrPC is readily digested by proteinase K and can be liberated from the cell surface in vitro by the enzyme phosphoinositide phospholipase C (PI-PLC), which cleaves the glycophosphatidylinositol (GPI) glycolipid anchor. PrP has been reported to play important roles in cell-cell adhesion and intracellular signaling in vivo, and may therefore be involved in cell-cell communication in the brain. PrPres Protease-resistant PrPSc-like protein (PrPres) is the name given to any isoform of PrPc which is structurally altered and converted into a misfolded proteinase K-resistant form. To model conversion of PrPC to PrPSc in vitro, Kocisko et al. showed that PrPSc could cause PrPC to convert to PrPres under cell-free conditions and Soto et al. demonstrated sustained amplification of PrPres and prion infectivity by a procedure involving cyclic amplification of protein misfolding. The term "PrPres" may refer either to protease-resistant forms of PrPSc, which is isolated from infectious tissue and associated with the transmissible spongiform encephalopathy agent, or to other protease-resistant forms of PrP that, for example, might be generated in vitro. Accordingly, unlike PrPSc, PrPres may not necessarily be infectious. PrPSc The infectious isoform of PrP, known as PrPSc, or simply the prion, is able to convert normal PrPC proteins into the infectious isoform by changing their conformation, or shape; this, in turn, alters the way the proteins interconnect. PrPSc always causes prion disease. PrPSc has a higher proportion of β-sheet structure in place of the normal α-helix structure. Several highly infectious, brain-derived PrPSc structures have been solved by cryo-electron microscopy, (e.g. see ). Another non-infectious, but brain-derived, fibril structure isolated from humans with Gerstmann-Straussler-Schienker syndrome has also been determined . All, so far, are highly structured amyloid fibers in which individual PrP molecules are stacked via intermolecular beta sheets. The glycolipid anchors and asparagine-linked glycans, when present, project outward from the lateral surfaces of the fiber cores. Often PrPSc is bound to cellular membranes, presumably via its array of glycolipid anchors, however, sometimes the fibers are dissociated from membranes and accumulate outside of cells in the form of plaques. The end of each fiber acts as a template onto which free protein molecules may attach, allowing the fiber to grow. This growth process requires complete refolding of PrPC. Different prion strains have distinct templates, or conformations, even when composed of PrP molecules of the same amino acid sequence, as occurs in a particular genotype of host. Under most circumstances, only PrP molecules with an identical amino acid sequence to the infectious PrPSc are incorporated into the growing fiber. However, rare cross-species transmission is also possible. Normal function of PrP The physiological function of the prion protein remains poorly understood. While data from in vitro experiments suggest many dissimilar roles, studies on PrP knockout mice have provided only limited information because these animals exhibit only minor abnormalities. In research done in mice, it was found that the cleavage of PrP in peripheral nerves causes the activation of myelin repair in Schwann cells and that the lack of PrP proteins caused demyelination in those cells. PrP and regulated cell death MAVS, RIP1, and RIP3 are prion-like proteins found in other parts of the body. They also polymerise into filamentous amyloid fibers which initiate regulated cell death in the case of a viral infection to prevent the spread of virions to other, surrounding cells. PrP and long-term memory A review of evidence in 2005 suggested that PrP may have a normal function in maintenance of long-term memory. As well, a 2004 study found that mice lacking genes for normal cellular PrP protein show altered hippocampal long-term potentiation. A recent study that also suggests why this might be the case, found that neuronal protein CPEB has a similar genetic sequence to yeast prion proteins. The prion-like formation of CPEB is essential for maintaining long-term synaptic changes associated with long-term memory formation. PrP and stem cell renewal A 2006 article from the Whitehead Institute for Biomedical Research indicates that PrP expression on stem cells is necessary for an organism's self-renewal of bone marrow. The study showed that all long-term hematopoietic stem cells express PrP on their cell membrane and that hematopoietic tissues with PrP-null stem cells exhibit increased sensitivity to cell depletion. PrP and innate immunity There is some evidence that PrP may play a role in innate immunity, as the expression of PRNP, the PrP gene, is upregulated in many viral infections and PrP has antiviral properties against many viruses, including HIV. Replication The first hypothesis that tried to explain how prions replicate in a protein-only manner was the heterodimer model. This model assumed that a single PrPSc molecule binds to a single PrPC molecule and catalyzes its conversion into PrPSc. The two PrPSc molecules then come apart and can go on to convert more PrPC. However, a model of prion replication must explain both how prions propagate, and why their spontaneous appearance is so rare. Manfred Eigen showed that the heterodimer model requires PrPSc to be an extraordinarily effective catalyst, increasing the rate of the conversion reaction by a factor of around 1015. This problem does not arise if PrPSc exists only in aggregated forms such as amyloid, where cooperativity may act as a barrier to spontaneous conversion. What is more, despite considerable effort, infectious monomeric PrPSc has never been isolated.An alternative model assumes that PrPSc exists only as fibrils, and that fibril ends bind PrPC and convert it into PrPSc. If this were all, then the quantity of prions would increase linearly, forming ever longer fibrils. But exponential growth of both PrPSc and of the quantity of infectious particles is observed during prion disease. This can be explained by taking into account fibril breakage. A mathematical solution for the exponential growth rate resulting from the combination of fibril growth and fibril breakage has been found. The exponential growth rate depends largely on the square root of the PrPC concentration. The incubation period is determined by the exponential growth rate, and in vivo data on prion diseases in transgenic mice match this prediction. The same square root dependence is also seen in vitro in experiments with a variety of different amyloid proteins.The mechanism of prion replication has implications for designing drugs. Since the incubation period of prion diseases is so long, an effective drug does not need to eliminate all prions, but simply needs to slow down the rate of exponential growth. Models predict that the most effective way to achieve this, using a drug with the lowest possible dose, is to find a drug that binds to fibril ends and blocks them from growing any further.Researchers at Dartmouth College discovered that endogenous host cofactor molecules such as the phospholipid molecule (e.g. phosphatidylethanolamine) and polyanions (e.g. single stranded RNA molecules) are necessary to form PrPSc molecules with high levels of specific infectivity in vitro, whereas protein-only PrPSc molecules appear to lack significant levels of biological infectivity. Transmissible spongiform encephalopathies Prions cause neurodegenerative disease by aggregating extracellularly within the central nervous system to form plaques known as amyloids, which disrupt the normal tissue structure. This disruption is characterized by "holes" in the tissue with resultant spongy architecture due to the vacuole formation in the neurons. Other histological changes include astrogliosis and the absence of an inflammatory reaction. While the incubation period for prion diseases is relatively long (5 to 20 years), once symptoms appear the disease progresses rapidly, leading to brain damage and death. Neurodegenerative symptoms can include convulsions, dementia, ataxia (balance and coordination dysfunction), and behavioural or personality changes.Many different mammalian species can be affected by prion diseases, as the prion protein (PrP) is very similar in all mammals. Due to small differences in PrP between different species it is unusual for a prion disease to transmit from one species to another. The human prion disease variant Creutzfeldt–Jakob disease, however, is thought to be caused by a prion that typically infects cattle, causing bovine spongiform encephalopathy and is transmitted through infected meat.All known prion diseases are untreatable and fatal. However, a vaccine developed in mice may provide insight into providing a vaccine to resist prion infections in humans. Additionally, in 2006 scientists announced that they had genetically engineered cattle lacking a necessary gene for prion production – thus theoretically making them immune to BSE, building on research indicating that mice lacking normally occurring prion protein are resistant to infection by scrapie prion protein. In 2013, a study revealed that 1 in 2,000 people in the United Kingdom might harbour the infectious prion protein that causes vCJD.Until 2015 all known mammalian prion diseases were considered to be caused by the prion protein, PrP; in 2015 multiple system atrophy was found to be transmissible and was hypothesized to be caused by a new prion, the misfolded form of a protein called alpha-synuclein. The endogenous, properly folded form of the prion protein is denoted PrPC (for Common or Cellular), whereas the disease-linked, misfolded form is denoted PrPSc (for Scrapie), after one of the diseases first linked to prions and neurodegeneration. The precise structure of the prion is not known, though they can be formed spontaneously by combining PrPC, homopolymeric polyadenylic acid, and lipids in a protein misfolding cyclic amplification (PMCA) reaction even in the absence of pre-existing infectious prions. This result is further evidence that prion replication does not require genetic information. Transmission It has been recognized that prion diseases can arise in three different ways: acquired, familial, or sporadic. It is often assumed that the diseased form directly interacts with the normal form to make it rearrange its structure. One idea, the "Protein X" hypothesis, is that an as-yet unidentified cellular protein (Protein X) enables the conversion of PrPC to PrPSc by bringing a molecule of each of the two together into a complex.The primary method of infection in animals is through ingestion. It is thought that prions may be deposited in the environment through the remains of dead animals and via urine, saliva, and other body fluids. They may then linger in the soil by binding to clay and other minerals.A University of California research team has provided evidence for the theory that infection can occur from prions in manure. And, since manure is present in many areas surrounding water reservoirs, as well as used on many crop fields, it raises the possibility of widespread transmission. It was reported in January 2011 that researchers had discovered prions spreading through airborne transmission on aerosol particles, in an animal testing experiment focusing on scrapie infection in laboratory mice. Preliminary evidence supporting the notion that prions can be transmitted through use of urine-derived human menopausal gonadotropin, administered for the treatment of infertility, was published in 2011. Prions in plants In 2015, researchers at The University of Texas Health Science Center at Houston found that plants can be a vector for prions. When researchers fed hamsters grass that grew on ground where a deer that died with chronic wasting disease (CWD) was buried, the hamsters became ill with CWD, suggesting that prions can bind to plants, which then take them up into the leaf and stem structure, where they can be eaten by herbivores, thus completing the cycle. It is thus possible that there is a progressively accumulating number of prions in the environment. Sterilization Infectious particles possessing nucleic acid are dependent upon it to direct their continued replication. Prions, however, are infectious by their effect on normal versions of the protein. Sterilizing prions, therefore, requires the denaturation of the protein to a state in which the molecule is no longer able to induce the abnormal folding of normal proteins. In general, prions are quite resistant to proteases, heat, ionizing radiation, and formaldehyde treatments, although their infectivity can be reduced by such treatments. Effective prion decontamination relies upon protein hydrolysis or reduction or destruction of protein tertiary structure. Examples include sodium hypochlorite, sodium hydroxide, and strongly acidic detergents such as LpH.The World Health Organization recommends any of the following three procedures for the sterilization of all heat-resistant surgical instruments to ensure that they are not contaminated with prions: Immerse in 1N sodium hydroxide and place in a gravity-displacement autoclave at 121 °C for 30 minutes; clean; rinse in water; and then perform routine sterilization processes. Immerse in 1N sodium hypochlorite (20,000 parts per million available chlorine) for 1 hour; transfer instruments to water; heat in a gravity-displacement autoclave at 121 °C for 1 hour; clean; and then perform routine sterilization processes. Immerse in 1N sodium hydroxide or sodium hypochlorite (20,000 parts per million available chlorine) for 1 hour; remove and rinse in water, then transfer to an open pan and heat in a gravity-displacement (121 °C) or in a porous-load (134 °C) autoclave for 1 hour; clean; and then perform routine sterilization processes.134 °C (273 °F) for 18 minutes in a pressurized steam autoclave has been found to be somewhat effective in deactivating the agent of disease. Ozone sterilization is currently being studied as a potential method for prion denaturation and deactivation. Other approaches being developed include thiourea-urea treatment, guanidinium chloride treatment, and special heat-resistant subtilisin combined with heat and detergent. A method sufficient for sterilizing prions on one material may fail on another.Renaturation of a completely denatured prion to infectious status has not yet been achieved; however, partially denatured prions can be renatured to an infective status under certain artificial conditions. Degradation resistance in nature Overwhelming evidence shows that prions resist degradation and persist in the environment for years, and proteases do not degrade them. Experimental evidence shows that unbound prions degrade over time, while soil-bound prions remain at stable or increasing levels, suggesting that prions likely accumulate in the environment. One 2015 study by US scientists found that repeated drying and wetting may render soil bound prions less infectious, although this was dependent on the soil type they were bound to. Fungi Proteins showing prion-type behavior are also found in some fungi, which has been useful in helping to understand mammalian prions. Fungal prions do not always cause disease in their hosts. In yeast, protein refolding to the prion configuration is assisted by chaperone proteins such as Hsp104. All known prions induce the formation of an amyloid fold, in which the protein polymerises into an aggregate consisting of tightly packed beta sheets. Amyloid aggregates are fibrils, growing at their ends, and replicate when breakage causes two growing ends to become four growing ends. The incubation period of prion diseases is determined by the exponential growth rate associated with prion replication, which is a balance between the linear growth and the breakage of aggregates.Fungal proteins exhibiting templated conformational change were discovered in the yeast Saccharomyces cerevisiae by Reed Wickner in the early 1990s. For their mechanistic similarity to mammalian prions, they were termed yeast prions. Subsequent to this, a prion has also been found in the fungus Podospora anserina. These prions behave similarly to PrP, but, in general, are nontoxic to their hosts. Susan Lindquist's group at the Whitehead Institute has argued some of the fungal prions are not associated with any disease state, but may have a useful role; however, researchers at the NIH have also provided arguments suggesting that fungal prions could be considered a diseased state. There is evidence that fungal proteins have evolved specific functions that are beneficial to the microorganism that enhance their ability to adapt to their diverse environments. Further, within yeasts, prions can act as vectors of epigenetic inheritance, transferring traits to offspring without any genomic change.Research into fungal prions has given strong support to the protein-only concept, since purified protein extracted from cells with a prion state has been demonstrated to convert the normal form of the protein into a misfolded form in vitro, and in the process, preserve the information corresponding to different strains of the prion state. It has also shed some light on prion domains, which are regions in a protein that promote the conversion into a prion. Fungal prions have helped to suggest mechanisms of conversion that may apply to all prions, though fungal prions appear distinct from infectious mammalian prions in the lack of cofactor required for propagation. The characteristic prion domains may vary between species – e.g., characteristic fungal prion domains are not found in mammalian prions. Treatments There are no effective treatments for prion diseases. Clinical trials in humans have not met with success and have been hampered by the rarity of prion diseases. Although some potential treatments have shown promise in the laboratory, none have been effective once the disease has commenced. In other diseases Prion-like domains have been found in a variety of other mammalian proteins. Some of these proteins have been implicated in the ontogeny of age-related neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U), Alzheimer's disease, Parkinson's disease, and Huntington's disease. They are also implicated in some forms of systemic amyloidosis including AA amyloidosis that develops in humans and animals with inflammatory and infectious diseases such as tuberculosis, Crohn's disease, rheumatoid arthritis, and HIV/AIDS. AA amyloidosis, like prion disease, may be transmissible. This has given rise to the 'prion paradigm', where otherwise harmless proteins can be converted to a pathogenic form by a small number of misfolded, nucleating proteins.The definition of a prion-like domain arises from the study of fungal prions. In yeast, prionogenic proteins have a portable prion domain that is both necessary and sufficient for self-templating and protein aggregation. This has been shown by attaching the prion domain to a reporter protein, which then aggregates like a known prion. Similarly, removing the prion domain from a fungal prion protein inhibits prionogenesis. This modular view of prion behaviour has led to the hypothesis that similar prion domains are present in animal proteins, in addition to PrP. These fungal prion domains have several characteristic sequence features. They are typically enriched in asparagine, glutamine, tyrosine and glycine residues, with an asparagine bias being particularly conducive to the aggregative property of prions. Historically, prionogenesis has been seen as independent of sequence and only dependent on relative residue content. However, this has been shown to be false, with the spacing of prolines and charged residues having been shown to be critical in amyloid formation.Bioinformatic screens have predicted that over 250 human proteins contain prion-like domains (PrLD). These domains are hypothesized to have the same transmissible, amyloidogenic properties of PrP and known fungal proteins. As in yeast, proteins involved in gene expression and RNA binding seem to be particularly enriched in PrLD's, compared to other classes of protein. In particular, 29 of the known 210 proteins with an RNA recognition motif also have a putative prion domain. Meanwhile, several of these RNA-binding proteins have been independently identified as pathogenic in cases of ALS, FTLD-U, Alzheimer's disease, and Huntington's disease. Role in neurodegenerative disease The pathogenicity of prions and proteins with prion-like domains is hypothesized to arise from their self-templating ability and the resulting exponential growth of amyloid fibrils. The presence of amyloid fibrils in patients with degenerative diseases has been well documented. These amyloid fibrils are seen as the result of pathogenic proteins that self-propagate and form highly stable, non-functional aggregates. While this does not necessarily imply a causal relationship between amyloid and degenerative diseases, the toxicity of certain amyloid forms and the overproduction of amyloid in familial cases of degenerative disorders supports the idea that amyloid formation is generally toxic.Specifically, aggregation of TDP-43, an RNA-binding protein, has been found in ALS/MND patients, and mutations in the genes coding for these proteins have been identified in familial cases of ALS/MND. These mutations promote the misfolding of the proteins into a prion-like conformation. The misfolded form of TDP-43 forms cytoplasmic inclusions in affected neurons, and is found depleted in the nucleus. In addition to ALS/MND and FTLD-U, TDP-43 pathology is a feature of many cases of Alzheimer's disease, Parkinson's disease and Huntington's disease. The misfolding of TDP-43 is largely directed by its prion-like domain. This domain is inherently prone to misfolding, while pathological mutations in TDP-43 have been found to increase this propensity to misfold, explaining the presence of these mutations in familial cases of ALS/MND. As in yeast, the prion-like domain of TDP-43 has been shown to be both necessary and sufficient for protein misfolding and aggregation.Similarly, pathogenic mutations have been identified in the prion-like domains of heterogeneous nuclear riboproteins hnRNPA2B1 and hnRNPA1 in familial cases of muscle, brain, bone and motor neuron degeneration. The wild-type form of all of these proteins show a tendency to self-assemble into amyloid fibrils, while the pathogenic mutations exacerbate this behaviour and lead to excess accumulation. Weaponization Prions could theoretically be employed as a weaponized agent. With potential fatality rates of 100%, prions could be an effective bioweapon, sometimes called a "biochemical weapon", because a prion is a biochemical. An unfavorable aspect is prions' very long incubation periods. Persistent heavy exposure of prions to the intestine might shorten the overall onset. Another aspect of using prions in warfare is the difficulty of detection and decontamination. History In the 18th and 19th centuries, exportation of sheep from Spain was observed to coincide with a disease called scrapie. This disease caused the affected animals to "lie down, bite at their feet and legs, rub their backs against posts, fail to thrive, stop feeding and finally become lame". The disease was also observed to have the long incubation period that is a key characteristic of transmissible spongiform encephalopathies (TSEs). Although the cause of scrapie was not known back then, it is probably the first transmissible spongiform encephalopathy to be recorded.In the 1950s, Carleton Gajdusek began research which eventually showed that kuru could be transmitted to chimpanzees by what was possibly a new infectious agent, work for which he eventually won the 1976 Nobel prize. During the 1960s, two London-based researchers, radiation biologist Tikvah Alper and biophysicist John Stanley Griffith, developed the hypothesis that the transmissible spongiform encephalopathies are caused by an infectious agent consisting solely of proteins. Earlier investigations by E.J. Field into scrapie and kuru had found evidence for the transfer of pathologically inert polysaccharides that only become infectious post-transfer, in the new host. Alper and Griffith wanted to account for the discovery that the mysterious infectious agent causing the diseases scrapie and Creutzfeldt–Jakob disease resisted ionizing radiation. Griffith proposed three ways in which a protein could be a pathogen.In the first hypothesis, he suggested that if the protein is the product of a normally suppressed gene, and introducing the protein could induce the gene's expression, that is, wake the dormant gene up, then the result would be a process indistinguishable from replication, as the gene's expression would produce the protein, which would then go wake the gene up in other cells.His second hypothesis forms the basis of the modern prion theory, and proposed that an abnormal form of a cellular protein can convert normal proteins of the same type into its abnormal form, thus leading to replication.His third hypothesis proposed that the agent could be an antibody if the antibody was its own target antigen, as such an antibody would result in more and more antibody being produced against itself. However, Griffith acknowledged that this third hypothesis was unlikely to be true due to the lack of a detectable immune response.Francis Crick recognized the potential significance of the Griffith protein-only hypothesis for scrapie propagation in the second edition of his "Central dogma of molecular biology" (1970): While asserting that the flow of sequence information from protein to protein, or from protein to RNA and DNA was "precluded", he noted that Griffith's hypothesis was a potential contradiction (although it was not so promoted by Griffith). The revised hypothesis was later formulated, in part, to accommodate reverse transcription (which both Howard Temin and David Baltimore discovered in 1970).In 1982, Stanley B. Prusiner of the University of California, San Francisco, announced that his team had purified the hypothetical infectious protein, which did not appear to be present in healthy hosts, though they did not manage to isolate the protein until two years after Prusiner's announcement. The protein was named a prion, for "proteinacious infectious particle", derived from the words protein and infection. When the prion was discovered, Griffith's first hypothesis, that the protein was the product of a normally silent gene was favored by many. It was subsequently discovered, however, that the same protein exists in normal hosts but in different form.Following the discovery of the same protein in different form in uninfected individuals, the specific protein that the prion was composed of was named the prion protein (PrP), and Griffith's second hypothesis that an abnormal form of a host protein can convert other proteins of the same type into its abnormal form, became the dominant theory. Prusiner was awarded the Nobel Prize in Physiology or Medicine in 1997 for his research into prions. See also Bovine spongiform encephalopathy (BSE) Diseases of abnormal polymerization Mad cow crisis Prion pseudoknot Subviral agents Tau protein References External links CDC – US Center for Disease Control and Prevention – information on prion diseases World Health Organisation – WHO information on prion diseases The UK BSE Inquiry – Report of the UK public inquiry into BSE and variant CJD UK Spongiform Encephalopathy Advisory Committee (SEAC)

A pronucleus (pl.: pronuclei) denotes the nucleus found in either a sperm or egg cell during the process of fertilization. The sperm cell undergoes a transformation into a pronucleus after entering the egg cell but prior to the fusion of the genetic material of both the sperm and egg. In contrast, the egg cell possesses a pronucleus once it becomes haploid, not upon the arrival of the sperm cell. Haploid cells, such as sperm and egg cells in humans, carry half the number of chromosomes present in somatic cells, with 23 chromosomes compared to the 46 found in somatic cells. It is noteworthy that the male and female pronuclei do not physically merge, although their genetic material does. Instead, their membranes dissolve, eliminating any barriers between the male and female chromosomes, facilitating the combination of their chromosomes into a single diploid nucleus in the resulting embryo, which contains a complete set of 46 chromosomes. The presence of two pronuclei serves as the initial indication of successful fertilization, often observed around 18 hours after insemination, or intracytoplasmic sperm injection (ICSI) during in vitro fertilization. At this stage, the zygote is termed a two-pronuclear zygote (2PN). Two-pronuclear zygotes transitioning through 1PN or 3PN states tend to yield poorer-quality embryos compared to those maintaining 2PN status throughout development, and this distinction may hold significance in the selection of embryos during in vitro fertilization (IVF) procedures. History The pronucleus was discovered the 1870s microscopically using staining techniques combined with microscopes with improved magnification levels. The pronucleus was originally found during the first studies on meiosis. Edouard Van Beneden published a paper in 1875 in which he first mentions the pronucleus by studying the eggs of rabbits and bats. He stated that the two pronuclei form together in the center of the cell to form the embryonic nucleus. Van Beneden also found that the sperm enters into the cell through the membrane in order to form the male pronucleus. In 1876, Oscar Hertwig did a study on sea urchin eggs because the eggs of sea urchins are transparent, so it allowed for much better magnification of the egg. Hertwig confirmed Van Beneden's finding of the pronucleus, and also found the formation of the female pronucleus involves the formation of polar bodies. Formation The female pronucleus is the female egg cell once it has become a haploid cell, and the male pronucleus forms when the sperm enters into the female egg. While the sperm develops inside of the male testes, the sperm does not become a pronucleus until it decondenses quickly inside of the female egg. When the sperm reaches the female egg, the sperm loses its outside membrane as well as its tail. The sperm does this because the membrane and the tail are no longer needed by the female ovum. The purpose of the cell membrane was to protect the DNA from the acidic vaginal fluid, and the purpose of the tail of the sperm was to help move the sperm cell to the egg cell. The formation of the female egg is asymmetrical, while the formation of the male sperm is symmetrical. Typically in a female mammal, meiosis starts with one diploid cell and becomes one haploid ovum and typically two polar bodies, however one may later divide to form a third polar body. In a male, meiosis starts with one diploid cell and ends with four sperm. In mammals, the female pronucleus starts in the center of the egg before fertilization. When the male pronucleus is formed, after the sperm cell reaches the egg, the two pronuclei migrate towards each other. However, in brown alga Pelvetia, the egg pronucleus starts in the center of the egg before fertilization and remain in the center after fertilization. This is because the egg cells of brown alga Pelvetia, the egg pronucleus is anchored down by microtubules so only the male pronucleus migrates towards the female pronucleus. Calcium concentration The calcium concentration within the egg cell cytoplasm has a very important role in the formation of an activated female egg. If there is no calcium influx, the female diploid cell will produce three pronuclei, rather than only one. This is due to the failure of release of the second polar body. Combination of male and female pronuclei In sea urchins, the formation of the zygote starts with the fusion of both the inner and outer nuclei of the male and female pronuclei. It is unknown if one of the pronuclei start the combination of the two, or if the microtubules that help the dissolution of membranes commence the action. The microtubules that make the two pronuclei combine come from the sperm's centrosome. There is a study that strongly supports that microtubules are an important part of the fusion of the pronuclei. Vinblastine is a chemotherapy drug that affects both the plus and minus ends of microtubules. When vinblastine is added to the ovum, there is a high rate of pronuclear fusion failure. This high rate of pronuclear fusion failure highly suggests that microtubules play a major role in the fusion of the pronucleus. In mammals, the pronuclei only last in the cell for about twelve hours, due to the fusion of the genetic material of the two pronuclei within the egg cell. Many studies of pronuclei have been in the egg cells of sea urchins, where the pronuclei are in the egg cell for less than an hour. The main difference between the process of fusion of genetic materials in mammals versus sea urchins is that in sea urchins, the pronuclei go directly into forming a zygote nucleus. In mammalian egg cells, the chromatin from the pronuclei form chromosomes that merge onto the same mitotic spindle. The diploid nucleus in mammals is first seen at the two-cell stage, whereas in sea urchins it is first found at the zygote stage. References == External links ==

The term proofreading is used in genetics to refer to the error-correcting processes, first proposed by John Hopfield and Jacques Ninio, involved in DNA replication, immune system specificity, and enzyme-substrate recognition among many other processes that require enhanced specificity. The proofreading mechanisms of Hopfield and Ninio are non-equilibrium active processes that consume ATP to enhance specificity of various biochemical reactions. In bacteria, all three DNA polymerases (I, II and III) have the ability to proofread, using 3’ → 5’ exonuclease activity. When an incorrect base pair is recognized, DNA polymerase reverses its direction by one base pair of DNA and excises the mismatched base. Following base excision, the polymerase can re-insert the correct base and replication can continue. In eukaryotes, only the polymerases that deal with the elongation (delta and epsilon) have proofreading ability (3’ → 5’ exonuclease activity).Proofreading also occurs in mRNA translation for protein synthesis. In this case, one mechanism is the release of any incorrect aminoacyl-tRNA before peptide bond formation.The extent of proofreading in DNA replication determines the mutation rate, and is different in different species. For example, loss of proofreading due to mutations in the DNA polymerase epsilon gene results in a hyper-mutated genotype with >100 mutations per Mbase of DNA in human colorectal cancers.The extent of proofreading in other molecular processes can depend on the effective population size of the species and the number of genes affected by the same proofreading mechanism. Bacteriophage T4 DNA polymerase Bacteriophage (phage) T4 gene 43 encodes the phage’s DNA polymerase replicative enzyme. Temperature-sensitive (ts) gene 43 mutants have been identified that have an antimutator phenotype, that is a lower rate of spontaneous mutation than wild type. Studies of one of these mutants, tsB120, showed that the DNA polymerase specified by this mutant copies DNA templates at a slower rate than the wild-type polymerase. However, the 3’ to 5’ exonuclease activity was no higher than wild-type. During DNA replication the ratio of nucleotides turned over to those stably incorporated into newly formed DNA is 10 to 100 times higher in the case of the tsB120 mutant than in wild-type. It was proposed that the antimutator effect may be explained by both greater accuracy in nucleotide selection and an increased efficiency of removal of noncomplementary nucleotides (proofreading) by the tsB120 polymerase. When phage T4 virions with a wild-type gene 43 DNA polymerase are exposed to either ultraviolet light, which introduces cyclobutane pyrimidine dimer damages in DNA, or psoralen-plus-light, which introduces pyrimidine adducts, the rate of mutation increases. However, these mutagenic effects are inhibited when the phage's DNA synthesis is catalyzed by the tsCB120 antimutator polymerase, or another antimutator polymerase, tsCB87. These findings indicate that the level of induction of mutations by DNA damage can be strongly influenced by the gene 43 DNA polymerase proofreading function. SARS-CoV-2 proofreading enzyme Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic. The SARS-CoV-2 RNA virus genome encodes a replication-and transcription complex, a multisubunit protein machine that carries out viral genome replication and transcription, processes essential to the virus life cycle. One of the proteins specified by the coronavirus genome is a non-structural protein, nsp14, that is a 3’-to-5’ exoribonuclease (ExoN). This protein resides in the protein complex nsp10-nsp14 that enhances replication fidelity by proofreading RNA synthesis, an activity critical for the virus life cycle. Furthermore the coronavirus proofreading exoribonuclease nsp14-ExoN is required for maintaining genetic recombination generated during infection. References External links Idaho U. DNA proofreading and repair "DNA polymerase ε and δ proofreading suppress discrete mutator and cancer phenotypes in mice" Tseng, Shun-Fu; Gabriel, Abram; Teng, Shu-Chun (2008). "Proofreading Activity of DNA Polymerase Pol2 Mediates 3′-End Processing during Nonhomologous End Joining in Yeast". PLOS Genetics. 4 (4): e1000060. doi:10.1371/journal.pgen.1000060. PMC 2312331. PMID 18437220.

Prophase (from Ancient Greek προ- (pro-) 'before', and φάσις (phásis) 'appearance') is the first stage of cell division in both mitosis and meiosis. Beginning after interphase, DNA has already been replicated when the cell enters prophase. The main occurrences in prophase are the condensation of the chromatin reticulum and the disappearance of the nucleolus. Staining and microscopy Microscopy can be used to visualize condensed chromosomes as they move through meiosis and mitosis.Various DNA stains are used to treat cells such that condensing chromosomes can be visualized as the move through prophase.The giemsa G-banding technique is commonly used to identify mammalian chromosomes, but utilizing the technology on plant cells was originally difficult due to the high degree of chromosome compaction in plant cells. G-banding was fully realized for plant chromosomes in 1990. During both meiotic and mitotic prophase, giemsa staining can be applied to cells to elicit G-banding in chromosomes. Silver staining, a more modern technology, in conjunction with giesma staining can be used to image the synaptonemal complex throughout the various stages of meiotic prophase. To perform G-banding, chromosomes must be fixed, and thus it is not possible to perform on living cells.Fluorescent stains such as DAPI can be used in both live plant and animal cells. These stains do not band chromosomes, but instead allow for DNA probing of specific regions and genes. Use of fluorescent microscopy has vastly improved spatial resolution. Mitotic prophase Prophase is the first stage of mitosis in animal cells, and the second stage of mitosis in plant cells. At the start of prophase there are two identical copies of each chromosome in the cell due to replication in interphase. These copies are referred to as sister chromatids and are attached by DNA element called the centromere. The main events of prophase are: the condensation of chromosomes, the movement of the centrosomes, the formation of the mitotic spindle, and the beginning of nucleoli break down. Condensation of chromosomes DNA that was replicated in interphase is condensed from DNA strands with lengths reaching 0.7 μm down to 0.2-0.3 μm. This process employs the condensin complex. Condensed chromosomes consist of two sister chromatids joined at the centromere. Movement of centrosomes During prophase in animal cells, centrosomes move far enough apart to be resolved using a light microscope. Microtubule activity in each centrosome is increased due to recruitment of γ-tubulin. Replicated centrosomes from interphase move apart towards opposite poles of the cell, powered by centrosome associated motor proteins. Interdigitated interpolar microtubules from each centrosome interact with each other, helping to move the centrosomes to opposite poles. Formation of the mitotic spindle Microtubules involved in the interphase scaffolding break down as the replicated centrosomes separate. The movement of centrosomes to opposite poles is accompanied in animal cells by the organization of individual radial microtubule arrays (asters) by each centriole. Interpolar microtubules from both centrosomes interact, joining the sets of microtubules and forming the basic structure of the mitotic spindle. Plant cells do not have centrosomes and the chromosomes can nucleate microtubule assembly into the mitotic apparatus. In plant cells, microtubules gather at opposite poles and begin to form the spindle apparatus at locations called foci. The mitotic spindle is of great importance in the process of mitosis and will eventually segregate the sister chromatids in metaphase. Beginning of nucleoli breakdown The nucleoli begin to break down in prophase, resulting in the discontinuation of ribosome production. This indicates a redirection of cellular energy from general cellular metabolism to cellular division. The nuclear envelope stays intact during this process. Meiotic prophase Meiosis involves two rounds of chromosome segregation and thus undergoes prophase twice, resulting in prophase I and prophase II. Prophase I is the most complex phase in all of meiosis because homologous chromosomes must pair and exchange genetic information.: 98  Prophase II is very similar to mitotic prophase. Prophase I Prophase I is divided into five phases: leptotene, zygotene, pachytene, diplotene, and diakinesis. In addition to the events that occur in mitotic prophase, several crucial events occur within these phases such as pairing of homologous chromosomes and the reciprocal exchange of genetic material between these homologous chromosomes. Prophase I occurs at different speeds dependent on species and sex. Many species arrest meiosis in diplotene of prophase I until ovulation.: 98  In humans, decades can pass as oocytes remain arrested in prophase I only to quickly complete meiosis I prior to ovulation. Leptotene In the first stage of prophase I, leptotene (from the Greek for "delicate"), chromosomes begin to condense. Each chromosome is in a diploid state and consists of two sister chromatids; however, the chromatin of the sister chromatids is not yet condensed enough to be resolvable in microscopy.: 98  Homologous regions within homologous chromosome pairs begin to associate with each other. Zygotene In the second phase of prophase I, zygotene (from the Greek for "conjugation"), all maternally and paternally derived chromosomes have found their homologous partner.: 98  The homologous pairs then undergo synapsis, a process by which the synaptonemal complex (a proteinaceous structure) aligns corresponding regions of genetic information on maternally and paternally derived non-sister chromatids of homologous chromosome pairs.: 98  The paired homologous chromosome bound by the synaptonemal complex are referred to as bivalents or tetrads.: 98  Sex (X and Y) chromosomes do not fully synapse because only a small region of the chromosomes are homologous.: 98 The nucleolus moves from a central to a peripheral position in the nucleus. Pachytene The third phase of prophase I, pachytene (from the Greek for "thick"), begins at the completion of synapsis.: 98  Chromatin has condensed enough that chromosomes can now be resolved in microscopy. Structures called recombination nodules form on the synaptonemal complex of bivalents. These recombination nodules facilitate genetic exchange between the non-sister chromatids of the synaptonemal complex in an event known as crossing-over or genetic recombination.: 98  Multiple recombination events can occur on each bivalent. In humans, an average of 2-3 events occur on each chromosome.: 681 Diplotene In the fourth phase of prophase I, diplotene (from the Greek for "twofold"), crossing-over is completed.: 99  Homologous chromosomes retain a full set of genetic information; however, the homologous chromosomes are now of mixed maternal and paternal descent.: 99  Visible junctions called chiasmata hold the homologous chromosomes together at locations where recombination occurred as the synaptonemal complex dissolves.: 99  It is at this stage where meiotic arrest occurs in many species.: 99 Diakinesis In the fifth and final phase of prophase I, diakinesis (from the Greek for "double movement"), full chromatin condensation has occurred and all four sister chromatids can be seen in bivalents with microscopy. The rest of the phase resemble the early stages of mitotic prometaphase, as the meiotic prophase ends with the spindle apparatus beginning to form, and the nuclear membrane beginning to break down.: 99 Prophase II Prophase II of meiosis is very similar to prophase of mitosis. The most noticeable difference is that prophase II occurs with a haploid number of chromosomes as opposed to the diploid number in mitotic prophase. In both animal and plant cells chromosomes may de-condense during telophase I requiring them to re-condense in prophase II.: 100  If chromosomes do not need to re-condense, prophase II often proceeds very quickly as is seen in the model organism Arabidopsis. Prophase I arrest Female mammals and birds are born possessing all the oocytes needed for future ovulations, and these oocytes are arrested at the prophase I stage of meiosis. In humans, as an example, oocytes are formed between three and four months of gestation within the fetus and are therefore present at birth. During this prophase I arrested stage (dictyate), which may last for decades, four copies of the genome are present in the oocytes. The adaptive significance of prophase I arrest is still not fully understood. However, it has been proposed that the arrest of oocytes at the four genome copy stage may provide the informational redundancy needed to repair damage in the DNA of the germline. The repair process used appears to be homologous recombinational repair Prophase arrested oocytes have a high capability for efficient repair of DNA damages. DNA repair capability appears to be a key quality control mechanism in the female germ line and a critical determinant of fertility. Differences in plant and animal cell prophase The most notable difference between prophase in plant cells and animal cells occurs because plant cells lack centrioles. The organization of the spindle apparatus is associated instead with foci at opposite poles of the cell or is mediated by chromosomes. Another notable difference is preprophase, an additional step in plant mitosis that results in formation of the preprophase band, a structure composed of microtubules. In mitotic prophase I of plants, this band disappears. Cell checkpoints Prophase I in meiosis is the most complex iteration of prophase that occurs in both plant cells and animal cells. To ensure pairing of homologous chromosomes and recombination of genetic material occurs properly, there are cellular checkpoints in place. The meiotic checkpoint network is a DNA damage response system that controls double strand break repair, chromatin structure, and the movement and pairing of chromosomes. The system consists of multiple pathways (including the meiotic recombination checkpoint) that prevent the cell from entering metaphase I with errors due to recombination. See also Prometaphase Metaphase Anaphase Telophase Meiosis Mitosis Cytoskeleton Homologous chromosome References External links Media related to Prophase at Wikimedia Commons

Pseudoallelism is a state in which two genes with similar functions are located so close to one another on a chromosome that they are genetically linked. This means that the two genes (pseudoalleles) are nearly always inherited together. Since the two genes have related functions, they may appear to act as a single gene. In rare cases, the two linked pseudoalleles can be separated, or recombined. One hypothesis is that pseudoalleles are formed as a result of gene duplication events, and the duplicated genes can undergo gene evolution to develop new functions. Characteristic of pseudoalleles: These are closely linked allele within which crossing over occur. They affect the same character.Example: Red eye colour of Drosophila has different mutants like white and apricot. They affect pigmentation i.e., affect the same character. So, they are allelic. They can undergo recombination, i.e., they are nonallelic. == References ==

In genetics, pseudolinkage is a characteristic of a heterozygote for a reciprocal translocation, in which genes located near the translocation breakpoint behave as if they are linked even though they originated on nonhomologous chromosomes. Linkage is the proximity of two or more markers on a chromosome; the closer together the markers are, the lower the probability that they will be separated by recombination. Genes are said to be linked when the frequency of parental type progeny exceeds that of recombinant progeny. Not occur in translocation homozygote During meiosis in a translocation homozygote, chromosomes segregate normally according to Mendelian principles. Even though the genes have been rearranged during crossover, both haploid sets of chromosomes in the individual have the same rearrangement. As a result, all chromosomes will find a single partner with which to pair at meiosis, and there will be no deleterious consequences for the progeny. In translocation heterozygote In translocation heterozygote, however, certain patterns of chromosome segregation during meiosis produce genetically unbalanced gametes that at fertilization become deleterious to the zygote. In a translocation heterozygote, the two haploid sets of chromosomes do not carry the same arrangement of genetic information. As a result, during prophase of the first meiotic division, the translocated chromosomes and their normal homologs assume a crosslike configuration in which four chromosomes, rather than the normal two, pair to achieve a maximum of synapsis between similar regions. We denote the chromosomes carrying translocated material with a T and the chromosomes with a normal order of genes with an N. Chromosomes N1 and T1 have homologous centromeres found in wild type on chromosome 1; N2 and T2 have centromeres found in wild type on chromosome 2. During anaphase of meiosis I, the mechanisms that attach the spindle to the chromosomes in this crosslike configuration still usually ensure the disjunction of homologous centromeres, bringing homologous chromosomes to opposite spindle poles. Depending on the arrangement of the four chromosomes on the metaphase plate, this normal disjunction of homologous produces one of two equally likely patterns of segregation. Alternate segregation pattern In the alternate segregation pattern, the two translocation chromosomes (T1 and T2) go to one pole, while the two normal chromosomes (N1 and N2) move to the opposite pole. Both kinds of gametes resulting from this segregation (T1, T2, and N1, N2) carry the correct haploid number of genes; and the zygotes formed by union of these gametes with normal gamete will be viable. Adjacent-1 segregation pattern In the adjacent-1 segregation pattern, homologous centromeres disjoin so that T1 and N2 go to one pole, while the N1 and T2 go to the opposite pole. Consequently, each gamete contains a large duplication (of the region found in both the normal and the translocated chromosome in that gamete) and a correspondingly large deletion (of the region found in neither of the chromosomes in that gametes), which make them genetically unbalanced. Zygotes formed by union of these gametes with a normal gametes are usually not viable. Adjacent-2 segregation pattern Because of the unusual cruciform pairing configuration in translocation heterozygotes, nondisjunction of homologous centromeres occurs at a measurable but low rate. This nondisjunction produces an adjacent-2 segregation pattern in which the homologous centromeres N1 and T1 go to the same spindle pole while the homologous centromeres N2 and T2 go to the other spindle pole. The resulting genetic imbalances are lethal after fertilization to the zygotes containing them. Thus, in a translocation heterozygote, only the alternate segregation pattern yields viable progeny in outcrosses, the equally likely adjacent-1 pattern and the rare adjacent-2 pattern do not. Because of this, genes near the translocation breakpoints on the nonhomologous chromosomes participating in a reciprocal translocation exhibit pseudolinkage: They behave as if they are linked. == References ==

Reassortment is the mixing of the genetic material of a species into new combinations in different individuals. Several different processes contribute to reassortment, including assortment of chromosomes, and chromosomal crossover. It is particularly used when two similar viruses that are infecting the same cell exchange genetic material. In particular, reassortment occurs among influenza viruses, whose genomes consist of eight distinct segments of RNA. These segments act like mini-chromosomes, and each time a flu virus is assembled, it requires one copy of each segment. If a single host (a human, a chicken, or other animal) is infected by two different strains of the influenza virus, then it is possible that new assembled viral particles will be created from segments whose origin is mixed, some coming from one strain and some coming from another. The new reassortant strain will share properties of both of its parental lineages. Reassortment is responsible for some of the major genetic shifts in the history of the influenza virus. In the 1957 "Asian flu" and 1968 "Hong Kong flu" pandemics, flu strains were caused by reassortment between an avian virus and a human virus. In addition, the H1N1 virus responsible for the 2009 swine flu pandemic has an unusual mix of swine, avian and human influenza genetic sequences.The reptarenavirus family, responsible for inclusion body disease in snakes, shows a very high degree of genetic diversity due to reassortment of genetic material from multiple strains in the same infected animal. Multiplicity reactivation When influenza viruses are inactivated by UV irradiation or ionizing radiation, they remain capable of multiplicity reactivation in infected host cells. If any of a virus's genome segments is damaged in such a way as to prevent replication or expression of an essential gene, the virus is inviable when it, alone, infects a host cell (single infection). However, when two or more damaged viruses infect the same cell (multiple infection), the infection can often succeed (multiplicity reactivation) due to reassortment of segments, provided that each of the eight genome segments is present in at least one undamaged copy. See also Other kinds of nonhereditary genetic change Antigenic shift Horizontal gene transfer References History of April-2009 flu collected by Bionyt. External links An animation from hhmi.org illustrating the process Archived 2005-11-23 at the Wayback Machine Hood E (February 2006). "Flu Vaccine Production Gets a Shot in the Arm". Environ Health Perspect. 114 (2): A108–11. doi:10.1289/ehp.114-a108. PMC 1367863. PMID 16451835. Simon-Loriere, Etienne; Holmes, Edward C. (2011). "Why do RNA viruses recombine?". Nature Reviews Microbiology. 9 (8): 617–626. doi:10.1038/nrmicro2614. PMC 3324781. PMID 21725337. Offers a good introduction with figures on the concept of reassortment (as well as recombination).

A reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. Reverse transcriptases are used by viruses such as HIV and hepatitis B to replicate their genomes, by retrotransposon mobile genetic elements to proliferate within the host genome, and by eukaryotic cells to extend the telomeres at the ends of their linear chromosomes. Contrary to a widely held belief, the process does not violate the flows of genetic information as described by the classical central dogma, as transfers of information from RNA to DNA are explicitly held possible.Retroviral RT has three sequential biochemical activities: RNA-dependent DNA polymerase activity, ribonuclease H (RNase H), and DNA-dependent DNA polymerase activity. Collectively, these activities enable the enzyme to convert single-stranded RNA into double-stranded cDNA. In retroviruses and retrotransposons, this cDNA can then integrate into the host genome, from which new RNA copies can be made via host-cell transcription. The same sequence of reactions is widely used in the laboratory to convert RNA to DNA for use in molecular cloning, RNA sequencing, polymerase chain reaction (PCR), or genome analysis. History Reverse transcriptases were discovered by Howard Temin at the University of Wisconsin–Madison in Rous sarcoma virions and independently isolated by David Baltimore in 1970 at MIT from two RNA tumour viruses: murine leukemia virus and again Rous sarcoma virus. For their achievements, they shared the 1975 Nobel Prize in Physiology or Medicine (with Renato Dulbecco). Well-studied reverse transcriptases include: HIV-1 reverse transcriptase from human immunodeficiency virus type 1 (PDB: 1HMV​) has two subunits, which have respective molecular weights of 66 and 51 kDas. M-MLV reverse transcriptase from the Moloney murine leukemia virus is a single 75 kDa monomer. AMV reverse transcriptase from the avian myeloblastosis virus also has two subunits, a 63 kDa subunit and a 95 kDa subunit. Telomerase reverse transcriptase that maintains the telomeres of eukaryotic chromosomes. Function in viruses The enzymes are encoded and used by viruses that use reverse transcription as a step in the process of replication. Reverse-transcribing RNA viruses, such as retroviruses, use the enzyme to reverse-transcribe their RNA genomes into DNA, which is then integrated into the host genome and replicated along with it. Reverse-transcribing DNA viruses, such as the hepadnaviruses, can allow RNA to serve as a template in assembling and making DNA strands. HIV infects humans with the use of this enzyme. Without reverse transcriptase, the viral genome would not be able to incorporate into the host cell, resulting in failure to replicate. Process of reverse transcription or retrotranscription Reverse transcriptase creates double-stranded DNA from an RNA template. In virus species with reverse transcriptase lacking DNA-dependent DNA polymerase activity, creation of double-stranded DNA can possibly be done by host-encoded DNA polymerase δ, mistaking the viral DNA-RNA for a primer and synthesizing a double-stranded DNA by a similar mechanism as in primer removal, where the newly synthesized DNA displaces the original RNA template.The process of reverse transcription, also called retrotranscription or retrotras, is extremely error-prone, and it is during this step that mutations may occur. Such mutations may cause drug resistance. Retroviral reverse transcription Retroviruses, also referred to as class VI ssRNA-RT viruses, are RNA reverse-transcribing viruses with a DNA intermediate. Their genomes consist of two molecules of positive-sense single-stranded RNA with a 5' cap and 3' polyadenylated tail. Examples of retroviruses include the human immunodeficiency virus (HIV) and the human T-lymphotropic virus (HTLV). Creation of double-stranded DNA occurs in the cytosol as a series of these steps: Lysyl tRNA acts as a primer and hybridizes to a complementary part of the virus RNA genome called the primer binding site or PBS. Reverse transcriptase then adds DNA nucleotides onto the 3' end of the primer, synthesizing DNA complementary to the U5 (non-coding region) and R region (a direct repeat found at both ends of the RNA molecule) of the viral RNA. A domain on the reverse transcriptase enzyme called RNAse H degrades the U5 and R regions on the 5’ end of the RNA. The tRNA primer then "jumps" to the 3’ end of the viral genome, and the newly synthesised DNA strands hybridizes to the complementary R region on the RNA. The complementary DNA (cDNA) added in (2) is further extended. The majority of viral RNA is degraded by RNAse H, leaving only the PP sequence. Synthesis of the second DNA strand begins, using the remaining PP fragment of viral RNA as a primer. The tRNA primer leaves and a "jump" happens. The PBS from the second strand hybridizes with the complementary PBS on the first strand. Both strands are extended to form a complete double-stranded DNA copy of the original viral RNA genome, which can then be incorporated into the host's genome by the enzyme integrase.Creation of double-stranded DNA also involves strand transfer, in which there is a translocation of short DNA product from initial RNA-dependent DNA synthesis to acceptor template regions at the other end of the genome, which are later reached and processed by the reverse transcriptase for its DNA-dependent DNA activity.Retroviral RNA is arranged in 5’ terminus to 3’ terminus. The site where the primer is annealed to viral RNA is called the primer-binding site (PBS). The RNA 5’end to the PBS site is called U5, and the RNA 3’ end to the PBS is called the leader. The tRNA primer is unwound between 14 and 22 nucleotides and forms a base-paired duplex with the viral RNA at PBS. The fact that the PBS is located near the 5’ terminus of viral RNA is unusual because reverse transcriptase synthesize DNA from 3’ end of the primer in the 5’ to 3’ direction (with respect to the newly synthesized DNA strand). Therefore, the primer and reverse transcriptase must be relocated to 3’ end of viral RNA. In order to accomplish this reposition, multiple steps and various enzymes including DNA polymerase, ribonuclease H(RNase H) and polynucleotide unwinding are needed.The HIV reverse transcriptase also has ribonuclease activity that degrades the viral RNA during the synthesis of cDNA, as well as DNA-dependent DNA polymerase activity that copies the sense cDNA strand into an antisense DNA to form a double-stranded viral DNA intermediate (vDNA). The HIV viral RNA structural elements regulate the progression of reverse transcription. In cellular life Self-replicating stretches of eukaryotic genomes known as retrotransposons utilize reverse transcriptase to move from one position in the genome to another via an RNA intermediate. They are found abundantly in the genomes of plants and animals. Telomerase is another reverse transcriptase found in many eukaryotes, including humans, which carries its own RNA template; this RNA is used as a template for DNA replication.Initial reports of reverse transcriptase in prokaryotes came as far back as 1971 in France (Beljanski et al., 1971a, 1972) and a few years later in the USSR (Romashchenko 1977). These have since been broadly described as part of bacterial Retrons, distinct sequences that code for reverse transcriptase, and are used in the synthesis of msDNA. In order to initiate synthesis of DNA, a primer is needed. In bacteria, the primer is synthesized during replication.Valerian Dolja of Oregon State argues that viruses, due to their diversity, have played an evolutionary role in the development of cellular life, with reverse transcriptase playing a central role. Structure The reverse transcriptase employs a "right hand" structure similar to that found in other viral nucleic acid polymerases. In addition to the transcription function, retroviral reverse transcriptases have a domain belonging to the RNase H family, which is vital to their replication. By degrading the RNA template, it allows the other strand of DNA to be synthesized. Some fragments from the digestion also serve as the primer for the DNA polymerase (either the same enzyme or a host protein), responsible for making the other (plus) strand. Replication fidelity There are three different replication systems during the life cycle of a retrovirus. The first process is the reverse transcriptase synthesis of viral DNA from viral RNA, which then forms newly made complementary DNA strands. The second replication process occurs when host cellular DNA polymerase replicates the integrated viral DNA. Lastly, RNA polymerase II transcribes the proviral DNA into RNA, which will be packed into virions. Mutation can occur during one or all of these replication steps.Reverse transcriptase has a high error rate when transcribing RNA into DNA since, unlike most other DNA polymerases, it has no proofreading ability. This high error rate allows mutations to accumulate at an accelerated rate relative to proofread forms of replication. The commercially available reverse transcriptases produced by Promega are quoted by their manuals as having error rates in the range of 1 in 17,000 bases for AMV and 1 in 30,000 bases for M-MLV.Other than creating single-nucleotide polymorphisms, reverse transcriptases have also been shown to be involved in processes such as transcript fusions, exon shuffling and creating artificial antisense transcripts. It has been speculated that this template switching activity of reverse transcriptase, which can be demonstrated completely in vivo, may have been one of the causes for finding several thousand unannotated transcripts in the genomes of model organisms. Template switching Two RNA genomes are packaged into each retrovirus particle, but, after an infection, each virus generates only one provirus. After infection, reverse transcription is accompanied by template switching between the two genome copies (copy choice recombination). There are two models that suggest why RNA transcriptase switches templates. The first, the forced copy-choice model, proposes that reverse transcriptase changes the RNA template when it encounters a nick, implying that recombination is obligatory to maintaining virus genome integrity. The second, the dynamic choice model, suggests that reverse transcriptase changes templates when the RNAse function and the polymerase function are not in sync rate-wise, implying that recombination occurs at random and is not in response to genomic damage. A study by Rawson et al. supported both models of recombination. From 5 to 14 recombination events per genome occur at each replication cycle. Template switching (recombination) appears to be necessary for maintaining genome integrity and as a repair mechanism for salvaging damaged genomes. Applications Antiviral drugs As HIV uses reverse transcriptase to copy its genetic material and generate new viruses (part of a retrovirus proliferation circle), specific drugs have been designed to disrupt the process and thereby suppress its growth. Collectively, these drugs are known as reverse-transcriptase inhibitors and include the nucleoside and nucleotide analogues zidovudine (trade name Retrovir), lamivudine (Epivir) and tenofovir (Viread), as well as non-nucleoside inhibitors, such as nevirapine (Viramune). Molecular biology Reverse transcriptase is commonly used in research to apply the polymerase chain reaction technique to RNA in a technique called reverse transcription polymerase chain reaction (RT-PCR). The classical PCR technique can be applied only to DNA strands, but, with the help of reverse transcriptase, RNA can be transcribed into DNA, thus making PCR analysis of RNA molecules possible. Reverse transcriptase is used also to create cDNA libraries from mRNA. The commercial availability of reverse transcriptase greatly improved knowledge in the area of molecular biology, as, along with other enzymes, it allowed scientists to clone, sequence, and characterise RNA. See also cDNA library DNA polymerase msDNA Reverse transcribing virus RNA polymerase Telomerase Retrotransposon marker References External links RNA+Transcriptase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) animation of reverse transcriptase action and three reverse transcriptase inhibitors Molecule of the month (September 2002) at the RCSB PDB HIV Replication 3D Medical Animation. (Nov 2008). Video by Boehringer Ingelheim. Goodsell DS. "Molecule of the Month: Reverse Transcriptase (Sep 2002)". Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB). Retrieved 2013-01-13. Overview of all the structural information available in the PDB for UniProt: P03366 (Human immunodeficiency virus Reverse transcriptase) at the PDBe-KB. TWiV 904: 50 years of reverse transcriptase Vincent Racaniello travels to Cold Spring Harbor Laboratory to speak with David Baltimore, John Coffin (scientist), and Harold Varmus about the discovery in 1970 of retroviral reverse transcriptase and its impact on life sciences research.

Revive & Restore is a nonprofit wildlife conservation organization focused on use of biotechnology in conservation. Headquartered in Sausalito, California, the organization's mission is to enhance biodiversity through the genetic rescue of endangered and extinct species. The organization was founded by Stewart Brand and his wife, Ryan Phelan. Revive & Restore has created a "Genetic Rescue Toolkit" for wildlife conservation – a suite of biotechnology tools adapted from human medicine and commercial agriculture that can improve wildlife conservation outcomes. The toolkit includes biobanking and cell culturing, genetic sequencing, and advanced reproductive technologies, such as cloning. The toolkit complements traditional conservation practices, such as captive breeding and habitat restoration.Revive & Restore has caused controversy. In particular, Brand's work in de-extinction has been characterized as "playing god" and criticized for taking time and money away from traditional conservation efforts. In addition, many are concerned by the concept of cloning, even in the context of conservation. History Revive & Restore was co-founded in 2012 by Stewart Brand and Ryan Phelan with the idea of bringing biotechnology solutions to conservation. The group was incubated by the Long Now Foundation until 2017, when it became an independent 501(c)(3) organization. In 2013 Revive & Restore organized the first public meeting on de-extinction. Their founding projects include the de-extinction of the passenger pigeon, heath hen, and woolly mammoth. Since then, Revive & Restore has established partnerships with research institutions, governmental agencies, and conservation organizations on a broad range of genetic rescue programs.Revive & Restore is a member of the International Union for Conservation of Nature (IUCN) and has long-standing partnerships with the US Fish & Wildlife Service, The San Diego Zoo Wildlife Alliance, Morris Animal Foundation, and ViaGen Pets & Equine, among others. Programs Advanced Coral Toolkit The Advanced Coral Toolkit supports research teams in the development and field testing of biotechnologies that benefit coral reef management and restoration efforts. Projects include coral cryopreservation methods for large scale biobanking and fieldable devices for measuring genetic information or molecular signals associated with coral stress. Launched in 2019, the program has funded 10 research teams. Wild Genomes Wild Genomes is a funding program to provide genomic tools to field scientists, wildlife managers, and citizens working to protect their local biodiversity. As of 2023, Wild Genomes has funded 30 individual projects. Program categories include Terrestrial Species, Marine Species, Amphibians, and Kelp Ecosystems Cloning for conservation To help mitigate inbreeding depression for two endangered species, the black-footed ferret (Mustela nigripes) and Przewalski's horse (Equus ferus przewalskii), Revive & Restore facilitates on-going efforts to clone individuals from historic cell lines stored at the San Diego Zoo Wildlife Alliance Frozen Zoo. On December 10, 2020, the world's first cloned black-footed ferret was born. This ferret, named Elizabeth Ann, marked the first time a U.S. endangered species was successfully cloned.On August 6, 2020, the world's first cloned Przewalski’s horse was born. Since the oocyte used was from a domestic horse, this was an example of interspecies somatic cell nuclear transfer (SCNT). In 2022, the horse, named Kurt, was paired with a female Przewalski's horse at the San Diego Zoo Wildlife Safari Park to learn the behaviors of his species. On February 17, 2023, a second cloned Przewalski's horse was born from the same historic cell line. Kurt and the new foal are genetic twins that may become the first cloned animals to restore lost genetic variation to their species. Intended Consequences Initiative In 2020, Revive & Restore developed a campaign around the concept of "Intended Consequences" – focusing on the benefits of conservation interventions, as opposed to focusing on the fears of unintended consequences. That year, Revive & Restore hosted a virtual workshop that resulted in the publication of a special issue in the journal Conservation Science and Practice. References External links Official website

Right To Know is a non profit support project for those who discover via genealogical genetic testing that their lineage is not what they had supposed it to be due to family secrets and misattributed parentage, thus raising existential issues of adoption, race, ethnicity, culture, rape, etc. See also Genealogy Genetic testing External links Right To Know - Your Genetic Identity == References ==

The scleraxis protein is a member of the basic helix-loop-helix (bHLH) superfamily of transcription factors. Currently two genes (SCXA and SCXB respectively) have been identified to code for identical scleraxis proteins. Function It is thought that early scleraxis-expressing progenitor cells lead to the eventual formation of tendon tissue and other muscle attachments. Scleraxis is involved in mesoderm formation and is expressed in the syndetome (a collection of embryonic tissue that develops into tendon and blood vessels) of developing somites (primitive segments or compartments of embryos). Inducing scleraxis expression The syndetome location within the somite is determined by FGF secreted from the center of the myotome (a collection of embryonic tissue that develops into skeletal muscle)- the FGF then induces the adjacent anterior and posterior sclerotome (a collection of embryonic tissue that develops into the axial skeleton) to adopt a tendon cell fate. This ultimately places future scleraxis-expressing cells between the two tissue types they will ultimately join. Scleraxis expression will be seen throughout the entire sclerotome (rather than just the sclerotome directly anterior and posterior to the myotome) with an overexpression of FGF8, demonstrating that all sclerotome cells are capable of expressing scleraxis in response to FGF signaling. While the FGF interaction has been shown to be necessary for scleraxis expression, it is still unclear as to whether the FGF signaling pathway directly induces the syndetome to secrete scleraxis, or indirectly through a secondary signaling pathway. Most likely, the syndetomal cells, through careful reading of the FGF concentration (coming from the myotome), can precisely determine their location and begin expressing scleraxis. Much of embryonic development follows this model of inducing specific cell fates through the reading of surrounding signaling molecule concentration gradients. Background bHLH transcription factors have been shown to have a wide array of functions in developmental processes. More precisely, they have critical roles in the control of cellular differentiation, proliferation and regulation of oncogenesis. To date, 242 eukaryotic proteins belonging to the HLH superfamily have been reported. They have varied expression patterns in all eukaryotes from yeast to humans.Structurally, bHLH proteins are characterised by a “highly conserved domain containing a stretch of basic amino acids adjacent to two amphipathic α-helices separated by a loop”.These helices have important functional properties, forming part of the DNA binding and transcription activating domains. With respect to scleraxis, the bHLH region spans amino acid residues 78 to 131. A proline rich region is also predicted to lie between residues 161–170. A stretch of basic residues, which aids in DNA binding, is found closer to the N terminal end of scleraxis.HLH proteins that lack this basic domain have been shown to negatively regulate the activities of bHLH proteins and are called inhibitors of differentiation (Id). Basic HLH proteins function normally as dimers and bind to a specific hexanucleotide DNA sequence (CAANTG) known as an E-box thus switching on the expression of various genes involved in cellular development and survival. == References ==

Ahna Renee Skop is an American geneticist, artist, and a professor at the University of Wisconsin–Madison. She is known for her research on the mechanisms underlying asymmetric cell division, particularly the importance of the midbody in this process. Education Skop grew up in New Haven, Connecticut and Fort Thomas, Kentucky. She graduated from Highlands High School in Fort Thomas, Ky before receiving a Bachelor of Science in biology and a minor in Ceramics from Syracuse University and went on to complete her Ph.D. in cellular and molecular biology at the University of Wisconsin-Madison. She then did postdoctoral work at the University of California, Berkeley in the laboratories of Rebecca Heald, Barbara Meyer and John Yates (Scripps). Skop then moved back to the University of Wisconsin–Madison in 2004, where, as of 2011, is a Full Professor of Genetics. Career Skop is known for her work on Caenorhabditis elegans, a free-living worm, and mammalian tissue culture cells where she has studied the mechanisms that control cell division. Her early work was on the final stages of cell division in C. elegans, and she identified the proteins in the midbody that are involved in cell division. Her more recent work examines defects that could be caused by problems in the midbody, where she has shown that midbody is an organelle that harbors translationally active RNA. Artistic career Skop has curated a scientific art show at the International C. elegans meeting, the "Worm Art Show", and she worked with a Madison, Wisconsin artist, Angela Johnson to create an art installation called "Genetic Reflections". Select publications Skop, Ahna R.; Bergmann, Dominique; Mohler, William A.; White, John G. (2001-05-15). "Completion of cytokinesis in C. elegans requires a brefeldin A-sensitive membrane accumulation at the cleavage furrow apex". Current Biology. 11 (10): 735–746. doi:10.1016/S0960-9822(01)00231-7. ISSN 0960-9822. PMC 3733387. PMID 11378383. Skop, Ahna R.; Liu, Hongbin; Yates, John; Meyer, Barbara J.; Heald, Rebecca (2004-07-02). "Dissection of the Mammalian Midbody Proteome Reveals Conserved Cytokinesis Mechanisms". Science. 305 (5680): 61–66. Bibcode:2004Sci...305...61S. doi:10.1126/science.1097931. ISSN 0036-8075. PMC 3679889. PMID 15166316. Skop, Ahna R.; White, John G. (1998-10-08). "The dynactin complex is required for cleavage plane specification in early Caenorhabditis elegans embryos". Current Biology. 8 (20): 1110–1117. doi:10.1016/S0960-9822(98)70465-8. ISSN 0960-9822. PMC 3690630. PMID 9778526. Thompson, Heather M.; Skop, Ahna R.; Euteneuer, Ursula; Meyer, Barbara J.; McNiven, Mark A. (2002-12-23). "The Large GTPase Dynamin Associates with the Spindle Midzone and Is Required for Cytokinesis". Current Biology. 12 (24): 2111–2117. doi:10.1016/S0960-9822(02)01390-8. ISSN 0960-9822. PMC 3690653. PMID 12498685. Otegui, Marisa S.; Verbrugghe, Koen J.; Skop, Ahna R. (2005-08-01). "Midbodies and phragmoplasts: analogous structures involved in cytokinesis". Trends in Cell Biology. 15 (8): 404–413. doi:10.1016/j.tcb.2005.06.003. ISSN 0962-8924. PMC 3677513. PMID 16009554. Honors and awards Skop was a 2006 Presidential Early Career Award for Scientists and Engineers award winner. In 2009 Skop received an honorary Doctorate of Science from the College of Saint Benedict, and in 2018 Skop was awarded by the American Society for Cell Biology for her work in inclusivity, the first time this prize was given. References External links Ahna Skop publications indexed by Google Scholar

A SNPSTR is a compound genetic marker composed of one or more SNPs and one microsatellite (STR). Autosomal SNPSTRs, which contain an SNP and a microsatellite within 500 base pairs of one another, were discovered in 2002. More recently a database that contains all SNPSTRs in five model genomes, including human, has been created. Usage and importance There has been widespread and growing interest in genetic markers suitable for drawing population genetic inferences about past demographic events and to detect the effects of selection. Single nucleotide polymorphisms (SNPs) and microsatellites (or short tandem repeats, STRs) have received great attention in the analysis of human population history, even though they have both disadvantages. It was thus suggested that the combination of these two markers could give rise to better conclusions. See also Population genetics Biological database Earth Human STR Allele Frequencies Database STR analysis STR multiplex system Y-STR == References ==

The staggered extension process (also referred to as StEP) is a common technique used in biotechnology and molecular biology to create new, mutated genes with qualities of one or more initial genes. The technique itself is a modified polymerase chain reaction with very short (approximately 10 seconds) cycles. In these cycles the elongation of DNA is very quick (only a few hundred base pairs) and synthesized fragments anneal with complementary fragments of other strands. In this way, mutations of the initial genes are shuffled and in the end genes with new combinations of mutations are amplified.The StEP protocol has been found to be useful as a method of directed evolution for the discovery of enzymes useful to industry. == References ==

The Strawberry Roan or Strawberry Roan may refer to: Red or “strawberry” roan, a horse coat color Strawberry Roan (1933 film), an American western film Strawberry Roan, a 1932 novel by A. G. Street Strawberry Roan (1945 film), a British drama based on the novel The Strawberry Roan, a 1948 American western film The Strawberry Roan (song), an American cowboy song